data_2jzq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jzq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.474 ' CA ' HG21 ' A' ' 46' ' ' ILE . 10.7 m-20 -63.23 93.62 0.07 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.407 -0.808 . . . . 0.0 109.178 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.511 ' N ' HG22 ' A' ' 46' ' ' ILE . 1.4 pt20 -130.13 175.12 9.16 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.179 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.579 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 34.9 m-70 -92.94 108.57 20.11 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.559 ' N ' ' O ' ' A' ' 42' ' ' CYS . 1.1 tp -111.75 126.47 55.09 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.091 -1.006 . . . . 0.0 111.022 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 11' ' ' LEU . 72.8 m -108.49 168.47 9.3 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.28 -45.65 0.1 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 12' ' ' VAL . 12.8 m -60.63 -69.8 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -1.189 . . . . 0.0 109.977 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.525 ' CB ' ' HG ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -66.42 -13.9 61.4 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 120.825 -1.172 . . . . 0.0 108.203 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -67.27 -49.64 63.54 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.269 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.614 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -64.75 -28.97 46.05 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.422 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.496 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 5.1 mt-10 -69.4 -59.82 2.74 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.543 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -52.82 -48.68 66.79 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.57 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.3 mt -63.13 -40.96 99.09 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.614 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.3 t80 -61.73 -21.42 64.49 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.18 -61.59 1.71 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.23 1.014 . . . . 0.0 108.47 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.579 ' CG1' ' HB3' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -54.46 -33.6 26.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.088 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -86.3 -65.05 1.05 Allowed 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.365 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.44 -72.12 0.23 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -130.32 -1.34 4.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -1.189 . . . . 0.0 109.808 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -72.8 -12.03 60.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.122 -0.986 . . . . 0.0 109.441 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 75.95 97.58 0.14 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.529 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -94.17 -176.82 4.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -1.163 . . . . 0.0 109.247 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.566 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 16.8 p90 -162.6 172.85 14.75 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.473 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.84 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.613 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 111.343 0.127 . . . . 0.0 111.343 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.93 -44.51 13.56 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 106.286 -2.726 . . . . 0.0 106.286 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.626 HG12 ' CD2' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -93.52 -60.11 2.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 122.487 1.137 . . . . 0.0 108.399 177.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.469 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 23.6 t -51.05 -35.06 14.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.738 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.671 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 42.6 mt-10 -92.02 -20.45 21.32 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.83 -1.169 . . . . 0.0 109.593 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.557 ' O ' ' N ' ' A' ' 45' ' ' SER . 5.1 tp60 -86.21 -87.18 0.14 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.406 -0.809 . . . . 0.0 109.86 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.559 ' O ' ' N ' ' A' ' 6' ' ' LEU . 22.7 m -39.34 -41.09 0.87 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.618 -0.676 . . . . 0.0 109.694 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 6' ' ' LEU . 9.8 t -68.95 -53.46 20.68 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.911 -1.118 . . . . 0.0 110.948 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.671 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 13.8 m-70 -85.18 -47.53 10.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.032 -1.043 . . . . 0.0 110.015 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 41' ' ' GLN . 29.0 t -100.78 -124.82 0.17 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 108.916 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.579 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -157.93 163.05 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.754 -1.217 . . . . 0.0 109.135 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.524 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -158.76 168.97 25.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.459 -0.775 . . . . 0.0 109.571 179.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -119.18 163.59 16.85 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.114 0.959 . . . . 0.0 109.527 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 53' ' ' GLU . 25.1 mt -42.53 -33.71 0.73 Allowed 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 121.497 0.665 . . . . 0.0 109.637 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.594 ' CE1' ' HG2' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -56.99 -37.26 71.41 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.594 ' HG2' ' CE1' ' A' ' 50' ' ' TYR . 2.0 mm-40 -69.62 -59.78 2.74 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.463 ' HB3' ' HG ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -62.02 -16.86 54.78 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.6 tm-20 -68.05 -24.2 65.05 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -91.05 -24.87 19.91 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.752 0.787 . . . . 0.0 108.911 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.626 ' CD2' HG12 ' A' ' 38' ' ' ILE . 17.0 m-85 -81.06 4.18 20.66 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.566 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -83.07 -164.66 0.91 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.395 -0.816 . . . . 0.0 109.63 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 4.1 p-10 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.793 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 3' ' ' ASN . 4.6 m . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.557 0.694 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.448 ' HA ' ' CG2' ' A' ' 46' ' ' ILE . 28.3 m120 -41.71 99.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.995 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.531 ' N ' HG23 ' A' ' 46' ' ' ILE . 4.2 tt0 -148.7 166.46 28.31 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.408 -0.808 . . . . 0.0 109.66 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.578 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 24.1 m-70 -91.79 113.86 26.24 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.587 ' CD2' ' CB ' ' A' ' 14' ' ' ALA . 1.2 tp -120.58 129.12 53.63 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.422 -0.799 . . . . 0.0 110.691 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 11' ' ' LEU . 89.8 m -113.18 170.76 7.99 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.94 -1.1 . . . . 0.0 108.404 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.527 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.25 -45.87 0.1 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 12' ' ' VAL . 15.7 m -63.05 -67.76 0.4 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.19 . . . . 0.0 110.216 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.534 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 2.2 m-20 -67.57 -11.59 58.43 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.75 -1.219 . . . . 0.0 108.531 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.559 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -69.76 -49.7 50.44 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.031 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.617 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -63.92 -30.95 51.34 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.553 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 7.8 tt0 -69.9 -55.25 10.21 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.587 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -55.64 -49.75 72.02 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 1.4 mt -62.63 -41.61 99.12 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.617 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 7.4 t80 -59.39 -20.23 53.21 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.14 -65.38 1.02 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.094 0.949 . . . . 0.0 108.881 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.574 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -48.42 -28.69 2.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.42 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.48 -70.12 0.68 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.515 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.86 -62.83 0.49 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 19' ' ' CYS . 7.9 mp0 -134.4 -2.24 2.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -1.201 . . . . 0.0 110.364 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -74.42 -8.96 58.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.985 -1.072 . . . . 0.0 109.606 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.42 86.55 0.11 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.574 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -83.43 179.63 7.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -1.181 . . . . 0.0 109.407 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.574 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 29.4 p90 -163.3 166.57 22.92 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.156 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.401 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.878 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.579 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 119.927 -0.082 . . . . 0.0 110.877 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.2 -41.96 8.51 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 106.147 -2.781 . . . . 0.0 106.147 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.631 HG12 ' CE2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -94.12 -61.18 2.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 122.544 1.164 . . . . 0.0 108.668 176.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.542 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 37.9 t -54.79 -30.97 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.321 -177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.651 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.7 tt0 -92.73 -23.96 18.75 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 120.809 -1.182 . . . . 0.0 109.549 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 45' ' ' SER . 5.6 tt0 -82.81 -90.34 0.08 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.072 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.569 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.24 -37.09 0.88 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 109.997 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.542 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 15.3 t -68.95 -52.94 23.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.538 -1.351 . . . . 0.0 110.664 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.651 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 8.1 m-70 -91.25 -55.48 3.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.925 -1.11 . . . . 0.0 108.471 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.542 ' N ' ' O ' ' A' ' 41' ' ' GLN . 64.2 m -85.47 -131.46 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.578 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -151.97 152.78 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.674 -1.266 . . . . 0.0 109.114 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.481 ' N ' HG21 ' A' ' 46' ' ' ILE . 8.3 p -149.63 172.86 14.37 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 49' ' ' LEU . 67.4 m -136.73 169.46 17.69 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.999 -1.063 . . . . 0.0 110.272 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.546 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -41.93 -34.52 0.69 Allowed 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.795 1.283 . . . . 0.0 108.492 178.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -53.21 -52.72 58.0 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.072 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 48' ' ' SER . 2.1 mt-30 -74.11 -45.55 48.36 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.292 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 55' ' ' TYR . 1.1 mp -65.83 -14.39 61.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.414 -0.804 . . . . 0.0 109.032 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.5 tt0 -70.06 -28.09 65.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.156 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -90.39 -8.32 50.93 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.528 -0.732 . . . . 0.0 109.55 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.631 ' CE2' HG12 ' A' ' 38' ' ' ILE . 12.1 m-85 -90.33 2.05 55.92 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.49 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.3 m -78.64 -166.05 0.81 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.51 -0.744 . . . . 0.0 110.092 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.6 t-20 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.895 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.456 ' O ' ' OE1' ' A' ' 4' ' ' GLN . 10.5 m . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.567 0.699 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.54 ' CA ' HG22 ' A' ' 46' ' ' ILE . 2.0 m-80 -73.06 98.88 2.63 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.539 -0.725 . . . . 0.0 109.911 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.468 ' O ' HG23 ' A' ' 46' ' ' ILE . 3.2 pm0 -132.44 170.05 15.68 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.773 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.581 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 27.9 m-70 -93.35 113.65 25.88 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.563 ' CD1' ' HB3' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -114.14 144.43 43.17 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.426 -0.796 . . . . 0.0 109.899 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.578 ' O ' ' N ' ' A' ' 9' ' ' SER . 2.4 t -144.07 112.66 6.55 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.187 -0.946 . . . . 0.0 109.63 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.521 ' N ' ' HB2' ' A' ' 11' ' ' LEU . . . 40.94 -90.36 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 7' ' ' CYS . 7.5 m -37.28 -67.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.578 -0.954 . . . . 0.0 110.549 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.563 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 81.5 m-20 -68.0 -19.14 64.9 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.647 -1.283 . . . . 0.0 108.441 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.33 -48.5 72.8 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.409 -0.807 . . . . 0.0 109.024 178.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.62 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.6 m -67.62 -26.23 34.89 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.489 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.671 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 5.4 tt0 -71.87 -57.97 3.86 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.551 ' O ' ' CG2' ' A' ' 18' ' ' VAL . . . -52.69 -49.08 66.01 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.583 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 3.5 mt -64.32 -41.64 96.71 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.62 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 8.2 t80 -59.76 -24.26 63.91 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.17 -63.52 1.33 Allowed 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 122.104 0.954 . . . . 0.0 108.899 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.583 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -53.09 -28.88 14.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.914 -179.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.37 -70.58 0.65 Allowed 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.484 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.72 -64.02 0.18 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -131.63 -0.65 3.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.172 -1.193 . . . . 0.0 109.884 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 2.2 mtt85 -77.8 -9.53 59.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.143 -0.973 . . . . 0.0 109.914 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.9 92.4 0.05 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.537 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -87.0 -176.68 5.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.338 -1.095 . . . . 0.0 110.173 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CD1' ' C ' ' A' ' 25' ' ' PHE . 13.3 p90 -162.36 173.63 13.88 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.748 0.785 . . . . 0.0 109.415 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.474 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.294 -1.826 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.475 ' N ' ' HG3' ' A' ' 36' ' ' ARG . . . -53.76 -42.42 68.33 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 105.252 -3.139 . . . . 0.0 105.252 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.649 HG12 ' CD2' ' A' ' 55' ' ' TYR . 1.2 mp -93.68 -50.43 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 121.838 0.828 . . . . 0.0 108.928 177.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.554 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 9.0 t -61.06 -29.66 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.813 -0.554 . . . . 0.0 110.21 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.638 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.2 tt0 -91.28 -12.62 34.59 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.483 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -90.75 -95.59 0.12 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.763 -0.585 . . . . 0.0 109.881 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.552 ' SG ' ' HB2' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -39.95 -28.27 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.37 -0.831 . . . . 0.0 110.002 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.556 ' N ' ' O ' ' A' ' 6' ' ' LEU . 18.7 t -73.76 -58.05 3.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.751 -1.218 . . . . 0.0 109.409 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.638 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 16.8 m-70 -80.28 -45.49 17.8 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.341 -0.849 . . . . 0.0 109.118 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 41' ' ' GLN . 14.9 t -106.42 -126.69 0.25 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.581 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.7 mp -150.25 165.87 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.742 -1.224 . . . . 0.0 109.561 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.564 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 20.2 p -154.13 178.04 10.42 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.556 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -139.63 163.7 31.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.719 -1.238 . . . . 0.0 110.888 -178.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.8 mp -39.2 -39.94 0.67 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.902 0.858 . . . . 0.0 109.978 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 2.3 p90 -63.36 -41.73 98.86 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.585 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 7.1 tp60 -66.18 -44.18 84.71 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.583 ' HA ' ' CD2' ' A' ' 55' ' ' TYR . 1.4 mp -75.75 -23.45 55.99 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.7 tt0 -60.86 -30.0 69.87 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -90.12 -8.92 50.14 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.649 ' CD2' HG12 ' A' ' 38' ' ' ILE . 13.8 m-30 -90.03 -0.45 57.59 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.54 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -90.55 -164.98 1.25 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.645 -0.659 . . . . 0.0 110.536 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.9 t-20 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.909 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.449 ' O ' ' OE1' ' A' ' 4' ' ' GLN . 17.0 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.525 ' O ' ' ND2' ' A' ' 3' ' ' ASN . 4.3 p-10 -89.17 95.41 10.29 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.412 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.521 ' N ' HG23 ' A' ' 46' ' ' ILE . 3.9 pm0 -135.51 174.22 10.86 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 118.254 -1.378 . . . . 0.0 109.933 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.579 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 30.1 m-70 -90.8 106.77 18.74 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.586 ' CD2' ' CB ' ' A' ' 14' ' ' ALA . 1.1 tp -110.9 127.81 55.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.114 -0.991 . . . . 0.0 110.782 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 11' ' ' LEU . 61.1 m -111.94 169.05 9.11 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.42 -44.79 0.09 OUTLIER Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.472 ' O ' HG21 ' A' ' 12' ' ' VAL . 58.7 m -61.59 -69.44 0.24 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.133 -1.216 . . . . 0.0 110.078 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.512 ' CB ' ' HG ' ' A' ' 6' ' ' LEU . 31.6 m-20 -67.06 -12.52 60.16 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.906 -1.121 . . . . 0.0 108.205 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -68.21 -50.37 54.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -65.04 -31.65 54.84 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.527 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.275 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.71 -58.35 4.8 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.586 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -53.94 -51.94 62.19 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.57 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 1.2 mt -59.18 -44.56 92.17 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.606 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 14.5 t80 -56.07 -21.71 23.54 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -90.58 -67.22 0.86 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.94 0.876 . . . . 0.0 109.427 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.57 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -46.08 -29.41 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 121.613 0.72 . . . . 0.0 109.171 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -87.74 -72.89 0.5 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.846 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 69.16 -1.11 12.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER 159.45 -19.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.053 -1.263 . . . . 0.0 110.101 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -54.87 -18.33 4.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.097 -1.002 . . . . 0.0 109.37 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.64 68.5 1.27 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.939 -1.665 . . . . 0.0 108.939 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.499 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -72.06 178.74 3.62 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.338 -1.095 . . . . 0.0 109.836 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 10.4 p90 -162.77 -175.45 4.43 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.817 0.818 . . . . 0.0 109.359 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.444 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.835 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.584 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.486 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.84 -44.08 17.41 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 106.173 -2.771 . . . . 0.0 106.173 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.613 HG12 ' CD2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -93.81 -57.67 4.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.447 1.117 . . . . 0.0 108.7 177.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 53.7 t -56.24 -32.09 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.075 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.658 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 4.3 tt0 -91.87 -17.96 24.49 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 120.849 -1.157 . . . . 0.0 109.156 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 45' ' ' SER . 7.4 tt0 -89.97 -85.98 0.2 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.623 -0.673 . . . . 0.0 109.377 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.571 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 22.4 m -39.75 -39.01 0.71 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.845 . . . . 0.0 109.677 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 39' ' ' VAL . 6.3 t -71.0 -53.86 13.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 110.587 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.658 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 15.7 m-70 -82.58 -51.84 7.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.127 -0.983 . . . . 0.0 109.68 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' GLN . 18.4 t -97.7 -123.84 0.14 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 108.747 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.579 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -159.9 162.5 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.797 -1.19 . . . . 0.0 108.839 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.535 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -157.63 174.73 14.91 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.283 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.601 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 5.1 m -126.93 159.65 33.38 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.192 -0.942 . . . . 0.0 110.328 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.542 ' CB ' ' CG1' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -38.79 -37.59 0.35 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.573 0.701 . . . . 0.0 111.033 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 3.4 p90 -54.53 -42.95 71.47 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.625 0.726 . . . . 0.0 109.813 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.625 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -75.01 -31.12 61.31 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.442 -0.786 . . . . 0.0 109.968 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.545 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 1.3 mp -79.29 -20.38 48.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.995 -1.066 . . . . 0.0 108.137 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -64.4 -23.31 67.24 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -90.44 -16.41 29.06 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.613 ' CD2' HG12 ' A' ' 38' ' ' ILE . 11.6 m-85 -86.53 1.77 50.38 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.573 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -90.81 -165.52 1.37 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.522 -0.736 . . . . 0.0 110.09 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' CYS . 3.5 t30 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.766 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 4' ' ' GLN . 6.8 m . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.561 0.696 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.518 ' CA ' HG23 ' A' ' 46' ' ' ILE . 2.2 m120 -41.56 96.83 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.437 -0.789 . . . . 0.0 110.075 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.557 ' HG2' ' N ' ' A' ' 5' ' ' HIS . 5.0 tt0 -140.36 164.92 28.82 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.499 -0.751 . . . . 0.0 109.592 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.595 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 23.1 m-70 -89.27 104.41 16.96 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.612 ' CD2' ' CB ' ' A' ' 14' ' ' ALA . 1.1 tp -113.18 125.49 54.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.0 -1.062 . . . . 0.0 111.236 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.558 ' O ' ' N ' ' A' ' 11' ' ' LEU . 64.5 m -106.55 168.12 9.38 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.534 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . . . -32.99 -42.1 0.14 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.0 m -61.5 -69.95 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -1.204 . . . . 0.0 109.593 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.522 ' CB ' ' HG ' ' A' ' 6' ' ' LEU . 6.5 m-20 -66.42 -13.45 60.74 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.879 -1.138 . . . . 0.0 107.939 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.564 ' CD2' HD12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -64.74 -52.2 58.31 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.035 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.621 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -64.6 -29.3 46.98 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.512 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.443 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 4.0 tt0 -71.85 -54.08 11.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.612 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -54.13 -51.79 63.12 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.569 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 1.3 mt -61.92 -44.64 96.36 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.621 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 8.1 t80 -56.63 -21.5 27.59 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.11 -67.02 0.86 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.569 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -46.92 -29.68 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.22 -71.19 0.63 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.494 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.95 -66.6 0.19 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 19' ' ' CYS . 1.7 tt0 -129.23 -0.51 5.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 109.809 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.78 -6.78 55.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.995 . . . . 0.0 109.717 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 57' ' ' ASN . . . 67.77 94.5 0.04 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.513 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -91.56 -177.88 4.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.254 -1.145 . . . . 0.0 109.905 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 11.6 p90 -162.37 -178.02 6.03 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.677 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.529 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -50.35 -48.17 41.69 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.642 ' CG2' ' CZ ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -93.43 -21.18 6.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.93 -0.747 . . . . 0.0 109.413 178.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.503 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 0.9 OUTLIER -86.56 -59.47 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 0.0 109.196 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.594 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 23.0 tt0 -62.39 -14.46 40.53 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.115 -0.991 . . . . 0.0 108.478 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -81.96 -77.75 0.21 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.308 -0.87 . . . . 0.0 108.872 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 6' ' ' LEU . 23.6 m -42.75 -45.98 4.98 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' LEU . 11.5 t -64.54 -54.37 33.23 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.318 -0.864 . . . . 0.0 110.113 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.594 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 8.7 m-70 -86.99 -69.13 0.7 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.992 -1.067 . . . . 0.0 108.746 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 41' ' ' GLN . 6.7 t -75.15 -132.27 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.595 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.1 mp -155.3 159.68 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.805 -1.185 . . . . 0.0 109.121 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.559 ' CB ' ' NE2' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -150.45 177.6 9.84 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.744 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.477 ' OG ' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -130.41 156.56 44.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 109.903 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.8 mm? -39.91 -35.28 0.34 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.667 0.746 . . . . 0.0 110.258 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.602 ' CG ' ' N ' ' A' ' 51' ' ' GLN . 0.9 OUTLIER -52.3 -47.56 65.85 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.722 0.773 . . . . 0.0 109.178 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.602 ' N ' ' CG ' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -75.01 -33.0 61.76 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.707 -179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.598 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 1.9 mp -78.05 -19.23 54.68 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.176 -0.953 . . . . 0.0 108.64 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 49' ' ' LEU . 19.3 tt0 -67.11 -20.43 65.78 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -90.62 -12.39 37.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.572 -0.705 . . . . 0.0 109.708 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.642 ' CZ ' ' CG2' ' A' ' 38' ' ' ILE . 56.5 m-85 -90.37 4.76 49.95 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.107 -0.996 . . . . 0.0 109.084 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.57 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -81.65 -164.54 0.8 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.687 -0.633 . . . . 0.0 109.446 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 12.8 t30 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.139 -0.934 . . . . 0.0 109.575 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 4' ' ' GLN . 14.3 m . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.703 0.763 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.461 ' CA ' HG22 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -53.04 88.94 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.016 -1.052 . . . . 0.0 110.092 -179.429 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 2' ' ' VAL . 18.6 pt20 -135.76 177.6 7.7 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.366 -0.834 . . . . 0.0 109.275 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.562 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 30.5 m-70 -93.53 109.71 21.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.644 -0.66 . . . . 0.0 109.385 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . 1.1 tp -108.43 141.92 39.57 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.861 0.839 . . . . 0.0 110.301 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.556 ' O ' ' C ' ' A' ' 8' ' ' GLY . 60.7 m -128.93 167.82 16.87 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.556 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -25.91 -48.25 0.04 OUTLIER Glycine 0 N--CA 1.498 2.772 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.493 ' O ' HG22 ' A' ' 12' ' ' VAL . 24.0 m -63.17 -68.29 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -1.199 . . . . 0.0 110.227 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.52 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 16.5 m-20 -68.27 -10.24 53.27 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.792 -1.192 . . . . 0.0 108.727 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.81 -48.09 40.85 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.446 -0.901 . . . . 0.0 109.228 178.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.604 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -69.02 -32.05 52.83 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.428 0 C-N-CA 119.024 -1.071 . . . . 0.0 108.324 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -67.31 -57.74 6.1 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.559 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -54.3 -48.94 70.71 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 11' ' ' LEU . 1.7 mt -64.4 -41.01 96.88 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.109 0.957 . . . . 0.0 108.592 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.604 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.2 t80 -57.61 -21.22 37.95 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.51 -64.92 1.07 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 122.072 0.939 . . . . 0.0 109.245 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.53 -28.32 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.412 0.625 . . . . 0.0 109.519 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -90.04 -71.41 0.62 Allowed 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.676 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.63 -59.03 0.19 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' CYS . 2.4 pm0 -129.43 -28.79 2.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.222 -1.163 . . . . 0.0 110.331 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.56 -20.69 2.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.355 -0.841 . . . . 0.0 109.645 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 72.9 94.34 0.09 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.613 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -83.45 -169.26 2.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.309 -1.112 . . . . 0.0 110.203 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.613 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 3.3 p90 -161.87 178.6 8.77 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.446 ' OH ' ' CG2' ' A' ' 39' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.295 -1.78 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 41' ' ' GLN . . . -53.3 -43.12 64.66 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 105.377 -3.089 . . . . 0.0 105.377 177.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.669 HG12 ' CD2' ' A' ' 55' ' ' TYR . 2.4 mp -94.45 -48.0 13.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.883 0.849 . . . . 0.0 109.175 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 2.1 t -60.68 -33.07 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.508 0.67 . . . . 0.0 109.571 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.647 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.4 tt0 -90.34 -17.36 27.45 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.56 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -90.08 -88.27 0.17 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.572 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 1.2 m -39.03 -33.45 0.12 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.845 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 39' ' ' VAL . 3.3 t -77.78 -46.61 21.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.029 -1.044 . . . . 0.0 110.986 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.647 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 16.1 m-70 -91.15 -34.01 15.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.886 -1.133 . . . . 0.0 109.111 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 41' ' ' GLN . 58.7 m -114.75 -126.41 0.29 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.579 ' CG2' ' N ' ' A' ' 47' ' ' CYS . 1.3 mp -159.87 165.39 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.514 -1.366 . . . . 0.0 109.633 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.579 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -156.11 -160.5 1.01 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.101 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 49' ' ' LEU . 4.5 p -160.38 161.67 33.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.097 -1.002 . . . . 0.0 109.643 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.518 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -41.95 -35.88 0.97 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.898 1.332 . . . . 0.0 108.353 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 13.2 t80 -57.47 -53.1 61.97 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.38 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -73.41 -40.37 64.34 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.682 ' HA ' ' CD2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -68.76 -21.23 64.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.485 -0.76 . . . . 0.0 109.048 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 49' ' ' LEU . 2.1 tt0 -62.09 -25.26 67.61 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -90.59 -10.21 44.23 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.748 -0.595 . . . . 0.0 109.513 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.682 ' CD2' ' HA ' ' A' ' 52' ' ' LEU . 13.2 m-85 -84.32 -4.15 58.69 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 24' ' ' PHE . 1.2 m -90.79 -169.15 2.28 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.744 0.783 . . . . 0.0 111.12 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 55.5 t30 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.456 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.401 HG22 ' OE1' ' A' ' 4' ' ' GLN . 12.8 m . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 121.45 0.643 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.496 ' CA ' HG23 ' A' ' 46' ' ' ILE . 1.3 m-80 -77.66 87.54 3.94 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 108.936 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.491 ' O ' HG21 ' A' ' 46' ' ' ILE . 5.9 pt20 -125.64 175.73 7.37 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.259 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.576 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 45.4 m-70 -92.1 112.01 23.79 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.58 ' N ' ' O ' ' A' ' 42' ' ' CYS . 1.0 OUTLIER -112.92 129.11 56.59 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.332 -0.855 . . . . 0.0 111.319 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 11' ' ' LEU . 91.4 m -111.15 170.52 8.06 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -29.93 -47.53 0.12 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' HG21 ' A' ' 12' ' ' VAL . 25.6 m -61.17 -68.11 0.34 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -1.189 . . . . 0.0 110.369 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.535 ' CB ' ' HG ' ' A' ' 6' ' ' LEU . 8.7 m-20 -67.46 -13.06 61.69 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.852 -1.155 . . . . 0.0 108.477 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -68.44 -49.18 61.77 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.195 -0.94 . . . . 0.0 108.551 177.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.614 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -64.48 -28.18 44.27 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.46 0 C-N-CA 119.114 -1.035 . . . . 0.0 108.509 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.4 OUTLIER -71.4 -56.55 5.75 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.547 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -55.41 -45.8 76.67 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.561 ' HA ' HG22 ' A' ' 18' ' ' VAL . 2.8 mt -66.31 -40.65 90.12 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.614 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 6.3 t80 -59.13 -20.12 50.85 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.95 -64.23 1.17 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 122.046 0.927 . . . . 0.0 108.791 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.75 -29.28 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.538 0.685 . . . . 0.0 109.294 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.92 -71.13 0.63 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.673 -179.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.6 -62.41 0.3 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 19' ' ' CYS . 25.6 mp0 -132.66 -10.96 3.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.132 -1.217 . . . . 0.0 110.663 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -67.96 -7.56 29.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.913 -1.117 . . . . 0.0 109.624 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.88 92.79 0.05 OUTLIER Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.626 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -86.36 -178.02 6.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.124 -1.221 . . . . 0.0 109.529 -179.747 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.626 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 16.6 p90 -162.19 168.38 22.54 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.495 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.29 -2.002 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.592 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.15 -44.4 14.49 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 106.358 -2.697 . . . . 0.0 106.358 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.63 HG12 ' CD2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -93.5 -60.36 2.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 122.554 1.169 . . . . 0.0 108.43 177.015 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.538 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 34.3 t -51.56 -33.26 14.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.72 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.669 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 3.6 tt0 -93.46 -14.87 26.19 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 120.896 -1.128 . . . . 0.0 109.412 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 45' ' ' SER . 35.4 tt0 -88.53 -96.88 0.09 Allowed 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.98 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.58 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -39.75 -34.52 0.26 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.862 . . . . 0.0 109.912 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 13.4 t -67.2 -54.82 17.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.371 -1.455 . . . . 0.0 110.087 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.669 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 14.8 m-70 -84.75 -40.66 17.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 109.691 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' GLN . 9.3 t -110.39 -128.26 0.28 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.847 . . . . 0.0 108.801 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.576 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.4 mp -147.64 162.51 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.727 -1.233 . . . . 0.0 108.984 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.526 ' N ' HG22 ' A' ' 46' ' ' ILE . 18.8 p -154.97 160.26 40.97 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.922 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 49' ' ' LEU . 5.3 m -114.46 159.12 20.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.48 -0.762 . . . . 0.0 109.952 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.539 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -39.64 -36.76 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.61 -0.681 . . . . 0.0 110.357 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.609 ' CE1' ' CG ' ' A' ' 51' ' ' GLN . 0.9 OUTLIER -53.0 -39.32 63.01 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 119.673 -0.811 . . . . 0.0 108.842 -179.091 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.609 ' CG ' ' CE1' ' A' ' 50' ' ' TYR . 1.5 mm-40 -72.98 -54.48 8.5 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.464 ' HB3' ' HG ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -64.21 -12.12 37.58 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 49' ' ' LEU . 12.1 tt0 -74.47 -28.0 60.83 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -90.92 -9.8 44.84 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.63 ' CD2' HG12 ' A' ' 38' ' ' ILE . 14.0 m-85 -89.76 1.6 55.9 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.473 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -90.51 -165.81 1.44 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.596 -0.69 . . . . 0.0 110.158 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 42.7 t-20 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.922 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.604 ' CG1' ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 122.381 1.086 . . . . 0.0 110.309 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.604 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 10.2 m120 -74.28 92.16 2.23 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.13 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.482 ' O ' HG23 ' A' ' 46' ' ' ILE . 18.1 pt20 -132.96 175.02 9.73 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.109 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.581 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 39.1 m-70 -94.57 113.51 25.34 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.565 ' CD1' ' HB3' ' A' ' 10' ' ' ASP . 1.0 OUTLIER -117.98 136.09 53.74 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.149 -0.969 . . . . 0.0 110.177 -179.224 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 9' ' ' SER . 4.4 t -135.32 116.7 14.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.102 -0.999 . . . . 0.0 109.994 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.52 ' N ' ' HB2' ' A' ' 11' ' ' LEU . . . 39.19 -90.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.567 ' N ' ' O ' ' A' ' 7' ' ' CYS . 4.2 m -36.6 -68.47 0.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.639 -0.918 . . . . 0.0 110.518 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.565 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 52.4 m-20 -67.86 -20.12 65.1 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.719 -1.238 . . . . 0.0 108.561 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -64.74 -48.82 73.19 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.462 -0.895 . . . . 0.0 108.975 177.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.624 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -66.41 -27.93 41.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.658 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 27.4 tt0 -71.7 -53.46 13.44 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.541 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -57.94 -48.42 79.98 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.5 mt -63.66 -38.61 91.75 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.624 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 10.3 t80 -62.17 -20.24 63.93 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.82 -63.59 1.28 Allowed 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.79 -32.29 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.31 -73.23 0.53 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.846 0.832 . . . . 0.0 109.144 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 41.43 25.69 0.18 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 1.3 mt-10 162.18 -32.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.262 -1.14 . . . . 0.0 110.06 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.463 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.8 mtp85 -71.41 -4.92 29.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.394 -0.816 . . . . 0.0 109.58 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 64.75 91.27 0.03 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.47 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -88.52 178.11 6.61 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.138 -1.213 . . . . 0.0 109.812 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.453 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 33.7 p90 -163.39 158.59 21.35 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.472 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.291 -1.936 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.581 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 111.358 0.132 . . . . 0.0 111.358 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -47.03 -42.62 16.24 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.643 HG12 ' CD2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -94.67 -60.82 2.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 122.629 1.204 . . . . 0.0 108.26 176.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 49.6 t -53.43 -30.75 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.112 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.642 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.8 tt0 -94.4 -16.54 23.35 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 120.795 -1.19 . . . . 0.0 109.318 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 45' ' ' SER . 2.7 tp60 -90.15 -92.64 0.13 Allowed 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.179 -178.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -42.28 -32.62 0.52 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.83 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.557 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 25.3 t -68.72 -56.9 6.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.64 -1.288 . . . . 0.0 109.853 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.642 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 17.1 m-70 -83.29 -48.02 10.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.391 -0.818 . . . . 0.0 109.77 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 41' ' ' GLN . 19.5 t -106.38 -118.94 0.24 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.391 -0.818 . . . . 0.0 109.017 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.581 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.7 mp -151.09 165.53 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.74 -1.225 . . . . 0.0 109.013 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.551 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 24.2 p -146.82 -166.7 2.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.446 -0.784 . . . . 0.0 109.015 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.577 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 5.4 m -156.25 156.51 34.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.826 -1.171 . . . . 0.0 110.555 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.7 mm? -39.93 -37.03 0.52 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.509 0.671 . . . . 0.0 109.901 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 0.7 OUTLIER -58.34 -46.5 86.12 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.597 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -72.6 -40.77 66.28 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.456 HD11 ' SG ' ' A' ' 47' ' ' CYS . 1.6 mp -76.4 -14.74 60.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.19 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.56 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.7 tt0 -74.33 -25.71 59.71 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -90.24 -11.21 41.58 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.643 ' CD2' HG12 ' A' ' 38' ' ' ILE . 12.7 m-85 -87.59 -2.55 58.69 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -91.43 -170.66 2.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.565 -0.71 . . . . 0.0 109.976 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 28.0 t-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.237 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.527 0.68 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.498 ' CA ' HG23 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -82.06 101.38 10.32 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.629 -0.669 . . . . 0.0 109.5 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.503 ' O ' ' CG1' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -131.85 176.36 8.42 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.665 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.578 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 25.7 m-70 -93.85 108.32 20.11 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.616 ' CD2' ' CB ' ' A' ' 14' ' ' ALA . 1.1 tp -110.0 128.43 55.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.99 -1.068 . . . . 0.0 111.198 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.536 ' O ' ' N ' ' A' ' 11' ' ' LEU . 37.3 m -113.08 170.81 7.94 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -31.81 -44.51 0.15 Allowed Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.467 ' O ' HG23 ' A' ' 12' ' ' VAL . 3.3 m -63.56 -67.45 0.43 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.922 -1.34 . . . . 0.0 110.028 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.529 ' CB ' ' HG ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.12 -11.66 57.85 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.91 -1.118 . . . . 0.0 108.273 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.558 ' CD2' ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -67.86 -50.68 55.11 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.248 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.611 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -64.71 -29.52 47.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.443 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.496 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -71.21 -57.72 4.22 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.162 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.616 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -50.48 -50.55 52.27 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.56 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 1.6 mt -63.42 -45.77 89.44 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.611 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 2.1 t80 -55.88 -21.92 22.74 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.98 -66.85 0.86 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.085 0.945 . . . . 0.0 108.848 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.56 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.38 -29.6 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-O 121.618 0.723 . . . . 0.0 109.118 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.7 -74.91 0.46 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.825 0.821 . . . . 0.0 108.851 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 67.11 -0.19 8.42 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.537 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 2.7 tt0 163.1 -22.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.035 -1.274 . . . . 0.0 109.783 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.04 -17.45 6.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.114 -0.991 . . . . 0.0 109.581 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.75 77.56 1.12 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.544 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -78.88 -172.26 2.96 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.255 -1.144 . . . . 0.0 109.621 -179.75 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.563 ' CE2' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -162.89 -164.4 0.98 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.751 178.108 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.613 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.554 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.582 0.23 . . . . 0.0 111.518 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.37 -51.94 53.0 Favored Glycine 0 C--N 1.295 -1.727 0 N-CA-C 105.794 -2.923 . . . . 0.0 105.794 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.649 ' CG2' ' CZ ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -93.72 -29.16 4.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 1.3 t -68.58 -55.69 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.607 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.5 tm-20 -61.24 -18.57 59.01 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -82.3 -82.4 0.14 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.545 ' O ' ' N ' ' A' ' 6' ' ' LEU . 29.0 m -39.87 -44.11 1.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.534 -0.728 . . . . 0.0 109.114 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.51 ' N ' ' O ' ' A' ' 6' ' ' LEU . 6.0 t -67.33 -52.99 33.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 110.659 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.607 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 12.6 m-70 -84.22 -57.82 3.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.063 . . . . 0.0 109.281 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 41' ' ' GLN . 14.0 t -88.23 -126.58 0.05 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.578 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -159.49 164.87 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.567 -1.333 . . . . 0.0 109.295 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.557 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -153.31 -168.14 2.92 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.39 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.453 ' O ' HD13 ' A' ' 52' ' ' LEU . 0.9 OUTLIER -150.44 160.45 43.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.955 . . . . 0.0 110.438 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.483 ' N ' ' CD1' ' A' ' 49' ' ' LEU . 2.4 mp -42.71 -35.47 1.15 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.62 1.2 . . . . 0.0 109.061 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -54.01 -55.66 25.16 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.878 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -75.56 -37.34 60.02 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.014 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 48' ' ' SER . 0.5 OUTLIER -67.68 -19.62 65.2 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.044 179.339 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 49' ' ' LEU . 4.4 tt0 -65.6 -18.96 65.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.3 -0.875 . . . . 0.0 109.101 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -90.59 -11.39 40.14 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.394 -0.816 . . . . 0.0 109.985 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.649 ' CZ ' ' CG2' ' A' ' 38' ' ' ILE . 18.1 m-85 -90.58 6.46 43.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.995 -1.065 . . . . 0.0 109.061 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.458 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.1 m -91.91 -166.93 1.66 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.533 -0.729 . . . . 0.0 109.39 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.563 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 5.7 p-10 . . . . . 0 C--N 1.304 -1.398 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.111 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.6 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.681 0.753 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.544 ' CA ' HG23 ' A' ' 46' ' ' ILE . 1.2 m-80 -60.22 91.4 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 109.482 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.493 ' N ' HG21 ' A' ' 46' ' ' ILE . 21.1 pt20 -132.16 175.43 9.25 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.119 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.563 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 27.2 m-70 -94.68 111.64 23.4 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 42' ' ' CYS . 1.1 tp -119.13 129.81 55.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.45 -0.781 . . . . 0.0 111.151 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.522 ' O ' ' C ' ' A' ' 8' ' ' GLY . 72.5 m -113.08 170.08 8.47 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.17 -44.93 0.08 OUTLIER Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.495 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 1.5 m -62.9 -68.39 0.34 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -1.159 . . . . 0.0 110.113 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.529 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.56 -11.09 57.24 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.863 -1.148 . . . . 0.0 108.412 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -70.36 -49.14 52.34 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.067 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.616 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 3.1 m -64.42 -31.26 52.79 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.492 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.671 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -68.61 -56.75 7.21 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.587 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.521 ' HB3' ' CD2' ' A' ' 6' ' ' LEU . . . -54.36 -50.91 66.38 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.55 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.4 mt -62.03 -41.0 97.64 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.616 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 17.9 t80 -58.78 -20.32 48.68 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.41 -66.94 0.88 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.898 0.856 . . . . 0.0 109.013 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.55 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -46.21 -30.92 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.583 0.706 . . . . 0.0 109.162 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.05 -67.6 0.83 Allowed 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.799 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.06 -66.36 0.49 Allowed Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' CYS . 14.8 mt-10 -136.28 -1.71 2.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -1.086 . . . . 0.0 110.009 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.453 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 3.0 mtm180 -66.89 -14.4 62.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.077 -1.015 . . . . 0.0 109.767 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.49 79.51 0.93 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.544 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -81.24 -177.32 6.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.362 -1.081 . . . . 0.0 109.406 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.544 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 8.4 p90 -161.52 -172.53 3.39 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.756 0.789 . . . . 0.0 109.449 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.452 ' OH ' ' CG2' ' A' ' 39' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.298 -1.641 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.587 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.211 -0.964 0 N-CA-C 110.526 -0.175 . . . . 0.0 110.526 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.97 -42.75 16.1 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 106.146 -2.781 . . . . 0.0 106.146 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.594 HG12 ' CE2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -93.55 -62.38 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 2.6 t -48.54 -31.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.173 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.662 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.5 mt-10 -92.76 -22.34 19.41 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.914 -1.117 . . . . 0.0 108.873 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.493 ' HG3' ' N ' ' A' ' 42' ' ' CYS . 28.4 tp60 -82.77 -95.14 0.05 Allowed 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.434 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.57 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -40.84 -33.31 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.366 -0.834 . . . . 0.0 109.776 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.549 ' N ' ' O ' ' A' ' 6' ' ' LEU . 13.9 t -67.82 -58.74 4.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.483 -1.385 . . . . 0.0 109.719 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.662 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 14.6 m-70 -82.74 -58.61 2.82 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.25 -0.906 . . . . 0.0 108.922 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.439 ' O ' HD11 ' A' ' 46' ' ' ILE . 25.3 t -87.23 -129.72 0.06 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.563 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.5 mp -150.52 162.37 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.719 -1.238 . . . . 0.0 108.978 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.518 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 15.2 p -151.27 -168.03 2.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.43 -0.794 . . . . 0.0 109.115 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -155.6 163.62 39.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.066 -1.021 . . . . 0.0 110.384 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -39.02 -39.01 0.5 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.641 0.734 . . . . 0.0 110.27 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.65 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 2.2 p90 -57.56 -44.03 84.95 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.65 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 2.8 tp60 -72.88 -41.75 64.34 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.441 HD12 ' SG ' ' A' ' 47' ' ' CYS . 1.1 mt -75.0 -15.72 60.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.125 -0.984 . . . . 0.0 109.019 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' LEU . 14.1 tt0 -70.38 -27.75 64.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.45 -0.781 . . . . 0.0 108.985 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -89.13 -10.53 46.92 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.594 ' CE2' HG12 ' A' ' 38' ' ' ILE . 10.5 m-85 -90.06 0.38 57.16 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.536 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.1 m -90.71 -165.89 1.46 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.477 -0.764 . . . . 0.0 110.293 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 56' ' ' CYS . 34.6 t30 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.911 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.59 0.709 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.521 ' CA ' HG21 ' A' ' 46' ' ' ILE . 4.6 m120 -63.96 91.29 0.07 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.414 -0.804 . . . . 0.0 109.188 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.512 ' N ' HG22 ' A' ' 46' ' ' ILE . 2.6 pt20 -130.16 173.43 10.77 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.053 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.575 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 37.4 m-70 -90.92 108.46 19.86 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.569 ' N ' ' O ' ' A' ' 42' ' ' CYS . 1.2 tp -110.99 125.41 53.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 111.026 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 11' ' ' LEU . 79.0 m -110.84 170.61 7.98 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -31.39 -43.99 0.11 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 12' ' ' VAL . 9.9 m -62.5 -68.86 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.117 -1.225 . . . . 0.0 109.875 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.539 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 34.9 m-20 -66.86 -11.97 57.59 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.828 -1.17 . . . . 0.0 108.34 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -69.41 -48.72 60.18 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -65.87 -28.47 44.06 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.461 0 C-N-CA 119.094 -1.042 . . . . 0.0 108.489 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 1.0 OUTLIER -70.86 -60.22 2.36 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.001 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.54 ' O ' ' CG2' ' A' ' 18' ' ' VAL . . . -49.42 -50.81 39.02 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.57 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 1.3 mt -62.25 -44.47 96.47 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.606 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.5 t80 -58.78 -24.99 62.64 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -80.25 -65.67 0.98 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 122.334 1.064 . . . . 0.0 108.315 178.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.57 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -55.53 -29.12 23.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.164 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.539 ' SG ' ' CB ' ' A' ' 24' ' ' PHE . 33.4 m -88.34 -55.42 3.74 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.113 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 45.93 61.92 3.65 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 1.9 tt0 80.49 -3.19 1.88 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.514 -0.991 . . . . 0.0 110.256 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.478 ' CB ' ' SG ' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -57.36 -17.75 14.01 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.951 -1.093 . . . . 0.0 109.008 179.484 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' CA ' ' A' ' 57' ' ' ASN . . . 95.29 65.9 0.98 Allowed Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.539 ' CB ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -87.36 178.89 6.71 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.355 -1.085 . . . . 0.0 109.44 -179.369 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -162.48 -163.21 0.88 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.488 178.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.478 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.294 -1.844 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.627 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -48.12 -44.08 25.94 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 106.146 -2.781 . . . . 0.0 106.146 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.623 HG12 ' CE2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -93.19 -56.54 5.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 122.414 1.102 . . . . 0.0 108.342 177.201 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.545 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 4.2 t -55.78 -29.32 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.683 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.677 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -93.44 -28.88 15.86 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 120.818 -1.176 . . . . 0.0 109.579 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.515 ' HG3' ' N ' ' A' ' 42' ' ' CYS . 1.7 tp60 -76.25 -97.53 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.507 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.569 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -40.77 -33.76 0.32 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 110.463 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 17.0 t -67.36 -53.47 29.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.353 -1.467 . . . . 0.0 110.889 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.677 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 15.9 m-70 -84.52 -52.96 5.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.02 -1.05 . . . . 0.0 110.059 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.465 ' O ' HD12 ' A' ' 46' ' ' ILE . 32.4 t -98.48 -113.82 0.15 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 108.977 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.575 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.4 mp -159.42 161.56 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.825 -1.172 . . . . 0.0 108.668 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.518 ' N ' HG23 ' A' ' 46' ' ' ILE . 14.7 p -152.76 -171.0 3.8 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.566 -0.853 . . . . 0.0 109.535 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.611 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 4.8 m -143.86 156.97 44.65 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.345 1.069 . . . . 0.0 110.589 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.607 ' O ' ' N ' ' A' ' 53' ' ' GLU . 17.5 mt -39.44 -34.4 0.21 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.622 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.65 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 5.7 p90 -51.14 -42.63 60.88 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 118.532 -1.267 . . . . 0.0 108.108 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.65 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 1.7 pt20 -74.43 -53.54 9.35 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.548 ' N ' ' CG ' ' A' ' 51' ' ' GLN . 1.0 OUTLIER -62.14 -14.37 36.52 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.202 -0.936 . . . . 0.0 108.653 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 49' ' ' LEU . 20.8 tt0 -72.99 -31.46 64.53 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -91.57 -13.59 31.73 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.719 -0.613 . . . . 0.0 109.573 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.623 ' CE2' HG12 ' A' ' 38' ' ' ILE . 13.1 m-85 -82.65 -0.53 47.65 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.975 -1.078 . . . . 0.0 108.44 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 22' ' ' ARG . 1.2 t -66.94 -155.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.558 -0.714 . . . . 0.0 109.779 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.526 ' CA ' ' O ' ' A' ' 23' ' ' GLY . 24.1 p30 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.823 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.487 0.661 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.533 ' CA ' HG22 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -70.15 109.36 4.57 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.474 -0.766 . . . . 0.0 109.394 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.524 ' HG2' ' N ' ' A' ' 5' ' ' HIS . 6.1 tt0 -134.54 163.13 30.4 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 110.189 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.601 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 20.0 m-70 -91.62 91.83 8.2 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.587 ' CD1' ' HB3' ' A' ' 10' ' ' ASP . 1.1 tp -91.19 165.98 13.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.929 -1.107 . . . . 0.0 109.694 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 9' ' ' SER . 16.4 t -167.44 112.32 0.71 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.588 -1.32 . . . . 0.0 109.43 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.508 ' N ' ' HB2' ' A' ' 11' ' ' LEU . . . 39.88 -90.15 0.01 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 7' ' ' CYS . 7.1 m -40.25 -68.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.406 -1.055 . . . . 0.0 110.655 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.587 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 26.6 m-20 -65.8 -24.19 66.86 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.502 -1.374 . . . . 0.0 108.644 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -59.93 -50.76 72.51 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.387 -0.925 . . . . 0.0 108.642 177.748 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.628 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -64.38 -26.12 39.59 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 C-N-CA 119.127 -1.029 . . . . 0.0 108.674 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.447 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -71.75 -57.77 4.06 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.436 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.558 ' CB ' HD22 ' A' ' 6' ' ' LEU . . . -54.21 -48.95 70.45 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.598 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.6 mt -62.77 -41.57 99.3 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.628 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 12.3 t80 -59.26 -20.9 58.09 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.6 -65.8 0.98 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.971 0.891 . . . . 0.0 109.178 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.598 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -46.72 -29.96 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-O 121.599 0.714 . . . . 0.0 109.258 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.19 -70.9 0.64 Allowed 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.543 -179.41 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.26 -67.52 0.37 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 19' ' ' CYS . 3.5 mt-10 -126.93 -7.62 6.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.223 -1.163 . . . . 0.0 109.825 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.465 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 3.8 mmt85 -70.16 -10.55 59.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.166 -0.959 . . . . 0.0 109.699 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.6 89.74 0.08 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -85.37 -177.12 6.39 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.348 -1.089 . . . . 0.0 109.731 -179.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.574 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 11.0 p90 -162.76 178.47 8.44 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.689 0.757 . . . . 0.0 109.337 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.459 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.743 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.563 ' CB ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 111.339 0.125 . . . . 0.0 111.339 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -48.21 -44.04 26.47 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 106.082 -2.807 . . . . 0.0 106.082 177.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.607 ' CG1' ' CZ ' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -93.27 -57.51 4.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 122.508 1.147 . . . . 0.0 108.513 177.145 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 54.6 t -57.03 -29.27 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.913 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.685 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.3 mt-10 -91.87 -32.96 15.11 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.862 -1.149 . . . . 0.0 109.02 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 45' ' ' SER . 1.5 tp-100 -74.86 -82.49 0.06 Allowed 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.8 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.536 ' C ' ' O ' ' A' ' 6' ' ' LEU . 15.5 m -42.21 -48.08 4.81 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.411 -0.805 . . . . 0.0 109.715 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 5.1 t -62.87 -47.94 81.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 110.429 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.685 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 8.8 m-70 -90.47 -65.41 1.02 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.888 -1.133 . . . . 0.0 108.963 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 41' ' ' GLN . 8.5 t -87.38 -137.31 0.09 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.601 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.4 mp -142.38 162.35 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.794 -1.191 . . . . 0.0 109.17 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.511 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -142.92 -161.58 1.28 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.408 179.213 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.591 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -152.45 149.81 28.96 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.329 -0.857 . . . . 0.0 109.818 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.539 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -38.96 -37.26 0.34 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.758 0.79 . . . . 0.0 110.805 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.595 ' C ' ' CD1' ' A' ' 50' ' ' TYR . 1.3 p90 -60.01 -37.8 80.8 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.556 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.586 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -77.56 -20.01 54.77 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.564 ' CD2' ' HG2' ' A' ' 51' ' ' GLN . 4.3 mm? -86.8 -28.03 23.21 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.08 -23.26 19.58 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -90.89 -23.23 20.58 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.607 ' CZ ' ' CG1' ' A' ' 38' ' ' ILE . 17.5 m-85 -81.25 0.23 37.75 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.574 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.1 m -90.78 -165.15 1.29 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.538 -0.726 . . . . 0.0 109.958 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.442 ' C ' ' O ' ' A' ' 56' ' ' CYS . 27.3 p-10 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.876 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.598 ' CG1' ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 122.328 1.061 . . . . 0.0 110.983 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.598 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 5.3 m120 -63.42 93.11 0.07 Allowed 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.51 ' HG2' ' N ' ' A' ' 5' ' ' HIS . 4.6 tt0 -129.22 160.34 33.24 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.001 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.6 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 17.1 m-70 -85.05 93.89 8.71 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.593 ' CD1' ' C ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -79.31 -163.79 0.55 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.174 -0.954 . . . . 0.0 109.134 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.586 ' O ' ' C ' ' A' ' 8' ' ' GLY . 0.8 OUTLIER 170.83 141.25 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.623 -179.422 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -17.15 -55.19 0.01 OUTLIER Glycine 0 N--CA 1.502 3.063 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 7' ' ' CYS . 15.3 m -60.66 -66.2 0.57 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.208 -1.172 . . . . 0.0 109.717 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.593 ' C ' ' CD1' ' A' ' 6' ' ' LEU . 1.2 m-20 -67.46 -17.91 64.88 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.73 -1.231 . . . . 0.0 107.984 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -59.58 -53.05 62.56 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.634 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -63.62 -27.94 43.97 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.44 0 C-N-CA 118.801 -1.16 . . . . 0.0 108.08 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -71.8 -60.25 2.33 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.534 ' O ' ' CG2' ' A' ' 18' ' ' VAL . . . -50.79 -49.2 58.94 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.609 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 1.6 mt -62.81 -47.62 82.64 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 7.1 t80 -53.65 -25.55 18.44 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -82.02 -67.79 0.75 Allowed 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.101 0.953 . . . . 0.0 108.521 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.609 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -49.83 -28.74 4.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.526 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -87.21 -55.69 3.7 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.349 -0.94 . . . . 0.0 109.937 -179.07 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 21' ' ' GLU . . . 46.1 65.85 1.9 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 17.4 mm-40 80.92 -9.98 1.28 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.675 -0.897 . . . . 0.0 110.199 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.481 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 2.2 mmt180 -56.79 -17.22 8.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.915 -1.116 . . . . 0.0 109.415 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 57' ' ' ASN . . . 85.19 80.02 1.12 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.608 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -92.12 179.01 5.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -1.108 . . . . 0.0 109.902 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.608 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 40.1 p90 -162.68 175.14 11.66 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.294 -1.816 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -48.82 -44.51 31.1 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.644 ' CG2' ' CZ ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -91.87 -34.19 6.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.192 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.569 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 1.4 t -76.48 -69.79 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.602 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.1 tt0 -45.06 -25.87 0.38 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.856 -1.152 . . . . 0.0 108.57 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -80.35 -78.62 0.17 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.568 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 1.7 m -42.39 -29.03 0.24 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.592 -0.692 . . . . 0.0 109.497 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.569 ' HB2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -85.08 -47.36 10.27 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.009 -1.057 . . . . 0.0 109.88 -179.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.602 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 7.0 m-70 -92.59 -53.27 4.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.11 -0.994 . . . . 0.0 109.288 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' GLN . 38.7 m -92.09 -122.85 0.08 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.6 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -160.6 166.07 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.652 -1.28 . . . . 0.0 109.07 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.567 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -156.35 -170.96 3.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.391 -0.818 . . . . 0.0 109.285 179.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.443 ' OG ' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -142.02 157.61 44.73 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.269 -0.894 . . . . 0.0 109.839 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.595 ' O ' ' N ' ' A' ' 53' ' ' GLU . 54.6 mt -42.65 -33.09 0.66 Allowed 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.661 0.743 . . . . 0.0 110.571 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.656 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 1.6 p90 -53.45 -44.01 68.53 Favored 'General case' 0 C--N 1.281 -2.406 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.046 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.656 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -74.95 -53.01 9.75 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.154 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.491 ' N ' ' CG ' ' A' ' 51' ' ' GLN . 1.2 mp -61.22 -15.47 34.83 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 49' ' ' LEU . 37.2 tt0 -70.59 -24.39 62.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -91.35 -14.18 31.19 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.635 -0.666 . . . . 0.0 109.415 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.644 ' CZ ' ' CG2' ' A' ' 38' ' ' ILE . 59.7 m-85 -86.15 4.34 38.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.126 -0.984 . . . . 0.0 108.879 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.521 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -77.51 -164.24 0.47 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.691 -0.631 . . . . 0.0 109.98 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 5.6 t-20 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.667 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.593 ' CG1' ' N ' ' A' ' 3' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 122.413 1.101 . . . . 0.0 110.387 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.593 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 2.0 m120 -89.85 99.81 12.75 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.982 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 46' ' ' ILE . 4.2 pm0 -132.71 171.95 13.19 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.165 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.582 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 32.5 m-70 -90.77 110.16 21.35 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 42' ' ' CYS . 1.1 tp -112.63 134.04 54.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.132 -0.98 . . . . 0.0 111.168 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.535 ' O ' ' C ' ' A' ' 8' ' ' GLY . 34.4 m -119.08 168.09 11.17 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.535 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -28.93 -45.24 0.06 OUTLIER Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 12' ' ' VAL . 19.5 m -63.15 -68.65 0.32 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -1.201 . . . . 0.0 109.997 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.519 ' CB ' ' HG ' ' A' ' 6' ' ' LEU . 53.3 m-20 -67.79 -10.01 49.1 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.845 -1.159 . . . . 0.0 108.572 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.579 ' CD2' HD11 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -72.66 -48.15 41.58 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.378 -0.826 . . . . 0.0 109.05 178.487 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.616 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -67.53 -28.9 43.62 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.43 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.726 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -70.83 -55.87 7.56 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.489 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.536 ' HB3' ' CD2' ' A' ' 6' ' ' LEU . . . -54.51 -50.79 66.98 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.571 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.1 mt -60.87 -45.17 95.6 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.616 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 17.3 t80 -57.19 -21.37 32.85 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.77 -65.76 0.99 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.132 0.968 . . . . 0.0 109.009 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.571 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -50.29 -28.45 5.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-O 121.409 0.623 . . . . 0.0 109.602 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -86.59 -65.46 1.01 Allowed 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.39 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.47 -71.0 1.07 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -132.97 -1.2 3.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -1.137 . . . . 0.0 109.93 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.469 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 26.1 mmm-85 -69.18 -11.86 61.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.056 -1.027 . . . . 0.0 109.658 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.409 ' O ' ' CG ' ' A' ' 57' ' ' ASN . . . 69.3 89.42 0.08 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.621 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -85.01 -175.67 5.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -1.128 . . . . 0.0 109.805 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.621 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 23.9 p90 -162.8 164.65 26.08 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.468 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.293 -1.859 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 120.716 0.293 . . . . 0.0 111.488 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -49.94 -45.38 41.28 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.191 -2.364 . . . . 0.0 107.191 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.632 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -93.54 -26.19 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.413 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.502 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 0.9 OUTLIER -82.91 -59.93 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.292 -0.88 . . . . 0.0 109.101 179.735 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.613 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 4.9 tt0 -58.72 -16.6 17.31 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.4 OUTLIER -80.47 -82.41 0.11 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.372 -0.83 . . . . 0.0 109.392 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.557 ' O ' ' N ' ' A' ' 6' ' ' LEU . 28.5 m -39.57 -42.5 1.17 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.36 -0.838 . . . . 0.0 108.955 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 6' ' ' LEU . 4.8 t -69.54 -53.03 20.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.829 . . . . 0.0 111.043 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.613 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 12.7 m-70 -83.51 -48.76 9.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.868 -1.145 . . . . 0.0 109.663 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 41' ' ' GLN . 45.1 t -99.95 -124.42 0.16 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.582 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -159.49 165.23 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.706 -1.246 . . . . 0.0 109.206 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.556 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -148.16 -156.64 0.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.469 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.587 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 5.6 m -160.05 154.08 23.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 110.387 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -39.13 -38.86 0.52 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.644 0.735 . . . . 0.0 110.412 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 1.4 p90 -57.76 -46.46 84.49 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.623 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -71.69 -37.57 70.68 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.519 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.403 HD11 ' O ' ' A' ' 48' ' ' SER . 0.9 OUTLIER -76.48 -20.09 57.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.161 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 49' ' ' LEU . 26.0 tt0 -68.19 -22.66 64.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.323 -0.86 . . . . 0.0 108.868 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -89.92 -11.52 41.56 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.548 -0.72 . . . . 0.0 109.812 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.632 ' CZ ' ' HB ' ' A' ' 38' ' ' ILE . 17.5 m-85 -91.09 6.99 42.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.127 -0.983 . . . . 0.0 108.5 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.541 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.3 m -78.06 -164.55 0.54 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.715 -0.616 . . . . 0.0 109.927 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.3 t-20 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.743 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 4' ' ' GLN . 12.3 m . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.488 0.661 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.427 ' C ' HG22 ' A' ' 46' ' ' ILE . 11.0 m-20 -59.9 87.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.449 -0.782 . . . . 0.0 108.976 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.499 ' NE2' HD12 ' A' ' 6' ' ' LEU . 20.3 pt20 -130.99 178.31 6.77 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.028 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.584 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 36.8 m-70 -91.84 106.05 18.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.542 ' CD2' ' HB1' ' A' ' 14' ' ' ALA . 1.1 tp -104.91 137.82 42.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.14 -0.975 . . . . 0.0 111.058 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.543 ' O ' ' C ' ' A' ' 8' ' ' GLY . 60.0 m -124.1 166.98 14.85 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -26.12 -47.91 0.04 OUTLIER Glycine 0 N--CA 1.498 2.798 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.4 m -61.82 -69.2 0.26 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.286 . . . . 0.0 109.948 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.526 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -68.17 -10.7 56.21 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.812 -1.18 . . . . 0.0 108.763 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.71 -47.42 39.63 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.246 -0.909 . . . . 0.0 109.316 178.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.607 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -71.57 -31.95 44.21 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.406 0 C-N-CA 118.789 -1.164 . . . . 0.0 108.485 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 16' ' ' TYR . 10.4 mt-10 -66.54 -54.27 25.6 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.542 ' HB1' ' CD2' ' A' ' 6' ' ' LEU . . . -59.69 -50.21 74.75 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.591 ' HB2' ' O ' ' A' ' 11' ' ' LEU . 2.8 mt -59.92 -39.89 86.99 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.607 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 7.9 t80 -59.45 -21.54 60.19 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.71 -65.54 1.01 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.969 0.89 . . . . 0.0 108.964 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.575 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -49.99 -27.43 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.578 0.704 . . . . 0.0 109.509 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 36.2 m -90.27 -69.24 0.74 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.854 -178.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.59 -71.82 1.55 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -137.7 1.83 2.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.351 -1.088 . . . . 0.0 109.964 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.475 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 42.4 mmm-85 -63.34 -12.35 29.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.004 -1.06 . . . . 0.0 109.864 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 57' ' ' ASN . . . 85.22 90.86 0.84 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -114.3 173.93 6.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -1.16 . . . . 0.0 109.668 -179.51 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.578 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 2.2 p90 -161.21 -61.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.408 -0.807 . . . . 0.0 109.025 178.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.578 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.298 -1.654 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.531 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.25 -39.98 7.43 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 106.18 -2.768 . . . . 0.0 106.18 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.624 HG12 ' CZ ' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -93.38 -63.67 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-O 122.346 1.07 . . . . 0.0 108.261 176.691 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 3.3 t -48.82 -35.95 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.23 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.662 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 3.3 tt0 -91.25 -17.07 26.58 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.076 -1.015 . . . . 0.0 109.423 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 45' ' ' SER . 33.2 tt0 -90.58 -82.91 0.27 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.359 -0.838 . . . . 0.0 109.594 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 6' ' ' LEU . 24.5 m -39.28 -41.17 0.86 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.495 -0.753 . . . . 0.0 109.731 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.483 ' N ' ' O ' ' A' ' 6' ' ' LEU . 3.7 t -73.58 -51.25 17.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 111.177 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.662 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 14.9 m-70 -83.23 -41.9 17.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.871 -1.143 . . . . 0.0 109.95 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 41' ' ' GLN . 37.7 t -110.31 -121.64 0.27 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.584 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -158.94 165.6 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.794 -1.191 . . . . 0.0 109.394 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.568 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -148.09 -164.52 2.03 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.407 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.609 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 10.3 m -143.78 151.82 40.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 110.128 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.521 ' O ' ' CG1' ' A' ' 18' ' ' VAL . 0.3 OUTLIER -39.11 -39.85 0.63 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.734 0.778 . . . . 0.0 110.143 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 48' ' ' SER . 1.2 p90 -63.13 -41.06 99.24 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.551 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 37.2 tp60 -63.67 -44.65 93.12 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.518 ' HA ' ' CD2' ' A' ' 55' ' ' TYR . 1.2 mp -72.38 -24.24 61.23 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -63.43 -24.08 67.68 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -0.821 . . . . 0.0 109.095 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -87.97 -9.16 54.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.492 -0.755 . . . . 0.0 109.457 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.624 ' CZ ' HG12 ' A' ' 38' ' ' ILE . 13.7 m-85 -90.14 2.0 55.79 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -80.28 -158.21 0.17 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.483 -0.761 . . . . 0.0 110.935 -178.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 23' ' ' GLY . 22.4 t-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.656 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 4' ' ' GLN . 12.9 m . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.674 0.75 . . . . 0.0 109.623 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -43.51 94.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.341 -0.849 . . . . 0.0 109.725 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.525 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -143.19 167.87 21.09 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.205 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.601 ' CE1' ' O ' ' A' ' 44' ' ' HIS . 18.1 m-70 -93.14 111.79 23.54 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.585 ' CD2' ' CB ' ' A' ' 14' ' ' ALA . 1.2 tp -113.76 128.12 56.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.026 -1.046 . . . . 0.0 110.84 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 11' ' ' LEU . 64.6 m -111.04 167.56 10.17 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.524 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -31.36 -42.38 0.08 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.469 ' O ' HG21 ' A' ' 12' ' ' VAL . 42.3 m -62.68 -69.27 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.275 . . . . 0.0 109.491 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.518 ' CB ' ' HG ' ' A' ' 6' ' ' LEU . 1.1 m-20 -67.47 -10.92 56.04 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.934 -1.104 . . . . 0.0 108.484 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.558 ' CD2' HD12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -70.78 -48.88 51.92 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.385 -0.822 . . . . 0.0 109.043 178.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.613 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -67.08 -28.52 43.05 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.454 0 C-N-CA 118.802 -1.159 . . . . 0.0 108.297 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.456 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 6.4 tt0 -70.32 -57.15 5.17 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.585 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -54.38 -49.71 69.22 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.556 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 3.0 mt -61.62 -44.04 97.74 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.613 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 11.5 t80 -58.5 -27.0 64.07 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -78.79 -64.04 1.27 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 122.042 0.925 . . . . 0.0 108.568 179.137 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.556 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -53.34 -31.79 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.509 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -86.49 -64.32 1.17 Allowed 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.601 -0.839 . . . . 0.0 109.563 -179.41 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.25 -64.63 0.39 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 19' ' ' CYS . 1.6 mt-10 -138.79 2.74 2.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.262 -1.14 . . . . 0.0 110.077 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.461 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 14.2 mmt85 -74.19 -11.21 60.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.099 -1.0 . . . . 0.0 109.882 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 69.69 93.9 0.06 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.627 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -89.7 -167.25 1.8 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -1.126 . . . . 0.0 110.061 -179.595 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.627 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 15.0 p90 -160.63 170.82 20.07 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.514 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 1.5 t80 . . . . . 0 C--N 1.297 -1.703 0 O-C-N 120.805 -1.184 . . . . 0.0 109.628 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.698 0.285 . . . . 0.0 111.119 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -49.65 -42.61 36.31 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.973 -2.451 . . . . 0.0 106.973 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.655 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -93.99 -26.69 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.233 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.497 HG11 ' N ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -84.46 -60.48 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.412 -0.805 . . . . 0.0 109.462 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.626 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 34.0 tt0 -61.63 -13.98 26.9 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.221 -0.925 . . . . 0.0 109.284 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -79.85 -85.75 0.08 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.178 -0.951 . . . . 0.0 109.845 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 6' ' ' LEU . 32.3 m -38.73 -42.65 0.83 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 6' ' ' LEU . 7.4 t -67.31 -54.82 17.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.478 -0.764 . . . . 0.0 110.553 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.626 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 10.6 m-70 -86.29 -59.13 2.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.837 -1.164 . . . . 0.0 109.18 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 41' ' ' GLN . 33.0 t -83.17 -132.89 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.574 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.5 mp -155.94 161.29 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.846 -1.159 . . . . 0.0 108.577 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.466 ' HA ' ' OE1' ' A' ' 51' ' ' GLN . 0.6 OUTLIER -141.54 -157.44 0.77 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.654 -1.218 . . . . 0.0 110.655 -179.064 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.589 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 5.4 m -151.18 146.44 26.11 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.874 0.845 . . . . 0.0 110.008 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.6 OUTLIER -37.7 -42.48 0.57 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.739 0.781 . . . . 0.0 111.04 -179.517 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.607 ' CZ ' ' CG ' ' A' ' 51' ' ' GLN . 3.6 p90 -61.94 -37.79 86.05 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.991 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.607 ' CG ' ' CZ ' ' A' ' 50' ' ' TYR . 72.0 mt-30 -67.64 -39.74 84.61 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.473 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -71.39 -28.87 64.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 109.057 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.46 ' OE1' HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -57.96 -23.04 52.01 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.214 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.494 ' ND2' ' N ' ' A' ' 54' ' ' ASN . 1.2 m120 -89.65 -15.52 32.49 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.807 -0.558 . . . . 0.0 109.573 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.655 ' CZ ' ' HB ' ' A' ' 38' ' ' ILE . 16.4 m-85 -90.54 5.51 47.49 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.448 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.1 m -90.89 -164.25 1.15 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.623 -0.673 . . . . 0.0 109.851 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 8.3 p-10 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.936 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.9 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.398 0.618 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.496 ' CA ' HG23 ' A' ' 46' ' ' ILE . 3.4 m-80 -60.07 93.86 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.453 -0.779 . . . . 0.0 109.264 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.48 ' O ' HG21 ' A' ' 46' ' ' ILE . 1.6 pt20 -134.42 173.84 11.19 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.154 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.548 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 43.3 m-70 -90.48 112.53 24.21 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 42' ' ' CYS . 1.1 tp -118.12 129.41 55.52 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.403 -0.811 . . . . 0.0 111.328 -178.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 11' ' ' LEU . 98.7 m -111.61 170.42 8.14 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -29.93 -45.71 0.09 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.514 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 1.1 m -62.1 -68.85 0.29 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.107 -1.231 . . . . 0.0 110.171 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.531 ' CB ' ' HG ' ' A' ' 6' ' ' LEU . 1.9 m-20 -67.46 -11.63 58.32 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.859 -1.15 . . . . 0.0 108.416 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.537 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -69.72 -49.09 56.58 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.607 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -63.83 -30.62 50.43 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.55 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.617 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.443 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 4.7 tt0 -69.09 -56.69 6.94 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.549 ' HB3' ' CD2' ' A' ' 6' ' ' LEU . . . -55.15 -49.38 71.95 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.556 ' HA ' HG22 ' A' ' 18' ' ' VAL . 1.5 mt -62.86 -40.97 99.12 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.607 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 8.7 t80 -58.36 -20.44 43.7 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.07 -66.67 0.9 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.982 0.896 . . . . 0.0 109.006 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.556 HG22 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -46.22 -30.08 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.516 ' SG ' ' CB ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -90.47 -71.1 0.64 Allowed 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.555 -179.358 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.24 -60.41 0.25 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 19' ' ' CYS . 17.0 mt-10 -138.11 -0.05 2.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.201 -1.176 . . . . 0.0 110.381 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.572 ' N ' ' CD ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -76.74 -4.07 41.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.99 -1.069 . . . . 0.0 109.685 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.99 84.85 0.18 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.546 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -83.13 -177.44 6.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.268 -1.136 . . . . 0.0 109.421 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.546 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 8.6 p90 -161.33 -172.69 3.49 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.394 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.47 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.605 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.595 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.4 -44.79 16.15 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 106.267 -2.733 . . . . 0.0 106.267 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.639 HG12 ' CD2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -93.92 -61.22 2.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 122.551 1.167 . . . . 0.0 108.229 176.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.538 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 13.9 t -49.11 -34.74 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.508 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.661 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 24.3 tt0 -93.35 -16.88 24.19 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 120.864 -1.147 . . . . 0.0 109.406 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 45' ' ' SER . 33.8 tt0 -86.65 -94.98 0.09 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.464 -0.772 . . . . 0.0 110.077 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.23 -34.9 0.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.469 -0.77 . . . . 0.0 109.895 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.542 ' N ' ' O ' ' A' ' 6' ' ' LEU . 16.3 t -66.34 -55.05 17.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.385 -1.447 . . . . 0.0 109.739 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.661 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 15.5 m-70 -84.22 -51.61 6.89 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.195 -0.941 . . . . 0.0 109.454 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' GLN . 35.1 t -98.44 -127.35 0.17 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.548 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.5 mp -148.04 164.57 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.679 -1.263 . . . . 0.0 108.818 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.539 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 21.4 p -149.97 -171.74 3.98 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.383 -0.823 . . . . 0.0 109.206 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.581 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 8.1 m -147.1 156.02 42.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.855 -1.153 . . . . 0.0 110.951 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -39.29 -38.57 0.54 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.79 0.805 . . . . 0.0 110.244 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.631 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 1.4 p90 -61.83 -47.83 83.29 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 121.772 0.796 . . . . 0.0 109.095 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.631 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -67.35 -39.99 85.8 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.52 ' HA ' ' CD2' ' A' ' 55' ' ' TYR . 1.4 mp -75.75 -18.37 59.58 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -62.82 -26.49 68.77 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.121 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -90.16 -10.76 43.33 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.287 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.639 ' CD2' HG12 ' A' ' 38' ' ' ILE . 11.2 m-85 -87.55 -1.81 58.19 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.489 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -90.61 -165.39 1.34 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.603 -0.686 . . . . 0.0 110.134 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 56' ' ' CYS . 4.3 t-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.816 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.464 ' O ' ' OE1' ' A' ' 4' ' ' GLN . 12.5 m . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.513 0.673 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.536 ' CA ' HG22 ' A' ' 46' ' ' ILE . 6.6 m120 -70.26 99.82 1.6 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.479 -0.763 . . . . 0.0 109.632 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.473 ' O ' HG23 ' A' ' 46' ' ' ILE . 3.0 pm0 -131.88 165.53 23.65 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.125 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.581 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 20.5 m-70 -89.72 108.53 19.74 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.6 ' CD2' ' CB ' ' A' ' 14' ' ' ALA . 1.1 tp -112.88 128.94 56.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.139 -0.976 . . . . 0.0 110.817 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 11' ' ' LEU . 67.5 m -111.26 168.06 9.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -29.6 -45.89 0.08 OUTLIER Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' HG22 ' A' ' 12' ' ' VAL . 17.9 m -60.85 -69.87 0.21 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.088 -1.242 . . . . 0.0 110.093 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.534 ' CB ' ' HG ' ' A' ' 6' ' ' LEU . 1.2 m-20 -66.43 -13.44 60.76 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.856 -1.152 . . . . 0.0 108.362 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.543 HD23 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -66.78 -50.35 62.95 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.455 -0.778 . . . . 0.0 108.982 178.372 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -65.8 -30.55 50.4 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.472 0 C-N-CA 119.019 -1.072 . . . . 0.0 108.123 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.28 -57.31 6.16 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.697 -1.224 . . . . 0.0 107.697 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.6 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -54.93 -49.48 71.19 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.3 mt -62.88 -42.63 99.84 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.606 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 9.9 t80 -56.74 -21.54 28.97 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.44 -66.14 0.95 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.019 0.914 . . . . 0.0 109.226 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.575 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -47.62 -28.58 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.505 0.669 . . . . 0.0 109.427 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -90.18 -70.35 0.67 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.679 -179.427 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.63 -68.74 1.83 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -130.33 -6.88 4.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.157 -1.202 . . . . 0.0 110.122 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -66.01 -11.8 50.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.036 -1.04 . . . . 0.0 109.837 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 68.07 95.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.46 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 0.5 OUTLIER -93.93 174.88 6.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -1.178 . . . . 0.0 110.238 -179.648 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 29.2 p90 -165.19 151.89 10.4 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.473 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.294 -1.805 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.537 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.502 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.57 -40.72 8.83 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 106.219 -2.752 . . . . 0.0 106.219 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.603 HG12 ' CE2' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -94.32 -65.52 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 122.464 1.126 . . . . 0.0 108.02 176.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 16.2 t -46.78 -34.85 2.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.289 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.624 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 9.2 tt0 -91.63 -19.38 22.75 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.117 -0.989 . . . . 0.0 109.567 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 45' ' ' SER . 16.5 tt0 -90.36 -81.81 0.29 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.294 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.559 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 23.1 m -40.8 -41.77 1.64 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.502 -0.749 . . . . 0.0 109.113 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.518 ' N ' ' O ' ' A' ' 6' ' ' LEU . 6.8 t -69.09 -53.9 17.88 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.207 -0.933 . . . . 0.0 110.026 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.624 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 12.3 m-70 -83.9 -64.4 1.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 108.937 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 41' ' ' GLN . 3.7 t -82.0 -132.7 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.581 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -153.85 166.0 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.823 -1.173 . . . . 0.0 109.076 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.576 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -155.09 171.09 20.35 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.601 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.605 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 4.9 m -124.28 158.16 33.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.368 -0.832 . . . . 0.0 109.485 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -38.74 -39.22 0.48 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.715 0.769 . . . . 0.0 110.48 -179.408 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.606 ' CZ ' ' CG ' ' A' ' 51' ' ' GLN . 3.1 p90 -60.33 -36.43 77.92 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.38 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.606 ' CG ' ' CZ ' ' A' ' 50' ' ' TYR . 10.5 mt-30 -71.81 -47.36 53.8 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.457 HD23 ' HG ' ' A' ' 15' ' ' LEU . 1.5 mp -69.84 -16.64 63.3 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.25 -25.82 67.07 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -87.0 -11.83 49.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.467 -0.771 . . . . 0.0 109.449 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.603 ' CE2' HG12 ' A' ' 38' ' ' ILE . 11.9 m-85 -89.83 3.18 53.72 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.146 -0.971 . . . . 0.0 108.653 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.3 m -83.3 -166.96 1.5 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.456 -0.777 . . . . 0.0 110.015 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 21.2 p-10 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.698 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.466 ' O ' ' OE1' ' A' ' 4' ' ' GLN . 10.2 m . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.505 0.669 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.444 ' C ' HG22 ' A' ' 46' ' ' ILE . 10.7 m120 -62.08 88.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.005 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.475 ' O ' HG23 ' A' ' 46' ' ' ILE . 1.6 pm0 -127.55 176.3 7.59 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.863 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.571 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 38.0 m-70 -90.48 104.55 17.12 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.558 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . 1.1 tp -102.0 139.12 38.05 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.084 -1.01 . . . . 0.0 110.684 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.553 ' O ' ' C ' ' A' ' 8' ' ' GLY . 53.6 m -127.11 167.9 15.36 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -26.49 -47.33 0.04 OUTLIER Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.48 ' O ' HG21 ' A' ' 12' ' ' VAL . 72.8 m -62.93 -68.95 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.095 -1.238 . . . . 0.0 110.304 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.523 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 35.1 m-20 -67.55 -10.47 52.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.826 -1.171 . . . . 0.0 108.568 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.551 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.34 -48.3 42.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.34 -0.85 . . . . 0.0 109.459 178.622 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.611 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -68.65 -30.52 47.52 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.497 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.292 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -68.74 -59.84 2.82 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.55 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.556 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -51.8 -49.17 63.26 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.556 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 1.3 mt -63.98 -43.42 95.8 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.611 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 11.0 t80 -56.52 -21.42 26.08 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.65 -66.73 0.89 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 122.103 0.954 . . . . 0.0 109.14 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.556 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -47.96 -30.86 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.534 0.683 . . . . 0.0 109.311 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -90.58 -73.38 0.53 Allowed 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.862 0.839 . . . . 0.0 109.288 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 43.85 23.42 0.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER 157.12 -20.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.524 -0.986 . . . . 0.0 109.807 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.405 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 3.7 mtt180 -75.31 0.41 16.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.961 . . . . 0.0 109.818 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.42 74.31 0.45 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.57 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -74.54 -175.38 2.37 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.313 -1.11 . . . . 0.0 109.881 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CE1' ' O ' ' A' ' 55' ' ' TYR . 3.7 p90 -161.99 -169.25 2.14 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.898 0.856 . . . . 0.0 109.778 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.513 ' OH ' ' CG2' ' A' ' 39' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.638 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 40' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.27 -41.62 11.91 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 106.15 -2.78 . . . . 0.0 106.15 177.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.561 HG12 ' CD2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -93.93 -61.08 2.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 122.339 1.066 . . . . 0.0 108.374 176.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 8.0 t -51.01 -34.32 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.483 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.646 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.9 tt0 -90.8 -18.76 24.36 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.893 -1.129 . . . . 0.0 108.661 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 45' ' ' SER . 9.6 tt0 -90.59 -84.79 0.23 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.447 -0.783 . . . . 0.0 109.461 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.558 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 1.3 m -39.5 -35.89 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 0.0 109.672 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.526 ' N ' ' O ' ' A' ' 6' ' ' LEU . 4.0 t -74.63 -54.54 7.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.041 -1.037 . . . . 0.0 110.383 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.646 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 15.2 m-70 -79.15 -43.02 24.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.994 . . . . 0.0 109.528 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.6 t -108.35 -126.46 0.26 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.571 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -158.44 165.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.79 -1.194 . . . . 0.0 109.231 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.567 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -155.46 177.71 11.05 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.536 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 51' ' ' GLN . 5.2 m -130.95 155.98 45.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 109.51 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -38.77 -39.06 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.458 -0.776 . . . . 0.0 110.454 -179.391 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.589 ' CE1' ' HG2' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -53.31 -40.54 64.87 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.589 ' HG2' ' CE1' ' A' ' 50' ' ' TYR . 2.8 mt-30 -72.9 -56.47 5.14 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.478 ' CD2' ' HB3' ' A' ' 14' ' ' ALA . 1.2 mp -54.44 -20.29 7.28 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' LEU . 20.2 tt0 -69.1 -18.76 64.02 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.571 ' OD1' ' CD1' ' A' ' 55' ' ' TYR . 14.6 p30 -89.02 -26.0 21.68 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.937 0.875 . . . . 0.0 108.888 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.581 ' O ' ' CE1' ' A' ' 25' ' ' PHE . 15.4 m-85 -80.26 -0.65 37.36 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.0 OUTLIER -92.48 175.82 6.69 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.539 -0.726 . . . . 0.0 109.16 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.6 m-20 . . . . . 0 C--N 1.298 -1.667 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.942 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.601 ' CG1' ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.216 -0.706 0 CA-C-O 122.346 1.07 . . . . 0.0 110.455 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.601 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 9.7 m120 -71.1 102.1 2.4 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.775 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.493 ' O ' HG21 ' A' ' 46' ' ' ILE . 2.8 tt0 -140.0 158.63 43.75 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.674 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.602 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 22.6 m-70 -81.53 97.72 7.95 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.604 ' CD1' ' CB ' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -82.92 -170.18 2.88 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.025 -1.047 . . . . 0.0 109.589 -179.104 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.575 ' O ' ' C ' ' A' ' 8' ' ' GLY . 5.5 t 173.31 142.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.583 ' HA2' ' OH ' ' A' ' 26' ' ' TYR . . . -14.12 -57.85 0.01 OUTLIER Glycine 0 N--CA 1.5 2.948 0 N-CA-C 111.957 -0.457 . . . . 0.0 111.957 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 7' ' ' CYS . 8.0 m -56.63 -69.91 0.14 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.007 -1.29 . . . . 0.0 109.675 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.604 ' CB ' ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.4 -17.83 64.88 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.704 -1.248 . . . . 0.0 108.041 179.447 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.561 ' HB2' ' CA ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -60.67 -51.85 67.62 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.239 -0.913 . . . . 0.0 108.679 178.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.63 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -64.14 -26.08 39.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.493 -1.283 . . . . 0.0 108.226 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 1.1 tt0 -72.01 -60.39 2.26 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.533 ' O ' ' CG2' ' A' ' 18' ' ' VAL . . . -52.57 -46.43 66.85 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.587 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 3.3 mt -64.39 -44.41 91.41 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.63 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 14.0 t80 -56.44 -21.1 23.17 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.22 -65.91 0.97 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.862 0.839 . . . . 0.0 109.292 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.587 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -47.25 -30.47 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.849 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -88.08 -73.84 0.47 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 65.22 2.31 9.04 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 11.7 tt0 164.41 -23.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.87 -1.37 . . . . 0.0 109.717 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.474 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 4.6 mtt-85 -60.95 -12.21 10.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.842 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 74.98 83.08 0.41 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.598 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -81.77 -167.86 1.68 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.024 -1.28 . . . . 0.0 109.894 -179.539 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.598 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -162.47 -171.01 2.61 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.412 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.583 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 1.8 t80 . . . . . 0 C--N 1.294 -1.84 0 C-N-CA 118.501 -1.28 . . . . 0.0 109.168 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.581 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.212 -0.889 0 CA-C-O 120.234 0.064 . . . . 0.0 110.961 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.505 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.59 -40.5 11.61 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 106.152 -2.779 . . . . 0.0 106.152 177.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.624 HG12 ' CZ ' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -93.34 -57.4 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-O 122.402 1.096 . . . . 0.0 108.674 177.045 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.466 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 8.9 t -59.15 -28.53 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.93 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.656 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.3 mt-10 -90.96 -32.03 16.12 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 120.919 -1.113 . . . . 0.0 108.609 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 45' ' ' SER . 40.8 tt0 -78.5 -75.82 0.22 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 121.641 0.734 . . . . 0.0 109.196 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.53 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 1.7 m -41.25 -44.73 2.73 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 121.533 -0.73 . . . . 0.0 109.996 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -75.18 -45.59 39.61 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.318 -0.864 . . . . 0.0 110.726 -178.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.656 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 7.5 m-70 -90.11 -60.56 1.9 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.7 -1.25 . . . . 0.0 109.422 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 41' ' ' GLN . 7.9 t -88.15 -127.73 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 108.779 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.602 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -153.67 160.13 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.784 -1.198 . . . . 0.0 108.975 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.459 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 1.8 m -133.29 -166.09 1.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.689 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.594 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 5.7 m -146.47 144.04 29.38 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.6 OUTLIER -39.29 -39.12 0.6 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.749 0.785 . . . . 0.0 110.191 -179.431 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.594 ' CE2' ' HB2' ' A' ' 48' ' ' SER . 1.1 p90 -61.8 -38.1 86.84 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.585 ' HG3' ' CZ ' ' A' ' 50' ' ' TYR . 63.6 mt-30 -67.82 -48.26 66.74 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' A' ' 49' ' ' LEU . 1.1 mp -67.48 -24.46 65.6 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -57.67 -29.17 64.42 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -90.64 -10.6 42.66 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.574 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.624 ' CZ ' HG12 ' A' ' 38' ' ' ILE . 12.0 m-85 -90.01 7.74 36.04 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.47 ' O ' ' C ' ' A' ' 57' ' ' ASN . 0.8 OUTLIER -91.98 -161.32 0.81 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.631 -0.668 . . . . 0.0 109.502 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.494 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 7.3 p-10 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.005 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.655 ' CD1' ' N ' ' A' ' 2' ' ' VAL . 12.9 t80 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.503 0.668 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.655 ' N ' ' CD1' ' A' ' 1' ' ' PHE . 6.4 m -160.81 -167.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.474 ' CA ' HG21 ' A' ' 46' ' ' ILE . 10.7 m-20 -63.23 93.62 0.07 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.407 -0.808 . . . . 0.0 109.178 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.644 ' NE2' ' CE2' ' A' ' 1' ' ' PHE . 1.4 pt20 -130.13 175.12 9.16 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.179 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.579 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 34.9 m-70 -92.94 108.57 20.11 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.559 ' N ' ' O ' ' A' ' 42' ' ' CYS . 1.1 tp -111.75 126.47 55.09 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.091 -1.006 . . . . 0.0 111.022 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 11' ' ' LEU . 72.8 m -108.49 168.47 9.3 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.28 -45.65 0.1 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 12' ' ' VAL . 12.8 m -60.63 -69.8 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -1.189 . . . . 0.0 109.977 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.525 ' CB ' ' HG ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -66.42 -13.9 61.4 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 120.825 -1.172 . . . . 0.0 108.203 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -67.27 -49.64 63.54 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.269 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.614 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -64.75 -28.97 46.05 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.422 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.496 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 5.1 mt-10 -69.4 -59.82 2.74 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.543 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -52.82 -48.68 66.79 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.57 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.3 mt -63.13 -40.96 99.09 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.614 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.3 t80 -61.73 -21.42 64.49 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.18 -61.59 1.71 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.23 1.014 . . . . 0.0 108.47 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.579 ' CG1' ' HB3' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -54.46 -33.6 26.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.088 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -86.3 -65.05 1.05 Allowed 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.365 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.44 -72.12 0.23 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -130.32 -1.34 4.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -1.189 . . . . 0.0 109.808 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -72.8 -12.03 60.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.122 -0.986 . . . . 0.0 109.441 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 75.95 97.58 0.14 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.529 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -94.17 -176.82 4.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -1.163 . . . . 0.0 109.247 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.566 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 16.8 p90 -162.6 172.85 14.75 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.63 ' CE2' ' NE ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -112.14 122.4 47.64 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.224 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.535 HG21 ' CB ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -77.77 165.84 23.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.186 -0.946 . . . . 0.0 110.779 -178.062 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.551 ' O ' ' CG ' ' A' ' 34' ' ' PRO . 4.7 m-20 34.94 62.68 2.14 Favored Pre-proline 0 N--CA 1.493 1.686 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.117 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 37.1 Cg_endo -80.43 72.48 6.5 Favored 'Trans proline' 0 C--N 1.3 -1.983 0 C-N-CA 122.471 2.114 . . . . 0.0 110.209 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.1 p -146.1 -77.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.676 -1.265 . . . . 0.0 111.001 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 34' ' ' PRO . . . -84.3 179.5 51.72 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 120.329 -0.939 . . . . 0.0 110.784 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' C ' ' HD3' ' A' ' 34' ' ' PRO . . . -73.04 142.45 31.8 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.621 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 42.14 51.48 5.19 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.621 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 36.7 Cg_endo -76.62 -39.4 0.73 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.215 1.944 . . . . 0.0 108.657 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.63 ' NE ' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -97.61 34.02 1.93 Allowed 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 177.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.613 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -42.26 -21.85 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.343 -178.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.93 -44.51 13.56 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 106.286 -2.726 . . . . 0.0 106.286 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.626 HG12 ' CD2' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -93.52 -60.11 2.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 122.487 1.137 . . . . 0.0 108.399 177.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.469 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 23.6 t -51.05 -35.06 14.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.738 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.671 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 42.6 mt-10 -92.02 -20.45 21.32 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.83 -1.169 . . . . 0.0 109.593 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.557 ' O ' ' N ' ' A' ' 45' ' ' SER . 5.1 tp60 -86.21 -87.18 0.14 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.406 -0.809 . . . . 0.0 109.86 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.559 ' O ' ' N ' ' A' ' 6' ' ' LEU . 22.7 m -39.34 -41.09 0.87 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.618 -0.676 . . . . 0.0 109.694 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 6' ' ' LEU . 9.8 t -68.95 -53.46 20.68 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.911 -1.118 . . . . 0.0 110.948 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.671 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 13.8 m-70 -85.18 -47.53 10.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.032 -1.043 . . . . 0.0 110.015 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 41' ' ' GLN . 29.0 t -100.78 -124.82 0.17 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 108.916 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.579 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -157.93 163.05 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.754 -1.217 . . . . 0.0 109.135 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.524 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -158.76 168.97 25.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.459 -0.775 . . . . 0.0 109.571 179.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -119.18 163.59 16.85 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.114 0.959 . . . . 0.0 109.527 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 53' ' ' GLU . 25.1 mt -42.53 -33.71 0.73 Allowed 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 121.497 0.665 . . . . 0.0 109.637 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.594 ' CE1' ' HG2' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -56.99 -37.26 71.41 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.594 ' HG2' ' CE1' ' A' ' 50' ' ' TYR . 2.0 mm-40 -69.62 -59.78 2.74 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.463 ' HB3' ' HG ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -62.02 -16.86 54.78 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.6 tm-20 -68.05 -24.2 65.05 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -91.05 -24.87 19.91 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.752 0.787 . . . . 0.0 108.911 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.626 ' CD2' HG12 ' A' ' 38' ' ' ILE . 17.0 m-85 -81.06 4.18 20.66 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.566 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -83.07 -164.66 0.91 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.395 -0.816 . . . . 0.0 109.63 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 4.1 p-10 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.793 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.587 ' CD2' ' O ' ' A' ' 2' ' ' VAL . 15.8 p90 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.587 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 4.6 m -137.71 -165.3 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.928 -1.108 . . . . 0.0 110.005 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.448 ' HA ' ' CG2' ' A' ' 46' ' ' ILE . 28.3 m120 -41.71 99.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.995 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.531 ' N ' HG23 ' A' ' 46' ' ' ILE . 4.2 tt0 -148.7 166.46 28.31 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.408 -0.808 . . . . 0.0 109.66 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.578 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 24.1 m-70 -91.79 113.86 26.24 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.587 ' CD2' ' CB ' ' A' ' 14' ' ' ALA . 1.2 tp -120.58 129.12 53.63 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.422 -0.799 . . . . 0.0 110.691 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 11' ' ' LEU . 89.8 m -113.18 170.76 7.99 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.94 -1.1 . . . . 0.0 108.404 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.527 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.25 -45.87 0.1 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 12' ' ' VAL . 15.7 m -63.05 -67.76 0.4 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.19 . . . . 0.0 110.216 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.534 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 2.2 m-20 -67.57 -11.59 58.43 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.75 -1.219 . . . . 0.0 108.531 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.559 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -69.76 -49.7 50.44 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.031 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.617 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -63.92 -30.95 51.34 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.553 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 7.8 tt0 -69.9 -55.25 10.21 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.587 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -55.64 -49.75 72.02 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 1.4 mt -62.63 -41.61 99.12 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.617 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 7.4 t80 -59.39 -20.23 53.21 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.14 -65.38 1.02 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.094 0.949 . . . . 0.0 108.881 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.574 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -48.42 -28.69 2.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.42 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.48 -70.12 0.68 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.515 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.86 -62.83 0.49 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 19' ' ' CYS . 7.9 mp0 -134.4 -2.24 2.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -1.201 . . . . 0.0 110.364 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -74.42 -8.96 58.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.985 -1.072 . . . . 0.0 109.606 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.42 86.55 0.11 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.574 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -83.43 179.63 7.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -1.181 . . . . 0.0 109.407 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.574 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 29.4 p90 -163.3 166.57 22.92 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.156 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.401 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.1 OUTLIER -109.01 123.09 48.58 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.494 HG23 ' CD ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -78.86 156.64 28.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.858 -1.151 . . . . 0.0 111.201 -178.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 34' ' ' PRO . 8.1 t70 28.54 67.5 0.62 Allowed Pre-proline 0 N--CA 1.496 1.832 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.861 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 36.9 Cg_endo -79.57 63.14 8.69 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.747 2.298 . . . . 0.0 110.379 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.8 p -133.66 -79.12 0.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.822 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.406 ' O ' ' HD3' ' A' ' 34' ' ' PRO . . . -66.14 164.98 39.56 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.25 135.24 25.55 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.507 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 48.52 57.5 8.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.53 ' CB ' ' O ' ' A' ' 28' ' ' ASP . 31.9 Cg_endo -71.93 -28.88 15.85 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.502 2.135 . . . . 0.0 109.548 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.494 ' CD ' HG23 ' A' ' 27' ' ' THR . 1.5 tpm_? -119.07 45.09 2.17 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.579 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -41.53 -22.83 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.877 -178.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.2 -41.96 8.51 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 106.147 -2.781 . . . . 0.0 106.147 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.631 HG12 ' CE2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -94.12 -61.18 2.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 122.544 1.164 . . . . 0.0 108.668 176.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.542 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 37.9 t -54.79 -30.97 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.321 -177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.651 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.7 tt0 -92.73 -23.96 18.75 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 120.809 -1.182 . . . . 0.0 109.549 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 45' ' ' SER . 5.6 tt0 -82.81 -90.34 0.08 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.072 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.569 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.24 -37.09 0.88 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 109.997 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.542 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 15.3 t -68.95 -52.94 23.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.538 -1.351 . . . . 0.0 110.664 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.651 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 8.1 m-70 -91.25 -55.48 3.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.925 -1.11 . . . . 0.0 108.471 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.542 ' N ' ' O ' ' A' ' 41' ' ' GLN . 64.2 m -85.47 -131.46 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.578 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -151.97 152.78 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.674 -1.266 . . . . 0.0 109.114 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.481 ' N ' HG21 ' A' ' 46' ' ' ILE . 8.3 p -149.63 172.86 14.37 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 1' ' ' PHE . 67.4 m -136.73 169.46 17.69 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.999 -1.063 . . . . 0.0 110.272 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.585 HD13 ' CD1' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -41.93 -34.52 0.69 Allowed 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.795 1.283 . . . . 0.0 108.492 178.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -53.21 -52.72 58.0 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.072 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 48' ' ' SER . 2.1 mt-30 -74.11 -45.55 48.36 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.292 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 55' ' ' TYR . 1.1 mp -65.83 -14.39 61.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.414 -0.804 . . . . 0.0 109.032 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.5 tt0 -70.06 -28.09 65.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.156 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -90.39 -8.32 50.93 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.528 -0.732 . . . . 0.0 109.55 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.631 ' CE2' HG12 ' A' ' 38' ' ' ILE . 12.1 m-85 -90.33 2.05 55.92 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.49 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.3 m -78.64 -166.05 0.81 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.51 -0.744 . . . . 0.0 110.092 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.6 t-20 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.895 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.541 ' CB ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 1' ' ' PHE . 10.5 m -157.58 -167.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.754 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.54 ' CA ' HG22 ' A' ' 46' ' ' ILE . 2.0 m-80 -73.06 98.88 2.63 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.539 -0.725 . . . . 0.0 109.911 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.468 ' O ' HG23 ' A' ' 46' ' ' ILE . 3.2 pm0 -132.44 170.05 15.68 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.773 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.581 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 27.9 m-70 -93.35 113.65 25.88 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.563 ' CD1' ' HB3' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -114.14 144.43 43.17 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.426 -0.796 . . . . 0.0 109.899 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.578 ' O ' ' N ' ' A' ' 9' ' ' SER . 2.4 t -144.07 112.66 6.55 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.187 -0.946 . . . . 0.0 109.63 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.521 ' N ' ' HB2' ' A' ' 11' ' ' LEU . . . 40.94 -90.36 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 7' ' ' CYS . 7.5 m -37.28 -67.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.578 -0.954 . . . . 0.0 110.549 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.563 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 81.5 m-20 -68.0 -19.14 64.9 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.647 -1.283 . . . . 0.0 108.441 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.33 -48.5 72.8 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.409 -0.807 . . . . 0.0 109.024 178.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.62 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.6 m -67.62 -26.23 34.89 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.489 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.671 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 5.4 tt0 -71.87 -57.97 3.86 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.551 ' O ' ' CG2' ' A' ' 18' ' ' VAL . . . -52.69 -49.08 66.01 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.583 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 3.5 mt -64.32 -41.64 96.71 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.62 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 8.2 t80 -59.76 -24.26 63.91 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.17 -63.52 1.33 Allowed 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 122.104 0.954 . . . . 0.0 108.899 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.583 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -53.09 -28.88 14.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.914 -179.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.37 -70.58 0.65 Allowed 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.484 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.72 -64.02 0.18 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -131.63 -0.65 3.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.172 -1.193 . . . . 0.0 109.884 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 2.2 mtt85 -77.8 -9.53 59.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.143 -0.973 . . . . 0.0 109.914 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.9 92.4 0.05 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.537 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -87.0 -176.68 5.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.338 -1.095 . . . . 0.0 110.173 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CD1' ' C ' ' A' ' 25' ' ' PHE . 13.3 p90 -162.36 173.63 13.88 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.748 0.785 . . . . 0.0 109.415 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.661 ' CZ ' ' CD ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -112.36 123.32 50.02 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.506 HG22 ' CB ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -78.1 166.16 23.13 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.956 -1.09 . . . . 0.0 110.64 -178.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 3.5 m-20 35.01 64.23 1.9 Allowed Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 36.0 Cg_endo -77.66 77.12 3.99 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.853 2.368 . . . . 0.0 110.735 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.61 -79.42 0.61 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.081 -1.012 . . . . 0.0 109.34 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.16 152.67 12.39 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.24 78.88 0.15 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.89 75.27 0.28 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 28' ' ' ASP . 31.7 Cg_endo -72.23 -29.42 14.27 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.347 2.031 . . . . 0.0 109.441 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.661 ' CD ' ' CZ ' ' A' ' 26' ' ' TYR . 7.9 ptm180 -121.56 30.31 6.79 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -39.25 -24.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.793 -0.567 . . . . 0.0 111.931 -178.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -53.76 -42.42 68.33 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 105.252 -3.139 . . . . 0.0 105.252 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.649 HG12 ' CD2' ' A' ' 55' ' ' TYR . 1.2 mp -93.68 -50.43 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 121.838 0.828 . . . . 0.0 108.928 177.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.554 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 9.0 t -61.06 -29.66 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.813 -0.554 . . . . 0.0 110.21 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.638 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.2 tt0 -91.28 -12.62 34.59 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.483 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -90.75 -95.59 0.12 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.763 -0.585 . . . . 0.0 109.881 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.552 ' SG ' ' HB2' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -39.95 -28.27 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.37 -0.831 . . . . 0.0 110.002 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.556 ' N ' ' O ' ' A' ' 6' ' ' LEU . 18.7 t -73.76 -58.05 3.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.751 -1.218 . . . . 0.0 109.409 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.638 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 16.8 m-70 -80.28 -45.49 17.8 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.341 -0.849 . . . . 0.0 109.118 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 41' ' ' GLN . 14.9 t -106.42 -126.69 0.25 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.581 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.7 mp -150.25 165.87 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.742 -1.224 . . . . 0.0 109.561 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.564 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 20.2 p -154.13 178.04 10.42 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.556 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -139.63 163.7 31.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.719 -1.238 . . . . 0.0 110.888 -178.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.541 HD12 ' CB ' ' A' ' 1' ' ' PHE . 1.8 mp -39.2 -39.94 0.67 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.902 0.858 . . . . 0.0 109.978 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 2.3 p90 -63.36 -41.73 98.86 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.585 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 7.1 tp60 -66.18 -44.18 84.71 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.583 ' HA ' ' CD2' ' A' ' 55' ' ' TYR . 1.4 mp -75.75 -23.45 55.99 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.7 tt0 -60.86 -30.0 69.87 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -90.12 -8.92 50.14 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.649 ' CD2' HG12 ' A' ' 38' ' ' ILE . 13.8 m-30 -90.03 -0.45 57.59 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.54 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -90.55 -164.98 1.25 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.645 -0.659 . . . . 0.0 110.536 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.9 t-20 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.909 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.452 ' N ' ' CD2' ' A' ' 49' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.449 ' O ' ' OE1' ' A' ' 4' ' ' GLN . 17.0 m -146.85 -168.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.424 -0.798 . . . . 0.0 108.925 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.525 ' O ' ' ND2' ' A' ' 3' ' ' ASN . 4.3 p-10 -89.17 95.41 10.29 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.412 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.521 ' N ' HG23 ' A' ' 46' ' ' ILE . 3.9 pm0 -135.51 174.22 10.86 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 118.254 -1.378 . . . . 0.0 109.933 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.579 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 30.1 m-70 -90.8 106.77 18.74 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.586 ' CD2' ' CB ' ' A' ' 14' ' ' ALA . 1.1 tp -110.9 127.81 55.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.114 -0.991 . . . . 0.0 110.782 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 11' ' ' LEU . 61.1 m -111.94 169.05 9.11 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.42 -44.79 0.09 OUTLIER Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.472 ' O ' HG21 ' A' ' 12' ' ' VAL . 58.7 m -61.59 -69.44 0.24 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.133 -1.216 . . . . 0.0 110.078 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.512 ' CB ' ' HG ' ' A' ' 6' ' ' LEU . 31.6 m-20 -67.06 -12.52 60.16 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.906 -1.121 . . . . 0.0 108.205 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -68.21 -50.37 54.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -65.04 -31.65 54.84 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.527 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.275 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.71 -58.35 4.8 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.586 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -53.94 -51.94 62.19 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.57 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 1.2 mt -59.18 -44.56 92.17 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.606 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 14.5 t80 -56.07 -21.71 23.54 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -90.58 -67.22 0.86 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.94 0.876 . . . . 0.0 109.427 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.57 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -46.08 -29.41 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 121.613 0.72 . . . . 0.0 109.171 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -87.74 -72.89 0.5 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.846 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 69.16 -1.11 12.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER 159.45 -19.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.053 -1.263 . . . . 0.0 110.101 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -54.87 -18.33 4.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.097 -1.002 . . . . 0.0 109.37 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.64 68.5 1.27 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.939 -1.665 . . . . 0.0 108.939 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.499 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -72.06 178.74 3.62 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.338 -1.095 . . . . 0.0 109.836 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 10.4 p90 -162.77 -175.45 4.43 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.817 0.818 . . . . 0.0 109.359 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.62 ' CD2' ' CZ ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -131.87 109.53 10.16 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.034 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' HG2' ' A' ' 35' ' ' ARG . 11.0 t -77.9 -171.32 2.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.688 -1.258 . . . . 0.0 110.68 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.505 ' O ' ' HB2' ' A' ' 34' ' ' PRO . 2.7 m-20 38.93 69.08 1.7 Allowed Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.36 72.49 5.44 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.301 2.001 . . . . 0.0 110.627 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 p -134.66 -78.72 0.45 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.452 -0.78 . . . . 0.0 109.432 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.0 175.98 23.43 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.2 59.85 7.44 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.509 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 52.52 57.66 13.23 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 35' ' ' ARG . 31.3 Cg_endo -72.2 -49.72 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.476 2.117 . . . . 0.0 109.753 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.62 ' CZ ' ' CD2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -94.81 28.12 2.83 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.584 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -39.59 -24.71 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.766 -0.584 . . . . 0.0 111.782 -178.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.486 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.84 -44.08 17.41 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 106.173 -2.771 . . . . 0.0 106.173 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.613 HG12 ' CD2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -93.81 -57.67 4.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.447 1.117 . . . . 0.0 108.7 177.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 53.7 t -56.24 -32.09 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.075 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.658 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 4.3 tt0 -91.87 -17.96 24.49 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 120.849 -1.157 . . . . 0.0 109.156 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 45' ' ' SER . 7.4 tt0 -89.97 -85.98 0.2 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.623 -0.673 . . . . 0.0 109.377 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.571 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 22.4 m -39.75 -39.01 0.71 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.845 . . . . 0.0 109.677 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 39' ' ' VAL . 6.3 t -71.0 -53.86 13.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 110.587 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.658 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 15.7 m-70 -82.58 -51.84 7.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.127 -0.983 . . . . 0.0 109.68 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' GLN . 18.4 t -97.7 -123.84 0.14 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 108.747 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.579 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -159.9 162.5 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.797 -1.19 . . . . 0.0 108.839 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.535 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -157.63 174.73 14.91 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.283 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.601 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 5.1 m -126.93 159.65 33.38 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.192 -0.942 . . . . 0.0 110.328 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.542 ' CB ' ' CG1' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -38.79 -37.59 0.35 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.573 0.701 . . . . 0.0 111.033 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 3.4 p90 -54.53 -42.95 71.47 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.625 0.726 . . . . 0.0 109.813 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.625 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -75.01 -31.12 61.31 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.442 -0.786 . . . . 0.0 109.968 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.545 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 1.3 mp -79.29 -20.38 48.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.995 -1.066 . . . . 0.0 108.137 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -64.4 -23.31 67.24 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -90.44 -16.41 29.06 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.613 ' CD2' HG12 ' A' ' 38' ' ' ILE . 11.6 m-85 -86.53 1.77 50.38 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.573 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -90.81 -165.52 1.37 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.522 -0.736 . . . . 0.0 110.09 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' CYS . 3.5 t30 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.766 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' A' ' 2' ' ' VAL . 18.2 p90 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.546 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 6.8 m -123.08 -165.65 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.014 -1.054 . . . . 0.0 110.201 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.518 ' CA ' HG23 ' A' ' 46' ' ' ILE . 2.2 m120 -41.56 96.83 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.437 -0.789 . . . . 0.0 110.075 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.557 ' HG2' ' N ' ' A' ' 5' ' ' HIS . 5.0 tt0 -140.36 164.92 28.82 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.499 -0.751 . . . . 0.0 109.592 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.595 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 23.1 m-70 -89.27 104.41 16.96 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.612 ' CD2' ' CB ' ' A' ' 14' ' ' ALA . 1.1 tp -113.18 125.49 54.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.0 -1.062 . . . . 0.0 111.236 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.558 ' O ' ' N ' ' A' ' 11' ' ' LEU . 64.5 m -106.55 168.12 9.38 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.534 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . . . -32.99 -42.1 0.14 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.0 m -61.5 -69.95 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -1.204 . . . . 0.0 109.593 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.522 ' CB ' ' HG ' ' A' ' 6' ' ' LEU . 6.5 m-20 -66.42 -13.45 60.74 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.879 -1.138 . . . . 0.0 107.939 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.564 ' CD2' HD12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -64.74 -52.2 58.31 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.035 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.621 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -64.6 -29.3 46.98 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.512 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.443 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 4.0 tt0 -71.85 -54.08 11.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.612 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -54.13 -51.79 63.12 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.569 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 1.3 mt -61.92 -44.64 96.36 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.621 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 8.1 t80 -56.63 -21.5 27.59 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.11 -67.02 0.86 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.569 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -46.92 -29.68 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.22 -71.19 0.63 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.494 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.95 -66.6 0.19 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 19' ' ' CYS . 1.7 tt0 -129.23 -0.51 5.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 109.809 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.78 -6.78 55.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.995 . . . . 0.0 109.717 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 57' ' ' ASN . . . 67.77 94.5 0.04 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.513 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -91.56 -177.88 4.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.254 -1.145 . . . . 0.0 109.905 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 11.6 p90 -162.37 -178.02 6.03 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.599 ' CE1' ' CZ ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -122.65 115.58 22.35 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.534 ' CG2' ' HG2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -78.11 167.53 21.28 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.246 -0.909 . . . . 0.0 110.327 -178.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.528 ' O ' ' CG ' ' A' ' 34' ' ' PRO . 14.4 m-20 35.0 63.67 2.01 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 35.1 Cg_endo -77.12 90.79 1.22 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.657 2.238 . . . . 0.0 110.583 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 34' ' ' PRO . 35.6 p -127.97 -78.92 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.151 -0.968 . . . . 0.0 109.459 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.0 176.47 45.77 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 46.93 -115.18 1.85 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.47 ' O ' ' HD2' ' A' ' 36' ' ' ARG . . . -132.83 89.34 0.26 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 35' ' ' ARG . 31.0 Cg_endo -73.05 -51.2 0.17 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.431 2.087 . . . . 0.0 108.91 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.599 ' CZ ' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -99.26 33.39 2.44 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 177.146 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.529 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -46.21 -19.82 0.09 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.616 -177.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -50.35 -48.17 41.69 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.642 ' CG2' ' CZ ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -93.43 -21.18 6.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.93 -0.747 . . . . 0.0 109.413 178.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.503 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 0.9 OUTLIER -86.56 -59.47 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 0.0 109.196 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.594 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 23.0 tt0 -62.39 -14.46 40.53 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.115 -0.991 . . . . 0.0 108.478 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -81.96 -77.75 0.21 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.308 -0.87 . . . . 0.0 108.872 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 6' ' ' LEU . 23.6 m -42.75 -45.98 4.98 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' LEU . 11.5 t -64.54 -54.37 33.23 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.318 -0.864 . . . . 0.0 110.113 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.594 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 8.7 m-70 -86.99 -69.13 0.7 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.992 -1.067 . . . . 0.0 108.746 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 41' ' ' GLN . 6.7 t -75.15 -132.27 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.595 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.1 mp -155.3 159.68 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.805 -1.185 . . . . 0.0 109.121 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.559 ' CB ' ' NE2' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -150.45 177.6 9.84 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.744 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.477 ' OG ' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -130.41 156.56 44.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 109.903 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.8 mm? -39.91 -35.28 0.34 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.667 0.746 . . . . 0.0 110.258 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.602 ' CG ' ' N ' ' A' ' 51' ' ' GLN . 0.9 OUTLIER -52.3 -47.56 65.85 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.722 0.773 . . . . 0.0 109.178 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.602 ' N ' ' CG ' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -75.01 -33.0 61.76 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.707 -179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.598 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 1.9 mp -78.05 -19.23 54.68 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.176 -0.953 . . . . 0.0 108.64 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 49' ' ' LEU . 19.3 tt0 -67.11 -20.43 65.78 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -90.62 -12.39 37.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.572 -0.705 . . . . 0.0 109.708 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.642 ' CZ ' ' CG2' ' A' ' 38' ' ' ILE . 56.5 m-85 -90.37 4.76 49.95 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.107 -0.996 . . . . 0.0 109.084 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.57 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -81.65 -164.54 0.8 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.687 -0.633 . . . . 0.0 109.446 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 12.8 t30 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.139 -0.934 . . . . 0.0 109.575 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.65 ' CD2' ' NE2' ' A' ' 4' ' ' GLN . 22.2 p90 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.593 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 14.3 m -131.91 -165.59 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.866 -1.146 . . . . 0.0 110.583 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.461 ' CA ' HG22 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -53.04 88.94 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.016 -1.052 . . . . 0.0 110.092 -179.429 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.65 ' NE2' ' CD2' ' A' ' 1' ' ' PHE . 18.6 pt20 -135.76 177.6 7.7 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.366 -0.834 . . . . 0.0 109.275 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.562 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 30.5 m-70 -93.53 109.71 21.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.644 -0.66 . . . . 0.0 109.385 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . 1.1 tp -108.43 141.92 39.57 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.861 0.839 . . . . 0.0 110.301 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.556 ' O ' ' C ' ' A' ' 8' ' ' GLY . 60.7 m -128.93 167.82 16.87 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.556 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -25.91 -48.25 0.04 OUTLIER Glycine 0 N--CA 1.498 2.772 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.493 ' O ' HG22 ' A' ' 12' ' ' VAL . 24.0 m -63.17 -68.29 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -1.199 . . . . 0.0 110.227 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.52 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 16.5 m-20 -68.27 -10.24 53.27 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.792 -1.192 . . . . 0.0 108.727 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.81 -48.09 40.85 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.446 -0.901 . . . . 0.0 109.228 178.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.604 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -69.02 -32.05 52.83 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.428 0 C-N-CA 119.024 -1.071 . . . . 0.0 108.324 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -67.31 -57.74 6.1 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.559 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -54.3 -48.94 70.71 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 11' ' ' LEU . 1.7 mt -64.4 -41.01 96.88 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.109 0.957 . . . . 0.0 108.592 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.604 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.2 t80 -57.61 -21.22 37.95 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.51 -64.92 1.07 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 122.072 0.939 . . . . 0.0 109.245 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.53 -28.32 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.412 0.625 . . . . 0.0 109.519 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -90.04 -71.41 0.62 Allowed 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.676 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.63 -59.03 0.19 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' CYS . 2.4 pm0 -129.43 -28.79 2.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.222 -1.163 . . . . 0.0 110.331 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.56 -20.69 2.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.355 -0.841 . . . . 0.0 109.645 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 72.9 94.34 0.09 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.613 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -83.45 -169.26 2.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.309 -1.112 . . . . 0.0 110.203 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.613 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 3.3 p90 -161.87 178.6 8.77 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.53 ' CD2' ' HB2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -130.96 114.4 15.18 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.511 HG21 ' NH1' ' A' ' 35' ' ' ARG . 2.4 t -78.7 -178.91 6.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.922 -1.111 . . . . 0.0 111.235 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.478 ' CB ' ' CB ' ' A' ' 34' ' ' PRO . 12.6 p-10 -176.48 94.99 0.25 Allowed Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.547 ' CD ' ' O ' ' A' ' 34' ' ' PRO . 37.1 Cg_endo -77.37 11.0 2.25 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.682 2.255 . . . . 0.0 111.553 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.529 ' CG2' ' N ' ' A' ' 31' ' ' GLY . 0.8 OUTLIER 179.03 -68.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.587 -1.321 . . . . 0.0 109.814 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.529 ' N ' ' CG2' ' A' ' 30' ' ' THR . . . 172.05 -90.32 0.09 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 31' ' ' GLY . . . -44.46 115.37 1.3 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.544 ' O ' ' CD ' ' A' ' 36' ' ' ARG . . . 60.48 72.45 0.62 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.547 ' O ' ' CD ' ' A' ' 29' ' ' PRO . 31.1 Cg_endo -72.9 -51.55 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.507 2.138 . . . . 0.0 109.171 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.628 ' CG ' ' CD1' ' A' ' 38' ' ' ILE . 10.1 ttt85 -95.05 28.55 2.74 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.544 ' CD ' ' O ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -55.08 -23.82 22.27 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.735 -0.603 . . . . 0.0 111.97 -177.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 41' ' ' GLN . . . -53.3 -43.12 64.66 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 105.377 -3.089 . . . . 0.0 105.377 177.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.669 HG12 ' CD2' ' A' ' 55' ' ' TYR . 2.4 mp -94.45 -48.0 13.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.883 0.849 . . . . 0.0 109.175 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 2.1 t -60.68 -33.07 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.508 0.67 . . . . 0.0 109.571 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.647 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.4 tt0 -90.34 -17.36 27.45 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.56 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -90.08 -88.27 0.17 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.572 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 1.2 m -39.03 -33.45 0.12 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.845 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 39' ' ' VAL . 3.3 t -77.78 -46.61 21.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.029 -1.044 . . . . 0.0 110.986 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.647 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 16.1 m-70 -91.15 -34.01 15.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.886 -1.133 . . . . 0.0 109.111 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 41' ' ' GLN . 58.7 m -114.75 -126.41 0.29 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.579 ' CG2' ' N ' ' A' ' 47' ' ' CYS . 1.3 mp -159.87 165.39 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.514 -1.366 . . . . 0.0 109.633 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.579 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -156.11 -160.5 1.01 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.101 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 1' ' ' PHE . 4.5 p -160.38 161.67 33.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.097 -1.002 . . . . 0.0 109.643 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 0.3 OUTLIER -41.95 -35.88 0.97 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.898 1.332 . . . . 0.0 108.353 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 13.2 t80 -57.47 -53.1 61.97 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.38 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -73.41 -40.37 64.34 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.682 ' HA ' ' CD2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -68.76 -21.23 64.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.485 -0.76 . . . . 0.0 109.048 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 49' ' ' LEU . 2.1 tt0 -62.09 -25.26 67.61 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -90.59 -10.21 44.23 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.748 -0.595 . . . . 0.0 109.513 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.682 ' CD2' ' HA ' ' A' ' 52' ' ' LEU . 13.2 m-85 -84.32 -4.15 58.69 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 24' ' ' PHE . 1.2 m -90.79 -169.15 2.28 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.744 0.783 . . . . 0.0 111.12 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 55.5 t30 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.456 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.568 ' CE1' HD21 ' A' ' 49' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.455 ' N ' ' CD1' ' A' ' 1' ' ' PHE . 12.8 m -149.45 -168.63 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.693 -1.254 . . . . 0.0 109.58 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.496 ' CA ' HG23 ' A' ' 46' ' ' ILE . 1.3 m-80 -77.66 87.54 3.94 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 108.936 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.491 ' O ' HG21 ' A' ' 46' ' ' ILE . 5.9 pt20 -125.64 175.73 7.37 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.259 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.576 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 45.4 m-70 -92.1 112.01 23.79 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.58 ' N ' ' O ' ' A' ' 42' ' ' CYS . 1.0 OUTLIER -112.92 129.11 56.59 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.332 -0.855 . . . . 0.0 111.319 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 11' ' ' LEU . 91.4 m -111.15 170.52 8.06 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -29.93 -47.53 0.12 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' HG21 ' A' ' 12' ' ' VAL . 25.6 m -61.17 -68.11 0.34 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -1.189 . . . . 0.0 110.369 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.535 ' CB ' ' HG ' ' A' ' 6' ' ' LEU . 8.7 m-20 -67.46 -13.06 61.69 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.852 -1.155 . . . . 0.0 108.477 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -68.44 -49.18 61.77 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.195 -0.94 . . . . 0.0 108.551 177.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.614 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -64.48 -28.18 44.27 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.46 0 C-N-CA 119.114 -1.035 . . . . 0.0 108.509 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.4 OUTLIER -71.4 -56.55 5.75 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.547 ' CB ' HD21 ' A' ' 6' ' ' LEU . . . -55.41 -45.8 76.67 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.561 ' HA ' HG22 ' A' ' 18' ' ' VAL . 2.8 mt -66.31 -40.65 90.12 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.614 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 6.3 t80 -59.13 -20.12 50.85 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.95 -64.23 1.17 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 122.046 0.927 . . . . 0.0 108.791 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.75 -29.28 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.538 0.685 . . . . 0.0 109.294 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.92 -71.13 0.63 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.673 -179.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.6 -62.41 0.3 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 19' ' ' CYS . 25.6 mp0 -132.66 -10.96 3.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.132 -1.217 . . . . 0.0 110.663 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -67.96 -7.56 29.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.913 -1.117 . . . . 0.0 109.624 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.88 92.79 0.05 OUTLIER Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.626 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -86.36 -178.02 6.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.124 -1.221 . . . . 0.0 109.529 -179.747 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.626 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 16.6 p90 -162.19 168.38 22.54 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.617 ' CD1' ' HD2' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -109.18 125.87 52.66 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.458 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.493 ' O ' ' C ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -77.98 156.25 30.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.065 -1.022 . . . . 0.0 110.437 -178.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.537 ' O ' ' CG ' ' A' ' 34' ' ' PRO . 26.7 m-20 31.61 67.17 0.92 Allowed Pre-proline 0 N--CA 1.496 1.826 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.265 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 36.3 Cg_endo -78.76 78.64 3.62 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.739 2.293 . . . . 0.0 110.745 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.65 -76.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.057 -1.027 . . . . 0.0 109.921 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 34' ' ' PRO . . . -58.9 174.95 2.99 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.437 ' C ' ' HD3' ' A' ' 34' ' ' PRO . . . -74.22 -37.72 48.02 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.536 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . -132.04 57.9 0.71 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.537 ' CG ' ' O ' ' A' ' 28' ' ' ASP . 32.0 Cg_endo -73.49 -44.44 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.468 2.112 . . . . 0.0 109.412 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.617 ' HD2' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -98.22 31.52 2.74 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.592 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -40.17 -22.98 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.617 -178.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.15 -44.4 14.49 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 106.358 -2.697 . . . . 0.0 106.358 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.63 HG12 ' CD2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -93.5 -60.36 2.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 122.554 1.169 . . . . 0.0 108.43 177.015 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.538 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 34.3 t -51.56 -33.26 14.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.72 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.669 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 3.6 tt0 -93.46 -14.87 26.19 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 120.896 -1.128 . . . . 0.0 109.412 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 45' ' ' SER . 35.4 tt0 -88.53 -96.88 0.09 Allowed 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.98 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.58 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -39.75 -34.52 0.26 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.862 . . . . 0.0 109.912 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 13.4 t -67.2 -54.82 17.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.371 -1.455 . . . . 0.0 110.087 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.669 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 14.8 m-70 -84.75 -40.66 17.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 109.691 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' GLN . 9.3 t -110.39 -128.26 0.28 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.847 . . . . 0.0 108.801 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.576 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.4 mp -147.64 162.51 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.727 -1.233 . . . . 0.0 108.984 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.526 ' N ' HG22 ' A' ' 46' ' ' ILE . 18.8 p -154.97 160.26 40.97 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.922 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.532 ' HA ' ' CZ ' ' A' ' 1' ' ' PHE . 5.3 m -114.46 159.12 20.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.48 -0.762 . . . . 0.0 109.952 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.568 HD21 ' CE1' ' A' ' 1' ' ' PHE . 0.4 OUTLIER -39.64 -36.76 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.61 -0.681 . . . . 0.0 110.357 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.609 ' CE1' ' CG ' ' A' ' 51' ' ' GLN . 0.9 OUTLIER -53.0 -39.32 63.01 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 119.673 -0.811 . . . . 0.0 108.842 -179.091 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.609 ' CG ' ' CE1' ' A' ' 50' ' ' TYR . 1.5 mm-40 -72.98 -54.48 8.5 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.464 ' HB3' ' HG ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -64.21 -12.12 37.58 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 49' ' ' LEU . 12.1 tt0 -74.47 -28.0 60.83 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -90.92 -9.8 44.84 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.63 ' CD2' HG12 ' A' ' 38' ' ' ILE . 14.0 m-85 -89.76 1.6 55.9 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.473 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -90.51 -165.81 1.44 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.596 -0.69 . . . . 0.0 110.158 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 42.7 t-20 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.922 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.615 ' CD2' ' NE2' ' A' ' 4' ' ' GLN . 9.6 p90 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.721 0.772 . . . . 0.0 109.735 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.606 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 0.9 OUTLIER -104.34 -151.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 122.381 1.086 . . . . 0.0 110.309 -178.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.604 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 10.2 m120 -74.28 92.16 2.23 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.13 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.615 ' NE2' ' CD2' ' A' ' 1' ' ' PHE . 18.1 pt20 -132.96 175.02 9.73 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.109 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.581 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 39.1 m-70 -94.57 113.51 25.34 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.565 ' CD1' ' HB3' ' A' ' 10' ' ' ASP . 1.0 OUTLIER -117.98 136.09 53.74 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.149 -0.969 . . . . 0.0 110.177 -179.224 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 9' ' ' SER . 4.4 t -135.32 116.7 14.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.102 -0.999 . . . . 0.0 109.994 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.52 ' N ' ' HB2' ' A' ' 11' ' ' LEU . . . 39.19 -90.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.567 ' N ' ' O ' ' A' ' 7' ' ' CYS . 4.2 m -36.6 -68.47 0.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.639 -0.918 . . . . 0.0 110.518 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.565 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 52.4 m-20 -67.86 -20.12 65.1 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.719 -1.238 . . . . 0.0 108.561 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -64.74 -48.82 73.19 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.462 -0.895 . . . . 0.0 108.975 177.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.624 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -66.41 -27.93 41.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.658 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 27.4 tt0 -71.7 -53.46 13.44 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.541 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -57.94 -48.42 79.98 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.5 mt -63.66 -38.61 91.75 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.624 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 10.3 t80 -62.17 -20.24 63.93 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.82 -63.59 1.28 Allowed 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.79 -32.29 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.31 -73.23 0.53 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.846 0.832 . . . . 0.0 109.144 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 41.43 25.69 0.18 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 1.3 mt-10 162.18 -32.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.262 -1.14 . . . . 0.0 110.06 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.463 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.8 mtp85 -71.41 -4.92 29.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.394 -0.816 . . . . 0.0 109.58 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 64.75 91.27 0.03 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.47 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -88.52 178.11 6.61 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.138 -1.213 . . . . 0.0 109.812 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.453 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 33.7 p90 -163.39 158.59 21.35 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.625 ' CD1' ' CD ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -90.86 114.37 26.79 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.492 ' O ' ' C ' ' A' ' 28' ' ' ASP . 7.3 t -78.23 -165.53 0.69 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.857 -1.152 . . . . 0.0 110.303 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 34' ' ' PRO . 64.3 m-20 35.45 66.09 1.71 Allowed Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 34.7 Cg_endo -76.43 72.78 5.37 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 122.42 2.08 . . . . 0.0 110.542 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 34' ' ' PRO . 7.8 p -135.77 -78.33 0.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 109.519 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 153.55 169.06 18.15 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 33' ' ' GLY . . . 65.69 69.72 1.28 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.535 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 42.4 59.35 3.11 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 33.2 Cg_endo -75.8 -45.93 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.341 2.027 . . . . 0.0 109.078 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.625 ' CD ' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -94.48 22.51 6.07 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.581 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -39.67 -25.59 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.777 -0.577 . . . . 0.0 111.358 -178.319 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -47.03 -42.62 16.24 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.643 HG12 ' CD2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -94.67 -60.82 2.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 122.629 1.204 . . . . 0.0 108.26 176.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 49.6 t -53.43 -30.75 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.112 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.642 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.8 tt0 -94.4 -16.54 23.35 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 120.795 -1.19 . . . . 0.0 109.318 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 45' ' ' SER . 2.7 tp60 -90.15 -92.64 0.13 Allowed 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.179 -178.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -42.28 -32.62 0.52 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.83 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.557 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 25.3 t -68.72 -56.9 6.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.64 -1.288 . . . . 0.0 109.853 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.642 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 17.1 m-70 -83.29 -48.02 10.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.391 -0.818 . . . . 0.0 109.77 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 41' ' ' GLN . 19.5 t -106.38 -118.94 0.24 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.391 -0.818 . . . . 0.0 109.017 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.581 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.7 mp -151.09 165.53 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.74 -1.225 . . . . 0.0 109.013 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.551 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 24.2 p -146.82 -166.7 2.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.446 -0.784 . . . . 0.0 109.015 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.577 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 5.4 m -156.25 156.51 34.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.826 -1.171 . . . . 0.0 110.555 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.7 mm? -39.93 -37.03 0.52 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.509 0.671 . . . . 0.0 109.901 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 0.7 OUTLIER -58.34 -46.5 86.12 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.597 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -72.6 -40.77 66.28 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.481 HD12 ' CE1' ' A' ' 1' ' ' PHE . 1.6 mp -76.4 -14.74 60.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.19 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.56 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.7 tt0 -74.33 -25.71 59.71 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -90.24 -11.21 41.58 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.643 ' CD2' HG12 ' A' ' 38' ' ' ILE . 12.7 m-85 -87.59 -2.55 58.69 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -91.43 -170.66 2.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.565 -0.71 . . . . 0.0 109.976 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 28.0 t-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.237 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.635 ' CE2' ' NE2' ' A' ' 4' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.417 HG13 ' C ' ' A' ' 1' ' ' PHE . 35.4 m -139.83 -166.64 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.141 -0.975 . . . . 0.0 110.004 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.498 ' CA ' HG23 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -82.06 101.38 10.32 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.629 -0.669 . . . . 0.0 109.5 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.635 ' NE2' ' CE2' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -131.85 176.36 8.42 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.665 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.578 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 25.7 m-70 -93.85 108.32 20.11 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.616 ' CD2' ' CB ' ' A' ' 14' ' ' ALA . 1.1 tp -110.0 128.43 55.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.99 -1.068 . . . . 0.0 111.198 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.536 ' O ' ' N ' ' A' ' 11' ' ' LEU . 37.3 m -113.08 170.81 7.94 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -31.81 -44.51 0.15 Allowed Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.467 ' O ' HG23 ' A' ' 12' ' ' VAL . 3.3 m -63.56 -67.45 0.43 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.922 -1.34 . . . . 0.0 110.028 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.529 ' CB ' ' HG ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.12 -11.66 57.85 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.91 -1.118 . . . . 0.0 108.273 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.558 ' CD2' ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -67.86 -50.68 55.11 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.248 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.611 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -64.71 -29.52 47.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.443 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.496 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -71.21 -57.72 4.22 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.162 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.616 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -50.48 -50.55 52.27 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.56 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 1.6 mt -63.42 -45.77 89.44 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.611 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 2.1 t80 -55.88 -21.92 22.74 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.98 -66.85 0.86 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.085 0.945 . . . . 0.0 108.848 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.56 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.38 -29.6 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-O 121.618 0.723 . . . . 0.0 109.118 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.7 -74.91 0.46 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.825 0.821 . . . . 0.0 108.851 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 67.11 -0.19 8.42 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.537 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 2.7 tt0 163.1 -22.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.035 -1.274 . . . . 0.0 109.783 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.04 -17.45 6.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.114 -0.991 . . . . 0.0 109.581 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.75 77.56 1.12 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.544 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -78.88 -172.26 2.96 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.255 -1.144 . . . . 0.0 109.621 -179.75 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.563 ' CE2' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -162.89 -164.4 0.98 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.751 178.108 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.552 ' CE2' ' HG2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -144.75 97.87 3.09 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.37 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.518 ' O ' ' HB3' ' A' ' 28' ' ' ASP . 9.7 t -78.48 -172.57 2.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.99 -1.069 . . . . 0.0 110.149 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.531 ' CB ' ' HA ' ' A' ' 34' ' ' PRO . 4.3 p-10 168.7 70.54 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.43 19.03 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.894 2.396 . . . . 0.0 111.37 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.2 p -134.03 -79.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.813 -1.179 . . . . 0.0 109.923 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 32' ' ' GLY . . . 168.46 177.52 39.55 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 31' ' ' GLY . . . 43.41 -122.83 3.98 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' A' ' 36' ' ' ARG . . . -46.13 112.75 0.9 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.552 ' HG2' ' CE2' ' A' ' 26' ' ' TYR . 28.6 Cg_endo -67.39 -20.67 48.15 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.186 1.924 . . . . 0.0 110.247 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.491 ' HD2' ' HA ' ' A' ' 26' ' ' TYR . 14.3 mtp85 -148.19 28.87 0.9 Allowed 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.554 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -48.65 -20.1 0.42 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.518 -177.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.37 -51.94 53.0 Favored Glycine 0 C--N 1.295 -1.727 0 N-CA-C 105.794 -2.923 . . . . 0.0 105.794 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.649 ' CG2' ' CZ ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -93.72 -29.16 4.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 1.3 t -68.58 -55.69 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.607 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.5 tm-20 -61.24 -18.57 59.01 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -82.3 -82.4 0.14 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.545 ' O ' ' N ' ' A' ' 6' ' ' LEU . 29.0 m -39.87 -44.11 1.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.534 -0.728 . . . . 0.0 109.114 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.51 ' N ' ' O ' ' A' ' 6' ' ' LEU . 6.0 t -67.33 -52.99 33.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 110.659 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.607 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 12.6 m-70 -84.22 -57.82 3.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.063 . . . . 0.0 109.281 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 41' ' ' GLN . 14.0 t -88.23 -126.58 0.05 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.578 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -159.49 164.87 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.567 -1.333 . . . . 0.0 109.295 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.557 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -153.31 -168.14 2.92 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.39 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.453 ' O ' HD13 ' A' ' 52' ' ' LEU . 0.9 OUTLIER -150.44 160.45 43.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.955 . . . . 0.0 110.438 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.567 ' CD1' ' CD2' ' A' ' 1' ' ' PHE . 2.4 mp -42.71 -35.47 1.15 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.62 1.2 . . . . 0.0 109.061 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -54.01 -55.66 25.16 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.878 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -75.56 -37.34 60.02 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.014 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 48' ' ' SER . 0.5 OUTLIER -67.68 -19.62 65.2 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.044 179.339 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 49' ' ' LEU . 4.4 tt0 -65.6 -18.96 65.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.3 -0.875 . . . . 0.0 109.101 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -90.59 -11.39 40.14 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.394 -0.816 . . . . 0.0 109.985 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.649 ' CZ ' ' CG2' ' A' ' 38' ' ' ILE . 18.1 m-85 -90.58 6.46 43.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.995 -1.065 . . . . 0.0 109.061 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.458 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.1 m -91.91 -166.93 1.66 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.533 -0.729 . . . . 0.0 109.39 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.563 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 5.7 p-10 . . . . . 0 C--N 1.304 -1.398 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.111 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.644 ' CD2' ' NE2' ' A' ' 4' ' ' GLN . 12.2 p90 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.587 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 8.6 m -129.96 -166.73 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.083 -1.01 . . . . 0.0 109.99 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.544 ' CA ' HG23 ' A' ' 46' ' ' ILE . 1.2 m-80 -60.22 91.4 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 109.482 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.644 ' NE2' ' CD2' ' A' ' 1' ' ' PHE . 21.1 pt20 -132.16 175.43 9.25 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.119 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.563 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 27.2 m-70 -94.68 111.64 23.4 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 42' ' ' CYS . 1.1 tp -119.13 129.81 55.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.45 -0.781 . . . . 0.0 111.151 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.522 ' O ' ' C ' ' A' ' 8' ' ' GLY . 72.5 m -113.08 170.08 8.47 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.17 -44.93 0.08 OUTLIER Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.495 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 1.5 m -62.9 -68.39 0.34 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -1.159 . . . . 0.0 110.113 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.529 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.56 -11.09 57.24 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.863 -1.148 . . . . 0.0 108.412 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -70.36 -49.14 52.34 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.067 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.616 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 3.1 m -64.42 -31.26 52.79 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.492 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.671 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -68.61 -56.75 7.21 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.587 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.521 ' HB3' ' CD2' ' A' ' 6' ' ' LEU . . . -54.36 -50.91 66.38 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.55 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.4 mt -62.03 -41.0 97.64 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.616 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 17.9 t80 -58.78 -20.32 48.68 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.41 -66.94 0.88 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.898 0.856 . . . . 0.0 109.013 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.55 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -46.21 -30.92 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.583 0.706 . . . . 0.0 109.162 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.05 -67.6 0.83 Allowed 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.799 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.06 -66.36 0.49 Allowed Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' CYS . 14.8 mt-10 -136.28 -1.71 2.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -1.086 . . . . 0.0 110.009 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.453 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 3.0 mtm180 -66.89 -14.4 62.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.077 -1.015 . . . . 0.0 109.767 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.49 79.51 0.93 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.544 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -81.24 -177.32 6.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.362 -1.081 . . . . 0.0 109.406 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.544 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 8.4 p90 -161.52 -172.53 3.39 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.756 0.789 . . . . 0.0 109.449 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.452 ' OH ' ' CG2' ' A' ' 39' ' ' VAL . 0.6 OUTLIER -145.43 97.63 3.02 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.525 HG23 ' NE ' ' A' ' 35' ' ' ARG . 6.5 t -78.43 -176.03 4.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.927 -1.108 . . . . 0.0 110.264 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.544 ' CA ' ' HB2' ' A' ' 34' ' ' PRO . 4.2 p-10 173.5 108.28 0.06 OUTLIER Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD3' ' NH2' ' A' ' 35' ' ' ARG . 36.1 Cg_endo -74.19 6.65 2.92 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.3 2.0 . . . . 0.0 111.643 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.56 ' CG2' ' N ' ' A' ' 31' ' ' GLY . 0.8 OUTLIER -176.14 -69.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.619 -1.301 . . . . 0.0 110.148 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.56 ' N ' ' CG2' ' A' ' 30' ' ' THR . . . 153.7 179.12 28.85 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 50.55 87.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.592 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 51.02 54.31 23.37 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.063 -2.015 . . . . 0.0 108.063 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 33.3 Cg_endo -72.38 -47.42 0.4 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.561 2.174 . . . . 0.0 109.789 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.57 ' HG3' ' CD1' ' A' ' 38' ' ' ILE . 7.3 tpp180 -99.05 36.95 1.61 Allowed 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 177.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.587 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -46.68 -17.46 0.05 OUTLIER 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.526 -179.351 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.97 -42.75 16.1 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 106.146 -2.781 . . . . 0.0 106.146 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.594 HG12 ' CE2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -93.55 -62.38 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 2.6 t -48.54 -31.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.173 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.662 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.5 mt-10 -92.76 -22.34 19.41 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.914 -1.117 . . . . 0.0 108.873 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.493 ' HG3' ' N ' ' A' ' 42' ' ' CYS . 28.4 tp60 -82.77 -95.14 0.05 Allowed 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.434 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.57 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -40.84 -33.31 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.366 -0.834 . . . . 0.0 109.776 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.549 ' N ' ' O ' ' A' ' 6' ' ' LEU . 13.9 t -67.82 -58.74 4.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.483 -1.385 . . . . 0.0 109.719 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.662 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 14.6 m-70 -82.74 -58.61 2.82 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.25 -0.906 . . . . 0.0 108.922 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.439 ' O ' HD11 ' A' ' 46' ' ' ILE . 25.3 t -87.23 -129.72 0.06 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.563 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.5 mp -150.52 162.37 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.719 -1.238 . . . . 0.0 108.978 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.518 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 15.2 p -151.27 -168.03 2.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.43 -0.794 . . . . 0.0 109.115 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.6 ' HA ' ' CZ ' ' A' ' 1' ' ' PHE . 0.3 OUTLIER -155.6 163.62 39.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.066 -1.021 . . . . 0.0 110.384 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.571 HD12 ' CE1' ' A' ' 1' ' ' PHE . 0.2 OUTLIER -39.02 -39.01 0.5 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.641 0.734 . . . . 0.0 110.27 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.65 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 2.2 p90 -57.56 -44.03 84.95 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.65 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 2.8 tp60 -72.88 -41.75 64.34 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.441 HD12 ' SG ' ' A' ' 47' ' ' CYS . 1.1 mt -75.0 -15.72 60.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.125 -0.984 . . . . 0.0 109.019 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' LEU . 14.1 tt0 -70.38 -27.75 64.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.45 -0.781 . . . . 0.0 108.985 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -89.13 -10.53 46.92 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.594 ' CE2' HG12 ' A' ' 38' ' ' ILE . 10.5 m-85 -90.06 0.38 57.16 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.536 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.1 m -90.71 -165.89 1.46 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.477 -0.764 . . . . 0.0 110.293 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 56' ' ' CYS . 34.6 t30 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.911 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.646 ' CD1' ' N ' ' A' ' 2' ' ' VAL . 15.0 t80 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.646 ' N ' ' CD1' ' A' ' 1' ' ' PHE . 10.9 m -160.62 -167.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.382 -0.824 . . . . 0.0 109.589 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.521 ' CA ' HG21 ' A' ' 46' ' ' ILE . 4.6 m120 -63.96 91.29 0.07 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.414 -0.804 . . . . 0.0 109.188 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.646 ' NE2' ' CE2' ' A' ' 1' ' ' PHE . 2.6 pt20 -130.16 173.43 10.77 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.053 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.575 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 37.4 m-70 -90.92 108.46 19.86 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.569 ' N ' ' O ' ' A' ' 42' ' ' CYS . 1.2 tp -110.99 125.41 53.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 111.026 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 11' ' ' LEU . 79.0 m -110.84 170.61 7.98 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -31.39 -43.99 0.11 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 12' ' ' VAL . 9.9 m -62.5 -68.86 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.117 -1.225 . . . . 0.0 109.875 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.539 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 34.9 m-20 -66.86 -11.97 57.59 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.828 -1.17 . . . . 0.0 108.34 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -69.41 -48.72 60.18 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -65.87 -28.47 44.06 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.461 0 C-N-CA 119.094 -1.042 . . . . 0.0 108.489 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 1.0 OUTLIER -70.86 -60.22 2.36 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.001 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.54 ' O ' ' CG2' ' A' ' 18' ' ' VAL . . . -49.42 -50.81 39.02 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.57 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 1.3 mt -62.25 -44.47 96.47 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.606 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.5 t80 -58.78 -24.99 62.64 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -80.25 -65.67 0.98 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 122.334 1.064 . . . . 0.0 108.315 178.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.57 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -55.53 -29.12 23.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.164 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.539 ' SG ' ' CB ' ' A' ' 24' ' ' PHE . 33.4 m -88.34 -55.42 3.74 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.113 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 45.93 61.92 3.65 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 1.9 tt0 80.49 -3.19 1.88 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.514 -0.991 . . . . 0.0 110.256 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' CB ' ' SG ' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -57.36 -17.75 14.01 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.951 -1.093 . . . . 0.0 109.008 179.484 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' CA ' ' A' ' 57' ' ' ASN . . . 95.29 65.9 0.98 Allowed Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.539 ' CB ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -87.36 178.89 6.71 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.355 -1.085 . . . . 0.0 109.44 -179.369 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -162.48 -163.21 0.88 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.488 178.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.536 ' CE2' ' HD2' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -144.22 100.98 3.64 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.204 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 7.2 t -78.46 -176.2 4.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.931 -1.105 . . . . 0.0 110.935 -177.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.543 ' HA ' ' HB2' ' A' ' 34' ' ' PRO . 2.1 p30 173.43 106.42 0.06 OUTLIER Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.442 ' HD2' ' C ' ' A' ' 34' ' ' PRO . 36.0 Cg_endo -75.3 6.21 3.66 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.483 2.122 . . . . 0.0 111.924 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' A' ' 31' ' ' GLY . 0.8 OUTLIER 179.04 -68.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.605 -1.31 . . . . 0.0 109.9 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.555 ' N ' ' CG2' ' A' ' 30' ' ' THR . . . 158.69 -171.03 35.33 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . 42.69 90.07 0.01 OUTLIER Glycine 0 N--CA 1.494 2.566 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.585 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 49.37 56.32 11.11 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -178.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 35.3 Cg_endo -74.31 -49.07 0.19 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.392 2.061 . . . . 0.0 109.22 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.536 ' HD2' ' CE2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -96.29 28.67 3.16 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.174 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.627 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -46.59 -19.33 0.09 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.499 -178.371 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -48.12 -44.08 25.94 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 106.146 -2.781 . . . . 0.0 106.146 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.623 HG12 ' CE2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -93.19 -56.54 5.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 122.414 1.102 . . . . 0.0 108.342 177.201 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.545 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 4.2 t -55.78 -29.32 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.683 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.677 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -93.44 -28.88 15.86 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 120.818 -1.176 . . . . 0.0 109.579 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.515 ' HG3' ' N ' ' A' ' 42' ' ' CYS . 1.7 tp60 -76.25 -97.53 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.507 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.569 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -40.77 -33.76 0.32 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 110.463 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 17.0 t -67.36 -53.47 29.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.353 -1.467 . . . . 0.0 110.889 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.677 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 15.9 m-70 -84.52 -52.96 5.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.02 -1.05 . . . . 0.0 110.059 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.465 ' O ' HD12 ' A' ' 46' ' ' ILE . 32.4 t -98.48 -113.82 0.15 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 108.977 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.575 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.4 mp -159.42 161.56 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.825 -1.172 . . . . 0.0 108.668 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.518 ' N ' HG23 ' A' ' 46' ' ' ILE . 14.7 p -152.76 -171.0 3.8 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.566 -0.853 . . . . 0.0 109.535 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.611 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 4.8 m -143.86 156.97 44.65 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.345 1.069 . . . . 0.0 110.589 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.607 ' O ' ' N ' ' A' ' 53' ' ' GLU . 17.5 mt -39.44 -34.4 0.21 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.622 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.65 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 5.7 p90 -51.14 -42.63 60.88 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 118.532 -1.267 . . . . 0.0 108.108 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.65 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 1.7 pt20 -74.43 -53.54 9.35 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.548 ' N ' ' CG ' ' A' ' 51' ' ' GLN . 1.0 OUTLIER -62.14 -14.37 36.52 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.202 -0.936 . . . . 0.0 108.653 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 49' ' ' LEU . 20.8 tt0 -72.99 -31.46 64.53 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -91.57 -13.59 31.73 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.719 -0.613 . . . . 0.0 109.573 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.623 ' CE2' HG12 ' A' ' 38' ' ' ILE . 13.1 m-85 -82.65 -0.53 47.65 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.975 -1.078 . . . . 0.0 108.44 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 22' ' ' ARG . 1.2 t -66.94 -155.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.558 -0.714 . . . . 0.0 109.779 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.526 ' CA ' ' O ' ' A' ' 23' ' ' GLY . 24.1 p30 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.823 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.458 ' HB2' HD23 ' A' ' 49' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 m -141.6 -167.1 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.89 . . . . 0.0 109.548 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.533 ' CA ' HG22 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -70.15 109.36 4.57 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.474 -0.766 . . . . 0.0 109.394 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.524 ' HG2' ' N ' ' A' ' 5' ' ' HIS . 6.1 tt0 -134.54 163.13 30.4 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 110.189 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.601 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 20.0 m-70 -91.62 91.83 8.2 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.587 ' CD1' ' HB3' ' A' ' 10' ' ' ASP . 1.1 tp -91.19 165.98 13.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.929 -1.107 . . . . 0.0 109.694 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 9' ' ' SER . 16.4 t -167.44 112.32 0.71 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.588 -1.32 . . . . 0.0 109.43 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.508 ' N ' ' HB2' ' A' ' 11' ' ' LEU . . . 39.88 -90.15 0.01 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 7' ' ' CYS . 7.1 m -40.25 -68.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.406 -1.055 . . . . 0.0 110.655 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.587 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 26.6 m-20 -65.8 -24.19 66.86 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.502 -1.374 . . . . 0.0 108.644 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -59.93 -50.76 72.51 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.387 -0.925 . . . . 0.0 108.642 177.748 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.628 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -64.38 -26.12 39.59 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 C-N-CA 119.127 -1.029 . . . . 0.0 108.674 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.447 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -71.75 -57.77 4.06 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.436 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.558 ' CB ' HD22 ' A' ' 6' ' ' LEU . . . -54.21 -48.95 70.45 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.598 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.6 mt -62.77 -41.57 99.3 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.628 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 12.3 t80 -59.26 -20.9 58.09 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.6 -65.8 0.98 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.971 0.891 . . . . 0.0 109.178 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.598 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -46.72 -29.96 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-O 121.599 0.714 . . . . 0.0 109.258 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.19 -70.9 0.64 Allowed 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.543 -179.41 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.26 -67.52 0.37 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 19' ' ' CYS . 3.5 mt-10 -126.93 -7.62 6.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.223 -1.163 . . . . 0.0 109.825 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.465 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 3.8 mmt85 -70.16 -10.55 59.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.166 -0.959 . . . . 0.0 109.699 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.6 89.74 0.08 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -85.37 -177.12 6.39 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.348 -1.089 . . . . 0.0 109.731 -179.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.574 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 11.0 p90 -162.76 178.47 8.44 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.689 0.757 . . . . 0.0 109.337 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.593 ' CD1' ' HD2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -123.13 113.66 19.27 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 178.128 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.538 HG23 ' HG2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -77.24 169.75 17.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.752 -1.217 . . . . 0.0 110.835 -177.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.537 ' O ' ' CG ' ' A' ' 34' ' ' PRO . 10.5 m-20 33.15 61.83 1.56 Allowed Pre-proline 0 N--CA 1.494 1.773 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.922 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 36.3 Cg_endo -78.11 78.41 3.61 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.727 2.285 . . . . 0.0 110.543 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.83 -78.05 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.017 -1.052 . . . . 0.0 109.715 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 34' ' ' PRO . . . -67.71 179.35 17.42 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.453 ' C ' ' HD3' ' A' ' 34' ' ' PRO . . . -77.36 -32.02 49.18 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.529 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . -130.28 56.76 0.74 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.537 ' CG ' ' O ' ' A' ' 28' ' ' ASP . 33.8 Cg_endo -74.73 -35.95 3.11 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.492 2.128 . . . . 0.0 109.235 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.593 ' HD2' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -103.95 35.6 2.6 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 178.193 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.563 ' CB ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -42.06 -21.46 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.339 -178.46 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -48.21 -44.04 26.47 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 106.082 -2.807 . . . . 0.0 106.082 177.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.607 ' CG1' ' CZ ' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -93.27 -57.51 4.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 122.508 1.147 . . . . 0.0 108.513 177.145 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 54.6 t -57.03 -29.27 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.913 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.685 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.3 mt-10 -91.87 -32.96 15.11 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.862 -1.149 . . . . 0.0 109.02 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 45' ' ' SER . 1.5 tp-100 -74.86 -82.49 0.06 Allowed 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.8 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.536 ' C ' ' O ' ' A' ' 6' ' ' LEU . 15.5 m -42.21 -48.08 4.81 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.411 -0.805 . . . . 0.0 109.715 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 5.1 t -62.87 -47.94 81.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 110.429 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.685 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 8.8 m-70 -90.47 -65.41 1.02 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.888 -1.133 . . . . 0.0 108.963 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 41' ' ' GLN . 8.5 t -87.38 -137.31 0.09 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.601 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.4 mp -142.38 162.35 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.794 -1.191 . . . . 0.0 109.17 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.511 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -142.92 -161.58 1.28 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.408 179.213 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.591 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -152.45 149.81 28.96 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.329 -0.857 . . . . 0.0 109.818 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.539 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -38.96 -37.26 0.34 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.758 0.79 . . . . 0.0 110.805 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.595 ' C ' ' CD1' ' A' ' 50' ' ' TYR . 1.3 p90 -60.01 -37.8 80.8 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.556 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.586 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -77.56 -20.01 54.77 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.564 ' CD2' ' HG2' ' A' ' 51' ' ' GLN . 4.3 mm? -86.8 -28.03 23.21 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.08 -23.26 19.58 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -90.89 -23.23 20.58 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.607 ' CZ ' ' CG1' ' A' ' 38' ' ' ILE . 17.5 m-85 -81.25 0.23 37.75 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.574 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.1 m -90.78 -165.15 1.29 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.538 -0.726 . . . . 0.0 109.958 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.442 ' C ' ' O ' ' A' ' 56' ' ' CYS . 27.3 p-10 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.876 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 2' ' ' VAL . 34.5 p90 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.572 0.701 . . . . 0.0 109.641 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.598 ' CG1' ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER -94.13 -152.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 122.328 1.061 . . . . 0.0 110.983 -178.329 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.598 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 5.3 m120 -63.42 93.11 0.07 Allowed 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.55 ' HB3' ' CD2' ' A' ' 1' ' ' PHE . 4.6 tt0 -129.22 160.34 33.24 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.001 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.6 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 17.1 m-70 -85.05 93.89 8.71 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.593 ' CD1' ' C ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -79.31 -163.79 0.55 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.174 -0.954 . . . . 0.0 109.134 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.586 ' O ' ' C ' ' A' ' 8' ' ' GLY . 0.8 OUTLIER 170.83 141.25 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.623 -179.422 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -17.15 -55.19 0.01 OUTLIER Glycine 0 N--CA 1.502 3.063 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 7' ' ' CYS . 15.3 m -60.66 -66.2 0.57 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.208 -1.172 . . . . 0.0 109.717 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.593 ' C ' ' CD1' ' A' ' 6' ' ' LEU . 1.2 m-20 -67.46 -17.91 64.88 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.73 -1.231 . . . . 0.0 107.984 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -59.58 -53.05 62.56 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.634 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -63.62 -27.94 43.97 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.44 0 C-N-CA 118.801 -1.16 . . . . 0.0 108.08 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -71.8 -60.25 2.33 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.534 ' O ' ' CG2' ' A' ' 18' ' ' VAL . . . -50.79 -49.2 58.94 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.609 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 1.6 mt -62.81 -47.62 82.64 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 7.1 t80 -53.65 -25.55 18.44 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -82.02 -67.79 0.75 Allowed 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.101 0.953 . . . . 0.0 108.521 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.609 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -49.83 -28.74 4.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.526 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -87.21 -55.69 3.7 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.349 -0.94 . . . . 0.0 109.937 -179.07 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 21' ' ' GLU . . . 46.1 65.85 1.9 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 17.4 mm-40 80.92 -9.98 1.28 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.675 -0.897 . . . . 0.0 110.199 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.481 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 2.2 mmt180 -56.79 -17.22 8.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.915 -1.116 . . . . 0.0 109.415 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 57' ' ' ASN . . . 85.19 80.02 1.12 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.608 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -92.12 179.01 5.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -1.108 . . . . 0.0 109.902 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.608 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 40.1 p90 -162.68 175.14 11.66 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.88 121.17 43.87 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.529 ' CG2' ' HB3' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -77.61 170.99 15.62 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.004 -1.06 . . . . 0.0 110.528 -178.261 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 34' ' ' PRO . 0.7 OUTLIER 36.0 62.1 2.79 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -179.637 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 36.1 Cg_endo -77.53 66.37 7.98 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.578 2.185 . . . . 0.0 110.464 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.56 -79.36 0.55 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.124 -0.985 . . . . 0.0 109.812 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.2 -160.67 34.66 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 33' ' ' GLY . . . -91.75 159.38 25.74 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.521 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 43.79 57.32 4.69 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.546 ' CB ' ' O ' ' A' ' 28' ' ' ASP . 31.8 Cg_endo -72.24 -52.44 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.367 2.045 . . . . 0.0 108.933 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.529 ' HB3' ' CG2' ' A' ' 27' ' ' THR . 0.0 OUTLIER -97.85 31.32 2.69 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.077 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -39.93 -25.51 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.844 -177.443 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -48.82 -44.51 31.1 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.644 ' CG2' ' CZ ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -91.87 -34.19 6.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.192 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.569 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 1.4 t -76.48 -69.79 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.602 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.1 tt0 -45.06 -25.87 0.38 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.856 -1.152 . . . . 0.0 108.57 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -80.35 -78.62 0.17 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.568 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 1.7 m -42.39 -29.03 0.24 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.592 -0.692 . . . . 0.0 109.497 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.569 ' HB2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -85.08 -47.36 10.27 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.009 -1.057 . . . . 0.0 109.88 -179.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.602 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 7.0 m-70 -92.59 -53.27 4.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.11 -0.994 . . . . 0.0 109.288 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' GLN . 38.7 m -92.09 -122.85 0.08 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.6 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -160.6 166.07 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.652 -1.28 . . . . 0.0 109.07 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.567 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -156.35 -170.96 3.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.391 -0.818 . . . . 0.0 109.285 179.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.443 ' OG ' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -142.02 157.61 44.73 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.269 -0.894 . . . . 0.0 109.839 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.595 ' O ' ' N ' ' A' ' 53' ' ' GLU . 54.6 mt -42.65 -33.09 0.66 Allowed 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.661 0.743 . . . . 0.0 110.571 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.656 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 1.6 p90 -53.45 -44.01 68.53 Favored 'General case' 0 C--N 1.281 -2.406 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.046 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.656 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -74.95 -53.01 9.75 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.154 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.491 ' N ' ' CG ' ' A' ' 51' ' ' GLN . 1.2 mp -61.22 -15.47 34.83 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 49' ' ' LEU . 37.2 tt0 -70.59 -24.39 62.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -91.35 -14.18 31.19 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.635 -0.666 . . . . 0.0 109.415 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.644 ' CZ ' ' CG2' ' A' ' 38' ' ' ILE . 59.7 m-85 -86.15 4.34 38.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.126 -0.984 . . . . 0.0 108.879 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.521 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -77.51 -164.24 0.47 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.691 -0.631 . . . . 0.0 109.98 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 5.6 t-20 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.667 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.494 ' HB2' ' CD2' ' A' ' 49' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.564 0.697 . . . . 0.0 109.561 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.593 ' CG1' ' N ' ' A' ' 3' ' ' ASN . 0.8 OUTLIER -126.81 -153.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-O 122.413 1.101 . . . . 0.0 110.387 -178.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.593 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 2.0 m120 -89.85 99.81 12.75 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.982 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 46' ' ' ILE . 4.2 pm0 -132.71 171.95 13.19 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.165 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.582 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 32.5 m-70 -90.77 110.16 21.35 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 42' ' ' CYS . 1.1 tp -112.63 134.04 54.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.132 -0.98 . . . . 0.0 111.168 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.535 ' O ' ' C ' ' A' ' 8' ' ' GLY . 34.4 m -119.08 168.09 11.17 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.535 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -28.93 -45.24 0.06 OUTLIER Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 12' ' ' VAL . 19.5 m -63.15 -68.65 0.32 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -1.201 . . . . 0.0 109.997 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.519 ' CB ' ' HG ' ' A' ' 6' ' ' LEU . 53.3 m-20 -67.79 -10.01 49.1 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.845 -1.159 . . . . 0.0 108.572 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.579 ' CD2' HD11 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -72.66 -48.15 41.58 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.378 -0.826 . . . . 0.0 109.05 178.487 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.616 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -67.53 -28.9 43.62 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.43 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.726 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -70.83 -55.87 7.56 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.489 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.536 ' HB3' ' CD2' ' A' ' 6' ' ' LEU . . . -54.51 -50.79 66.98 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.571 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.1 mt -60.87 -45.17 95.6 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.616 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 17.3 t80 -57.19 -21.37 32.85 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.77 -65.76 0.99 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.132 0.968 . . . . 0.0 109.009 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.571 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -50.29 -28.45 5.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-O 121.409 0.623 . . . . 0.0 109.602 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -86.59 -65.46 1.01 Allowed 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.39 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.47 -71.0 1.07 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -132.97 -1.2 3.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -1.137 . . . . 0.0 109.93 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.469 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 26.1 mmm-85 -69.18 -11.86 61.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.056 -1.027 . . . . 0.0 109.658 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' O ' ' CG ' ' A' ' 57' ' ' ASN . . . 69.3 89.42 0.08 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.621 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -85.01 -175.67 5.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -1.128 . . . . 0.0 109.805 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.621 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 23.9 p90 -162.8 164.65 26.08 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.468 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.2 OUTLIER -103.7 127.57 51.14 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.072 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.529 HG22 ' CG ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -78.45 160.64 27.61 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.063 -1.023 . . . . 0.0 110.824 -178.245 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 34' ' ' PRO . 22.5 t70 32.73 64.6 1.27 Allowed Pre-proline 0 N--CA 1.494 1.761 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.313 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 36.3 Cg_endo -78.94 65.95 8.78 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.673 2.249 . . . . 0.0 110.245 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.76 -79.53 0.61 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.053 -1.029 . . . . 0.0 109.773 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.03 -156.2 32.24 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 33' ' ' GLY . . . -93.21 151.81 20.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.547 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 42.41 55.38 4.46 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 31.4 Cg_endo -72.64 -50.43 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.532 2.155 . . . . 0.0 109.078 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.576 ' CG ' ' CG2' ' A' ' 38' ' ' ILE . 6.3 tpm_? -98.37 34.09 2.07 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -39.51 -24.36 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.488 -178.105 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -49.94 -45.38 41.28 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.191 -2.364 . . . . 0.0 107.191 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.632 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -93.54 -26.19 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.413 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.502 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 0.9 OUTLIER -82.91 -59.93 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.292 -0.88 . . . . 0.0 109.101 179.735 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.613 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 4.9 tt0 -58.72 -16.6 17.31 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.4 OUTLIER -80.47 -82.41 0.11 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.372 -0.83 . . . . 0.0 109.392 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.557 ' O ' ' N ' ' A' ' 6' ' ' LEU . 28.5 m -39.57 -42.5 1.17 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.36 -0.838 . . . . 0.0 108.955 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 6' ' ' LEU . 4.8 t -69.54 -53.03 20.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.829 . . . . 0.0 111.043 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.613 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 12.7 m-70 -83.51 -48.76 9.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.868 -1.145 . . . . 0.0 109.663 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 41' ' ' GLN . 45.1 t -99.95 -124.42 0.16 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.582 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -159.49 165.23 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.706 -1.246 . . . . 0.0 109.206 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.556 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -148.16 -156.64 0.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.469 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.587 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 5.6 m -160.05 154.08 23.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 110.387 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -39.13 -38.86 0.52 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.644 0.735 . . . . 0.0 110.412 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 1.4 p90 -57.76 -46.46 84.49 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.623 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -71.69 -37.57 70.68 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.519 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.403 HD11 ' O ' ' A' ' 48' ' ' SER . 0.9 OUTLIER -76.48 -20.09 57.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.161 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 49' ' ' LEU . 26.0 tt0 -68.19 -22.66 64.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.323 -0.86 . . . . 0.0 108.868 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -89.92 -11.52 41.56 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.548 -0.72 . . . . 0.0 109.812 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.632 ' CZ ' ' HB ' ' A' ' 38' ' ' ILE . 17.5 m-85 -91.09 6.99 42.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.127 -0.983 . . . . 0.0 108.5 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.541 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.3 m -78.06 -164.55 0.54 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.715 -0.616 . . . . 0.0 109.927 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.3 t-20 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.743 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.563 ' CD1' HD11 ' A' ' 49' ' ' LEU . 2.5 t80 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.469 0.652 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.549 ' N ' ' CD1' ' A' ' 1' ' ' PHE . 12.3 m -161.53 -167.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.73 . . . . 0.0 109.467 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.427 ' C ' HG22 ' A' ' 46' ' ' ILE . 11.0 m-20 -59.9 87.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.449 -0.782 . . . . 0.0 108.976 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.499 ' NE2' HD12 ' A' ' 6' ' ' LEU . 20.3 pt20 -130.99 178.31 6.77 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.028 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.584 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 36.8 m-70 -91.84 106.05 18.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.542 ' CD2' ' HB1' ' A' ' 14' ' ' ALA . 1.1 tp -104.91 137.82 42.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.14 -0.975 . . . . 0.0 111.058 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.543 ' O ' ' C ' ' A' ' 8' ' ' GLY . 60.0 m -124.1 166.98 14.85 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -26.12 -47.91 0.04 OUTLIER Glycine 0 N--CA 1.498 2.798 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.4 m -61.82 -69.2 0.26 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.286 . . . . 0.0 109.948 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.526 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -68.17 -10.7 56.21 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.812 -1.18 . . . . 0.0 108.763 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.71 -47.42 39.63 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.246 -0.909 . . . . 0.0 109.316 178.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.607 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -71.57 -31.95 44.21 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.406 0 C-N-CA 118.789 -1.164 . . . . 0.0 108.485 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 16' ' ' TYR . 10.4 mt-10 -66.54 -54.27 25.6 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.542 ' HB1' ' CD2' ' A' ' 6' ' ' LEU . . . -59.69 -50.21 74.75 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.591 ' HB2' ' O ' ' A' ' 11' ' ' LEU . 2.8 mt -59.92 -39.89 86.99 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.607 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 7.9 t80 -59.45 -21.54 60.19 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.71 -65.54 1.01 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.969 0.89 . . . . 0.0 108.964 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.575 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -49.99 -27.43 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.578 0.704 . . . . 0.0 109.509 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 36.2 m -90.27 -69.24 0.74 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.854 -178.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.59 -71.82 1.55 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -137.7 1.83 2.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.351 -1.088 . . . . 0.0 109.964 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.475 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 42.4 mmm-85 -63.34 -12.35 29.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.004 -1.06 . . . . 0.0 109.864 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 57' ' ' ASN . . . 85.22 90.86 0.84 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -114.3 173.93 6.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -1.16 . . . . 0.0 109.668 -179.51 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.578 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 2.2 p90 -161.21 -61.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.408 -0.807 . . . . 0.0 109.025 178.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.578 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER 162.38 -88.81 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.575 ' CG2' ' CB ' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -166.05 -80.06 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.09 0.948 . . . . 0.0 108.946 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.542 ' N ' ' OG1' ' A' ' 27' ' ' THR . 45.4 t0 -143.79 112.64 5.38 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -74.7 83.81 1.7 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.268 1.979 . . . . 0.0 110.84 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 p -128.2 -78.71 0.57 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.318 -0.864 . . . . 0.0 109.484 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 32' ' ' GLY . . . -106.09 -150.37 18.35 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 34' ' ' PRO . . . -60.56 -131.39 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 32' ' ' GLY . . . -40.06 98.0 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.49 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 25.5 Cg_endo -63.12 -20.4 71.07 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.242 1.961 . . . . 0.0 109.556 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.575 ' CB ' ' CG2' ' A' ' 27' ' ' THR . 1.4 tpp180 -151.36 61.82 0.89 Allowed 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.531 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -38.96 -25.45 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.099 -179.36 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -45.25 -39.98 7.43 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 106.18 -2.768 . . . . 0.0 106.18 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.624 HG12 ' CZ ' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -93.38 -63.67 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-O 122.346 1.07 . . . . 0.0 108.261 176.691 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 3.3 t -48.82 -35.95 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.23 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.662 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 3.3 tt0 -91.25 -17.07 26.58 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.076 -1.015 . . . . 0.0 109.423 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 45' ' ' SER . 33.2 tt0 -90.58 -82.91 0.27 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.359 -0.838 . . . . 0.0 109.594 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 6' ' ' LEU . 24.5 m -39.28 -41.17 0.86 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.495 -0.753 . . . . 0.0 109.731 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.483 ' N ' ' O ' ' A' ' 6' ' ' LEU . 3.7 t -73.58 -51.25 17.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 111.177 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.662 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 14.9 m-70 -83.23 -41.9 17.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.871 -1.143 . . . . 0.0 109.95 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 41' ' ' GLN . 37.7 t -110.31 -121.64 0.27 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.584 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -158.94 165.6 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.794 -1.191 . . . . 0.0 109.394 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.568 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -148.09 -164.52 2.03 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.407 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.609 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 10.3 m -143.78 151.82 40.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 110.128 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.563 HD11 ' CD1' ' A' ' 1' ' ' PHE . 0.3 OUTLIER -39.11 -39.85 0.63 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.734 0.778 . . . . 0.0 110.143 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 48' ' ' SER . 1.2 p90 -63.13 -41.06 99.24 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.551 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 37.2 tp60 -63.67 -44.65 93.12 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.518 ' HA ' ' CD2' ' A' ' 55' ' ' TYR . 1.2 mp -72.38 -24.24 61.23 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -63.43 -24.08 67.68 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -0.821 . . . . 0.0 109.095 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -87.97 -9.16 54.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.492 -0.755 . . . . 0.0 109.457 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.624 ' CZ ' HG12 ' A' ' 38' ' ' ILE . 13.7 m-85 -90.14 2.0 55.79 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -80.28 -158.21 0.17 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.483 -0.761 . . . . 0.0 110.935 -178.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 23' ' ' GLY . 22.4 t-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.656 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.642 ' CD2' ' CD1' ' A' ' 49' ' ' LEU . 6.9 p90 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 4' ' ' GLN . 12.9 m -122.21 -168.93 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.137 -0.977 . . . . 0.0 109.623 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -43.51 94.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.341 -0.849 . . . . 0.0 109.725 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.546 ' NE2' ' CG ' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -143.19 167.87 21.09 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.205 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.601 ' CE1' ' O ' ' A' ' 44' ' ' HIS . 18.1 m-70 -93.14 111.79 23.54 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.585 ' CD2' ' CB ' ' A' ' 14' ' ' ALA . 1.2 tp -113.76 128.12 56.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.026 -1.046 . . . . 0.0 110.84 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 11' ' ' LEU . 64.6 m -111.04 167.56 10.17 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.524 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -31.36 -42.38 0.08 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.469 ' O ' HG21 ' A' ' 12' ' ' VAL . 42.3 m -62.68 -69.27 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.275 . . . . 0.0 109.491 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.518 ' CB ' ' HG ' ' A' ' 6' ' ' LEU . 1.1 m-20 -67.47 -10.92 56.04 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.934 -1.104 . . . . 0.0 108.484 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.558 ' CD2' HD12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -70.78 -48.88 51.92 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.385 -0.822 . . . . 0.0 109.043 178.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.613 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -67.08 -28.52 43.05 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.454 0 C-N-CA 118.802 -1.159 . . . . 0.0 108.297 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.456 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 6.4 tt0 -70.32 -57.15 5.17 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.585 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -54.38 -49.71 69.22 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.556 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 3.0 mt -61.62 -44.04 97.74 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.613 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 11.5 t80 -58.5 -27.0 64.07 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -78.79 -64.04 1.27 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 122.042 0.925 . . . . 0.0 108.568 179.137 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.556 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -53.34 -31.79 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.509 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -86.49 -64.32 1.17 Allowed 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.601 -0.839 . . . . 0.0 109.563 -179.41 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.25 -64.63 0.39 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 19' ' ' CYS . 1.6 mt-10 -138.79 2.74 2.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.262 -1.14 . . . . 0.0 110.077 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.461 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 14.2 mmt85 -74.19 -11.21 60.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.099 -1.0 . . . . 0.0 109.882 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 69.69 93.9 0.06 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.627 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -89.7 -167.25 1.8 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -1.126 . . . . 0.0 110.061 -179.595 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.627 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 15.0 p90 -160.63 170.82 20.07 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.514 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 1.5 t80 -107.04 -108.42 0.31 Allowed 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.805 -1.184 . . . . 0.0 109.628 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.556 HG21 ' CB ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -161.23 -159.73 0.67 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.185 -1.572 . . . . 0.0 109.414 -179.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.507 ' N ' ' OG1' ' A' ' 27' ' ' THR . 18.4 t0 -60.14 110.55 2.93 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.682 -0.636 . . . . 0.0 109.553 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 27' ' ' THR . 36.9 Cg_endo -81.56 71.95 6.59 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.568 2.179 . . . . 0.0 110.385 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.4 p -131.66 -79.09 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 109.78 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.9 166.88 30.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.73 121.15 9.36 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.456 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 77.03 60.75 2.82 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.499 ' CB ' ' O ' ' A' ' 28' ' ' ASP . 30.4 Cg_endo -71.54 -44.95 0.89 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.439 2.093 . . . . 0.0 108.865 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.556 ' CB ' HG21 ' A' ' 27' ' ' THR . 5.5 tpt180 -108.04 36.07 2.91 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -39.48 -27.34 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.119 -177.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -49.65 -42.61 36.31 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.973 -2.451 . . . . 0.0 106.973 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.655 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -93.99 -26.69 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.233 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.497 HG11 ' N ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -84.46 -60.48 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.412 -0.805 . . . . 0.0 109.462 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.626 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 34.0 tt0 -61.63 -13.98 26.9 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.221 -0.925 . . . . 0.0 109.284 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -79.85 -85.75 0.08 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.178 -0.951 . . . . 0.0 109.845 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.553 ' O ' ' N ' ' A' ' 6' ' ' LEU . 32.3 m -38.73 -42.65 0.83 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 6' ' ' LEU . 7.4 t -67.31 -54.82 17.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.478 -0.764 . . . . 0.0 110.553 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.626 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 10.6 m-70 -86.29 -59.13 2.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.837 -1.164 . . . . 0.0 109.18 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 41' ' ' GLN . 33.0 t -83.17 -132.89 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.574 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.5 mp -155.94 161.29 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.846 -1.159 . . . . 0.0 108.577 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.466 ' HA ' ' OE1' ' A' ' 51' ' ' GLN . 0.6 OUTLIER -141.54 -157.44 0.77 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.654 -1.218 . . . . 0.0 110.655 -179.064 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.589 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 5.4 m -151.18 146.44 26.11 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.874 0.845 . . . . 0.0 110.008 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.642 ' CD1' ' CD2' ' A' ' 1' ' ' PHE . 0.6 OUTLIER -37.7 -42.48 0.57 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.739 0.781 . . . . 0.0 111.04 -179.517 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.607 ' CZ ' ' CG ' ' A' ' 51' ' ' GLN . 3.6 p90 -61.94 -37.79 86.05 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.991 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.607 ' CG ' ' CZ ' ' A' ' 50' ' ' TYR . 72.0 mt-30 -67.64 -39.74 84.61 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.473 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -71.39 -28.87 64.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 109.057 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.46 ' OE1' HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -57.96 -23.04 52.01 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.214 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' ND2' ' N ' ' A' ' 54' ' ' ASN . 1.2 m120 -89.65 -15.52 32.49 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.807 -0.558 . . . . 0.0 109.573 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.655 ' CZ ' ' HB ' ' A' ' 38' ' ' ILE . 16.4 m-85 -90.54 5.51 47.49 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.448 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.1 m -90.89 -164.25 1.15 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.623 -0.673 . . . . 0.0 109.851 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 8.3 p-10 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.936 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.63 ' CD2' ' NE2' ' A' ' 4' ' ' GLN . 3.1 t80 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.508 0.671 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.594 ' N ' ' CD1' ' A' ' 1' ' ' PHE . 8.9 m -161.19 -167.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.49 -0.756 . . . . 0.0 109.439 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.496 ' CA ' HG23 ' A' ' 46' ' ' ILE . 3.4 m-80 -60.07 93.86 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.453 -0.779 . . . . 0.0 109.264 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.63 ' NE2' ' CD2' ' A' ' 1' ' ' PHE . 1.6 pt20 -134.42 173.84 11.19 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.154 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.548 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 43.3 m-70 -90.48 112.53 24.21 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 42' ' ' CYS . 1.1 tp -118.12 129.41 55.52 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.403 -0.811 . . . . 0.0 111.328 -178.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 11' ' ' LEU . 98.7 m -111.61 170.42 8.14 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -29.93 -45.71 0.09 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.514 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 1.1 m -62.1 -68.85 0.29 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.107 -1.231 . . . . 0.0 110.171 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.531 ' CB ' ' HG ' ' A' ' 6' ' ' LEU . 1.9 m-20 -67.46 -11.63 58.32 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.859 -1.15 . . . . 0.0 108.416 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.537 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -69.72 -49.09 56.58 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.607 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -63.83 -30.62 50.43 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.55 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.617 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.443 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 4.7 tt0 -69.09 -56.69 6.94 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.549 ' HB3' ' CD2' ' A' ' 6' ' ' LEU . . . -55.15 -49.38 71.95 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.556 ' HA ' HG22 ' A' ' 18' ' ' VAL . 1.5 mt -62.86 -40.97 99.12 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.607 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 8.7 t80 -58.36 -20.44 43.7 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.07 -66.67 0.9 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.982 0.896 . . . . 0.0 109.006 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.556 HG22 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -46.22 -30.08 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.516 ' SG ' ' CB ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -90.47 -71.1 0.64 Allowed 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.555 -179.358 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.24 -60.41 0.25 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 19' ' ' CYS . 17.0 mt-10 -138.11 -0.05 2.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.201 -1.176 . . . . 0.0 110.381 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.572 ' N ' ' CD ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -76.74 -4.07 41.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.99 -1.069 . . . . 0.0 109.685 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.99 84.85 0.18 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.546 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -83.13 -177.44 6.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.268 -1.136 . . . . 0.0 109.421 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.546 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 8.6 p90 -161.33 -172.69 3.49 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.394 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.47 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.2 OUTLIER -144.29 102.53 3.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.477 ' O ' ' HD3' ' A' ' 35' ' ' ARG . 8.8 t -78.94 -172.78 3.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.903 -1.123 . . . . 0.0 110.18 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.598 ' HA ' ' HB2' ' A' ' 34' ' ' PRO . 1.2 p30 167.5 84.44 0.02 OUTLIER Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 34' ' ' PRO . 35.5 Cg_endo -77.01 6.19 4.43 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.637 2.224 . . . . 0.0 112.661 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.31 -85.02 0.22 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.385 -1.447 . . . . 0.0 109.808 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 34' ' ' PRO . . . 171.53 -67.56 0.13 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 33' ' ' GLY . . . -82.26 112.64 3.53 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.576 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 46.74 57.48 6.71 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.598 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 35.2 Cg_endo -75.47 -44.03 0.33 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.582 2.188 . . . . 0.0 109.205 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.477 ' HD3' ' O ' ' A' ' 27' ' ' THR . 0.7 OUTLIER -96.43 30.83 2.41 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 177.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.595 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -46.28 -20.03 0.1 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.479 -178.405 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.4 -44.79 16.15 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 106.267 -2.733 . . . . 0.0 106.267 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.639 HG12 ' CD2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -93.92 -61.22 2.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 122.551 1.167 . . . . 0.0 108.229 176.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.538 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 13.9 t -49.11 -34.74 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.508 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.661 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 24.3 tt0 -93.35 -16.88 24.19 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 120.864 -1.147 . . . . 0.0 109.406 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 45' ' ' SER . 33.8 tt0 -86.65 -94.98 0.09 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.464 -0.772 . . . . 0.0 110.077 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.23 -34.9 0.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.469 -0.77 . . . . 0.0 109.895 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.542 ' N ' ' O ' ' A' ' 6' ' ' LEU . 16.3 t -66.34 -55.05 17.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.385 -1.447 . . . . 0.0 109.739 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.661 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 15.5 m-70 -84.22 -51.61 6.89 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.195 -0.941 . . . . 0.0 109.454 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' GLN . 35.1 t -98.44 -127.35 0.17 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.548 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.5 mp -148.04 164.57 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.679 -1.263 . . . . 0.0 108.818 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.539 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 21.4 p -149.97 -171.74 3.98 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.383 -0.823 . . . . 0.0 109.206 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.581 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 8.1 m -147.1 156.02 42.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.855 -1.153 . . . . 0.0 110.951 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -39.29 -38.57 0.54 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.79 0.805 . . . . 0.0 110.244 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.631 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 1.4 p90 -61.83 -47.83 83.29 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 121.772 0.796 . . . . 0.0 109.095 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.631 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -67.35 -39.99 85.8 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.52 ' HA ' ' CD2' ' A' ' 55' ' ' TYR . 1.4 mp -75.75 -18.37 59.58 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -62.82 -26.49 68.77 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.121 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -90.16 -10.76 43.33 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.287 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.639 ' CD2' HG12 ' A' ' 38' ' ' ILE . 11.2 m-85 -87.55 -1.81 58.19 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.489 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -90.61 -165.39 1.34 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.603 -0.686 . . . . 0.0 110.134 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 56' ' ' CYS . 4.3 t-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.816 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.522 ' CE2' ' CD ' ' A' ' 4' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 1' ' ' PHE . 12.5 m -153.13 -167.56 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.858 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.536 ' CA ' HG22 ' A' ' 46' ' ' ILE . 6.6 m120 -70.26 99.82 1.6 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.479 -0.763 . . . . 0.0 109.632 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.522 ' CD ' ' CE2' ' A' ' 1' ' ' PHE . 3.0 pm0 -131.88 165.53 23.65 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.125 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.581 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 20.5 m-70 -89.72 108.53 19.74 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.6 ' CD2' ' CB ' ' A' ' 14' ' ' ALA . 1.1 tp -112.88 128.94 56.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.139 -0.976 . . . . 0.0 110.817 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 11' ' ' LEU . 67.5 m -111.26 168.06 9.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -29.6 -45.89 0.08 OUTLIER Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' HG22 ' A' ' 12' ' ' VAL . 17.9 m -60.85 -69.87 0.21 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.088 -1.242 . . . . 0.0 110.093 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.534 ' CB ' ' HG ' ' A' ' 6' ' ' LEU . 1.2 m-20 -66.43 -13.44 60.76 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.856 -1.152 . . . . 0.0 108.362 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.543 HD23 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -66.78 -50.35 62.95 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.455 -0.778 . . . . 0.0 108.982 178.372 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -65.8 -30.55 50.4 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.472 0 C-N-CA 119.019 -1.072 . . . . 0.0 108.123 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.28 -57.31 6.16 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.697 -1.224 . . . . 0.0 107.697 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.6 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -54.93 -49.48 71.19 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.3 mt -62.88 -42.63 99.84 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.606 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 9.9 t80 -56.74 -21.54 28.97 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.44 -66.14 0.95 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.019 0.914 . . . . 0.0 109.226 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.575 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -47.62 -28.58 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.505 0.669 . . . . 0.0 109.427 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -90.18 -70.35 0.67 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.679 -179.427 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.63 -68.74 1.83 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -130.33 -6.88 4.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.157 -1.202 . . . . 0.0 110.122 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -66.01 -11.8 50.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.036 -1.04 . . . . 0.0 109.837 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 68.07 95.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.46 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 0.5 OUTLIER -93.93 174.88 6.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -1.178 . . . . 0.0 110.238 -179.648 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 29.2 p90 -165.19 151.89 10.4 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.473 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.2 OUTLIER -70.95 -115.42 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.454 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.57 ' CG2' ' HB2' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -164.06 -80.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.371 -1.456 . . . . 0.0 108.611 178.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.505 ' O ' ' CB ' ' A' ' 34' ' ' PRO . 6.2 t70 -106.37 99.09 22.18 Favored Pre-proline 0 C--N 1.296 -1.722 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 27' ' ' THR . 34.1 Cg_endo -75.91 85.99 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.562 2.175 . . . . 0.0 110.541 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.6 p -137.58 -77.74 0.39 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.323 -0.861 . . . . 0.0 109.77 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.89 -176.43 51.51 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.478 ' O ' ' HD3' ' A' ' 34' ' ' PRO . . . -62.13 -36.48 93.0 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.96 85.3 0.4 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.505 ' CB ' ' O ' ' A' ' 28' ' ' ASP . 27.1 Cg_endo -64.35 -19.53 65.62 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.422 2.081 . . . . 0.0 109.519 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.57 ' HB2' ' CG2' ' A' ' 27' ' ' THR . 0.0 OUTLIER -148.48 58.98 1.08 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.587 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.537 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -42.55 -23.76 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.908 -179.523 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.502 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.57 -40.72 8.83 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 106.219 -2.752 . . . . 0.0 106.219 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.603 HG12 ' CE2' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -94.32 -65.52 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 122.464 1.126 . . . . 0.0 108.02 176.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 16.2 t -46.78 -34.85 2.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.289 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.624 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 9.2 tt0 -91.63 -19.38 22.75 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.117 -0.989 . . . . 0.0 109.567 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 45' ' ' SER . 16.5 tt0 -90.36 -81.81 0.29 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.294 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.559 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 23.1 m -40.8 -41.77 1.64 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.502 -0.749 . . . . 0.0 109.113 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.518 ' N ' ' O ' ' A' ' 6' ' ' LEU . 6.8 t -69.09 -53.9 17.88 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.207 -0.933 . . . . 0.0 110.026 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.624 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 12.3 m-70 -83.9 -64.4 1.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 108.937 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 41' ' ' GLN . 3.7 t -82.0 -132.7 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.581 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -153.85 166.0 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.823 -1.173 . . . . 0.0 109.076 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.576 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -155.09 171.09 20.35 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.601 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.605 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 4.9 m -124.28 158.16 33.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.368 -0.832 . . . . 0.0 109.485 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -38.74 -39.22 0.48 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.715 0.769 . . . . 0.0 110.48 -179.408 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.606 ' CZ ' ' CG ' ' A' ' 51' ' ' GLN . 3.1 p90 -60.33 -36.43 77.92 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.38 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.606 ' CG ' ' CZ ' ' A' ' 50' ' ' TYR . 10.5 mt-30 -71.81 -47.36 53.8 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.457 HD23 ' HG ' ' A' ' 15' ' ' LEU . 1.5 mp -69.84 -16.64 63.3 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.25 -25.82 67.07 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -87.0 -11.83 49.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.467 -0.771 . . . . 0.0 109.449 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.603 ' CE2' HG12 ' A' ' 38' ' ' ILE . 11.9 m-85 -89.83 3.18 53.72 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.146 -0.971 . . . . 0.0 108.653 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.3 m -83.3 -166.96 1.5 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.456 -0.777 . . . . 0.0 110.015 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 21.2 p-10 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.698 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.575 ' CE2' ' OE1' ' A' ' 4' ' ' GLN . 2.0 t80 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.56 0.695 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.512 ' CG1' ' O ' ' A' ' 1' ' ' PHE . 10.2 m -161.6 -166.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.543 -0.723 . . . . 0.0 109.613 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.444 ' C ' HG22 ' A' ' 46' ' ' ILE . 10.7 m120 -62.08 88.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.005 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.575 ' OE1' ' CE2' ' A' ' 1' ' ' PHE . 1.6 pm0 -127.55 176.3 7.59 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.863 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.571 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 38.0 m-70 -90.48 104.55 17.12 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.558 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . 1.1 tp -102.0 139.12 38.05 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.084 -1.01 . . . . 0.0 110.684 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.553 ' O ' ' C ' ' A' ' 8' ' ' GLY . 53.6 m -127.11 167.9 15.36 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -26.49 -47.33 0.04 OUTLIER Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.48 ' O ' HG21 ' A' ' 12' ' ' VAL . 72.8 m -62.93 -68.95 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.095 -1.238 . . . . 0.0 110.304 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.523 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 35.1 m-20 -67.55 -10.47 52.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.826 -1.171 . . . . 0.0 108.568 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.551 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.34 -48.3 42.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.34 -0.85 . . . . 0.0 109.459 178.622 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.611 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -68.65 -30.52 47.52 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.497 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.292 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -68.74 -59.84 2.82 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.55 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.556 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . . . -51.8 -49.17 63.26 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.556 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 1.3 mt -63.98 -43.42 95.8 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.611 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 11.0 t80 -56.52 -21.42 26.08 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.65 -66.73 0.89 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 122.103 0.954 . . . . 0.0 109.14 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.556 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -47.96 -30.86 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.534 0.683 . . . . 0.0 109.311 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -90.58 -73.38 0.53 Allowed 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.862 0.839 . . . . 0.0 109.288 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 43.85 23.42 0.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER 157.12 -20.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.524 -0.986 . . . . 0.0 109.807 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.405 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 3.7 mtt180 -75.31 0.41 16.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.961 . . . . 0.0 109.818 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.42 74.31 0.45 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.57 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -74.54 -175.38 2.37 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.313 -1.11 . . . . 0.0 109.881 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CE1' ' O ' ' A' ' 55' ' ' TYR . 3.7 p90 -161.99 -169.25 2.14 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.898 0.856 . . . . 0.0 109.778 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.589 ' CE2' ' HG2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -151.98 104.99 3.04 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.131 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 1.8 t -77.83 -166.58 0.81 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.907 -1.121 . . . . 0.0 111.0 -177.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.568 ' HA ' ' O ' ' A' ' 34' ' ' PRO . 5.9 t0 172.2 77.83 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.25 12.65 2.0 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.774 2.316 . . . . 0.0 111.479 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.92 -78.93 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.756 -1.215 . . . . 0.0 109.812 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 32' ' ' GLY . . . 178.84 -96.01 0.1 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 33' ' ' GLY . . . -44.85 140.87 4.11 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 32' ' ' GLY . . . 52.11 94.82 0.01 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.064 -2.014 . . . . 0.0 108.064 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.589 ' HG2' ' CE2' ' A' ' 26' ' ' TYR . 21.3 Cg_endo -60.33 -15.41 35.03 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.431 2.087 . . . . 0.0 110.168 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.566 ' CG ' HD13 ' A' ' 38' ' ' ILE . 7.5 tpt85 -165.41 56.4 0.12 Allowed 'General case' 0 C--N 1.279 -2.48 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -43.59 -23.55 0.08 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.436 -179.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.27 -41.62 11.91 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 106.15 -2.78 . . . . 0.0 106.15 177.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.566 HD13 ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -93.93 -61.08 2.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 122.339 1.066 . . . . 0.0 108.374 176.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 8.0 t -51.01 -34.32 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.483 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.646 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.9 tt0 -90.8 -18.76 24.36 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.893 -1.129 . . . . 0.0 108.661 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 45' ' ' SER . 9.6 tt0 -90.59 -84.79 0.23 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.447 -0.783 . . . . 0.0 109.461 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.558 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 1.3 m -39.5 -35.89 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 0.0 109.672 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.526 ' N ' ' O ' ' A' ' 6' ' ' LEU . 4.0 t -74.63 -54.54 7.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.041 -1.037 . . . . 0.0 110.383 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.646 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 15.2 m-70 -79.15 -43.02 24.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.994 . . . . 0.0 109.528 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.6 t -108.35 -126.46 0.26 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.571 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -158.44 165.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.79 -1.194 . . . . 0.0 109.231 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.567 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -155.46 177.71 11.05 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.536 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 51' ' ' GLN . 5.2 m -130.95 155.98 45.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 109.51 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -38.77 -39.06 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.458 -0.776 . . . . 0.0 110.454 -179.391 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.589 ' CE1' ' HG2' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -53.31 -40.54 64.87 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.589 ' HG2' ' CE1' ' A' ' 50' ' ' TYR . 2.8 mt-30 -72.9 -56.47 5.14 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.478 ' CD2' ' HB3' ' A' ' 14' ' ' ALA . 1.2 mp -54.44 -20.29 7.28 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' LEU . 20.2 tt0 -69.1 -18.76 64.02 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.571 ' OD1' ' CD1' ' A' ' 55' ' ' TYR . 14.6 p30 -89.02 -26.0 21.68 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.937 0.875 . . . . 0.0 108.888 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.581 ' O ' ' CE1' ' A' ' 25' ' ' PHE . 15.4 m-85 -80.26 -0.65 37.36 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.0 OUTLIER -92.48 175.82 6.69 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.539 -0.726 . . . . 0.0 109.16 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.6 m-20 . . . . . 0 C--N 1.298 -1.667 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.942 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 2' ' ' VAL . 27.3 t80 . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 121.462 0.649 . . . . 0.0 109.628 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.601 ' CG1' ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER -153.82 -152.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-O 122.346 1.07 . . . . 0.0 110.455 -178.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.601 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 9.7 m120 -71.1 102.1 2.4 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.775 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.493 ' O ' HG21 ' A' ' 46' ' ' ILE . 2.8 tt0 -140.0 158.63 43.75 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.674 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.602 ' NE2' ' CD1' ' A' ' 46' ' ' ILE . 22.6 m-70 -81.53 97.72 7.95 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.604 ' CD1' ' CB ' ' A' ' 10' ' ' ASP . 0.4 OUTLIER -82.92 -170.18 2.88 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.025 -1.047 . . . . 0.0 109.589 -179.104 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.575 ' O ' ' C ' ' A' ' 8' ' ' GLY . 5.5 t 173.31 142.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.583 ' HA2' ' OH ' ' A' ' 26' ' ' TYR . . . -14.12 -57.85 0.01 OUTLIER Glycine 0 N--CA 1.5 2.948 0 N-CA-C 111.957 -0.457 . . . . 0.0 111.957 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 7' ' ' CYS . 8.0 m -56.63 -69.91 0.14 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.007 -1.29 . . . . 0.0 109.675 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.604 ' CB ' ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.4 -17.83 64.88 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.704 -1.248 . . . . 0.0 108.041 179.447 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.561 ' HB2' ' CA ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -60.67 -51.85 67.62 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.239 -0.913 . . . . 0.0 108.679 178.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.63 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -64.14 -26.08 39.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.493 -1.283 . . . . 0.0 108.226 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 1.1 tt0 -72.01 -60.39 2.26 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.533 ' O ' ' CG2' ' A' ' 18' ' ' VAL . . . -52.57 -46.43 66.85 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.587 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 3.3 mt -64.39 -44.41 91.41 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.63 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 14.0 t80 -56.44 -21.1 23.17 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.22 -65.91 0.97 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.862 0.839 . . . . 0.0 109.292 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.587 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -47.25 -30.47 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.849 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -88.08 -73.84 0.47 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 65.22 2.31 9.04 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 11.7 tt0 164.41 -23.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.87 -1.37 . . . . 0.0 109.717 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.474 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 4.6 mtt-85 -60.95 -12.21 10.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.842 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 74.98 83.08 0.41 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.598 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -81.77 -167.86 1.68 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.024 -1.28 . . . . 0.0 109.894 -179.539 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.598 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -162.47 -171.01 2.61 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.412 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.583 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 1.8 t80 -117.1 -101.06 0.43 Allowed 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 118.501 -1.28 . . . . 0.0 109.168 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.583 HG21 ' CB ' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -160.8 -155.15 0.4 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.315 -1.49 . . . . 0.0 109.879 -179.631 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.526 ' N ' ' OG1' ' A' ' 27' ' ' THR . 10.3 t0 -66.65 114.5 17.83 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.73 82.39 2.32 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.326 2.017 . . . . 0.0 110.544 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.1 p -119.62 -78.56 0.59 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.305 -0.872 . . . . 0.0 109.41 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.75 -121.83 3.07 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.4 140.37 15.99 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.51 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 61.49 56.03 25.56 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 30.9 Cg_endo -70.27 -28.11 23.21 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.412 2.075 . . . . 0.0 109.591 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.583 ' CB ' HG21 ' A' ' 27' ' ' THR . 5.1 tpt85 -125.37 49.75 1.87 Allowed 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.581 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -40.59 -21.91 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.961 -179.032 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -46.59 -40.5 11.61 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 106.152 -2.779 . . . . 0.0 106.152 177.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.624 HG12 ' CZ ' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -93.34 -57.4 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-O 122.402 1.096 . . . . 0.0 108.674 177.045 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.466 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 8.9 t -59.15 -28.53 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.93 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.656 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.3 mt-10 -90.96 -32.03 16.12 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 120.919 -1.113 . . . . 0.0 108.609 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 45' ' ' SER . 40.8 tt0 -78.5 -75.82 0.22 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 121.641 0.734 . . . . 0.0 109.196 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.53 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 1.7 m -41.25 -44.73 2.73 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 121.533 -0.73 . . . . 0.0 109.996 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -75.18 -45.59 39.61 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.318 -0.864 . . . . 0.0 110.726 -178.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.656 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 7.5 m-70 -90.11 -60.56 1.9 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.7 -1.25 . . . . 0.0 109.422 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 41' ' ' GLN . 7.9 t -88.15 -127.73 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 108.779 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.602 ' CD1' ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -153.67 160.13 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.784 -1.198 . . . . 0.0 108.975 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.459 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 1.8 m -133.29 -166.09 1.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.689 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.594 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 5.7 m -146.47 144.04 29.38 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.543 HD11 ' CD1' ' A' ' 1' ' ' PHE . 0.6 OUTLIER -39.29 -39.12 0.6 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.749 0.785 . . . . 0.0 110.191 -179.431 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.594 ' CE2' ' HB2' ' A' ' 48' ' ' SER . 1.1 p90 -61.8 -38.1 86.84 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.585 ' HG3' ' CZ ' ' A' ' 50' ' ' TYR . 63.6 mt-30 -67.82 -48.26 66.74 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' A' ' 49' ' ' LEU . 1.1 mp -67.48 -24.46 65.6 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -57.67 -29.17 64.42 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -90.64 -10.6 42.66 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.574 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.624 ' CZ ' HG12 ' A' ' 38' ' ' ILE . 12.0 m-85 -90.01 7.74 36.04 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.47 ' O ' ' C ' ' A' ' 57' ' ' ASN . 0.8 OUTLIER -91.98 -161.32 0.81 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.631 -0.668 . . . . 0.0 109.502 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.494 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 7.3 p-10 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.005 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.496 ' C ' HG21 ' A' ' 46' ' ' ILE . 10.7 m-20 -63.23 93.62 0.07 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.407 -0.808 . . . . 0.0 109.178 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.57 ' HG3' HD13 ' A' ' 6' ' ' LEU . 1.4 pt20 -130.13 175.12 9.16 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.179 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.933 ' NE2' HD11 ' A' ' 46' ' ' ILE . 34.9 m-70 -92.94 108.57 20.11 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.851 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -111.75 126.47 55.09 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.091 -1.006 . . . . 0.0 111.022 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.522 ' O ' ' C ' ' A' ' 8' ' ' GLY . 72.8 m -108.49 168.47 9.3 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.28 -45.65 0.1 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 12' ' ' VAL . 12.8 m -60.63 -69.8 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -1.189 . . . . 0.0 109.977 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.554 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -66.42 -13.9 61.4 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 120.825 -1.172 . . . . 0.0 108.203 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.072 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -67.27 -49.64 63.54 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.269 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.614 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -64.75 -28.97 46.05 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.422 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.496 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.428 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 5.1 mt-10 -69.4 -59.82 2.74 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.851 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -52.82 -48.68 66.79 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.751 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.3 mt -63.13 -40.96 99.09 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.614 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.3 t80 -61.73 -21.42 64.49 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -86.18 -61.59 1.71 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.23 1.014 . . . . 0.0 108.47 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.751 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -54.46 -33.6 26.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.088 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -86.3 -65.05 1.05 Allowed 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.365 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.44 -72.12 0.23 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -130.32 -1.34 4.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -1.189 . . . . 0.0 109.808 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -72.8 -12.03 60.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.122 -0.986 . . . . 0.0 109.441 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 75.95 97.58 0.14 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.529 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -94.17 -176.82 4.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -1.163 . . . . 0.0 109.247 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.566 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 16.8 p90 -162.6 172.85 14.75 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.496 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.84 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.633 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 111.343 0.127 . . . . 0.0 111.343 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.93 -44.51 13.56 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 106.286 -2.726 . . . . 0.0 106.286 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.072 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -93.52 -60.11 2.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 122.487 1.137 . . . . 0.0 108.399 177.115 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.495 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 23.6 t -51.05 -35.06 14.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.738 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.633 ' HB2' ' HB2' ' A' ' 36' ' ' ARG . 42.6 mt-10 -92.02 -20.45 21.32 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.83 -1.169 . . . . 0.0 109.593 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.557 ' O ' ' N ' ' A' ' 45' ' ' SER . 5.1 tp60 -86.21 -87.18 0.14 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.406 -0.809 . . . . 0.0 109.86 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.559 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 22.7 m -39.34 -41.09 0.87 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.618 -0.676 . . . . 0.0 109.694 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 6' ' ' LEU . 9.8 t -68.95 -53.46 20.68 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.911 -1.118 . . . . 0.0 110.948 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.482 ' ND1' ' HA ' ' A' ' 40' ' ' GLU . 11.7 m80 -85.18 -47.53 10.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.032 -1.043 . . . . 0.0 110.015 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 41' ' ' GLN . 29.0 t -100.78 -124.82 0.17 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 108.916 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.933 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -157.93 163.05 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.754 -1.217 . . . . 0.0 109.135 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.524 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -158.76 168.97 25.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.459 -0.775 . . . . 0.0 109.571 179.558 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.566 ' HG ' ' HD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -119.18 163.59 16.85 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.114 0.959 . . . . 0.0 109.527 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.617 ' HB3' HG13 ' A' ' 18' ' ' VAL . 25.1 mt -42.53 -33.71 0.73 Allowed 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 121.497 0.665 . . . . 0.0 109.637 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.616 ' CE1' ' HG2' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -56.99 -37.26 71.41 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.616 ' HG2' ' CE1' ' A' ' 50' ' ' TYR . 2.0 mm-40 -69.62 -59.78 2.74 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.473 ' HB3' ' HG ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -62.02 -16.86 54.78 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.6 tm-20 -68.05 -24.2 65.05 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -91.05 -24.87 19.91 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.752 0.787 . . . . 0.0 108.911 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.641 ' CD2' HG12 ' A' ' 38' ' ' ILE . 17.0 m-85 -81.06 4.18 20.66 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.566 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -83.07 -164.66 0.91 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.395 -0.816 . . . . 0.0 109.63 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 4.1 p-10 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.793 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 3' ' ' ASN . 4.6 m . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.557 0.694 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.452 ' HA ' ' CG2' ' A' ' 46' ' ' ILE . 28.3 m120 -41.71 99.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.995 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.651 ' H ' HG23 ' A' ' 46' ' ' ILE . 12.6 tt0 -148.7 166.46 28.31 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.408 -0.808 . . . . 0.0 109.66 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 1.025 ' NE2' HD11 ' A' ' 46' ' ' ILE . 24.1 m-70 -91.79 113.86 26.24 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.885 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.2 tp -120.58 129.12 53.63 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.422 -0.799 . . . . 0.0 110.691 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.527 ' O ' ' C ' ' A' ' 8' ' ' GLY . 89.8 m -113.18 170.76 7.99 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.94 -1.1 . . . . 0.0 108.404 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.527 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.25 -45.87 0.1 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.448 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 15.7 m -63.05 -67.76 0.4 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.19 . . . . 0.0 110.216 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 2.2 m-20 -67.57 -11.59 58.43 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.75 -1.219 . . . . 0.0 108.531 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.914 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.76 -49.7 50.44 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.031 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.617 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -63.92 -30.95 51.34 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.553 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.448 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 7.8 tt0 -69.9 -55.25 10.21 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.885 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -55.64 -49.75 72.02 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.77 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.4 mt -62.63 -41.61 99.12 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.617 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 7.4 t80 -59.39 -20.23 53.21 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -90.14 -65.38 1.02 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.094 0.949 . . . . 0.0 108.881 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.77 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -48.42 -28.69 2.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.42 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.48 -70.12 0.68 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.515 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.86 -62.83 0.49 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 19' ' ' CYS . 7.9 mp0 -134.4 -2.24 2.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -1.201 . . . . 0.0 110.364 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.485 ' HD3' ' O ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -74.42 -8.96 58.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.985 -1.072 . . . . 0.0 109.606 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.42 86.55 0.11 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.574 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -83.43 179.63 7.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -1.181 . . . . 0.0 109.407 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.574 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 29.4 p90 -163.3 166.57 22.92 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.156 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.423 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.878 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.599 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 119.927 -0.082 . . . . 0.0 110.877 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.2 -41.96 8.51 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 106.147 -2.781 . . . . 0.0 106.147 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.914 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -94.12 -61.18 2.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 122.544 1.164 . . . . 0.0 108.668 176.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.581 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 37.9 t -54.79 -30.97 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.321 -177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.599 ' CB ' ' HB2' ' A' ' 36' ' ' ARG . 1.7 tt0 -92.73 -23.96 18.75 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 120.809 -1.182 . . . . 0.0 109.549 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 45' ' ' SER . 29.6 tt0 -82.81 -90.34 0.08 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.072 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.569 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.24 -37.09 0.88 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 109.997 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 15.3 t -68.95 -52.94 23.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.538 -1.351 . . . . 0.0 110.664 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.46 ' ND1' ' HA ' ' A' ' 40' ' ' GLU . 5.5 m80 -91.25 -55.48 3.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.925 -1.11 . . . . 0.0 108.471 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.625 ' C ' HD12 ' A' ' 46' ' ' ILE . 64.2 m -85.47 -131.46 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 1.025 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -151.97 152.78 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.674 -1.266 . . . . 0.0 109.114 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.656 ' SG ' HD11 ' A' ' 52' ' ' LEU . 8.3 p -149.63 172.86 14.37 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.549 ' O ' HD12 ' A' ' 52' ' ' LEU . 67.4 m -136.73 169.46 17.69 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.999 -1.063 . . . . 0.0 110.272 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.702 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -41.93 -34.52 0.69 Allowed 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.795 1.283 . . . . 0.0 108.492 178.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -53.21 -52.72 58.0 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.072 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 48' ' ' SER . 2.1 mt-30 -74.11 -45.55 48.36 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.292 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.656 HD11 ' SG ' ' A' ' 47' ' ' CYS . 1.1 mp -65.83 -14.39 61.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.414 -0.804 . . . . 0.0 109.032 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.5 tt0 -70.06 -28.09 65.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.156 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -90.39 -8.32 50.93 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.528 -0.732 . . . . 0.0 109.55 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.742 ' CE2' HG23 ' A' ' 38' ' ' ILE . 12.1 m-85 -90.33 2.05 55.92 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.49 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.3 m -78.64 -166.05 0.81 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.51 -0.744 . . . . 0.0 110.092 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.6 t-20 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.895 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.606 ' O ' ' NE2' ' A' ' 4' ' ' GLN . 10.5 m . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.567 0.699 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.549 ' CA ' HG21 ' A' ' 46' ' ' ILE . 2.0 m-80 -73.06 98.88 2.63 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.539 -0.725 . . . . 0.0 109.911 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.606 ' NE2' ' O ' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -132.44 170.05 15.68 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.773 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.973 ' NE2' HD11 ' A' ' 46' ' ' ILE . 27.9 m-70 -93.35 113.65 25.88 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.941 HD21 ' HB2' ' A' ' 14' ' ' ALA . 0.9 OUTLIER -114.14 144.43 43.17 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.426 -0.796 . . . . 0.0 109.899 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.578 ' O ' ' N ' ' A' ' 9' ' ' SER . 2.4 t -144.07 112.66 6.55 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.187 -0.946 . . . . 0.0 109.63 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.532 ' N ' ' HB2' ' A' ' 11' ' ' LEU . . . 40.94 -90.36 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 7' ' ' CYS . 7.5 m -37.28 -67.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.578 -0.954 . . . . 0.0 110.549 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.593 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 81.5 m-20 -68.0 -19.14 64.9 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.647 -1.283 . . . . 0.0 108.441 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.84 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -65.33 -48.5 72.8 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.409 -0.807 . . . . 0.0 109.024 178.142 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.62 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.6 m -67.62 -26.23 34.89 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.489 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.671 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.475 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 5.4 tt0 -71.87 -57.97 3.86 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.941 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -52.69 -49.08 66.01 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.773 ' HA ' HG23 ' A' ' 18' ' ' VAL . 3.5 mt -64.32 -41.64 96.71 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.62 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 8.2 t80 -59.76 -24.26 63.91 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -84.17 -63.52 1.33 Allowed 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 122.104 0.954 . . . . 0.0 108.899 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -53.09 -28.88 14.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.914 -179.688 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.37 -70.58 0.65 Allowed 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.484 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.72 -64.02 0.18 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -131.63 -0.65 3.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.172 -1.193 . . . . 0.0 109.884 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 2.2 mtt85 -77.8 -9.53 59.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.143 -0.973 . . . . 0.0 109.914 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.9 92.4 0.05 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.537 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -87.0 -176.68 5.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.338 -1.095 . . . . 0.0 110.173 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CD1' ' C ' ' A' ' 25' ' ' PHE . 13.3 p90 -162.36 173.63 13.88 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.748 0.785 . . . . 0.0 109.415 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.492 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.294 -1.826 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.532 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -53.76 -42.42 68.33 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 105.252 -3.139 . . . . 0.0 105.252 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.84 ' CG2' HD21 ' A' ' 11' ' ' LEU . 1.2 mp -93.68 -50.43 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 121.838 0.828 . . . . 0.0 108.928 177.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 9.0 t -61.06 -29.66 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.813 -0.554 . . . . 0.0 110.21 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 36' ' ' ARG . 2.2 tt0 -91.28 -12.62 34.59 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -90.75 -95.59 0.12 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.763 -0.585 . . . . 0.0 109.881 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -39.95 -28.27 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.37 -0.831 . . . . 0.0 110.002 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.557 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 18.7 t -73.76 -58.05 3.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.751 -1.218 . . . . 0.0 109.409 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.45 ' ND1' ' HA ' ' A' ' 40' ' ' GLU . 16.0 m80 -80.28 -45.49 17.8 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.341 -0.849 . . . . 0.0 109.118 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.645 ' C ' HD12 ' A' ' 46' ' ' ILE . 14.9 t -106.42 -126.69 0.25 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.973 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.7 mp -150.25 165.87 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.742 -1.224 . . . . 0.0 109.561 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.564 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 20.2 p -154.13 178.04 10.42 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.55 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -139.63 163.7 31.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.719 -1.238 . . . . 0.0 110.888 -178.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.793 ' O ' HG11 ' A' ' 18' ' ' VAL . 1.8 mp -39.2 -39.94 0.67 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.902 0.858 . . . . 0.0 109.978 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 2.3 p90 -63.36 -41.73 98.86 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.585 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 7.1 tp60 -66.18 -44.18 84.71 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.594 ' CB ' HG21 ' A' ' 18' ' ' VAL . 1.4 mp -75.75 -23.45 55.99 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.7 tt0 -60.86 -30.0 69.87 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -90.12 -8.92 50.14 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.827 ' CE2' HG23 ' A' ' 38' ' ' ILE . 13.8 m-30 -90.03 -0.45 57.59 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.54 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -90.55 -164.98 1.25 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.645 -0.659 . . . . 0.0 110.536 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.9 t-20 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.909 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.449 ' O ' ' OE1' ' A' ' 4' ' ' GLN . 17.0 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 3' ' ' ASN . 4.3 p-10 -89.17 95.41 10.29 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.412 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.541 ' N ' HG23 ' A' ' 46' ' ' ILE . 3.9 pm0 -135.51 174.22 10.86 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 118.254 -1.378 . . . . 0.0 109.933 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.979 ' NE2' HD11 ' A' ' 46' ' ' ILE . 30.1 m-70 -90.8 106.77 18.74 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.949 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -110.9 127.81 55.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.114 -0.991 . . . . 0.0 110.782 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 11' ' ' LEU . 61.1 m -111.94 169.05 9.11 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.42 -44.79 0.09 OUTLIER Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 7' ' ' CYS . 58.7 m -61.59 -69.44 0.24 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.133 -1.216 . . . . 0.0 110.078 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.541 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 31.6 m-20 -67.06 -12.52 60.16 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.906 -1.121 . . . . 0.0 108.205 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.045 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -68.21 -50.37 54.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.488 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -65.04 -31.65 54.84 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.527 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.275 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.71 -58.35 4.8 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.949 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -53.94 -51.94 62.19 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.799 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.2 mt -59.18 -44.56 92.17 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.606 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 14.5 t80 -56.07 -21.71 23.54 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.58 -67.22 0.86 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.94 0.876 . . . . 0.0 109.427 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.059 HG13 ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -46.08 -29.41 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 121.613 0.72 . . . . 0.0 109.171 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -87.74 -72.89 0.5 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.846 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 69.16 -1.11 12.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER 159.45 -19.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.053 -1.263 . . . . 0.0 110.101 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -54.87 -18.33 4.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.097 -1.002 . . . . 0.0 109.37 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.64 68.5 1.27 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.939 -1.665 . . . . 0.0 108.939 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.499 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -72.06 178.74 3.62 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.338 -1.095 . . . . 0.0 109.836 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 10.4 p90 -162.77 -175.45 4.43 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.817 0.818 . . . . 0.0 109.359 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.465 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.835 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.599 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.486 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.84 -44.08 17.41 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 106.173 -2.771 . . . . 0.0 106.173 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.045 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.81 -57.67 4.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.447 1.117 . . . . 0.0 108.7 177.385 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 53.7 t -56.24 -32.09 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.075 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.599 ' CB ' ' HB2' ' A' ' 36' ' ' ARG . 4.3 tt0 -91.87 -17.96 24.49 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 120.849 -1.157 . . . . 0.0 109.156 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 45' ' ' SER . 7.4 tt0 -89.97 -85.98 0.2 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.623 -0.673 . . . . 0.0 109.377 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.585 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 22.4 m -39.75 -39.01 0.71 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.845 . . . . 0.0 109.677 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 39' ' ' VAL . 6.3 t -71.0 -53.86 13.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 110.587 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.456 ' ND1' ' HA ' ' A' ' 40' ' ' GLU . 14.1 m80 -82.58 -51.84 7.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.127 -0.983 . . . . 0.0 109.68 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' GLN . 18.4 t -97.7 -123.84 0.14 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 108.747 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.979 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -159.9 162.5 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.797 -1.19 . . . . 0.0 108.839 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.536 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -157.63 174.73 14.91 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.283 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.633 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 5.1 m -126.93 159.65 33.38 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.192 -0.942 . . . . 0.0 110.328 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.059 ' HG ' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -38.79 -37.59 0.35 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.573 0.701 . . . . 0.0 111.033 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.633 ' CD2' ' HB2' ' A' ' 48' ' ' SER . 3.4 p90 -54.53 -42.95 71.47 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.625 0.726 . . . . 0.0 109.813 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.625 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -75.01 -31.12 61.31 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.442 -0.786 . . . . 0.0 109.968 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.64 HD23 ' HG ' ' A' ' 15' ' ' LEU . 1.3 mp -79.29 -20.38 48.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.995 -1.066 . . . . 0.0 108.137 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -64.4 -23.31 67.24 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -90.44 -16.41 29.06 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.63 ' CD2' HG12 ' A' ' 38' ' ' ILE . 11.6 m-85 -86.53 1.77 50.38 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.573 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -90.81 -165.52 1.37 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.522 -0.736 . . . . 0.0 110.09 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' CYS . 3.5 t30 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.766 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 4' ' ' GLN . 6.8 m . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.561 0.696 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.505 ' HA ' ' CG2' ' A' ' 46' ' ' ILE . 2.2 m120 -41.56 96.83 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.437 -0.789 . . . . 0.0 110.075 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.577 ' HG2' ' N ' ' A' ' 5' ' ' HIS . 23.2 tt0 -140.36 164.92 28.82 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.499 -0.751 . . . . 0.0 109.592 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 1.064 ' NE2' HD11 ' A' ' 46' ' ' ILE . 23.1 m-70 -89.27 104.41 16.96 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.97 ' CD2' ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -113.18 125.49 54.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.0 -1.062 . . . . 0.0 111.236 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.558 ' O ' ' N ' ' A' ' 11' ' ' LEU . 64.5 m -106.55 168.12 9.38 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.555 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . . . -32.99 -42.1 0.14 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 7' ' ' CYS . 4.0 m -61.5 -69.95 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -1.204 . . . . 0.0 109.593 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.549 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 6.5 m-20 -66.42 -13.45 60.74 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.879 -1.138 . . . . 0.0 107.939 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.843 HD21 ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -64.74 -52.2 58.31 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.035 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.621 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -64.6 -29.3 46.98 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.512 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.443 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 4.0 tt0 -71.85 -54.08 11.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.97 ' HB2' ' CD2' ' A' ' 6' ' ' LEU . . . -54.13 -51.79 63.12 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.797 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.3 mt -61.92 -44.64 96.36 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.621 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 8.1 t80 -56.63 -21.5 27.59 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -88.11 -67.02 0.86 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.797 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -46.92 -29.68 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.22 -71.19 0.63 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.494 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.95 -66.6 0.19 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 19' ' ' CYS . 1.7 tt0 -129.23 -0.51 5.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 109.809 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.78 -6.78 55.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.995 . . . . 0.0 109.717 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 57' ' ' ASN . . . 67.77 94.5 0.04 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.513 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -91.56 -177.88 4.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.254 -1.145 . . . . 0.0 109.905 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 11.6 p90 -162.37 -178.02 6.03 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.677 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.562 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -50.35 -48.17 41.69 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.07 HG21 ' CE1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -93.43 -21.18 6.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.93 -0.747 . . . . 0.0 109.413 178.407 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.562 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 0.9 OUTLIER -86.56 -59.47 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 0.0 109.196 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.549 ' N ' HG12 ' A' ' 39' ' ' VAL . 23.0 tt0 -62.39 -14.46 40.53 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.115 -0.991 . . . . 0.0 108.478 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -81.96 -77.75 0.21 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.308 -0.87 . . . . 0.0 108.872 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.543 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 23.6 m -42.75 -45.98 4.98 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' LEU . 11.5 t -64.54 -54.37 33.23 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.318 -0.864 . . . . 0.0 110.113 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.567 ' O ' ' CE1' ' A' ' 5' ' ' HIS . 6.4 m80 -86.99 -69.13 0.7 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.992 -1.067 . . . . 0.0 108.746 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.553 ' C ' HD12 ' A' ' 46' ' ' ILE . 6.7 t -75.15 -132.27 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 1.064 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.1 mp -155.3 159.68 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.805 -1.185 . . . . 0.0 109.121 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.464 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -150.45 177.6 9.84 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.744 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.469 ' OG ' ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -130.41 156.56 44.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 109.903 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.786 HD22 ' H ' ' A' ' 49' ' ' LEU . 1.8 mm? -39.91 -35.28 0.34 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.667 0.746 . . . . 0.0 110.258 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.602 ' CG ' ' N ' ' A' ' 51' ' ' GLN . 0.9 OUTLIER -52.3 -47.56 65.85 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.722 0.773 . . . . 0.0 109.178 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.609 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -75.01 -33.0 61.76 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.707 -179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.609 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 1.9 mp -78.05 -19.23 54.68 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.176 -0.953 . . . . 0.0 108.64 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 49' ' ' LEU . 19.3 tt0 -67.11 -20.43 65.78 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -90.62 -12.39 37.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.572 -0.705 . . . . 0.0 109.708 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 1.07 ' CE1' HG21 ' A' ' 38' ' ' ILE . 56.5 m-85 -90.37 4.76 49.95 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.107 -0.996 . . . . 0.0 109.084 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.57 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -81.65 -164.54 0.8 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.687 -0.633 . . . . 0.0 109.446 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 12.8 t30 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.139 -0.934 . . . . 0.0 109.575 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 4' ' ' GLN . 14.3 m . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.703 0.763 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.468 ' CA ' HG21 ' A' ' 46' ' ' ILE . 2.7 m-20 -53.04 88.94 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.016 -1.052 . . . . 0.0 110.092 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 2' ' ' VAL . 18.6 pt20 -135.76 177.6 7.7 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.366 -0.834 . . . . 0.0 109.275 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.925 ' NE2' HD11 ' A' ' 46' ' ' ILE . 30.5 m-70 -93.53 109.71 21.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.644 -0.66 . . . . 0.0 109.385 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.0 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -108.43 141.92 39.57 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.861 0.839 . . . . 0.0 110.301 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.556 ' O ' ' C ' ' A' ' 8' ' ' GLY . 60.7 m -128.93 167.82 16.87 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.579 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -25.91 -48.25 0.04 OUTLIER Glycine 0 N--CA 1.498 2.772 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 7' ' ' CYS . 24.0 m -63.17 -68.29 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -1.199 . . . . 0.0 110.227 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.547 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 16.5 m-20 -68.27 -10.24 53.27 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.792 -1.192 . . . . 0.0 108.727 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.087 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -72.81 -48.09 40.85 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.446 -0.901 . . . . 0.0 109.228 178.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.604 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -69.02 -32.05 52.83 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.428 0 C-N-CA 119.024 -1.071 . . . . 0.0 108.324 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -67.31 -57.74 6.1 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 1.0 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.3 -48.94 70.71 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.777 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.7 mt -64.4 -41.01 96.88 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.109 0.957 . . . . 0.0 108.592 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.604 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.2 t80 -57.61 -21.22 37.95 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.51 -64.92 1.07 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 122.072 0.939 . . . . 0.0 109.245 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.777 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.53 -28.32 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.412 0.625 . . . . 0.0 109.519 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -90.04 -71.41 0.62 Allowed 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.676 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.63 -59.03 0.19 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' CYS . 2.4 pm0 -129.43 -28.79 2.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.222 -1.163 . . . . 0.0 110.331 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.56 -20.69 2.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.355 -0.841 . . . . 0.0 109.645 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 72.9 94.34 0.09 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.613 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -83.45 -169.26 2.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.309 -1.112 . . . . 0.0 110.203 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.613 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 3.3 p90 -161.87 178.6 8.77 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.452 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.7 OUTLIER . . . . . 0 C--N 1.295 -1.78 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.527 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 41' ' ' GLN . . . -53.3 -43.12 64.66 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 105.377 -3.089 . . . . 0.0 105.377 177.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.087 ' CG2' HD21 ' A' ' 11' ' ' LEU . 2.4 mp -94.45 -48.0 13.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.883 0.849 . . . . 0.0 109.175 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 2.1 t -60.68 -33.07 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.508 0.67 . . . . 0.0 109.571 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 36' ' ' ARG . 1.4 tt0 -90.34 -17.36 27.45 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.56 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -90.08 -88.27 0.17 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.579 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 1.2 m -39.03 -33.45 0.12 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.845 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 39' ' ' VAL . 3.3 t -77.78 -46.61 21.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.029 -1.044 . . . . 0.0 110.986 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 15.3 m80 -91.15 -34.01 15.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.886 -1.133 . . . . 0.0 109.111 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 41' ' ' GLN . 58.7 m -114.75 -126.41 0.29 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.925 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -159.87 165.39 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.514 -1.366 . . . . 0.0 109.633 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.579 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -156.11 -160.5 1.01 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.101 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.539 ' O ' HD12 ' A' ' 52' ' ' LEU . 4.5 p -160.38 161.67 33.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.097 -1.002 . . . . 0.0 109.643 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.618 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -41.95 -35.88 0.97 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.898 1.332 . . . . 0.0 108.353 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 13.2 t80 -57.47 -53.1 61.97 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.38 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -73.41 -40.37 64.34 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.694 ' HA ' ' CD2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -68.76 -21.23 64.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.485 -0.76 . . . . 0.0 109.048 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 49' ' ' LEU . 2.1 tt0 -62.09 -25.26 67.61 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -90.59 -10.21 44.23 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.748 -0.595 . . . . 0.0 109.513 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.696 ' CD2' HG12 ' A' ' 38' ' ' ILE . 13.2 m-85 -84.32 -4.15 58.69 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 24' ' ' PHE . 1.2 m -90.79 -169.15 2.28 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.744 0.783 . . . . 0.0 111.12 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 55.5 t30 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.456 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 121.45 0.643 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.522 ' CA ' HG21 ' A' ' 46' ' ' ILE . 2.7 m120 -77.66 87.54 3.94 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 108.936 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.622 ' HG3' HD13 ' A' ' 6' ' ' LEU . 5.9 pt20 -125.64 175.73 7.37 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.259 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.833 ' NE2' HD11 ' A' ' 46' ' ' ILE . 45.4 m-70 -92.1 112.01 23.79 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.816 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -112.92 129.11 56.59 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.332 -0.855 . . . . 0.0 111.319 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' O ' ' C ' ' A' ' 8' ' ' GLY . 91.4 m -111.15 170.52 8.06 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.522 ' HA2' ' OH ' ' A' ' 26' ' ' TYR . . . -29.93 -47.53 0.12 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.462 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 25.6 m -61.17 -68.11 0.34 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -1.189 . . . . 0.0 110.369 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.574 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 8.7 m-20 -67.46 -13.06 61.69 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.852 -1.155 . . . . 0.0 108.477 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.996 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -68.44 -49.18 61.77 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.195 -0.94 . . . . 0.0 108.551 177.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.614 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -64.48 -28.18 44.27 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.46 0 C-N-CA 119.114 -1.035 . . . . 0.0 108.509 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.4 OUTLIER -71.4 -56.55 5.75 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.816 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -55.41 -45.8 76.67 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.765 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.8 mt -66.31 -40.65 90.12 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.614 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 6.3 t80 -59.13 -20.12 50.85 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -89.95 -64.23 1.17 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 122.046 0.927 . . . . 0.0 108.791 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.765 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.75 -29.28 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.538 0.685 . . . . 0.0 109.294 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.92 -71.13 0.63 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.673 -179.401 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.6 -62.41 0.3 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 19' ' ' CYS . 25.6 mp0 -132.66 -10.96 3.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.132 -1.217 . . . . 0.0 110.663 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -67.96 -7.56 29.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.913 -1.117 . . . . 0.0 109.624 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.88 92.79 0.05 OUTLIER Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.626 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -86.36 -178.02 6.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.124 -1.221 . . . . 0.0 109.529 -179.747 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.626 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 16.6 p90 -162.19 168.38 22.54 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.522 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.29 -2.002 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.605 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.15 -44.4 14.49 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 106.358 -2.697 . . . . 0.0 106.358 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.996 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.5 -60.36 2.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 122.554 1.169 . . . . 0.0 108.43 177.015 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.574 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 34.3 t -51.56 -33.26 14.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.72 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.605 ' CB ' ' HB2' ' A' ' 36' ' ' ARG . 3.6 tt0 -93.46 -14.87 26.19 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 120.896 -1.128 . . . . 0.0 109.412 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 45' ' ' SER . 35.4 tt0 -88.53 -96.88 0.09 Allowed 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.98 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.58 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -39.75 -34.52 0.26 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.862 . . . . 0.0 109.912 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.574 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 13.4 t -67.2 -54.82 17.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.371 -1.455 . . . . 0.0 110.087 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.49 ' ND1' ' HA ' ' A' ' 40' ' ' GLU . 13.0 m80 -84.75 -40.66 17.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 109.691 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' GLN . 9.3 t -110.39 -128.26 0.28 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.847 . . . . 0.0 108.801 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.833 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.4 mp -147.64 162.51 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.727 -1.233 . . . . 0.0 108.984 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.494 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 18.8 p -154.97 160.26 40.97 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.922 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 49' ' ' LEU . 5.3 m -114.46 159.12 20.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.48 -0.762 . . . . 0.0 109.952 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -39.64 -36.76 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.61 -0.681 . . . . 0.0 110.357 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.623 ' CZ ' ' HG2' ' A' ' 51' ' ' GLN . 0.9 OUTLIER -53.0 -39.32 63.01 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 119.673 -0.811 . . . . 0.0 108.842 -179.091 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.623 ' HG2' ' CZ ' ' A' ' 50' ' ' TYR . 1.5 mm-40 -72.98 -54.48 8.5 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.492 ' HB2' HG21 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -64.21 -12.12 37.58 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 49' ' ' LEU . 12.1 tt0 -74.47 -28.0 60.83 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -90.92 -9.8 44.84 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.65 ' CD2' HG12 ' A' ' 38' ' ' ILE . 14.0 m-85 -89.76 1.6 55.9 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.473 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -90.51 -165.81 1.44 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.596 -0.69 . . . . 0.0 110.158 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 42.7 t-20 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.922 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.842 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 122.381 1.086 . . . . 0.0 110.309 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.842 ' N ' HG13 ' A' ' 2' ' ' VAL . 10.2 m120 -74.28 92.16 2.23 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.13 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.503 ' O ' HG23 ' A' ' 46' ' ' ILE . 18.1 pt20 -132.96 175.02 9.73 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.109 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.903 ' NE2' HD11 ' A' ' 46' ' ' ILE . 39.1 m-70 -94.57 113.51 25.34 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.857 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -117.98 136.09 53.74 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.149 -0.969 . . . . 0.0 110.177 -179.224 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 9' ' ' SER . 4.4 t -135.32 116.7 14.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.102 -0.999 . . . . 0.0 109.994 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.534 ' N ' ' HB2' ' A' ' 11' ' ' LEU . . . 39.19 -90.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.567 ' N ' ' O ' ' A' ' 7' ' ' CYS . 4.2 m -36.6 -68.47 0.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.639 -0.918 . . . . 0.0 110.518 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.597 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 52.4 m-20 -67.86 -20.12 65.1 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.719 -1.238 . . . . 0.0 108.561 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.984 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -64.74 -48.82 73.19 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.462 -0.895 . . . . 0.0 108.975 177.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.624 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -66.41 -27.93 41.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.658 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.462 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 27.4 tt0 -71.7 -53.46 13.44 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.857 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -57.94 -48.42 79.98 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.751 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.5 mt -63.66 -38.61 91.75 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.624 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 10.3 t80 -62.17 -20.24 63.93 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -87.82 -63.59 1.28 Allowed 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.912 HG13 HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -48.79 -32.29 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.673 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.31 -73.23 0.53 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.846 0.832 . . . . 0.0 109.144 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 41.43 25.69 0.18 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 1.3 mt-10 162.18 -32.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.262 -1.14 . . . . 0.0 110.06 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.48 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.8 mtp85 -71.41 -4.92 29.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.394 -0.816 . . . . 0.0 109.58 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 64.75 91.27 0.03 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.491 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -88.52 178.11 6.61 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.138 -1.213 . . . . 0.0 109.812 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.453 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 33.7 p90 -163.39 158.59 21.35 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.489 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.291 -1.936 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.592 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 111.358 0.132 . . . . 0.0 111.358 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -47.03 -42.62 16.24 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.984 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -94.67 -60.82 2.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 122.629 1.204 . . . . 0.0 108.26 176.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.595 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 49.6 t -53.43 -30.75 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.112 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.592 ' CB ' ' HB2' ' A' ' 36' ' ' ARG . 8.8 tt0 -94.4 -16.54 23.35 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 120.795 -1.19 . . . . 0.0 109.318 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 45' ' ' SER . 2.7 tp60 -90.15 -92.64 0.13 Allowed 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.179 -178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -42.28 -32.62 0.52 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.83 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.595 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 25.3 t -68.72 -56.9 6.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.64 -1.288 . . . . 0.0 109.853 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.449 ' ND1' ' HA ' ' A' ' 40' ' ' GLU . 16.7 m80 -83.29 -48.02 10.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.391 -0.818 . . . . 0.0 109.77 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.598 ' C ' HD12 ' A' ' 46' ' ' ILE . 19.5 t -106.38 -118.94 0.24 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.391 -0.818 . . . . 0.0 109.017 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.903 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.7 mp -151.09 165.53 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.74 -1.225 . . . . 0.0 109.013 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.885 ' SG ' HD11 ' A' ' 52' ' ' LEU . 24.2 p -146.82 -166.7 2.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.446 -0.784 . . . . 0.0 109.015 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.627 ' O ' HD12 ' A' ' 52' ' ' LEU . 5.4 m -156.25 156.51 34.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.826 -1.171 . . . . 0.0 110.555 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.912 HD12 HG13 ' A' ' 18' ' ' VAL . 1.7 mm? -39.93 -37.03 0.52 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.509 0.671 . . . . 0.0 109.901 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.604 ' CD2' ' HB2' ' A' ' 48' ' ' SER . 0.7 OUTLIER -58.34 -46.5 86.12 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.597 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -72.6 -40.77 66.28 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.885 HD11 ' SG ' ' A' ' 47' ' ' CYS . 1.6 mp -76.4 -14.74 60.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.19 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.56 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.7 tt0 -74.33 -25.71 59.71 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -90.24 -11.21 41.58 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.668 ' CD2' HG12 ' A' ' 38' ' ' ILE . 12.7 m-85 -87.59 -2.55 58.69 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -91.43 -170.66 2.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.565 -0.71 . . . . 0.0 109.976 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 28.0 t-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.237 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.527 0.68 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.51 ' CA ' HG21 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -82.06 101.38 10.32 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.629 -0.669 . . . . 0.0 109.5 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.556 ' CG ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -131.85 176.36 8.42 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.665 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.996 ' NE2' HD11 ' A' ' 46' ' ' ILE . 25.7 m-70 -93.85 108.32 20.11 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.975 ' CD2' ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -110.0 128.43 55.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.99 -1.068 . . . . 0.0 111.198 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.536 ' O ' ' N ' ' A' ' 11' ' ' LEU . 37.3 m -113.08 170.81 7.94 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -31.81 -44.51 0.15 Allowed Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.405 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 3.3 m -63.56 -67.45 0.43 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.922 -1.34 . . . . 0.0 110.028 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.563 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.12 -11.66 57.85 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.91 -1.118 . . . . 0.0 108.273 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.075 HD21 ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -67.86 -50.68 55.11 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.248 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.611 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -64.71 -29.52 47.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.443 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.498 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -71.21 -57.72 4.22 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.162 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.975 ' HB2' ' CD2' ' A' ' 6' ' ' LEU . . . -50.48 -50.55 52.27 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.771 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.6 mt -63.42 -45.77 89.44 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.611 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 2.1 t80 -55.88 -21.92 22.74 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -86.98 -66.85 0.86 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.085 0.945 . . . . 0.0 108.848 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.38 -29.6 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-O 121.618 0.723 . . . . 0.0 109.118 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.7 -74.91 0.46 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.825 0.821 . . . . 0.0 108.851 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 67.11 -0.19 8.42 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.537 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 2.7 tt0 163.1 -22.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.035 -1.274 . . . . 0.0 109.783 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.04 -17.45 6.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.114 -0.991 . . . . 0.0 109.581 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.75 77.56 1.12 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.544 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -78.88 -172.26 2.96 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.255 -1.144 . . . . 0.0 109.621 -179.75 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.563 ' CE2' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -162.89 -164.4 0.98 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.751 178.108 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.613 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.604 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.582 0.23 . . . . 0.0 111.518 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -56.37 -51.94 53.0 Favored Glycine 0 C--N 1.295 -1.727 0 N-CA-C 105.794 -2.923 . . . . 0.0 105.794 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.075 ' CD1' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -93.72 -29.16 4.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.507 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 1.3 t -68.58 -55.69 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.744 ' HG2' ' CE1' ' A' ' 44' ' ' HIS . 8.5 tm-20 -61.24 -18.57 59.01 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 45' ' ' SER . 2.0 tp60 -82.3 -82.4 0.14 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.552 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 29.0 m -39.87 -44.11 1.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.534 -0.728 . . . . 0.0 109.114 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.51 ' N ' ' O ' ' A' ' 6' ' ' LEU . 6.0 t -67.33 -52.99 33.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 110.659 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.744 ' CE1' ' HG2' ' A' ' 40' ' ' GLU . 9.4 m80 -84.22 -57.82 3.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.063 . . . . 0.0 109.281 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 41' ' ' GLN . 14.0 t -88.23 -126.58 0.05 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.996 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -159.49 164.87 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.567 -1.333 . . . . 0.0 109.295 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.557 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -153.31 -168.14 2.92 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.39 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.54 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.9 OUTLIER -150.44 160.45 43.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.955 . . . . 0.0 110.438 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.608 ' HG ' HG13 ' A' ' 18' ' ' VAL . 2.4 mp -42.71 -35.47 1.15 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.62 1.2 . . . . 0.0 109.061 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -54.01 -55.66 25.16 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.878 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -75.56 -37.34 60.02 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.014 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 48' ' ' SER . 0.5 OUTLIER -67.68 -19.62 65.2 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.044 179.339 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 49' ' ' LEU . 4.4 tt0 -65.6 -18.96 65.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.3 -0.875 . . . . 0.0 109.101 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -90.59 -11.39 40.14 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.394 -0.816 . . . . 0.0 109.985 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.649 ' CZ ' ' CG2' ' A' ' 38' ' ' ILE . 18.1 m-85 -90.58 6.46 43.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.995 -1.065 . . . . 0.0 109.061 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.458 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.1 m -91.91 -166.93 1.66 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.533 -0.729 . . . . 0.0 109.39 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.563 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 5.7 p-10 . . . . . 0 C--N 1.304 -1.398 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.111 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.6 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.681 0.753 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.556 ' CA ' HG21 ' A' ' 46' ' ' ILE . 3.4 m-20 -60.22 91.4 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 109.482 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.504 ' HG3' HD13 ' A' ' 6' ' ' LEU . 21.1 pt20 -132.16 175.43 9.25 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.119 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 1.01 ' NE2' HD11 ' A' ' 46' ' ' ILE . 27.2 m-70 -94.68 111.64 23.4 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.801 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -119.13 129.81 55.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.45 -0.781 . . . . 0.0 111.151 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.522 ' O ' ' C ' ' A' ' 8' ' ' GLY . 72.5 m -113.08 170.08 8.47 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.17 -44.93 0.08 OUTLIER Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.506 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.5 m -62.9 -68.39 0.34 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -1.159 . . . . 0.0 110.113 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.556 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.56 -11.09 57.24 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.863 -1.148 . . . . 0.0 108.412 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.923 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -70.36 -49.14 52.34 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.067 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.616 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 3.1 m -64.42 -31.26 52.79 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.492 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.671 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.425 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -68.61 -56.75 7.21 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.587 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.801 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.36 -50.91 66.38 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.785 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.4 mt -62.03 -41.0 97.64 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.616 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 17.9 t80 -58.78 -20.32 48.68 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -90.41 -66.94 0.88 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.898 0.856 . . . . 0.0 109.013 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.957 HG13 ' HG ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -46.21 -30.92 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.583 0.706 . . . . 0.0 109.162 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.05 -67.6 0.83 Allowed 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.799 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.06 -66.36 0.49 Allowed Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 19' ' ' CYS . 14.8 mt-10 -136.28 -1.71 2.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -1.086 . . . . 0.0 110.009 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 3.0 mtm180 -66.89 -14.4 62.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.077 -1.015 . . . . 0.0 109.767 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.49 79.51 0.93 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.544 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -81.24 -177.32 6.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.362 -1.081 . . . . 0.0 109.406 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.544 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 8.4 p90 -161.52 -172.53 3.39 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.756 0.789 . . . . 0.0 109.449 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.452 ' OH ' ' CG2' ' A' ' 39' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.298 -1.641 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.211 -0.964 0 N-CA-C 110.526 -0.175 . . . . 0.0 110.526 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -46.97 -42.75 16.1 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 106.146 -2.781 . . . . 0.0 106.146 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.935 HG23 ' CE2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -93.55 -62.38 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.333 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.553 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 2.6 t -48.54 -31.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.173 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.591 ' HB2' ' O ' ' A' ' 36' ' ' ARG . 2.5 mt-10 -92.76 -22.34 19.41 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.914 -1.117 . . . . 0.0 108.873 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.488 ' HG3' ' N ' ' A' ' 42' ' ' CYS . 28.4 tp60 -82.77 -95.14 0.05 Allowed 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.434 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.57 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -40.84 -33.31 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.366 -0.834 . . . . 0.0 109.776 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 13.9 t -67.82 -58.74 4.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.483 -1.385 . . . . 0.0 109.719 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.51 ' O ' ' CE1' ' A' ' 5' ' ' HIS . 13.0 m80 -82.74 -58.61 2.82 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.25 -0.906 . . . . 0.0 108.922 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.618 ' C ' HD12 ' A' ' 46' ' ' ILE . 25.3 t -87.23 -129.72 0.06 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 1.01 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.5 mp -150.52 162.37 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.719 -1.238 . . . . 0.0 108.978 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.518 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 15.2 p -151.27 -168.03 2.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.43 -0.794 . . . . 0.0 109.115 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.504 ' C ' HD12 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -155.6 163.62 39.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.066 -1.021 . . . . 0.0 110.384 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.957 ' HG ' HG13 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -39.02 -39.01 0.5 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.641 0.734 . . . . 0.0 110.27 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.65 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 2.2 p90 -57.56 -44.03 84.95 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.65 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -72.88 -41.75 64.34 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.514 ' CB ' HG21 ' A' ' 18' ' ' VAL . 1.1 mt -75.0 -15.72 60.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.125 -0.984 . . . . 0.0 109.019 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' LEU . 14.1 tt0 -70.38 -27.75 64.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.45 -0.781 . . . . 0.0 108.985 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -89.13 -10.53 46.92 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.935 ' CE2' HG23 ' A' ' 38' ' ' ILE . 10.5 m-85 -90.06 0.38 57.16 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.536 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.1 m -90.71 -165.89 1.46 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.477 -0.764 . . . . 0.0 110.293 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 56' ' ' CYS . 34.6 t30 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.911 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.59 0.709 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.539 ' CA ' HG21 ' A' ' 46' ' ' ILE . 4.6 m120 -63.96 91.29 0.07 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.414 -0.804 . . . . 0.0 109.188 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.567 ' HG3' HD13 ' A' ' 6' ' ' LEU . 2.6 pt20 -130.16 173.43 10.77 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.053 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.899 ' NE2' HD11 ' A' ' 46' ' ' ILE . 37.4 m-70 -90.92 108.46 19.86 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.939 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.2 tp -110.99 125.41 53.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 111.026 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' O ' ' C ' ' A' ' 8' ' ' GLY . 79.0 m -110.84 170.61 7.98 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -31.39 -43.99 0.11 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.406 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 9.9 m -62.5 -68.86 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.117 -1.225 . . . . 0.0 109.875 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.567 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 34.9 m-20 -66.86 -11.97 57.59 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.828 -1.17 . . . . 0.0 108.34 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.986 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.41 -48.72 60.18 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.351 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -65.87 -28.47 44.06 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.461 0 C-N-CA 119.094 -1.042 . . . . 0.0 108.489 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 1.0 OUTLIER -70.86 -60.22 2.36 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.001 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.939 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -49.42 -50.81 39.02 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.751 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.3 mt -62.25 -44.47 96.47 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.606 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.5 t80 -58.78 -24.99 62.64 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -80.25 -65.67 0.98 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 122.334 1.064 . . . . 0.0 108.315 178.846 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -55.53 -29.12 23.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.164 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.539 ' SG ' ' CB ' ' A' ' 24' ' ' PHE . 33.4 m -88.34 -55.42 3.74 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.113 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 45.93 61.92 3.65 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 1.9 tt0 80.49 -3.19 1.88 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.514 -0.991 . . . . 0.0 110.256 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.478 ' CB ' ' SG ' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -57.36 -17.75 14.01 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.951 -1.093 . . . . 0.0 109.008 179.484 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' CA ' ' A' ' 57' ' ' ASN . . . 95.29 65.9 0.98 Allowed Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.539 ' CB ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -87.36 178.89 6.71 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.355 -1.085 . . . . 0.0 109.44 -179.369 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -162.48 -163.21 0.88 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.488 178.625 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.502 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.294 -1.844 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.626 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -48.12 -44.08 25.94 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 106.146 -2.781 . . . . 0.0 106.146 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.986 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.19 -56.54 5.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 122.414 1.102 . . . . 0.0 108.342 177.201 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.583 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 4.2 t -55.78 -29.32 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.683 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -93.44 -28.88 15.86 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 120.818 -1.176 . . . . 0.0 109.579 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.525 ' HG3' ' N ' ' A' ' 42' ' ' CYS . 2.4 tp-100 -76.25 -97.53 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.507 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.569 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -40.77 -33.76 0.32 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 110.463 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.583 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 17.0 t -67.36 -53.47 29.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.353 -1.467 . . . . 0.0 110.889 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.503 ' O ' ' CE1' ' A' ' 5' ' ' HIS . 14.3 m80 -84.52 -52.96 5.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.02 -1.05 . . . . 0.0 110.059 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.477 ' C ' HD12 ' A' ' 46' ' ' ILE . 32.4 t -98.48 -113.82 0.15 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 108.977 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.899 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.4 mp -159.42 161.56 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.825 -1.172 . . . . 0.0 108.668 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.513 ' SG ' ' NE2' ' A' ' 51' ' ' GLN . 14.7 p -152.76 -171.0 3.8 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.566 -0.853 . . . . 0.0 109.535 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.641 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 4.8 m -143.86 156.97 44.65 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.345 1.069 . . . . 0.0 110.589 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.607 ' O ' ' N ' ' A' ' 53' ' ' GLU . 17.5 mt -39.44 -34.4 0.21 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.622 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.65 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 5.7 p90 -51.14 -42.63 60.88 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 118.532 -1.267 . . . . 0.0 108.108 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.65 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 1.7 pt20 -74.43 -53.54 9.35 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -62.14 -14.37 36.52 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.202 -0.936 . . . . 0.0 108.653 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 49' ' ' LEU . 20.8 tt0 -72.99 -31.46 64.53 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -91.57 -13.59 31.73 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.719 -0.613 . . . . 0.0 109.573 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.653 ' CE2' HG12 ' A' ' 38' ' ' ILE . 13.1 m-85 -82.65 -0.53 47.65 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.975 -1.078 . . . . 0.0 108.44 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 22' ' ' ARG . 1.2 t -66.94 -155.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.558 -0.714 . . . . 0.0 109.779 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.526 ' CA ' ' O ' ' A' ' 23' ' ' GLY . 24.1 p30 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.823 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.487 0.661 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.525 ' CA ' HG21 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -70.15 109.36 4.57 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.474 -0.766 . . . . 0.0 109.394 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.546 ' HG2' ' N ' ' A' ' 5' ' ' HIS . 32.9 tt0 -134.54 163.13 30.4 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 110.189 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 1.071 ' NE2' HD11 ' A' ' 46' ' ' ILE . 20.0 m-70 -91.62 91.83 8.2 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.872 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -91.19 165.98 13.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.929 -1.107 . . . . 0.0 109.694 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 9' ' ' SER . 16.4 t -167.44 112.32 0.71 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.588 -1.32 . . . . 0.0 109.43 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.52 ' N ' ' HB2' ' A' ' 11' ' ' LEU . . . 39.88 -90.15 0.01 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 7' ' ' CYS . 7.1 m -40.25 -68.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.406 -1.055 . . . . 0.0 110.655 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.622 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 26.6 m-20 -65.8 -24.19 66.86 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.502 -1.374 . . . . 0.0 108.644 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.05 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -59.93 -50.76 72.51 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.387 -0.925 . . . . 0.0 108.642 177.748 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.628 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -64.38 -26.12 39.59 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 C-N-CA 119.127 -1.029 . . . . 0.0 108.674 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.439 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -71.75 -57.77 4.06 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.436 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.872 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.21 -48.95 70.45 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.825 ' HG ' HD12 ' A' ' 52' ' ' LEU . 2.6 mt -62.77 -41.57 99.3 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.628 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 12.3 t80 -59.26 -20.9 58.09 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -90.6 -65.8 0.98 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.971 0.891 . . . . 0.0 109.178 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.767 HG13 ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -46.72 -29.96 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-O 121.599 0.714 . . . . 0.0 109.258 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.19 -70.9 0.64 Allowed 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.543 -179.41 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.26 -67.52 0.37 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 19' ' ' CYS . 3.5 mt-10 -126.93 -7.62 6.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.223 -1.163 . . . . 0.0 109.825 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.477 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 3.8 mmt85 -70.16 -10.55 59.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.166 -0.959 . . . . 0.0 109.699 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.6 89.74 0.08 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -85.37 -177.12 6.39 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.348 -1.089 . . . . 0.0 109.731 -179.643 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.574 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 11.0 p90 -162.76 178.47 8.44 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.689 0.757 . . . . 0.0 109.337 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.475 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.743 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.571 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 111.339 0.125 . . . . 0.0 111.339 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -48.21 -44.04 26.47 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 106.082 -2.807 . . . . 0.0 106.082 177.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.05 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.27 -57.51 4.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 122.508 1.147 . . . . 0.0 108.513 177.145 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 54.6 t -57.03 -29.27 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.913 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.571 ' HB2' ' O ' ' A' ' 36' ' ' ARG . 2.3 mt-10 -91.87 -32.96 15.11 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.862 -1.149 . . . . 0.0 109.02 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 45' ' ' SER . 1.5 tp-100 -74.86 -82.49 0.06 Allowed 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.8 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.541 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 15.5 m -42.21 -48.08 4.81 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.411 -0.805 . . . . 0.0 109.715 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 5.1 t -62.87 -47.94 81.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 110.429 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.478 ' ND1' ' HA ' ' A' ' 40' ' ' GLU . 6.0 m80 -90.47 -65.41 1.02 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.888 -1.133 . . . . 0.0 108.963 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 41' ' ' GLN . 8.5 t -87.38 -137.31 0.09 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 1.071 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.4 mp -142.38 162.35 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.794 -1.191 . . . . 0.0 109.17 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.511 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -142.92 -161.58 1.28 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.408 179.213 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.588 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -152.45 149.81 28.96 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.329 -0.857 . . . . 0.0 109.818 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.767 ' HG ' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -38.96 -37.26 0.34 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.758 0.79 . . . . 0.0 110.805 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 1.3 p90 -60.01 -37.8 80.8 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.556 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.596 ' HG2' ' CD2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -77.56 -20.01 54.77 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.842 HD13 ' HD2' ' A' ' 55' ' ' TYR . 4.3 mm? -86.8 -28.03 23.21 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.08 -23.26 19.58 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -90.89 -23.23 20.58 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.842 ' HD2' HD13 ' A' ' 52' ' ' LEU . 17.5 m-85 -81.25 0.23 37.75 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.574 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.1 m -90.78 -165.15 1.29 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.538 -0.726 . . . . 0.0 109.958 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.442 ' C ' ' O ' ' A' ' 56' ' ' CYS . 27.3 p-10 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.876 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.853 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 122.328 1.061 . . . . 0.0 110.983 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.853 ' N ' HG13 ' A' ' 2' ' ' VAL . 5.3 m120 -63.42 93.11 0.07 Allowed 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.526 ' HG2' ' N ' ' A' ' 5' ' ' HIS . 28.6 tt0 -129.22 160.34 33.24 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.001 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 1.082 ' NE2' HD11 ' A' ' 46' ' ' ILE . 17.1 m-70 -85.05 93.89 8.71 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.662 HD13 ' CB ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -79.31 -163.79 0.55 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.174 -0.954 . . . . 0.0 109.134 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.586 ' O ' ' C ' ' A' ' 8' ' ' GLY . 0.8 OUTLIER 170.83 141.25 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.623 -179.422 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -17.15 -55.19 0.01 OUTLIER Glycine 0 N--CA 1.502 3.063 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 7' ' ' CYS . 15.3 m -60.66 -66.2 0.57 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.208 -1.172 . . . . 0.0 109.717 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.662 ' CB ' HD13 ' A' ' 6' ' ' LEU . 1.2 m-20 -67.46 -17.91 64.88 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.73 -1.231 . . . . 0.0 107.984 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.903 HD21 ' CD1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -59.58 -53.05 62.56 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.093 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.634 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -63.62 -27.94 43.97 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.44 0 C-N-CA 118.801 -1.16 . . . . 0.0 108.08 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -71.8 -60.25 2.33 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.759 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -50.79 -49.2 58.94 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.774 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.6 mt -62.81 -47.62 82.64 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 7.1 t80 -53.65 -25.55 18.44 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -82.02 -67.79 0.75 Allowed 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.101 0.953 . . . . 0.0 108.521 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.91 HG13 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -49.83 -28.74 4.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.526 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -87.21 -55.69 3.7 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.349 -0.94 . . . . 0.0 109.937 -179.07 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 21' ' ' GLU . . . 46.1 65.85 1.9 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 17.4 mm-40 80.92 -9.98 1.28 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.675 -0.897 . . . . 0.0 110.199 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 2.2 mmt180 -56.79 -17.22 8.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.915 -1.116 . . . . 0.0 109.415 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' CA ' ' A' ' 57' ' ' ASN . . . 85.19 80.02 1.12 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.608 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -92.12 179.01 5.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -1.108 . . . . 0.0 109.902 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.608 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 40.1 p90 -162.68 175.14 11.66 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.294 -1.816 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.61 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -48.82 -44.51 31.1 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.963 HG21 ' CE1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -91.87 -34.19 6.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.192 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 1.4 t -76.48 -69.79 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.603 ' N ' HG12 ' A' ' 39' ' ' VAL . 2.1 tt0 -45.06 -25.87 0.38 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.856 -1.152 . . . . 0.0 108.57 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -80.35 -78.62 0.17 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 1.7 m -42.39 -29.03 0.24 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.592 -0.692 . . . . 0.0 109.497 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -85.08 -47.36 10.27 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.009 -1.057 . . . . 0.0 109.88 -179.486 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.415 ' ND1' ' HA ' ' A' ' 40' ' ' GLU . 3.5 m80 -92.59 -53.27 4.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.11 -0.994 . . . . 0.0 109.288 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' GLN . 38.7 m -92.09 -122.85 0.08 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 1.082 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -160.6 166.07 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.652 -1.28 . . . . 0.0 109.07 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.567 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -156.35 -170.96 3.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.391 -0.818 . . . . 0.0 109.285 179.311 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.489 ' HG ' ' HE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -142.02 157.61 44.73 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.269 -0.894 . . . . 0.0 109.839 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.91 HD22 HG13 ' A' ' 18' ' ' VAL . 54.6 mt -42.65 -33.09 0.66 Allowed 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.661 0.743 . . . . 0.0 110.571 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.656 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 1.6 p90 -53.45 -44.01 68.53 Favored 'General case' 0 C--N 1.281 -2.406 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.046 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.656 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -74.95 -53.01 9.75 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.154 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.491 ' N ' ' CG ' ' A' ' 51' ' ' GLN . 1.2 mp -61.22 -15.47 34.83 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 49' ' ' LEU . 37.2 tt0 -70.59 -24.39 62.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -91.35 -14.18 31.19 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.635 -0.666 . . . . 0.0 109.415 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.963 ' CE1' HG21 ' A' ' 38' ' ' ILE . 59.7 m-85 -86.15 4.34 38.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.126 -0.984 . . . . 0.0 108.879 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.521 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -77.51 -164.24 0.47 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.691 -0.631 . . . . 0.0 109.98 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.448 ' CA ' ' O ' ' A' ' 23' ' ' GLY . 5.6 t-20 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.667 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.836 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 122.413 1.101 . . . . 0.0 110.387 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.836 ' N ' HG13 ' A' ' 2' ' ' VAL . 2.0 m120 -89.85 99.81 12.75 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.982 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.506 ' O ' HG23 ' A' ' 46' ' ' ILE . 4.2 pm0 -132.71 171.95 13.19 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.165 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.955 ' NE2' HD11 ' A' ' 46' ' ' ILE . 32.5 m-70 -90.77 110.16 21.35 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.833 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -112.63 134.04 54.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.132 -0.98 . . . . 0.0 111.168 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.535 ' O ' ' C ' ' A' ' 8' ' ' GLY . 34.4 m -119.08 168.09 11.17 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.555 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -28.93 -45.24 0.06 OUTLIER Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 7' ' ' CYS . 19.5 m -63.15 -68.65 0.32 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -1.201 . . . . 0.0 109.997 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.545 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 53.3 m-20 -67.79 -10.01 49.1 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.845 -1.159 . . . . 0.0 108.572 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.904 HD21 HD11 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -72.66 -48.15 41.58 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.378 -0.826 . . . . 0.0 109.05 178.487 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.616 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -67.53 -28.9 43.62 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.43 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.726 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -70.83 -55.87 7.56 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.489 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.833 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.51 -50.79 66.98 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.77 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.1 mt -60.87 -45.17 95.6 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.616 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 17.3 t80 -57.19 -21.37 32.85 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -88.77 -65.76 0.99 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.132 0.968 . . . . 0.0 109.009 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.77 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -50.29 -28.45 5.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-O 121.409 0.623 . . . . 0.0 109.602 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -86.59 -65.46 1.01 Allowed 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.39 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.47 -71.0 1.07 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -132.97 -1.2 3.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -1.137 . . . . 0.0 109.93 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.482 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 26.1 mmm-85 -69.18 -11.86 61.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.056 -1.027 . . . . 0.0 109.658 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.409 ' O ' ' CG ' ' A' ' 57' ' ' ASN . . . 69.3 89.42 0.08 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.621 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -85.01 -175.67 5.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -1.128 . . . . 0.0 109.805 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.621 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 23.9 p90 -162.8 164.65 26.08 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.491 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.293 -1.859 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 120.716 0.293 . . . . 0.0 111.488 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -49.94 -45.38 41.28 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.191 -2.364 . . . . 0.0 107.191 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.904 HD11 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -93.54 -26.19 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.413 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -82.91 -59.93 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.292 -0.88 . . . . 0.0 109.101 179.735 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.568 ' N ' HG12 ' A' ' 39' ' ' VAL . 4.9 tt0 -58.72 -16.6 17.31 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.4 OUTLIER -80.47 -82.41 0.11 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.372 -0.83 . . . . 0.0 109.392 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.557 ' O ' ' N ' ' A' ' 6' ' ' LEU . 28.5 m -39.57 -42.5 1.17 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.36 -0.838 . . . . 0.0 108.955 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 6' ' ' LEU . 4.8 t -69.54 -53.03 20.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.829 . . . . 0.0 111.043 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.488 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 10.4 m80 -83.51 -48.76 9.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.868 -1.145 . . . . 0.0 109.663 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 41' ' ' GLN . 45.1 t -99.95 -124.42 0.16 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.955 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -159.49 165.23 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.706 -1.246 . . . . 0.0 109.206 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.556 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -148.16 -156.64 0.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.469 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.62 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 5.6 m -160.05 154.08 23.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 110.387 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.631 ' HG ' HG13 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -39.13 -38.86 0.52 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.644 0.735 . . . . 0.0 110.412 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 1.4 p90 -57.76 -46.46 84.49 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.623 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -71.69 -37.57 70.68 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.519 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.509 ' HB3' HG21 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -76.48 -20.09 57.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.161 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 49' ' ' LEU . 26.0 tt0 -68.19 -22.66 64.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.323 -0.86 . . . . 0.0 108.868 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.92 -11.52 41.56 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.548 -0.72 . . . . 0.0 109.812 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.651 ' CZ ' ' HB ' ' A' ' 38' ' ' ILE . 17.5 m-85 -91.09 6.99 42.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.127 -0.983 . . . . 0.0 108.5 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.541 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.3 m -78.06 -164.55 0.54 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.715 -0.616 . . . . 0.0 109.927 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.3 t-20 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.743 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 4' ' ' GLN . 12.3 m . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.488 0.661 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.436 ' C ' HG21 ' A' ' 46' ' ' ILE . 11.0 m-20 -59.9 87.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.449 -0.782 . . . . 0.0 108.976 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 46' ' ' ILE . 2.0 pt20 -130.99 178.31 6.77 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.028 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.901 ' NE2' HD11 ' A' ' 46' ' ' ILE . 36.8 m-70 -91.84 106.05 18.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.85 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -104.91 137.82 42.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.14 -0.975 . . . . 0.0 111.058 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.543 ' O ' ' C ' ' A' ' 8' ' ' GLY . 60.0 m -124.1 166.98 14.85 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.685 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -26.12 -47.91 0.04 OUTLIER Glycine 0 N--CA 1.498 2.798 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 7' ' ' CYS . 1.4 m -61.82 -69.2 0.26 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.286 . . . . 0.0 109.948 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.549 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -68.17 -10.7 56.21 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.812 -1.18 . . . . 0.0 108.763 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.814 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -73.71 -47.42 39.63 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.246 -0.909 . . . . 0.0 109.316 178.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 8' ' ' GLY . 2.9 m -71.57 -31.95 44.21 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.406 0 C-N-CA 118.789 -1.164 . . . . 0.0 108.485 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 16' ' ' TYR . 10.4 mt-10 -66.54 -54.27 25.6 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.85 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -59.69 -50.21 74.75 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.801 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.8 mt -59.92 -39.89 86.99 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.607 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 7.9 t80 -59.45 -21.54 60.19 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.71 -65.54 1.01 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.969 0.89 . . . . 0.0 108.964 179.442 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.981 HG11 ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -49.99 -27.43 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.578 0.704 . . . . 0.0 109.509 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 24' ' ' PHE . 36.2 m -90.27 -69.24 0.74 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.854 -178.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.59 -71.82 1.55 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -137.7 1.83 2.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.351 -1.088 . . . . 0.0 109.964 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.495 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 42.4 mmm-85 -63.34 -12.35 29.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.004 -1.06 . . . . 0.0 109.864 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 57' ' ' ASN . . . 85.22 90.86 0.84 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -114.3 173.93 6.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -1.16 . . . . 0.0 109.668 -179.51 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.589 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 2.2 p90 -161.21 -61.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.408 -0.807 . . . . 0.0 109.025 178.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.589 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.298 -1.654 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.25 -39.98 7.43 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 106.18 -2.768 . . . . 0.0 106.18 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.946 HG23 ' CE2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -93.38 -63.67 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-O 122.346 1.07 . . . . 0.0 108.261 176.691 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 3.3 t -48.82 -35.95 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.23 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 36' ' ' ARG . 3.3 tt0 -91.25 -17.07 26.58 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.076 -1.015 . . . . 0.0 109.423 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 45' ' ' SER . 33.2 tt0 -90.58 -82.91 0.27 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.359 -0.838 . . . . 0.0 109.594 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 6' ' ' LEU . 24.5 m -39.28 -41.17 0.86 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.495 -0.753 . . . . 0.0 109.731 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.483 ' N ' ' O ' ' A' ' 6' ' ' LEU . 3.7 t -73.58 -51.25 17.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 111.177 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.464 ' ND1' ' HA ' ' A' ' 40' ' ' GLU . 12.8 m80 -83.23 -41.9 17.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.871 -1.143 . . . . 0.0 109.95 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 41' ' ' GLN . 37.7 t -110.31 -121.64 0.27 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.901 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -158.94 165.6 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.794 -1.191 . . . . 0.0 109.394 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.568 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -148.09 -164.52 2.03 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.407 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.632 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 10.3 m -143.78 151.82 40.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 110.128 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.981 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -39.11 -39.85 0.63 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.734 0.778 . . . . 0.0 110.143 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.632 ' CE2' ' HB2' ' A' ' 48' ' ' SER . 1.2 p90 -63.13 -41.06 99.24 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.551 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 37.2 tp60 -63.67 -44.65 93.12 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.541 HD23 ' HG ' ' A' ' 15' ' ' LEU . 1.2 mp -72.38 -24.24 61.23 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -63.43 -24.08 67.68 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -0.821 . . . . 0.0 109.095 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -87.97 -9.16 54.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.492 -0.755 . . . . 0.0 109.457 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.946 ' CE2' HG23 ' A' ' 38' ' ' ILE . 13.7 m-85 -90.14 2.0 55.79 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -80.28 -158.21 0.17 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.483 -0.761 . . . . 0.0 110.935 -178.822 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 23' ' ' GLY . 22.4 t-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.656 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 4' ' ' GLN . 12.9 m . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.674 0.75 . . . . 0.0 109.623 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 2' ' ' VAL . 2.5 m-20 -43.51 94.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.341 -0.849 . . . . 0.0 109.725 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.664 ' NE2' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -143.19 167.87 21.09 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.205 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 1.061 ' NE2' HD11 ' A' ' 46' ' ' ILE . 18.1 m-70 -93.14 111.79 23.54 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.947 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.2 tp -113.76 128.12 56.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.026 -1.046 . . . . 0.0 110.84 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 11' ' ' LEU . 64.6 m -111.04 167.56 10.17 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.553 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -31.36 -42.38 0.08 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 7' ' ' CYS . 42.3 m -62.68 -69.27 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.275 . . . . 0.0 109.491 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.543 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 1.1 m-20 -67.47 -10.92 56.04 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.934 -1.104 . . . . 0.0 108.484 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.711 ' CD2' HD11 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -70.78 -48.88 51.92 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.385 -0.822 . . . . 0.0 109.043 178.549 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.613 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -67.08 -28.52 43.05 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.454 0 C-N-CA 118.802 -1.159 . . . . 0.0 108.297 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 6.4 tt0 -70.32 -57.15 5.17 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.947 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.38 -49.71 69.22 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.752 ' HA ' HG23 ' A' ' 18' ' ' VAL . 3.0 mt -61.62 -44.04 97.74 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.613 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 11.5 t80 -58.5 -27.0 64.07 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -78.79 -64.04 1.27 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 122.042 0.925 . . . . 0.0 108.568 179.137 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.886 HG12 ' OE1' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -53.34 -31.79 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.509 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -86.49 -64.32 1.17 Allowed 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.601 -0.839 . . . . 0.0 109.563 -179.41 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.25 -64.63 0.39 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 19' ' ' CYS . 1.6 mt-10 -138.79 2.74 2.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.262 -1.14 . . . . 0.0 110.077 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 14.2 mmt85 -74.19 -11.21 60.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.099 -1.0 . . . . 0.0 109.882 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 69.69 93.9 0.06 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.627 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -89.7 -167.25 1.8 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -1.126 . . . . 0.0 110.061 -179.595 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.627 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 15.0 p90 -160.63 170.82 20.07 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.545 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 1.5 t80 . . . . . 0 C--N 1.297 -1.703 0 O-C-N 120.805 -1.184 . . . . 0.0 109.628 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.698 0.285 . . . . 0.0 111.119 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -49.65 -42.61 36.31 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.973 -2.451 . . . . 0.0 106.973 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.711 HD11 ' CD2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -93.99 -26.69 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.233 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.602 HG12 ' N ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -84.46 -60.48 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.412 -0.805 . . . . 0.0 109.462 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.602 ' N ' HG12 ' A' ' 39' ' ' VAL . 34.0 tt0 -61.63 -13.98 26.9 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.221 -0.925 . . . . 0.0 109.284 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -79.85 -85.75 0.08 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.178 -0.951 . . . . 0.0 109.845 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.57 ' HB2' HD11 ' A' ' 11' ' ' LEU . 32.3 m -38.73 -42.65 0.83 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 6' ' ' LEU . 7.4 t -67.31 -54.82 17.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.478 -0.764 . . . . 0.0 110.553 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.601 ' O ' ' CE1' ' A' ' 5' ' ' HIS . 8.2 m80 -86.29 -59.13 2.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.837 -1.164 . . . . 0.0 109.18 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.595 ' C ' HD12 ' A' ' 46' ' ' ILE . 33.0 t -83.17 -132.89 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 1.061 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.5 mp -155.94 161.29 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.846 -1.159 . . . . 0.0 108.577 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.46 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.6 OUTLIER -141.54 -157.44 0.77 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.654 -1.218 . . . . 0.0 110.655 -179.064 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.616 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 5.4 m -151.18 146.44 26.11 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.874 0.845 . . . . 0.0 110.008 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.721 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -37.7 -42.48 0.57 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.739 0.781 . . . . 0.0 111.04 -179.517 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.616 ' CE2' ' HB2' ' A' ' 48' ' ' SER . 3.6 p90 -61.94 -37.79 86.05 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.991 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.607 ' CG ' ' CZ ' ' A' ' 50' ' ' TYR . 72.0 mt-30 -67.64 -39.74 84.61 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.581 HD23 ' HG ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -71.39 -28.87 64.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 109.057 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.886 ' OE1' HG12 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -57.96 -23.04 52.01 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.214 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -89.65 -15.52 32.49 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.807 -0.558 . . . . 0.0 109.573 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.678 ' CZ ' ' HB ' ' A' ' 38' ' ' ILE . 16.4 m-85 -90.54 5.51 47.49 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.448 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.1 m -90.89 -164.25 1.15 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.623 -0.673 . . . . 0.0 109.851 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 8.3 p-10 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.936 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.9 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.398 0.618 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.506 ' CA ' HG21 ' A' ' 46' ' ' ILE . 3.4 m-80 -60.07 93.86 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.453 -0.779 . . . . 0.0 109.264 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.686 ' HG3' HD13 ' A' ' 6' ' ' LEU . 1.6 pt20 -134.42 173.84 11.19 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.154 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.877 ' NE2' HD11 ' A' ' 46' ' ' ILE . 43.3 m-70 -90.48 112.53 24.21 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.742 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -118.12 129.41 55.52 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.403 -0.811 . . . . 0.0 111.328 -178.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' O ' ' C ' ' A' ' 8' ' ' GLY . 98.7 m -111.61 170.42 8.14 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -29.93 -45.71 0.09 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.518 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.1 m -62.1 -68.85 0.29 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.107 -1.231 . . . . 0.0 110.171 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.572 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 1.9 m-20 -67.46 -11.63 58.32 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.859 -1.15 . . . . 0.0 108.416 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.985 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.72 -49.09 56.58 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.788 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.607 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -63.83 -30.62 50.43 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.55 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.617 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 4.7 tt0 -69.09 -56.69 6.94 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.742 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -55.15 -49.38 71.95 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.771 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.5 mt -62.86 -40.97 99.12 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.607 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 8.7 t80 -58.36 -20.44 43.7 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -90.07 -66.67 0.9 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.982 0.896 . . . . 0.0 109.006 179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -46.22 -30.08 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.47 -71.1 0.64 Allowed 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.555 -179.358 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.24 -60.41 0.25 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 19' ' ' CYS . 17.0 mt-10 -138.11 -0.05 2.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.201 -1.176 . . . . 0.0 110.381 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.572 ' CD ' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -76.74 -4.07 41.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.99 -1.069 . . . . 0.0 109.685 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.99 84.85 0.18 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.546 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -83.13 -177.44 6.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.268 -1.136 . . . . 0.0 109.421 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.546 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 8.6 p90 -161.33 -172.69 3.49 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.394 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.492 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.605 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.612 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.4 -44.79 16.15 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 106.267 -2.733 . . . . 0.0 106.267 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.985 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.92 -61.22 2.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 122.551 1.167 . . . . 0.0 108.229 176.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.573 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 13.9 t -49.11 -34.74 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.508 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.612 ' CB ' ' HB2' ' A' ' 36' ' ' ARG . 24.3 tt0 -93.35 -16.88 24.19 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 120.864 -1.147 . . . . 0.0 109.406 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 45' ' ' SER . 33.8 tt0 -86.65 -94.98 0.09 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.464 -0.772 . . . . 0.0 110.077 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.23 -34.9 0.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.469 -0.77 . . . . 0.0 109.895 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 16.3 t -66.34 -55.05 17.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.385 -1.447 . . . . 0.0 109.739 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.526 ' O ' ' CE1' ' A' ' 5' ' ' HIS . 13.6 m80 -84.22 -51.61 6.89 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.195 -0.941 . . . . 0.0 109.454 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' GLN . 35.1 t -98.44 -127.35 0.17 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.877 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.5 mp -148.04 164.57 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.679 -1.263 . . . . 0.0 108.818 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.769 ' SG ' HD11 ' A' ' 52' ' ' LEU . 21.4 p -149.97 -171.74 3.98 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.383 -0.823 . . . . 0.0 109.206 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.753 ' O ' HD12 ' A' ' 52' ' ' LEU . 8.1 m -147.1 156.02 42.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.855 -1.153 . . . . 0.0 110.951 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.71 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -39.29 -38.57 0.54 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.79 0.805 . . . . 0.0 110.244 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.631 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 1.4 p90 -61.83 -47.83 83.29 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 121.772 0.796 . . . . 0.0 109.095 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.631 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -67.35 -39.99 85.8 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.769 HD11 ' SG ' ' A' ' 47' ' ' CYS . 1.4 mp -75.75 -18.37 59.58 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -62.82 -26.49 68.77 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.121 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -90.16 -10.76 43.33 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.287 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.809 ' CE2' HG23 ' A' ' 38' ' ' ILE . 11.2 m-85 -87.55 -1.81 58.19 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.489 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -90.61 -165.39 1.34 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.603 -0.686 . . . . 0.0 110.134 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 56' ' ' CYS . 4.3 t-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.816 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.464 ' O ' ' OE1' ' A' ' 4' ' ' GLN . 12.5 m . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.513 0.673 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.544 ' CA ' HG21 ' A' ' 46' ' ' ILE . 6.6 m120 -70.26 99.82 1.6 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.479 -0.763 . . . . 0.0 109.632 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.482 ' O ' HG23 ' A' ' 46' ' ' ILE . 3.0 pm0 -131.88 165.53 23.65 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.125 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 1.046 ' NE2' HD11 ' A' ' 46' ' ' ILE . 20.5 m-70 -89.72 108.53 19.74 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.907 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -112.88 128.94 56.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.139 -0.976 . . . . 0.0 110.817 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.523 ' O ' ' C ' ' A' ' 8' ' ' GLY . 67.5 m -111.26 168.06 9.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -29.6 -45.89 0.08 OUTLIER Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.9 m -60.85 -69.87 0.21 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.088 -1.242 . . . . 0.0 110.093 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.558 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 1.2 m-20 -66.43 -13.44 60.76 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.856 -1.152 . . . . 0.0 108.362 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.721 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -66.78 -50.35 62.95 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.455 -0.778 . . . . 0.0 108.982 178.372 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -65.8 -30.55 50.4 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.472 0 C-N-CA 119.019 -1.072 . . . . 0.0 108.123 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.28 -57.31 6.16 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.697 -1.224 . . . . 0.0 107.697 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.907 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.93 -49.48 71.19 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.786 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.3 mt -62.88 -42.63 99.84 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.606 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 9.9 t80 -56.74 -21.54 28.97 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.44 -66.14 0.95 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.019 0.914 . . . . 0.0 109.226 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.786 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -47.62 -28.58 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.505 0.669 . . . . 0.0 109.427 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -90.18 -70.35 0.67 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.679 -179.427 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.63 -68.74 1.83 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -130.33 -6.88 4.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.157 -1.202 . . . . 0.0 110.122 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -66.01 -11.8 50.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.036 -1.04 . . . . 0.0 109.837 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 68.07 95.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.477 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 0.5 OUTLIER -93.93 174.88 6.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -1.178 . . . . 0.0 110.238 -179.648 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 29.2 p90 -165.19 151.89 10.4 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.496 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.294 -1.805 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.554 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.502 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.57 -40.72 8.83 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 106.219 -2.752 . . . . 0.0 106.219 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.924 HG23 ' CE2' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -94.32 -65.52 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 122.464 1.126 . . . . 0.0 108.02 176.342 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.502 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 16.2 t -46.78 -34.85 2.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.289 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.554 ' HB3' ' O ' ' A' ' 36' ' ' ARG . 9.2 tt0 -91.63 -19.38 22.75 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.117 -0.989 . . . . 0.0 109.567 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 45' ' ' SER . 16.5 tt0 -90.36 -81.81 0.29 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.294 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.568 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 23.1 m -40.8 -41.77 1.64 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.502 -0.749 . . . . 0.0 109.113 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.518 ' N ' ' O ' ' A' ' 6' ' ' LEU . 6.8 t -69.09 -53.9 17.88 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.207 -0.933 . . . . 0.0 110.026 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.578 ' O ' ' CE1' ' A' ' 5' ' ' HIS . 9.8 m80 -83.9 -64.4 1.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 108.937 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 41' ' ' GLN . 3.7 t -82.0 -132.7 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 1.046 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -153.85 166.0 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.823 -1.173 . . . . 0.0 109.076 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.576 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -155.09 171.09 20.35 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.601 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.639 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 4.9 m -124.28 158.16 33.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.368 -0.832 . . . . 0.0 109.485 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.671 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -38.74 -39.22 0.48 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.715 0.769 . . . . 0.0 110.48 -179.408 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.639 ' CD2' ' HB2' ' A' ' 48' ' ' SER . 3.1 p90 -60.33 -36.43 77.92 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.38 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.611 ' HG2' ' CE1' ' A' ' 50' ' ' TYR . 10.5 mt-30 -71.81 -47.36 53.8 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.429 HD22 ' HB3' ' A' ' 14' ' ' ALA . 1.5 mp -69.84 -16.64 63.3 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.25 -25.82 67.07 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -87.0 -11.83 49.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.467 -0.771 . . . . 0.0 109.449 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.924 ' CE2' HG23 ' A' ' 38' ' ' ILE . 11.9 m-85 -89.83 3.18 53.72 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.146 -0.971 . . . . 0.0 108.653 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.3 m -83.3 -166.96 1.5 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.456 -0.777 . . . . 0.0 110.015 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 21.2 p-10 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.698 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.466 ' O ' ' OE1' ' A' ' 4' ' ' GLN . 10.2 m . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.505 0.669 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.478 ' C ' HG21 ' A' ' 46' ' ' ILE . 10.7 m120 -62.08 88.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.005 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.476 ' O ' HG23 ' A' ' 46' ' ' ILE . 1.6 pm0 -127.55 176.3 7.59 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.863 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.903 ' NE2' HD11 ' A' ' 46' ' ' ILE . 38.0 m-70 -90.48 104.55 17.12 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.992 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -102.0 139.12 38.05 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.084 -1.01 . . . . 0.0 110.684 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.553 ' O ' ' C ' ' A' ' 8' ' ' GLY . 53.6 m -127.11 167.9 15.36 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.562 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -26.49 -47.33 0.04 OUTLIER Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 7' ' ' CYS . 72.8 m -62.93 -68.95 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.095 -1.238 . . . . 0.0 110.304 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.548 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 35.1 m-20 -67.55 -10.47 52.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.826 -1.171 . . . . 0.0 108.568 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.884 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -72.34 -48.3 42.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.34 -0.85 . . . . 0.0 109.459 178.622 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.611 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -68.65 -30.52 47.52 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.497 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.292 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -68.74 -59.84 2.82 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.55 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.992 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -51.8 -49.17 63.26 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.771 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.3 mt -63.98 -43.42 95.8 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.611 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 11.0 t80 -56.52 -21.42 26.08 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -88.65 -66.73 0.89 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 122.103 0.954 . . . . 0.0 109.14 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -47.96 -30.86 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.534 0.683 . . . . 0.0 109.311 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -90.58 -73.38 0.53 Allowed 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.862 0.839 . . . . 0.0 109.288 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 43.85 23.42 0.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER 157.12 -20.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.524 -0.986 . . . . 0.0 109.807 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 3.7 mtt180 -75.31 0.41 16.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.961 . . . . 0.0 109.818 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.42 74.31 0.45 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.57 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -74.54 -175.38 2.37 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.313 -1.11 . . . . 0.0 109.881 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CE1' ' O ' ' A' ' 55' ' ' TYR . 3.7 p90 -161.99 -169.25 2.14 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.898 0.856 . . . . 0.0 109.778 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.513 ' OH ' ' CG2' ' A' ' 39' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.638 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.572 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.27 -41.62 11.91 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 106.15 -2.78 . . . . 0.0 106.15 177.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.884 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -93.93 -61.08 2.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 122.339 1.066 . . . . 0.0 108.374 176.838 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 8.0 t -51.01 -34.32 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.483 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 36' ' ' ARG . 2.9 tt0 -90.8 -18.76 24.36 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.893 -1.129 . . . . 0.0 108.661 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 45' ' ' SER . 9.6 tt0 -90.59 -84.79 0.23 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.447 -0.783 . . . . 0.0 109.461 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.567 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 1.3 m -39.5 -35.89 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 0.0 109.672 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.526 ' N ' ' O ' ' A' ' 6' ' ' LEU . 4.0 t -74.63 -54.54 7.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.041 -1.037 . . . . 0.0 110.383 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 13.9 m80 -79.15 -43.02 24.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.994 . . . . 0.0 109.528 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.6 t -108.35 -126.46 0.26 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.903 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -158.44 165.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.79 -1.194 . . . . 0.0 109.231 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.567 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -155.46 177.71 11.05 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.536 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 51' ' ' GLN . 5.2 m -130.95 155.98 45.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 109.51 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -38.77 -39.06 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.458 -0.776 . . . . 0.0 110.454 -179.391 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.617 ' CE1' ' HG2' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -53.31 -40.54 64.87 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.617 ' HG2' ' CE1' ' A' ' 50' ' ' TYR . 2.8 mt-30 -72.9 -56.47 5.14 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.466 HD22 ' CB ' ' A' ' 14' ' ' ALA . 1.2 mp -54.44 -20.29 7.28 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 50' ' ' TYR . 20.2 tt0 -69.1 -18.76 64.02 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.571 ' OD1' ' CD1' ' A' ' 55' ' ' TYR . 14.6 p30 -89.02 -26.0 21.68 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.937 0.875 . . . . 0.0 108.888 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.727 ' CE2' HG23 ' A' ' 38' ' ' ILE . 15.4 m-85 -80.26 -0.65 37.36 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.0 OUTLIER -92.48 175.82 6.69 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.539 -0.726 . . . . 0.0 109.16 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.6 m-20 . . . . . 0 C--N 1.298 -1.667 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.942 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.839 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.216 -0.706 0 CA-C-O 122.346 1.07 . . . . 0.0 110.455 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.839 ' N ' HG13 ' A' ' 2' ' ' VAL . 9.7 m120 -71.1 102.1 2.4 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.775 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.604 ' O ' HG23 ' A' ' 46' ' ' ILE . 13.4 tt0 -140.0 158.63 43.75 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.674 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 1.003 ' NE2' HD11 ' A' ' 46' ' ' ILE . 22.6 m-70 -81.53 97.72 7.95 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -82.92 -170.18 2.88 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.025 -1.047 . . . . 0.0 109.589 -179.104 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.575 ' O ' ' C ' ' A' ' 8' ' ' GLY . 5.5 t 173.31 142.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.623 ' HA2' ' OH ' ' A' ' 26' ' ' TYR . . . -14.12 -57.85 0.01 OUTLIER Glycine 0 N--CA 1.5 2.948 0 N-CA-C 111.957 -0.457 . . . . 0.0 111.957 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 7' ' ' CYS . 8.0 m -56.63 -69.91 0.14 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.007 -1.29 . . . . 0.0 109.675 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.604 ' CB ' ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.4 -17.83 64.88 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.704 -1.248 . . . . 0.0 108.041 179.447 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.689 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -60.67 -51.85 67.62 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.239 -0.913 . . . . 0.0 108.679 178.108 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.63 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -64.14 -26.08 39.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.493 -1.283 . . . . 0.0 108.226 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 1.1 tt0 -72.01 -60.39 2.26 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.72 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -52.57 -46.43 66.85 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.779 ' HA ' HG23 ' A' ' 18' ' ' VAL . 3.3 mt -64.39 -44.41 91.41 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.63 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 14.0 t80 -56.44 -21.1 23.17 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.22 -65.91 0.97 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.862 0.839 . . . . 0.0 109.292 179.724 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.779 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -47.25 -30.47 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.849 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -88.08 -73.84 0.47 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 65.22 2.31 9.04 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 11.7 tt0 164.41 -23.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.87 -1.37 . . . . 0.0 109.717 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.488 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 4.6 mtt-85 -60.95 -12.21 10.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.842 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 74.98 83.08 0.41 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.598 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -81.77 -167.86 1.68 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.024 -1.28 . . . . 0.0 109.894 -179.539 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.598 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -162.47 -171.01 2.61 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.412 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.623 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 1.8 t80 . . . . . 0 C--N 1.294 -1.84 0 C-N-CA 118.501 -1.28 . . . . 0.0 109.168 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.569 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.212 -0.889 0 CA-C-O 120.234 0.064 . . . . 0.0 110.961 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.505 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.59 -40.5 11.61 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 106.152 -2.779 . . . . 0.0 106.152 177.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.752 HG23 ' CE2' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -93.34 -57.4 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-O 122.402 1.096 . . . . 0.0 108.674 177.045 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 8.9 t -59.15 -28.53 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.93 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 36' ' ' ARG . 2.3 mt-10 -90.96 -32.03 16.12 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 120.919 -1.113 . . . . 0.0 108.609 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 45' ' ' SER . 6.0 tt0 -78.5 -75.82 0.22 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 121.641 0.734 . . . . 0.0 109.196 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 1.7 m -41.25 -44.73 2.73 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 121.533 -0.73 . . . . 0.0 109.996 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -75.18 -45.59 39.61 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.318 -0.864 . . . . 0.0 110.726 -178.781 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.516 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 4.7 m80 -90.11 -60.56 1.9 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.7 -1.25 . . . . 0.0 109.422 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 41' ' ' GLN . 7.9 t -88.15 -127.73 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 108.779 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 1.003 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -153.67 160.13 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.784 -1.198 . . . . 0.0 108.975 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.459 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 1.8 m -133.29 -166.09 1.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.689 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.619 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 5.7 m -146.47 144.04 29.38 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.693 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -39.29 -39.12 0.6 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.749 0.785 . . . . 0.0 110.191 -179.431 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.619 ' CE2' ' HB2' ' A' ' 48' ' ' SER . 1.1 p90 -61.8 -38.1 86.84 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.611 ' HG3' ' CZ ' ' A' ' 50' ' ' TYR . 17.6 mt-30 -67.82 -48.26 66.74 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.444 ' HA ' ' CD2' ' A' ' 55' ' ' TYR . 1.1 mp -67.48 -24.46 65.6 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.454 ' OE1' HG12 ' A' ' 18' ' ' VAL . 6.4 tp10 -57.67 -29.17 64.42 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -90.64 -10.6 42.66 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.574 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.752 ' CE2' HG23 ' A' ' 38' ' ' ILE . 12.0 m-85 -90.01 7.74 36.04 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -91.98 -161.32 0.81 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.631 -0.668 . . . . 0.0 109.502 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 7.3 p-10 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.005 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.657 ' O ' HG13 ' A' ' 2' ' ' VAL . 12.9 t80 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.503 0.668 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 1' ' ' PHE . 6.4 m -160.81 -167.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.496 ' C ' HG21 ' A' ' 46' ' ' ILE . 10.7 m-20 -63.23 93.62 0.07 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.407 -0.808 . . . . 0.0 109.178 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.644 ' NE2' ' CE2' ' A' ' 1' ' ' PHE . 1.4 pt20 -130.13 175.12 9.16 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.179 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.933 ' NE2' HD11 ' A' ' 46' ' ' ILE . 34.9 m-70 -92.94 108.57 20.11 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.851 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -111.75 126.47 55.09 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.091 -1.006 . . . . 0.0 111.022 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.522 ' O ' ' C ' ' A' ' 8' ' ' GLY . 72.8 m -108.49 168.47 9.3 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.28 -45.65 0.1 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 12' ' ' VAL . 12.8 m -60.63 -69.8 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -1.189 . . . . 0.0 109.977 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.554 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -66.42 -13.9 61.4 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 120.825 -1.172 . . . . 0.0 108.203 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.072 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -67.27 -49.64 63.54 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.269 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.614 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -64.75 -28.97 46.05 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.422 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.496 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.428 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 5.1 mt-10 -69.4 -59.82 2.74 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.851 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -52.82 -48.68 66.79 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.751 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.3 mt -63.13 -40.96 99.09 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.614 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.3 t80 -61.73 -21.42 64.49 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -86.18 -61.59 1.71 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.23 1.014 . . . . 0.0 108.47 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.751 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -54.46 -33.6 26.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.088 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -86.3 -65.05 1.05 Allowed 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.365 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.44 -72.12 0.23 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -130.32 -1.34 4.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -1.189 . . . . 0.0 109.808 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -72.8 -12.03 60.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.122 -0.986 . . . . 0.0 109.441 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 75.95 97.58 0.14 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.529 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -94.17 -176.82 4.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -1.163 . . . . 0.0 109.247 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.566 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 16.8 p90 -162.6 172.85 14.75 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.63 ' CE2' ' NE ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -112.14 122.4 47.64 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.224 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.914 HG23 ' CB ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -77.77 165.84 23.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.186 -0.946 . . . . 0.0 110.779 -178.062 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.551 ' O ' ' CG ' ' A' ' 34' ' ' PRO . 4.7 m-20 34.94 62.68 2.14 Favored Pre-proline 0 N--CA 1.493 1.686 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.117 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 37.1 Cg_endo -80.43 72.48 6.5 Favored 'Trans proline' 0 C--N 1.3 -1.983 0 C-N-CA 122.471 2.114 . . . . 0.0 110.209 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.1 p -146.1 -77.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.676 -1.265 . . . . 0.0 111.001 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.443 ' O ' ' HD3' ' A' ' 34' ' ' PRO . . . -84.3 179.5 51.72 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 120.329 -0.939 . . . . 0.0 110.784 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' C ' ' HD3' ' A' ' 34' ' ' PRO . . . -73.04 142.45 31.8 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.641 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 42.14 51.48 5.19 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.641 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 36.7 Cg_endo -76.62 -39.4 0.73 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.215 1.944 . . . . 0.0 108.657 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.914 ' CB ' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -97.61 34.02 1.93 Allowed 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 177.66 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.633 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -42.26 -21.85 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.343 -178.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.93 -44.51 13.56 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 106.286 -2.726 . . . . 0.0 106.286 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.072 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -93.52 -60.11 2.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 122.487 1.137 . . . . 0.0 108.399 177.115 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.641 HG21 ' HE ' ' A' ' 35' ' ' ARG . 23.6 t -51.05 -35.06 14.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.738 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.633 ' HB2' ' HB2' ' A' ' 36' ' ' ARG . 42.6 mt-10 -92.02 -20.45 21.32 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.83 -1.169 . . . . 0.0 109.593 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.557 ' O ' ' N ' ' A' ' 45' ' ' SER . 5.1 tp60 -86.21 -87.18 0.14 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.406 -0.809 . . . . 0.0 109.86 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.559 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 22.7 m -39.34 -41.09 0.87 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.618 -0.676 . . . . 0.0 109.694 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 6' ' ' LEU . 9.8 t -68.95 -53.46 20.68 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.911 -1.118 . . . . 0.0 110.948 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.482 ' ND1' ' HA ' ' A' ' 40' ' ' GLU . 11.7 m80 -85.18 -47.53 10.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.032 -1.043 . . . . 0.0 110.015 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 41' ' ' GLN . 29.0 t -100.78 -124.82 0.17 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 108.916 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.933 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -157.93 163.05 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.754 -1.217 . . . . 0.0 109.135 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.524 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -158.76 168.97 25.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.459 -0.775 . . . . 0.0 109.571 179.558 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.566 ' HG ' ' HD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -119.18 163.59 16.85 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.114 0.959 . . . . 0.0 109.527 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.617 ' HB3' HG13 ' A' ' 18' ' ' VAL . 25.1 mt -42.53 -33.71 0.73 Allowed 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 121.497 0.665 . . . . 0.0 109.637 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.616 ' CE1' ' HG2' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -56.99 -37.26 71.41 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.616 ' HG2' ' CE1' ' A' ' 50' ' ' TYR . 2.0 mm-40 -69.62 -59.78 2.74 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.473 ' HB3' ' HG ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -62.02 -16.86 54.78 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.6 tm-20 -68.05 -24.2 65.05 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -91.05 -24.87 19.91 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.752 0.787 . . . . 0.0 108.911 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.641 ' CD2' HG12 ' A' ' 38' ' ' ILE . 17.0 m-85 -81.06 4.18 20.66 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.566 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -83.07 -164.66 0.91 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.395 -0.816 . . . . 0.0 109.63 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 4.1 p-10 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.793 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.587 ' CD2' ' O ' ' A' ' 2' ' ' VAL . 15.8 p90 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.587 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 4.6 m -137.71 -165.3 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.928 -1.108 . . . . 0.0 110.005 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.452 ' HA ' ' CG2' ' A' ' 46' ' ' ILE . 28.3 m120 -41.71 99.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.995 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.651 ' H ' HG23 ' A' ' 46' ' ' ILE . 12.6 tt0 -148.7 166.46 28.31 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.408 -0.808 . . . . 0.0 109.66 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 1.025 ' NE2' HD11 ' A' ' 46' ' ' ILE . 24.1 m-70 -91.79 113.86 26.24 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.885 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.2 tp -120.58 129.12 53.63 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.422 -0.799 . . . . 0.0 110.691 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.527 ' O ' ' C ' ' A' ' 8' ' ' GLY . 89.8 m -113.18 170.76 7.99 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.94 -1.1 . . . . 0.0 108.404 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.527 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.25 -45.87 0.1 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.448 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 15.7 m -63.05 -67.76 0.4 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.19 . . . . 0.0 110.216 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 2.2 m-20 -67.57 -11.59 58.43 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.75 -1.219 . . . . 0.0 108.531 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.914 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.76 -49.7 50.44 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.031 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.617 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -63.92 -30.95 51.34 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.553 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.448 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 7.8 tt0 -69.9 -55.25 10.21 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.885 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -55.64 -49.75 72.02 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.77 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.4 mt -62.63 -41.61 99.12 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.617 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 7.4 t80 -59.39 -20.23 53.21 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -90.14 -65.38 1.02 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.094 0.949 . . . . 0.0 108.881 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.77 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -48.42 -28.69 2.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.42 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.48 -70.12 0.68 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.515 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.86 -62.83 0.49 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 19' ' ' CYS . 7.9 mp0 -134.4 -2.24 2.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -1.201 . . . . 0.0 110.364 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.485 ' HD3' ' O ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -74.42 -8.96 58.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.985 -1.072 . . . . 0.0 109.606 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.42 86.55 0.11 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.574 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -83.43 179.63 7.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -1.181 . . . . 0.0 109.407 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.574 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 29.4 p90 -163.3 166.57 22.92 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.156 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.423 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.1 OUTLIER -109.01 123.09 48.58 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.069 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.596 HG23 ' HB2' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -78.86 156.64 28.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.858 -1.151 . . . . 0.0 111.201 -178.089 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 34' ' ' PRO . 8.1 t70 28.54 67.5 0.62 Allowed Pre-proline 0 N--CA 1.496 1.832 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.861 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 36.9 Cg_endo -79.57 63.14 8.69 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.747 2.298 . . . . 0.0 110.379 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.8 p -133.66 -79.12 0.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.822 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.14 164.98 39.56 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.25 135.24 25.55 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.524 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 48.52 57.5 8.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.53 ' CB ' ' O ' ' A' ' 28' ' ' ASP . 31.9 Cg_endo -71.93 -28.88 15.85 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.502 2.135 . . . . 0.0 109.548 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.596 ' HB2' HG23 ' A' ' 27' ' ' THR . 1.5 tpm_? -119.07 45.09 2.17 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.599 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -41.53 -22.83 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.877 -178.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.2 -41.96 8.51 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 106.147 -2.781 . . . . 0.0 106.147 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.914 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -94.12 -61.18 2.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 122.544 1.164 . . . . 0.0 108.668 176.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.581 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 37.9 t -54.79 -30.97 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.321 -177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.599 ' CB ' ' HB2' ' A' ' 36' ' ' ARG . 1.7 tt0 -92.73 -23.96 18.75 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 120.809 -1.182 . . . . 0.0 109.549 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 45' ' ' SER . 29.6 tt0 -82.81 -90.34 0.08 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.072 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.569 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.24 -37.09 0.88 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 109.997 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 15.3 t -68.95 -52.94 23.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.538 -1.351 . . . . 0.0 110.664 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.46 ' ND1' ' HA ' ' A' ' 40' ' ' GLU . 5.5 m80 -91.25 -55.48 3.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.925 -1.11 . . . . 0.0 108.471 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.625 ' C ' HD12 ' A' ' 46' ' ' ILE . 64.2 m -85.47 -131.46 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 1.025 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -151.97 152.78 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.674 -1.266 . . . . 0.0 109.114 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.656 ' SG ' HD11 ' A' ' 52' ' ' LEU . 8.3 p -149.63 172.86 14.37 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 1' ' ' PHE . 67.4 m -136.73 169.46 17.69 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.999 -1.063 . . . . 0.0 110.272 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.702 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -41.93 -34.52 0.69 Allowed 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.795 1.283 . . . . 0.0 108.492 178.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -53.21 -52.72 58.0 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.072 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 48' ' ' SER . 2.1 mt-30 -74.11 -45.55 48.36 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.292 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.656 HD11 ' SG ' ' A' ' 47' ' ' CYS . 1.1 mp -65.83 -14.39 61.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.414 -0.804 . . . . 0.0 109.032 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.5 tt0 -70.06 -28.09 65.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.156 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -90.39 -8.32 50.93 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.528 -0.732 . . . . 0.0 109.55 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.742 ' CE2' HG23 ' A' ' 38' ' ' ILE . 12.1 m-85 -90.33 2.05 55.92 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.49 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.3 m -78.64 -166.05 0.81 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.51 -0.744 . . . . 0.0 110.092 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.6 t-20 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.895 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.592 ' CB ' HD13 ' A' ' 49' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 1' ' ' PHE . 10.5 m -157.58 -167.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.754 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.549 ' CA ' HG21 ' A' ' 46' ' ' ILE . 2.0 m-80 -73.06 98.88 2.63 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.539 -0.725 . . . . 0.0 109.911 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.479 ' O ' HG23 ' A' ' 46' ' ' ILE . 3.2 pm0 -132.44 170.05 15.68 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.773 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.973 ' NE2' HD11 ' A' ' 46' ' ' ILE . 27.9 m-70 -93.35 113.65 25.88 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.941 HD21 ' HB2' ' A' ' 14' ' ' ALA . 0.9 OUTLIER -114.14 144.43 43.17 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.426 -0.796 . . . . 0.0 109.899 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.578 ' O ' ' N ' ' A' ' 9' ' ' SER . 2.4 t -144.07 112.66 6.55 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.187 -0.946 . . . . 0.0 109.63 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.532 ' N ' ' HB2' ' A' ' 11' ' ' LEU . . . 40.94 -90.36 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 7' ' ' CYS . 7.5 m -37.28 -67.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.578 -0.954 . . . . 0.0 110.549 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.593 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 81.5 m-20 -68.0 -19.14 64.9 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.647 -1.283 . . . . 0.0 108.441 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.84 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -65.33 -48.5 72.8 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.409 -0.807 . . . . 0.0 109.024 178.142 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.62 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.6 m -67.62 -26.23 34.89 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.489 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.671 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.475 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 5.4 tt0 -71.87 -57.97 3.86 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.941 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -52.69 -49.08 66.01 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.773 ' HA ' HG23 ' A' ' 18' ' ' VAL . 3.5 mt -64.32 -41.64 96.71 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.62 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 8.2 t80 -59.76 -24.26 63.91 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -84.17 -63.52 1.33 Allowed 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 122.104 0.954 . . . . 0.0 108.899 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -53.09 -28.88 14.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.914 -179.688 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.37 -70.58 0.65 Allowed 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.484 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.72 -64.02 0.18 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -131.63 -0.65 3.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.172 -1.193 . . . . 0.0 109.884 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 2.2 mtt85 -77.8 -9.53 59.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.143 -0.973 . . . . 0.0 109.914 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.9 92.4 0.05 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.537 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -87.0 -176.68 5.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.338 -1.095 . . . . 0.0 110.173 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CD1' ' C ' ' A' ' 25' ' ' PHE . 13.3 p90 -162.36 173.63 13.88 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.748 0.785 . . . . 0.0 109.415 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.661 ' CZ ' ' CD ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -112.36 123.32 50.02 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.479 ' O ' ' C ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -78.1 166.16 23.13 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.956 -1.09 . . . . 0.0 110.64 -178.318 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 3.5 m-20 35.01 64.23 1.9 Allowed Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.485 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 36.0 Cg_endo -77.66 77.12 3.99 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.853 2.368 . . . . 0.0 110.735 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.61 -79.42 0.61 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.081 -1.012 . . . . 0.0 109.34 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.16 152.67 12.39 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.24 78.88 0.15 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.89 75.27 0.28 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 28' ' ' ASP . 31.7 Cg_endo -72.23 -29.42 14.27 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.347 2.031 . . . . 0.0 109.441 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.737 ' NE ' HD13 ' A' ' 38' ' ' ILE . 7.9 ptm180 -121.56 30.31 6.79 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.532 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -39.25 -24.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.793 -0.567 . . . . 0.0 111.931 -178.093 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -53.76 -42.42 68.33 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 105.252 -3.139 . . . . 0.0 105.252 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.84 ' CG2' HD21 ' A' ' 11' ' ' LEU . 1.2 mp -93.68 -50.43 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 121.838 0.828 . . . . 0.0 108.928 177.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.676 HG23 ' CG ' ' A' ' 35' ' ' ARG . 9.0 t -61.06 -29.66 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.813 -0.554 . . . . 0.0 110.21 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 36' ' ' ARG . 2.2 tt0 -91.28 -12.62 34.59 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -90.75 -95.59 0.12 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.763 -0.585 . . . . 0.0 109.881 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -39.95 -28.27 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.37 -0.831 . . . . 0.0 110.002 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.557 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 18.7 t -73.76 -58.05 3.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.751 -1.218 . . . . 0.0 109.409 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.45 ' ND1' ' HA ' ' A' ' 40' ' ' GLU . 16.0 m80 -80.28 -45.49 17.8 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.341 -0.849 . . . . 0.0 109.118 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.645 ' C ' HD12 ' A' ' 46' ' ' ILE . 14.9 t -106.42 -126.69 0.25 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.973 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.7 mp -150.25 165.87 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.742 -1.224 . . . . 0.0 109.561 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.564 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 20.2 p -154.13 178.04 10.42 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.55 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -139.63 163.7 31.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.719 -1.238 . . . . 0.0 110.888 -178.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.793 ' O ' HG11 ' A' ' 18' ' ' VAL . 1.8 mp -39.2 -39.94 0.67 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.902 0.858 . . . . 0.0 109.978 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 2.3 p90 -63.36 -41.73 98.86 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.585 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 7.1 tp60 -66.18 -44.18 84.71 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.594 ' CB ' HG21 ' A' ' 18' ' ' VAL . 1.4 mp -75.75 -23.45 55.99 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.7 tt0 -60.86 -30.0 69.87 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -90.12 -8.92 50.14 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.827 ' CE2' HG23 ' A' ' 38' ' ' ILE . 13.8 m-30 -90.03 -0.45 57.59 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.54 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -90.55 -164.98 1.25 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.645 -0.659 . . . . 0.0 110.536 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.9 t-20 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.909 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.873 ' HD2' HG22 ' A' ' 2' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.873 HG22 ' HD2' ' A' ' 1' ' ' PHE . 17.0 m -146.85 -168.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.424 -0.798 . . . . 0.0 108.925 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 3' ' ' ASN . 4.3 p-10 -89.17 95.41 10.29 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.412 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.541 ' N ' HG23 ' A' ' 46' ' ' ILE . 3.9 pm0 -135.51 174.22 10.86 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 118.254 -1.378 . . . . 0.0 109.933 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.979 ' NE2' HD11 ' A' ' 46' ' ' ILE . 30.1 m-70 -90.8 106.77 18.74 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.949 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -110.9 127.81 55.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.114 -0.991 . . . . 0.0 110.782 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 11' ' ' LEU . 61.1 m -111.94 169.05 9.11 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.42 -44.79 0.09 OUTLIER Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 7' ' ' CYS . 58.7 m -61.59 -69.44 0.24 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.133 -1.216 . . . . 0.0 110.078 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.541 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 31.6 m-20 -67.06 -12.52 60.16 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.906 -1.121 . . . . 0.0 108.205 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.045 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -68.21 -50.37 54.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.488 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -65.04 -31.65 54.84 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.527 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.275 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.71 -58.35 4.8 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.949 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -53.94 -51.94 62.19 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.799 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.2 mt -59.18 -44.56 92.17 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.606 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 14.5 t80 -56.07 -21.71 23.54 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.58 -67.22 0.86 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.94 0.876 . . . . 0.0 109.427 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.059 HG13 ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -46.08 -29.41 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 121.613 0.72 . . . . 0.0 109.171 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -87.74 -72.89 0.5 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.846 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 69.16 -1.11 12.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER 159.45 -19.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.053 -1.263 . . . . 0.0 110.101 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -54.87 -18.33 4.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.097 -1.002 . . . . 0.0 109.37 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.64 68.5 1.27 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.939 -1.665 . . . . 0.0 108.939 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.499 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -72.06 178.74 3.62 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.338 -1.095 . . . . 0.0 109.836 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 10.4 p90 -162.77 -175.45 4.43 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.817 0.818 . . . . 0.0 109.359 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.62 ' CD2' ' CZ ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -131.87 109.53 10.16 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.034 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.56 ' CG2' ' HG2' ' A' ' 35' ' ' ARG . 11.0 t -77.9 -171.32 2.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.688 -1.258 . . . . 0.0 110.68 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 34' ' ' PRO . 2.7 m-20 38.93 69.08 1.7 Allowed Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.36 72.49 5.44 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.301 2.001 . . . . 0.0 110.627 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 p -134.66 -78.72 0.45 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.452 -0.78 . . . . 0.0 109.432 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.0 175.98 23.43 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.2 59.85 7.44 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.524 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 52.52 57.66 13.23 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.552 ' HG2' ' CZ ' ' A' ' 35' ' ' ARG . 31.3 Cg_endo -72.2 -49.72 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.476 2.117 . . . . 0.0 109.753 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.69 ' HB3' HD12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -94.81 28.12 2.83 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.599 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -39.59 -24.71 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.766 -0.584 . . . . 0.0 111.782 -178.186 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.486 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.84 -44.08 17.41 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 106.173 -2.771 . . . . 0.0 106.173 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.045 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.81 -57.67 4.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.447 1.117 . . . . 0.0 108.7 177.385 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 53.7 t -56.24 -32.09 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.075 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.599 ' CB ' ' HB2' ' A' ' 36' ' ' ARG . 4.3 tt0 -91.87 -17.96 24.49 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 120.849 -1.157 . . . . 0.0 109.156 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 45' ' ' SER . 7.4 tt0 -89.97 -85.98 0.2 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.623 -0.673 . . . . 0.0 109.377 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.585 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 22.4 m -39.75 -39.01 0.71 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.845 . . . . 0.0 109.677 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 39' ' ' VAL . 6.3 t -71.0 -53.86 13.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 110.587 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.456 ' ND1' ' HA ' ' A' ' 40' ' ' GLU . 14.1 m80 -82.58 -51.84 7.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.127 -0.983 . . . . 0.0 109.68 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' GLN . 18.4 t -97.7 -123.84 0.14 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 108.747 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.979 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -159.9 162.5 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.797 -1.19 . . . . 0.0 108.839 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.536 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -157.63 174.73 14.91 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.283 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.633 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 5.1 m -126.93 159.65 33.38 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.192 -0.942 . . . . 0.0 110.328 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.059 ' HG ' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -38.79 -37.59 0.35 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.573 0.701 . . . . 0.0 111.033 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.633 ' CD2' ' HB2' ' A' ' 48' ' ' SER . 3.4 p90 -54.53 -42.95 71.47 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.625 0.726 . . . . 0.0 109.813 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.625 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -75.01 -31.12 61.31 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.442 -0.786 . . . . 0.0 109.968 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.64 HD23 ' HG ' ' A' ' 15' ' ' LEU . 1.3 mp -79.29 -20.38 48.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.995 -1.066 . . . . 0.0 108.137 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -64.4 -23.31 67.24 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -90.44 -16.41 29.06 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.63 ' CD2' HG12 ' A' ' 38' ' ' ILE . 11.6 m-85 -86.53 1.77 50.38 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.573 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -90.81 -165.52 1.37 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.522 -0.736 . . . . 0.0 110.09 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' CYS . 3.5 t30 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.766 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.706 ' N ' HD21 ' A' ' 49' ' ' LEU . 18.2 p90 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.546 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 6.8 m -123.08 -165.65 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.014 -1.054 . . . . 0.0 110.201 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.505 ' HA ' ' CG2' ' A' ' 46' ' ' ILE . 2.2 m120 -41.56 96.83 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.437 -0.789 . . . . 0.0 110.075 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.577 ' HG2' ' N ' ' A' ' 5' ' ' HIS . 23.2 tt0 -140.36 164.92 28.82 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.499 -0.751 . . . . 0.0 109.592 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 1.064 ' NE2' HD11 ' A' ' 46' ' ' ILE . 23.1 m-70 -89.27 104.41 16.96 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.97 ' CD2' ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -113.18 125.49 54.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.0 -1.062 . . . . 0.0 111.236 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.558 ' O ' ' N ' ' A' ' 11' ' ' LEU . 64.5 m -106.55 168.12 9.38 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.555 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . . . -32.99 -42.1 0.14 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 7' ' ' CYS . 4.0 m -61.5 -69.95 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -1.204 . . . . 0.0 109.593 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.549 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 6.5 m-20 -66.42 -13.45 60.74 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.879 -1.138 . . . . 0.0 107.939 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.843 HD21 ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -64.74 -52.2 58.31 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.035 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.621 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -64.6 -29.3 46.98 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.512 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.443 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 4.0 tt0 -71.85 -54.08 11.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.97 ' HB2' ' CD2' ' A' ' 6' ' ' LEU . . . -54.13 -51.79 63.12 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.797 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.3 mt -61.92 -44.64 96.36 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.621 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 8.1 t80 -56.63 -21.5 27.59 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -88.11 -67.02 0.86 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.797 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -46.92 -29.68 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.22 -71.19 0.63 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.494 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.95 -66.6 0.19 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 19' ' ' CYS . 1.7 tt0 -129.23 -0.51 5.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 109.809 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.78 -6.78 55.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.995 . . . . 0.0 109.717 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 57' ' ' ASN . . . 67.77 94.5 0.04 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.513 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -91.56 -177.88 4.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.254 -1.145 . . . . 0.0 109.905 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 11.6 p90 -162.37 -178.02 6.03 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.599 ' CE1' ' CZ ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -122.65 115.58 22.35 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.962 HG23 ' HG2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -78.11 167.53 21.28 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.246 -0.909 . . . . 0.0 110.327 -178.549 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.528 ' O ' ' CG ' ' A' ' 34' ' ' PRO . 14.4 m-20 35.0 63.67 2.01 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 35.1 Cg_endo -77.12 90.79 1.22 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.657 2.238 . . . . 0.0 110.583 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 34' ' ' PRO . 35.6 p -127.97 -78.92 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.151 -0.968 . . . . 0.0 109.459 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.0 176.47 45.77 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 46.93 -115.18 1.85 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.473 ' O ' ' HD2' ' A' ' 36' ' ' ARG . . . -132.83 89.34 0.26 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.547 ' HG2' ' CZ ' ' A' ' 35' ' ' ARG . 31.0 Cg_endo -73.05 -51.2 0.17 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.431 2.087 . . . . 0.0 108.91 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.962 ' HG2' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -99.26 33.39 2.44 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 177.146 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.562 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -46.21 -19.82 0.09 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.616 -177.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -50.35 -48.17 41.69 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.07 HG21 ' CE1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -93.43 -21.18 6.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.93 -0.747 . . . . 0.0 109.413 178.407 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.569 HG21 HH21 ' A' ' 35' ' ' ARG . 0.9 OUTLIER -86.56 -59.47 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 0.0 109.196 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.549 ' N ' HG12 ' A' ' 39' ' ' VAL . 23.0 tt0 -62.39 -14.46 40.53 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.115 -0.991 . . . . 0.0 108.478 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -81.96 -77.75 0.21 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.308 -0.87 . . . . 0.0 108.872 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.543 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 23.6 m -42.75 -45.98 4.98 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' LEU . 11.5 t -64.54 -54.37 33.23 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.318 -0.864 . . . . 0.0 110.113 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.567 ' O ' ' CE1' ' A' ' 5' ' ' HIS . 6.4 m80 -86.99 -69.13 0.7 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.992 -1.067 . . . . 0.0 108.746 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.553 ' C ' HD12 ' A' ' 46' ' ' ILE . 6.7 t -75.15 -132.27 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 1.064 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.1 mp -155.3 159.68 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.805 -1.185 . . . . 0.0 109.121 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.464 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -150.45 177.6 9.84 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.744 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.469 ' OG ' ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -130.41 156.56 44.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 109.903 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.786 HD22 ' H ' ' A' ' 49' ' ' LEU . 1.8 mm? -39.91 -35.28 0.34 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.667 0.746 . . . . 0.0 110.258 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.602 ' CG ' ' N ' ' A' ' 51' ' ' GLN . 0.9 OUTLIER -52.3 -47.56 65.85 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.722 0.773 . . . . 0.0 109.178 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.609 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -75.01 -33.0 61.76 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.707 -179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.609 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 1.9 mp -78.05 -19.23 54.68 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.176 -0.953 . . . . 0.0 108.64 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 49' ' ' LEU . 19.3 tt0 -67.11 -20.43 65.78 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -90.62 -12.39 37.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.572 -0.705 . . . . 0.0 109.708 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 1.07 ' CE1' HG21 ' A' ' 38' ' ' ILE . 56.5 m-85 -90.37 4.76 49.95 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.107 -0.996 . . . . 0.0 109.084 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.57 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -81.65 -164.54 0.8 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.687 -0.633 . . . . 0.0 109.446 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 12.8 t30 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.139 -0.934 . . . . 0.0 109.575 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.593 ' CD2' ' O ' ' A' ' 2' ' ' VAL . 22.2 p90 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.593 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 14.3 m -131.91 -165.59 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.866 -1.146 . . . . 0.0 110.583 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.468 ' CA ' HG21 ' A' ' 46' ' ' ILE . 2.7 m-20 -53.04 88.94 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.016 -1.052 . . . . 0.0 110.092 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 2' ' ' VAL . 1.7 pt20 -135.76 177.6 7.7 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.366 -0.834 . . . . 0.0 109.275 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.925 ' NE2' HD11 ' A' ' 46' ' ' ILE . 30.5 m-70 -93.53 109.71 21.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.644 -0.66 . . . . 0.0 109.385 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.0 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -108.43 141.92 39.57 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.861 0.839 . . . . 0.0 110.301 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.556 ' O ' ' C ' ' A' ' 8' ' ' GLY . 60.7 m -128.93 167.82 16.87 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.579 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -25.91 -48.25 0.04 OUTLIER Glycine 0 N--CA 1.498 2.772 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 7' ' ' CYS . 24.0 m -63.17 -68.29 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -1.199 . . . . 0.0 110.227 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.547 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 16.5 m-20 -68.27 -10.24 53.27 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.792 -1.192 . . . . 0.0 108.727 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.087 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -72.81 -48.09 40.85 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.446 -0.901 . . . . 0.0 109.228 178.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.604 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -69.02 -32.05 52.83 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.428 0 C-N-CA 119.024 -1.071 . . . . 0.0 108.324 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -67.31 -57.74 6.1 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 1.0 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.3 -48.94 70.71 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.777 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.7 mt -64.4 -41.01 96.88 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.109 0.957 . . . . 0.0 108.592 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.604 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.2 t80 -57.61 -21.22 37.95 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.51 -64.92 1.07 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 122.072 0.939 . . . . 0.0 109.245 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.777 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.53 -28.32 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.412 0.625 . . . . 0.0 109.519 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -90.04 -71.41 0.62 Allowed 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.676 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.63 -59.03 0.19 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' CYS . 2.4 pm0 -129.43 -28.79 2.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.222 -1.163 . . . . 0.0 110.331 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.56 -20.69 2.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.355 -0.841 . . . . 0.0 109.645 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 72.9 94.34 0.09 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.613 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -83.45 -169.26 2.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.309 -1.112 . . . . 0.0 110.203 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.613 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 3.3 p90 -161.87 178.6 8.77 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.55 ' CD2' ' HB2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -130.96 114.4 15.18 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.469 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 2.4 t -78.7 -178.91 6.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.922 -1.111 . . . . 0.0 111.235 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' A' ' 34' ' ' PRO . 12.6 p-10 -176.48 94.99 0.25 Allowed Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.547 ' CD ' ' O ' ' A' ' 34' ' ' PRO . 37.1 Cg_endo -77.37 11.0 2.25 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.682 2.255 . . . . 0.0 111.553 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.727 HG22 ' N ' ' A' ' 31' ' ' GLY . 0.8 OUTLIER 179.03 -68.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.587 -1.321 . . . . 0.0 109.814 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.727 ' N ' HG22 ' A' ' 30' ' ' THR . . . 172.05 -90.32 0.09 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 31' ' ' GLY . . . -44.46 115.37 1.3 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.544 ' O ' ' CD ' ' A' ' 36' ' ' ARG . . . 60.48 72.45 0.62 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.547 ' O ' ' CD ' ' A' ' 29' ' ' PRO . 31.1 Cg_endo -72.9 -51.55 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.507 2.138 . . . . 0.0 109.171 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.832 ' CG ' HD13 ' A' ' 38' ' ' ILE . 10.1 ttt85 -95.05 28.55 2.74 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.544 ' CD ' ' O ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -55.08 -23.82 22.27 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.735 -0.603 . . . . 0.0 111.97 -177.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 41' ' ' GLN . . . -53.3 -43.12 64.66 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 105.377 -3.089 . . . . 0.0 105.377 177.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.087 ' CG2' HD21 ' A' ' 11' ' ' LEU . 2.4 mp -94.45 -48.0 13.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.883 0.849 . . . . 0.0 109.175 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 2.1 t -60.68 -33.07 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.508 0.67 . . . . 0.0 109.571 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 36' ' ' ARG . 1.4 tt0 -90.34 -17.36 27.45 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.56 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -90.08 -88.27 0.17 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.579 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 1.2 m -39.03 -33.45 0.12 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.845 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 39' ' ' VAL . 3.3 t -77.78 -46.61 21.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.029 -1.044 . . . . 0.0 110.986 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 15.3 m80 -91.15 -34.01 15.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.886 -1.133 . . . . 0.0 109.111 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 41' ' ' GLN . 58.7 m -114.75 -126.41 0.29 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.925 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -159.87 165.39 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.514 -1.366 . . . . 0.0 109.633 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.579 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -156.11 -160.5 1.01 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.101 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 1' ' ' PHE . 4.5 p -160.38 161.67 33.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.097 -1.002 . . . . 0.0 109.643 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.618 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -41.95 -35.88 0.97 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.898 1.332 . . . . 0.0 108.353 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 13.2 t80 -57.47 -53.1 61.97 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.38 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -73.41 -40.37 64.34 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.694 ' HA ' ' CD2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -68.76 -21.23 64.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.485 -0.76 . . . . 0.0 109.048 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 49' ' ' LEU . 2.1 tt0 -62.09 -25.26 67.61 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -90.59 -10.21 44.23 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.748 -0.595 . . . . 0.0 109.513 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.696 ' CD2' HG12 ' A' ' 38' ' ' ILE . 13.2 m-85 -84.32 -4.15 58.69 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 24' ' ' PHE . 1.2 m -90.79 -169.15 2.28 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.744 0.783 . . . . 0.0 111.12 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 55.5 t30 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.456 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 48' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.455 ' N ' ' CD1' ' A' ' 1' ' ' PHE . 12.8 m -149.45 -168.63 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.693 -1.254 . . . . 0.0 109.58 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.522 ' CA ' HG21 ' A' ' 46' ' ' ILE . 2.7 m120 -77.66 87.54 3.94 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 108.936 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.622 ' HG3' HD13 ' A' ' 6' ' ' LEU . 5.9 pt20 -125.64 175.73 7.37 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.259 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.833 ' NE2' HD11 ' A' ' 46' ' ' ILE . 45.4 m-70 -92.1 112.01 23.79 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.816 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -112.92 129.11 56.59 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.332 -0.855 . . . . 0.0 111.319 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' O ' ' C ' ' A' ' 8' ' ' GLY . 91.4 m -111.15 170.52 8.06 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.522 ' HA2' ' OH ' ' A' ' 26' ' ' TYR . . . -29.93 -47.53 0.12 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.462 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 25.6 m -61.17 -68.11 0.34 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -1.189 . . . . 0.0 110.369 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.574 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 8.7 m-20 -67.46 -13.06 61.69 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.852 -1.155 . . . . 0.0 108.477 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.996 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -68.44 -49.18 61.77 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.195 -0.94 . . . . 0.0 108.551 177.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.614 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -64.48 -28.18 44.27 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.46 0 C-N-CA 119.114 -1.035 . . . . 0.0 108.509 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.4 OUTLIER -71.4 -56.55 5.75 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.816 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -55.41 -45.8 76.67 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.765 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.8 mt -66.31 -40.65 90.12 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.614 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 6.3 t80 -59.13 -20.12 50.85 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -89.95 -64.23 1.17 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 122.046 0.927 . . . . 0.0 108.791 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.765 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.75 -29.28 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.538 0.685 . . . . 0.0 109.294 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.92 -71.13 0.63 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.673 -179.401 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.6 -62.41 0.3 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 19' ' ' CYS . 25.6 mp0 -132.66 -10.96 3.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.132 -1.217 . . . . 0.0 110.663 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -67.96 -7.56 29.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.913 -1.117 . . . . 0.0 109.624 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.88 92.79 0.05 OUTLIER Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.626 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -86.36 -178.02 6.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.124 -1.221 . . . . 0.0 109.529 -179.747 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.626 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 16.6 p90 -162.19 168.38 22.54 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.615 ' CD1' ' HD2' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -109.18 125.87 52.66 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.458 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.889 HG23 ' HB3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -77.98 156.25 30.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.065 -1.022 . . . . 0.0 110.437 -178.434 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.546 ' CB ' ' HB2' ' A' ' 34' ' ' PRO . 26.7 m-20 31.61 67.17 0.92 Allowed Pre-proline 0 N--CA 1.496 1.826 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.265 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 36.3 Cg_endo -78.76 78.64 3.62 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.739 2.293 . . . . 0.0 110.745 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.65 -76.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.057 -1.027 . . . . 0.0 109.921 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.478 ' O ' ' HD3' ' A' ' 34' ' ' PRO . . . -58.9 174.95 2.99 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.468 ' C ' ' HD3' ' A' ' 34' ' ' PRO . . . -74.22 -37.72 48.02 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.551 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . -132.04 57.9 0.71 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 32.0 Cg_endo -73.49 -44.44 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.468 2.112 . . . . 0.0 109.412 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.889 ' HB3' HG23 ' A' ' 27' ' ' THR . 0.2 OUTLIER -98.22 31.52 2.74 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.605 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -40.17 -22.98 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.617 -178.599 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.15 -44.4 14.49 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 106.358 -2.697 . . . . 0.0 106.358 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.996 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.5 -60.36 2.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 122.554 1.169 . . . . 0.0 108.43 177.015 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.574 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 34.3 t -51.56 -33.26 14.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.72 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.605 ' CB ' ' HB2' ' A' ' 36' ' ' ARG . 3.6 tt0 -93.46 -14.87 26.19 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 120.896 -1.128 . . . . 0.0 109.412 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 45' ' ' SER . 35.4 tt0 -88.53 -96.88 0.09 Allowed 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.98 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.58 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -39.75 -34.52 0.26 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.862 . . . . 0.0 109.912 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.574 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 13.4 t -67.2 -54.82 17.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.371 -1.455 . . . . 0.0 110.087 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.49 ' ND1' ' HA ' ' A' ' 40' ' ' GLU . 13.0 m80 -84.75 -40.66 17.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 109.691 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' GLN . 9.3 t -110.39 -128.26 0.28 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.847 . . . . 0.0 108.801 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.833 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.4 mp -147.64 162.51 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.727 -1.233 . . . . 0.0 108.984 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.494 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 18.8 p -154.97 160.26 40.97 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.922 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 1' ' ' PHE . 5.3 m -114.46 159.12 20.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.48 -0.762 . . . . 0.0 109.952 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -39.64 -36.76 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.61 -0.681 . . . . 0.0 110.357 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.623 ' CZ ' ' HG2' ' A' ' 51' ' ' GLN . 0.9 OUTLIER -53.0 -39.32 63.01 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 119.673 -0.811 . . . . 0.0 108.842 -179.091 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.623 ' HG2' ' CZ ' ' A' ' 50' ' ' TYR . 1.5 mm-40 -72.98 -54.48 8.5 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.492 ' HB2' HG21 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -64.21 -12.12 37.58 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 49' ' ' LEU . 12.1 tt0 -74.47 -28.0 60.83 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -90.92 -9.8 44.84 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.65 ' CD2' HG12 ' A' ' 38' ' ' ILE . 14.0 m-85 -89.76 1.6 55.9 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.473 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -90.51 -165.81 1.44 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.596 -0.69 . . . . 0.0 110.158 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 42.7 t-20 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.922 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.743 ' HE1' HD13 ' A' ' 52' ' ' LEU . 9.6 p90 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.721 0.772 . . . . 0.0 109.735 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.842 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER -104.34 -151.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 122.381 1.086 . . . . 0.0 110.309 -178.866 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.842 ' N ' HG13 ' A' ' 2' ' ' VAL . 10.2 m120 -74.28 92.16 2.23 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.13 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.579 ' HG2' ' CD2' ' A' ' 1' ' ' PHE . 1.7 pt20 -132.96 175.02 9.73 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.109 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.903 ' NE2' HD11 ' A' ' 46' ' ' ILE . 39.1 m-70 -94.57 113.51 25.34 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.857 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -117.98 136.09 53.74 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.149 -0.969 . . . . 0.0 110.177 -179.224 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 9' ' ' SER . 4.4 t -135.32 116.7 14.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.102 -0.999 . . . . 0.0 109.994 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.534 ' N ' ' HB2' ' A' ' 11' ' ' LEU . . . 39.19 -90.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.567 ' N ' ' O ' ' A' ' 7' ' ' CYS . 4.2 m -36.6 -68.47 0.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.639 -0.918 . . . . 0.0 110.518 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.597 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 52.4 m-20 -67.86 -20.12 65.1 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.719 -1.238 . . . . 0.0 108.561 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.984 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -64.74 -48.82 73.19 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.462 -0.895 . . . . 0.0 108.975 177.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.624 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -66.41 -27.93 41.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.658 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.462 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 27.4 tt0 -71.7 -53.46 13.44 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.857 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -57.94 -48.42 79.98 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.751 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.5 mt -63.66 -38.61 91.75 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.624 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 10.3 t80 -62.17 -20.24 63.93 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -87.82 -63.59 1.28 Allowed 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.912 HG13 HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -48.79 -32.29 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.673 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.31 -73.23 0.53 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.846 0.832 . . . . 0.0 109.144 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 41.43 25.69 0.18 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 1.3 mt-10 162.18 -32.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.262 -1.14 . . . . 0.0 110.06 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.48 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.8 mtp85 -71.41 -4.92 29.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.394 -0.816 . . . . 0.0 109.58 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 64.75 91.27 0.03 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.491 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -88.52 178.11 6.61 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.138 -1.213 . . . . 0.0 109.812 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.453 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 33.7 p90 -163.39 158.59 21.35 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.625 ' CD1' ' CD ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -90.86 114.37 26.79 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.635 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.511 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 7.3 t -78.23 -165.53 0.69 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.857 -1.152 . . . . 0.0 110.303 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HB2' ' HG3' ' A' ' 35' ' ' ARG . 64.3 m-20 35.45 66.09 1.71 Allowed Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 34.7 Cg_endo -76.43 72.78 5.37 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 122.42 2.08 . . . . 0.0 110.542 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 34' ' ' PRO . 7.8 p -135.77 -78.33 0.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 109.519 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 153.55 169.06 18.15 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 33' ' ' GLY . . . 65.69 69.72 1.28 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.548 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 42.4 59.35 3.11 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 33.2 Cg_endo -75.8 -45.93 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.341 2.027 . . . . 0.0 109.078 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.625 ' CD ' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -94.48 22.51 6.07 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.592 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -39.67 -25.59 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.777 -0.577 . . . . 0.0 111.358 -178.319 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -47.03 -42.62 16.24 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.984 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -94.67 -60.82 2.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 122.629 1.204 . . . . 0.0 108.26 176.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.595 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 49.6 t -53.43 -30.75 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.112 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.592 ' CB ' ' HB2' ' A' ' 36' ' ' ARG . 8.8 tt0 -94.4 -16.54 23.35 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 120.795 -1.19 . . . . 0.0 109.318 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 45' ' ' SER . 2.7 tp60 -90.15 -92.64 0.13 Allowed 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.179 -178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -42.28 -32.62 0.52 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.83 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.595 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 25.3 t -68.72 -56.9 6.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.64 -1.288 . . . . 0.0 109.853 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.449 ' ND1' ' HA ' ' A' ' 40' ' ' GLU . 16.7 m80 -83.29 -48.02 10.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.391 -0.818 . . . . 0.0 109.77 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.598 ' C ' HD12 ' A' ' 46' ' ' ILE . 19.5 t -106.38 -118.94 0.24 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.391 -0.818 . . . . 0.0 109.017 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.903 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.7 mp -151.09 165.53 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.74 -1.225 . . . . 0.0 109.013 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.885 ' SG ' HD11 ' A' ' 52' ' ' LEU . 24.2 p -146.82 -166.7 2.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.446 -0.784 . . . . 0.0 109.015 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.627 ' O ' HD12 ' A' ' 52' ' ' LEU . 5.4 m -156.25 156.51 34.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.826 -1.171 . . . . 0.0 110.555 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.912 HD12 HG13 ' A' ' 18' ' ' VAL . 1.7 mm? -39.93 -37.03 0.52 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.509 0.671 . . . . 0.0 109.901 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.604 ' CD2' ' HB2' ' A' ' 48' ' ' SER . 0.7 OUTLIER -58.34 -46.5 86.12 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.597 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -72.6 -40.77 66.28 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.885 HD11 ' SG ' ' A' ' 47' ' ' CYS . 1.6 mp -76.4 -14.74 60.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.19 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.56 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.7 tt0 -74.33 -25.71 59.71 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -90.24 -11.21 41.58 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.668 ' CD2' HG12 ' A' ' 38' ' ' ILE . 12.7 m-85 -87.59 -2.55 58.69 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -91.43 -170.66 2.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.565 -0.71 . . . . 0.0 109.976 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 28.0 t-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.237 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.635 ' CE2' ' NE2' ' A' ' 4' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.83 -166.64 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.141 -0.975 . . . . 0.0 110.004 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.51 ' CA ' HG21 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -82.06 101.38 10.32 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.629 -0.669 . . . . 0.0 109.5 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.635 ' NE2' ' CE2' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -131.85 176.36 8.42 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.665 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.996 ' NE2' HD11 ' A' ' 46' ' ' ILE . 25.7 m-70 -93.85 108.32 20.11 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.975 ' CD2' ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -110.0 128.43 55.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.99 -1.068 . . . . 0.0 111.198 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.536 ' O ' ' N ' ' A' ' 11' ' ' LEU . 37.3 m -113.08 170.81 7.94 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -31.81 -44.51 0.15 Allowed Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.405 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 3.3 m -63.56 -67.45 0.43 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.922 -1.34 . . . . 0.0 110.028 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.563 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.12 -11.66 57.85 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.91 -1.118 . . . . 0.0 108.273 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.075 HD21 ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -67.86 -50.68 55.11 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.248 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.611 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -64.71 -29.52 47.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.443 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.498 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -71.21 -57.72 4.22 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.162 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.975 ' HB2' ' CD2' ' A' ' 6' ' ' LEU . . . -50.48 -50.55 52.27 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.771 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.6 mt -63.42 -45.77 89.44 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.611 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 2.1 t80 -55.88 -21.92 22.74 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -86.98 -66.85 0.86 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.085 0.945 . . . . 0.0 108.848 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.38 -29.6 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-O 121.618 0.723 . . . . 0.0 109.118 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.7 -74.91 0.46 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.825 0.821 . . . . 0.0 108.851 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 67.11 -0.19 8.42 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.537 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 2.7 tt0 163.1 -22.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.035 -1.274 . . . . 0.0 109.783 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.04 -17.45 6.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.114 -0.991 . . . . 0.0 109.581 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.75 77.56 1.12 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.544 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -78.88 -172.26 2.96 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.255 -1.144 . . . . 0.0 109.621 -179.75 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.563 ' CE2' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -162.89 -164.4 0.98 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.751 178.108 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.574 ' CE2' ' HG2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -144.75 97.87 3.09 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.37 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' ASP . 9.7 t -78.48 -172.57 2.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.99 -1.069 . . . . 0.0 110.149 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.576 ' CB ' ' HA ' ' A' ' 34' ' ' PRO . 4.3 p-10 168.7 70.54 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.43 19.03 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.894 2.396 . . . . 0.0 111.37 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.2 p -134.03 -79.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.813 -1.179 . . . . 0.0 109.923 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 32' ' ' GLY . . . 168.46 177.52 39.55 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 31' ' ' GLY . . . 43.41 -122.83 3.98 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 36' ' ' ARG . . . -46.13 112.75 0.9 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.576 ' HA ' ' CB ' ' A' ' 28' ' ' ASP . 28.6 Cg_endo -67.39 -20.67 48.15 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.186 1.924 . . . . 0.0 110.247 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.519 ' HD2' ' HA ' ' A' ' 26' ' ' TYR . 14.3 mtp85 -148.19 28.87 0.9 Allowed 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.604 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -48.65 -20.1 0.42 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.518 -177.634 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -56.37 -51.94 53.0 Favored Glycine 0 C--N 1.295 -1.727 0 N-CA-C 105.794 -2.923 . . . . 0.0 105.794 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.075 ' CD1' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -93.72 -29.16 4.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.507 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 1.3 t -68.58 -55.69 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.744 ' HG2' ' CE1' ' A' ' 44' ' ' HIS . 8.5 tm-20 -61.24 -18.57 59.01 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 45' ' ' SER . 2.0 tp60 -82.3 -82.4 0.14 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.552 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 29.0 m -39.87 -44.11 1.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.534 -0.728 . . . . 0.0 109.114 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.51 ' N ' ' O ' ' A' ' 6' ' ' LEU . 6.0 t -67.33 -52.99 33.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 110.659 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.744 ' CE1' ' HG2' ' A' ' 40' ' ' GLU . 9.4 m80 -84.22 -57.82 3.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.063 . . . . 0.0 109.281 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 41' ' ' GLN . 14.0 t -88.23 -126.58 0.05 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.996 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -159.49 164.87 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.567 -1.333 . . . . 0.0 109.295 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.557 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -153.31 -168.14 2.92 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.39 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.54 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.9 OUTLIER -150.44 160.45 43.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.955 . . . . 0.0 110.438 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.608 ' HG ' HG13 ' A' ' 18' ' ' VAL . 2.4 mp -42.71 -35.47 1.15 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.62 1.2 . . . . 0.0 109.061 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -54.01 -55.66 25.16 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.878 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -75.56 -37.34 60.02 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.014 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 48' ' ' SER . 0.5 OUTLIER -67.68 -19.62 65.2 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.044 179.339 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 49' ' ' LEU . 4.4 tt0 -65.6 -18.96 65.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.3 -0.875 . . . . 0.0 109.101 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -90.59 -11.39 40.14 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.394 -0.816 . . . . 0.0 109.985 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.649 ' CZ ' ' CG2' ' A' ' 38' ' ' ILE . 18.1 m-85 -90.58 6.46 43.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.995 -1.065 . . . . 0.0 109.061 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.458 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.1 m -91.91 -166.93 1.66 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.533 -0.729 . . . . 0.0 109.39 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.563 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 5.7 p-10 . . . . . 0 C--N 1.304 -1.398 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.111 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.616 ' CZ ' ' HA ' ' A' ' 48' ' ' SER . 12.2 p90 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.587 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 8.6 m -129.96 -166.73 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.083 -1.01 . . . . 0.0 109.99 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.556 ' CA ' HG21 ' A' ' 46' ' ' ILE . 3.4 m-20 -60.22 91.4 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 109.482 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.567 ' HG2' ' CE2' ' A' ' 1' ' ' PHE . 1.8 pt20 -132.16 175.43 9.25 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.119 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 1.01 ' NE2' HD11 ' A' ' 46' ' ' ILE . 27.2 m-70 -94.68 111.64 23.4 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.801 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -119.13 129.81 55.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.45 -0.781 . . . . 0.0 111.151 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.522 ' O ' ' C ' ' A' ' 8' ' ' GLY . 72.5 m -113.08 170.08 8.47 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.17 -44.93 0.08 OUTLIER Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.506 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.5 m -62.9 -68.39 0.34 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -1.159 . . . . 0.0 110.113 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.556 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.56 -11.09 57.24 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.863 -1.148 . . . . 0.0 108.412 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.923 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -70.36 -49.14 52.34 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.067 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.616 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 3.1 m -64.42 -31.26 52.79 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.492 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.671 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.425 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -68.61 -56.75 7.21 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.587 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.801 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.36 -50.91 66.38 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.785 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.4 mt -62.03 -41.0 97.64 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.616 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 17.9 t80 -58.78 -20.32 48.68 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -90.41 -66.94 0.88 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.898 0.856 . . . . 0.0 109.013 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.957 HG13 ' HG ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -46.21 -30.92 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.583 0.706 . . . . 0.0 109.162 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.05 -67.6 0.83 Allowed 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.799 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.06 -66.36 0.49 Allowed Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 19' ' ' CYS . 14.8 mt-10 -136.28 -1.71 2.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -1.086 . . . . 0.0 110.009 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 3.0 mtm180 -66.89 -14.4 62.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.077 -1.015 . . . . 0.0 109.767 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.49 79.51 0.93 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.544 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -81.24 -177.32 6.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.362 -1.081 . . . . 0.0 109.406 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.544 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 8.4 p90 -161.52 -172.53 3.39 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.756 0.789 . . . . 0.0 109.449 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.452 ' OH ' ' CG2' ' A' ' 39' ' ' VAL . 0.6 OUTLIER -145.43 97.63 3.02 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.665 HG23 ' NE ' ' A' ' 35' ' ' ARG . 6.5 t -78.43 -176.03 4.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.927 -1.108 . . . . 0.0 110.264 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.558 ' CA ' ' HB2' ' A' ' 34' ' ' PRO . 4.2 p-10 173.5 108.28 0.06 OUTLIER Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' NH2' ' A' ' 35' ' ' ARG . 36.1 Cg_endo -74.19 6.65 2.92 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.3 2.0 . . . . 0.0 111.643 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.756 HG22 ' N ' ' A' ' 31' ' ' GLY . 0.8 OUTLIER -176.14 -69.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.619 -1.301 . . . . 0.0 110.148 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.756 ' N ' HG22 ' A' ' 30' ' ' THR . . . 153.7 179.12 28.85 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 50.55 87.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.611 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 51.02 54.31 23.37 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.063 -2.015 . . . . 0.0 108.063 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.611 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 33.3 Cg_endo -72.38 -47.42 0.4 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.561 2.174 . . . . 0.0 109.789 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.665 ' NE ' HG23 ' A' ' 27' ' ' THR . 7.3 tpp180 -99.05 36.95 1.61 Allowed 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 177.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -46.68 -17.46 0.05 OUTLIER 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.526 -179.351 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -46.97 -42.75 16.1 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 106.146 -2.781 . . . . 0.0 106.146 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.935 HG23 ' CE2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -93.55 -62.38 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.333 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.553 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 2.6 t -48.54 -31.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.173 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.591 ' HB2' ' O ' ' A' ' 36' ' ' ARG . 2.5 mt-10 -92.76 -22.34 19.41 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.914 -1.117 . . . . 0.0 108.873 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.488 ' HG3' ' N ' ' A' ' 42' ' ' CYS . 28.4 tp60 -82.77 -95.14 0.05 Allowed 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.434 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.57 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -40.84 -33.31 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.366 -0.834 . . . . 0.0 109.776 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 13.9 t -67.82 -58.74 4.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.483 -1.385 . . . . 0.0 109.719 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.51 ' O ' ' CE1' ' A' ' 5' ' ' HIS . 13.0 m80 -82.74 -58.61 2.82 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.25 -0.906 . . . . 0.0 108.922 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.618 ' C ' HD12 ' A' ' 46' ' ' ILE . 25.3 t -87.23 -129.72 0.06 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 1.01 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.5 mp -150.52 162.37 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.719 -1.238 . . . . 0.0 108.978 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.518 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 15.2 p -151.27 -168.03 2.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.43 -0.794 . . . . 0.0 109.115 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.616 ' HA ' ' CZ ' ' A' ' 1' ' ' PHE . 0.3 OUTLIER -155.6 163.62 39.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.066 -1.021 . . . . 0.0 110.384 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.957 ' HG ' HG13 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -39.02 -39.01 0.5 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.641 0.734 . . . . 0.0 110.27 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.65 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 2.2 p90 -57.56 -44.03 84.95 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.65 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -72.88 -41.75 64.34 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.514 ' CB ' HG21 ' A' ' 18' ' ' VAL . 1.1 mt -75.0 -15.72 60.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.125 -0.984 . . . . 0.0 109.019 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' LEU . 14.1 tt0 -70.38 -27.75 64.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.45 -0.781 . . . . 0.0 108.985 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -89.13 -10.53 46.92 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.935 ' CE2' HG23 ' A' ' 38' ' ' ILE . 10.5 m-85 -90.06 0.38 57.16 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.536 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.1 m -90.71 -165.89 1.46 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.477 -0.764 . . . . 0.0 110.293 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 56' ' ' CYS . 34.6 t30 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.911 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.646 ' CE2' ' NE2' ' A' ' 4' ' ' GLN . 15.0 t80 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.646 ' N ' ' CD1' ' A' ' 1' ' ' PHE . 10.9 m -160.62 -167.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.382 -0.824 . . . . 0.0 109.589 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.539 ' CA ' HG21 ' A' ' 46' ' ' ILE . 4.6 m120 -63.96 91.29 0.07 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.414 -0.804 . . . . 0.0 109.188 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.646 ' NE2' ' CE2' ' A' ' 1' ' ' PHE . 2.6 pt20 -130.16 173.43 10.77 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.053 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.899 ' NE2' HD11 ' A' ' 46' ' ' ILE . 37.4 m-70 -90.92 108.46 19.86 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.939 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.2 tp -110.99 125.41 53.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 111.026 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' O ' ' C ' ' A' ' 8' ' ' GLY . 79.0 m -110.84 170.61 7.98 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -31.39 -43.99 0.11 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.406 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 9.9 m -62.5 -68.86 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.117 -1.225 . . . . 0.0 109.875 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.567 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 34.9 m-20 -66.86 -11.97 57.59 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.828 -1.17 . . . . 0.0 108.34 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.986 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.41 -48.72 60.18 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.351 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -65.87 -28.47 44.06 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.461 0 C-N-CA 119.094 -1.042 . . . . 0.0 108.489 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 1.0 OUTLIER -70.86 -60.22 2.36 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.001 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.939 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -49.42 -50.81 39.02 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.751 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.3 mt -62.25 -44.47 96.47 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.606 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.5 t80 -58.78 -24.99 62.64 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -80.25 -65.67 0.98 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 122.334 1.064 . . . . 0.0 108.315 178.846 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -55.53 -29.12 23.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.164 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.539 ' SG ' ' CB ' ' A' ' 24' ' ' PHE . 33.4 m -88.34 -55.42 3.74 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.113 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 45.93 61.92 3.65 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 1.9 tt0 80.49 -3.19 1.88 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.514 -0.991 . . . . 0.0 110.256 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' CB ' ' SG ' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -57.36 -17.75 14.01 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.951 -1.093 . . . . 0.0 109.008 179.484 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' CA ' ' A' ' 57' ' ' ASN . . . 95.29 65.9 0.98 Allowed Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.539 ' CB ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -87.36 178.89 6.71 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.355 -1.085 . . . . 0.0 109.44 -179.369 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -162.48 -163.21 0.88 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.488 178.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.545 ' CE2' ' HD2' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -144.22 100.98 3.64 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.204 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 7.2 t -78.46 -176.2 4.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.931 -1.105 . . . . 0.0 110.935 -177.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.575 ' HA ' ' HB2' ' A' ' 34' ' ' PRO . 2.1 p30 173.43 106.42 0.06 OUTLIER Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.462 ' HD2' ' C ' ' A' ' 34' ' ' PRO . 36.0 Cg_endo -75.3 6.21 3.66 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.483 2.122 . . . . 0.0 111.924 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.747 HG22 ' N ' ' A' ' 31' ' ' GLY . 0.8 OUTLIER 179.04 -68.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.605 -1.31 . . . . 0.0 109.9 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.747 ' N ' HG22 ' A' ' 30' ' ' THR . . . 158.69 -171.03 35.33 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . 42.69 90.07 0.01 OUTLIER Glycine 0 N--CA 1.494 2.566 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.595 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 49.37 56.32 11.11 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -178.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.595 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 35.3 Cg_endo -74.31 -49.07 0.19 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.392 2.061 . . . . 0.0 109.22 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.588 ' HG3' HD12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -96.29 28.67 3.16 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.174 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.626 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -46.59 -19.33 0.09 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.499 -178.371 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -48.12 -44.08 25.94 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 106.146 -2.781 . . . . 0.0 106.146 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.986 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.19 -56.54 5.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 122.414 1.102 . . . . 0.0 108.342 177.201 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.583 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 4.2 t -55.78 -29.32 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.683 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -93.44 -28.88 15.86 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 120.818 -1.176 . . . . 0.0 109.579 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.525 ' HG3' ' N ' ' A' ' 42' ' ' CYS . 2.4 tp-100 -76.25 -97.53 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.507 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.569 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -40.77 -33.76 0.32 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 110.463 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.583 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 17.0 t -67.36 -53.47 29.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.353 -1.467 . . . . 0.0 110.889 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.503 ' O ' ' CE1' ' A' ' 5' ' ' HIS . 14.3 m80 -84.52 -52.96 5.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.02 -1.05 . . . . 0.0 110.059 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.477 ' C ' HD12 ' A' ' 46' ' ' ILE . 32.4 t -98.48 -113.82 0.15 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 108.977 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.899 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.4 mp -159.42 161.56 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.825 -1.172 . . . . 0.0 108.668 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.513 ' SG ' ' NE2' ' A' ' 51' ' ' GLN . 14.7 p -152.76 -171.0 3.8 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.566 -0.853 . . . . 0.0 109.535 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.641 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 4.8 m -143.86 156.97 44.65 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.345 1.069 . . . . 0.0 110.589 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.607 ' O ' ' N ' ' A' ' 53' ' ' GLU . 17.5 mt -39.44 -34.4 0.21 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.622 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.65 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 5.7 p90 -51.14 -42.63 60.88 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 118.532 -1.267 . . . . 0.0 108.108 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.65 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 1.7 pt20 -74.43 -53.54 9.35 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -62.14 -14.37 36.52 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.202 -0.936 . . . . 0.0 108.653 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 49' ' ' LEU . 20.8 tt0 -72.99 -31.46 64.53 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -91.57 -13.59 31.73 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.719 -0.613 . . . . 0.0 109.573 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.653 ' CE2' HG12 ' A' ' 38' ' ' ILE . 13.1 m-85 -82.65 -0.53 47.65 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.975 -1.078 . . . . 0.0 108.44 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 22' ' ' ARG . 1.2 t -66.94 -155.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.558 -0.714 . . . . 0.0 109.779 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.526 ' CA ' ' O ' ' A' ' 23' ' ' GLY . 24.1 p30 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.823 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.546 ' HB2' HD22 ' A' ' 49' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 m -141.6 -167.1 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.89 . . . . 0.0 109.548 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.525 ' CA ' HG21 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -70.15 109.36 4.57 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.474 -0.766 . . . . 0.0 109.394 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.546 ' HG2' ' N ' ' A' ' 5' ' ' HIS . 32.9 tt0 -134.54 163.13 30.4 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 110.189 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 1.071 ' NE2' HD11 ' A' ' 46' ' ' ILE . 20.0 m-70 -91.62 91.83 8.2 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.872 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -91.19 165.98 13.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.929 -1.107 . . . . 0.0 109.694 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 9' ' ' SER . 16.4 t -167.44 112.32 0.71 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.588 -1.32 . . . . 0.0 109.43 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.52 ' N ' ' HB2' ' A' ' 11' ' ' LEU . . . 39.88 -90.15 0.01 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 7' ' ' CYS . 7.1 m -40.25 -68.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.406 -1.055 . . . . 0.0 110.655 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.622 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 26.6 m-20 -65.8 -24.19 66.86 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.502 -1.374 . . . . 0.0 108.644 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.05 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -59.93 -50.76 72.51 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.387 -0.925 . . . . 0.0 108.642 177.748 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.628 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -64.38 -26.12 39.59 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 C-N-CA 119.127 -1.029 . . . . 0.0 108.674 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.439 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -71.75 -57.77 4.06 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.436 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.872 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.21 -48.95 70.45 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.825 ' HG ' HD12 ' A' ' 52' ' ' LEU . 2.6 mt -62.77 -41.57 99.3 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.628 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 12.3 t80 -59.26 -20.9 58.09 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -90.6 -65.8 0.98 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.971 0.891 . . . . 0.0 109.178 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.767 HG13 ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -46.72 -29.96 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-O 121.599 0.714 . . . . 0.0 109.258 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.19 -70.9 0.64 Allowed 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.543 -179.41 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.26 -67.52 0.37 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 19' ' ' CYS . 3.5 mt-10 -126.93 -7.62 6.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.223 -1.163 . . . . 0.0 109.825 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.477 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 3.8 mmt85 -70.16 -10.55 59.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.166 -0.959 . . . . 0.0 109.699 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.6 89.74 0.08 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -85.37 -177.12 6.39 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.348 -1.089 . . . . 0.0 109.731 -179.643 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.574 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 11.0 p90 -162.76 178.47 8.44 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.689 0.757 . . . . 0.0 109.337 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.624 ' CD1' ' HD2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -123.13 113.66 19.27 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 178.128 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.915 HG23 ' HG2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -77.24 169.75 17.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.752 -1.217 . . . . 0.0 110.835 -177.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.542 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 10.5 m-20 33.15 61.83 1.56 Allowed Pre-proline 0 N--CA 1.494 1.773 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.922 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 36.3 Cg_endo -78.11 78.41 3.61 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.727 2.285 . . . . 0.0 110.543 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.83 -78.05 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.017 -1.052 . . . . 0.0 109.715 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.473 ' O ' ' HD3' ' A' ' 34' ' ' PRO . . . -67.71 179.35 17.42 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' C ' ' HD3' ' A' ' 34' ' ' PRO . . . -77.36 -32.02 49.18 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.551 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . -130.28 56.76 0.74 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 33.8 Cg_endo -74.73 -35.95 3.11 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.492 2.128 . . . . 0.0 109.235 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.915 ' HG2' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -103.95 35.6 2.6 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 178.193 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.571 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -42.06 -21.46 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.339 -178.46 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -48.21 -44.04 26.47 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 106.082 -2.807 . . . . 0.0 106.082 177.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.05 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.27 -57.51 4.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 122.508 1.147 . . . . 0.0 108.513 177.145 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 54.6 t -57.03 -29.27 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.913 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.571 ' HB2' ' O ' ' A' ' 36' ' ' ARG . 2.3 mt-10 -91.87 -32.96 15.11 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.862 -1.149 . . . . 0.0 109.02 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 45' ' ' SER . 1.5 tp-100 -74.86 -82.49 0.06 Allowed 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.8 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.541 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 15.5 m -42.21 -48.08 4.81 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.411 -0.805 . . . . 0.0 109.715 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 5.1 t -62.87 -47.94 81.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 110.429 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.478 ' ND1' ' HA ' ' A' ' 40' ' ' GLU . 6.0 m80 -90.47 -65.41 1.02 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.888 -1.133 . . . . 0.0 108.963 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 41' ' ' GLN . 8.5 t -87.38 -137.31 0.09 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 1.071 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.4 mp -142.38 162.35 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.794 -1.191 . . . . 0.0 109.17 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.511 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -142.92 -161.58 1.28 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.408 179.213 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.588 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -152.45 149.81 28.96 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.329 -0.857 . . . . 0.0 109.818 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.767 ' HG ' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -38.96 -37.26 0.34 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.758 0.79 . . . . 0.0 110.805 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 1.3 p90 -60.01 -37.8 80.8 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.556 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.596 ' HG2' ' CD2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -77.56 -20.01 54.77 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.842 HD13 ' HD2' ' A' ' 55' ' ' TYR . 4.3 mm? -86.8 -28.03 23.21 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.08 -23.26 19.58 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -90.89 -23.23 20.58 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.842 ' HD2' HD13 ' A' ' 52' ' ' LEU . 17.5 m-85 -81.25 0.23 37.75 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.574 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.1 m -90.78 -165.15 1.29 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.538 -0.726 . . . . 0.0 109.958 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.442 ' C ' ' O ' ' A' ' 56' ' ' CYS . 27.3 p-10 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.876 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 2' ' ' VAL . 34.5 p90 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.572 0.701 . . . . 0.0 109.641 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.853 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER -94.13 -152.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 122.328 1.061 . . . . 0.0 110.983 -178.329 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.853 ' N ' HG13 ' A' ' 2' ' ' VAL . 5.3 m120 -63.42 93.11 0.07 Allowed 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.572 ' HB3' ' CD2' ' A' ' 1' ' ' PHE . 4.6 tt0 -129.22 160.34 33.24 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.001 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 1.082 ' NE2' HD11 ' A' ' 46' ' ' ILE . 17.1 m-70 -85.05 93.89 8.71 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.662 HD13 ' CB ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -79.31 -163.79 0.55 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.174 -0.954 . . . . 0.0 109.134 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.586 ' O ' ' C ' ' A' ' 8' ' ' GLY . 0.8 OUTLIER 170.83 141.25 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.623 -179.422 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -17.15 -55.19 0.01 OUTLIER Glycine 0 N--CA 1.502 3.063 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 7' ' ' CYS . 15.3 m -60.66 -66.2 0.57 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.208 -1.172 . . . . 0.0 109.717 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.662 ' CB ' HD13 ' A' ' 6' ' ' LEU . 1.2 m-20 -67.46 -17.91 64.88 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.73 -1.231 . . . . 0.0 107.984 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.903 HD21 ' CD1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -59.58 -53.05 62.56 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.093 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.634 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -63.62 -27.94 43.97 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.44 0 C-N-CA 118.801 -1.16 . . . . 0.0 108.08 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -71.8 -60.25 2.33 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.759 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -50.79 -49.2 58.94 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.774 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.6 mt -62.81 -47.62 82.64 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 7.1 t80 -53.65 -25.55 18.44 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -82.02 -67.79 0.75 Allowed 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.101 0.953 . . . . 0.0 108.521 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.91 HG13 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -49.83 -28.74 4.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.526 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -87.21 -55.69 3.7 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.349 -0.94 . . . . 0.0 109.937 -179.07 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 21' ' ' GLU . . . 46.1 65.85 1.9 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 17.4 mm-40 80.92 -9.98 1.28 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.675 -0.897 . . . . 0.0 110.199 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 2.2 mmt180 -56.79 -17.22 8.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.915 -1.116 . . . . 0.0 109.415 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' CA ' ' A' ' 57' ' ' ASN . . . 85.19 80.02 1.12 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.608 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -92.12 179.01 5.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -1.108 . . . . 0.0 109.902 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.608 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 40.1 p90 -162.68 175.14 11.66 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.88 121.17 43.87 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.698 HG23 ' HB3' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -77.61 170.99 15.62 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.004 -1.06 . . . . 0.0 110.528 -178.261 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.55 ' CB ' ' HB2' ' A' ' 34' ' ' PRO . 0.7 OUTLIER 36.0 62.1 2.79 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -179.637 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 36.1 Cg_endo -77.53 66.37 7.98 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.578 2.185 . . . . 0.0 110.464 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.56 -79.36 0.55 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.124 -0.985 . . . . 0.0 109.812 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.2 -160.67 34.66 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 33' ' ' GLY . . . -91.75 159.38 25.74 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.529 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 43.79 57.32 4.69 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.55 ' HB2' ' CB ' ' A' ' 28' ' ' ASP . 31.8 Cg_endo -72.24 -52.44 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.367 2.045 . . . . 0.0 108.933 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.698 ' HB3' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -97.85 31.32 2.69 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.077 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.61 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -39.93 -25.51 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.844 -177.443 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -48.82 -44.51 31.1 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.963 HG21 ' CE1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -91.87 -34.19 6.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.192 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 1.4 t -76.48 -69.79 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.603 ' N ' HG12 ' A' ' 39' ' ' VAL . 2.1 tt0 -45.06 -25.87 0.38 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.856 -1.152 . . . . 0.0 108.57 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -80.35 -78.62 0.17 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 1.7 m -42.39 -29.03 0.24 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.592 -0.692 . . . . 0.0 109.497 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -85.08 -47.36 10.27 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.009 -1.057 . . . . 0.0 109.88 -179.486 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.415 ' ND1' ' HA ' ' A' ' 40' ' ' GLU . 3.5 m80 -92.59 -53.27 4.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.11 -0.994 . . . . 0.0 109.288 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' GLN . 38.7 m -92.09 -122.85 0.08 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 1.082 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -160.6 166.07 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.652 -1.28 . . . . 0.0 109.07 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.567 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -156.35 -170.96 3.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.391 -0.818 . . . . 0.0 109.285 179.311 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.489 ' HG ' ' HE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -142.02 157.61 44.73 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.269 -0.894 . . . . 0.0 109.839 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.91 HD22 HG13 ' A' ' 18' ' ' VAL . 54.6 mt -42.65 -33.09 0.66 Allowed 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.661 0.743 . . . . 0.0 110.571 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.656 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 1.6 p90 -53.45 -44.01 68.53 Favored 'General case' 0 C--N 1.281 -2.406 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.046 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.656 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -74.95 -53.01 9.75 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.154 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.491 ' N ' ' CG ' ' A' ' 51' ' ' GLN . 1.2 mp -61.22 -15.47 34.83 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 49' ' ' LEU . 37.2 tt0 -70.59 -24.39 62.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -91.35 -14.18 31.19 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.635 -0.666 . . . . 0.0 109.415 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.963 ' CE1' HG21 ' A' ' 38' ' ' ILE . 59.7 m-85 -86.15 4.34 38.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.126 -0.984 . . . . 0.0 108.879 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.521 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -77.51 -164.24 0.47 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.691 -0.631 . . . . 0.0 109.98 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.448 ' CA ' ' O ' ' A' ' 23' ' ' GLY . 5.6 t-20 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.667 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.514 ' HB2' ' CD2' ' A' ' 49' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.564 0.697 . . . . 0.0 109.561 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.836 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.8 OUTLIER -126.81 -153.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-O 122.413 1.101 . . . . 0.0 110.387 -178.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.836 ' N ' HG13 ' A' ' 2' ' ' VAL . 2.0 m120 -89.85 99.81 12.75 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.982 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.599 ' NE2' ' O ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -132.71 171.95 13.19 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.165 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.955 ' NE2' HD11 ' A' ' 46' ' ' ILE . 32.5 m-70 -90.77 110.16 21.35 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.833 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -112.63 134.04 54.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.132 -0.98 . . . . 0.0 111.168 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.535 ' O ' ' C ' ' A' ' 8' ' ' GLY . 34.4 m -119.08 168.09 11.17 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.555 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -28.93 -45.24 0.06 OUTLIER Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 7' ' ' CYS . 19.5 m -63.15 -68.65 0.32 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -1.201 . . . . 0.0 109.997 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.545 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 53.3 m-20 -67.79 -10.01 49.1 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.845 -1.159 . . . . 0.0 108.572 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.904 HD21 HD11 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -72.66 -48.15 41.58 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.378 -0.826 . . . . 0.0 109.05 178.487 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.616 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -67.53 -28.9 43.62 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.43 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.726 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -70.83 -55.87 7.56 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.489 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.833 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.51 -50.79 66.98 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.77 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.1 mt -60.87 -45.17 95.6 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.616 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 17.3 t80 -57.19 -21.37 32.85 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -88.77 -65.76 0.99 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.132 0.968 . . . . 0.0 109.009 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.77 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -50.29 -28.45 5.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-O 121.409 0.623 . . . . 0.0 109.602 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -86.59 -65.46 1.01 Allowed 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.39 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.47 -71.0 1.07 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -132.97 -1.2 3.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -1.137 . . . . 0.0 109.93 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.482 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 26.1 mmm-85 -69.18 -11.86 61.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.056 -1.027 . . . . 0.0 109.658 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' O ' ' CG ' ' A' ' 57' ' ' ASN . . . 69.3 89.42 0.08 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.621 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -85.01 -175.67 5.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -1.128 . . . . 0.0 109.805 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.621 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 23.9 p90 -162.8 164.65 26.08 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.491 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.2 OUTLIER -103.7 127.57 51.14 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.072 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.66 HG23 ' HB2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -78.45 160.64 27.61 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.063 -1.023 . . . . 0.0 110.824 -178.245 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 34' ' ' PRO . 22.5 t70 32.73 64.6 1.27 Allowed Pre-proline 0 N--CA 1.494 1.761 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.313 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 36.3 Cg_endo -78.94 65.95 8.78 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.673 2.249 . . . . 0.0 110.245 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.76 -79.53 0.61 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.053 -1.029 . . . . 0.0 109.773 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.03 -156.2 32.24 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 33' ' ' GLY . . . -93.21 151.81 20.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.563 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 42.41 55.38 4.46 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 31.4 Cg_endo -72.64 -50.43 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.532 2.155 . . . . 0.0 109.078 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.66 ' HB2' HG23 ' A' ' 27' ' ' THR . 6.3 tpm_? -98.37 34.09 2.07 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -39.51 -24.36 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.488 -178.105 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -49.94 -45.38 41.28 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.191 -2.364 . . . . 0.0 107.191 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.904 HD11 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -93.54 -26.19 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.413 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -82.91 -59.93 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.292 -0.88 . . . . 0.0 109.101 179.735 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.568 ' N ' HG12 ' A' ' 39' ' ' VAL . 4.9 tt0 -58.72 -16.6 17.31 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.4 OUTLIER -80.47 -82.41 0.11 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.372 -0.83 . . . . 0.0 109.392 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.557 ' O ' ' N ' ' A' ' 6' ' ' LEU . 28.5 m -39.57 -42.5 1.17 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.36 -0.838 . . . . 0.0 108.955 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 6' ' ' LEU . 4.8 t -69.54 -53.03 20.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.829 . . . . 0.0 111.043 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.488 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 10.4 m80 -83.51 -48.76 9.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.868 -1.145 . . . . 0.0 109.663 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 41' ' ' GLN . 45.1 t -99.95 -124.42 0.16 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.955 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -159.49 165.23 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.706 -1.246 . . . . 0.0 109.206 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.556 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -148.16 -156.64 0.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.469 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.62 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 5.6 m -160.05 154.08 23.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 110.387 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.631 ' HG ' HG13 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -39.13 -38.86 0.52 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.644 0.735 . . . . 0.0 110.412 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 1.4 p90 -57.76 -46.46 84.49 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.623 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -71.69 -37.57 70.68 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.519 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.509 ' HB3' HG21 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -76.48 -20.09 57.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.161 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 49' ' ' LEU . 26.0 tt0 -68.19 -22.66 64.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.323 -0.86 . . . . 0.0 108.868 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.92 -11.52 41.56 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.548 -0.72 . . . . 0.0 109.812 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.651 ' CZ ' ' HB ' ' A' ' 38' ' ' ILE . 17.5 m-85 -91.09 6.99 42.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.127 -0.983 . . . . 0.0 108.5 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.541 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.3 m -78.06 -164.55 0.54 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.715 -0.616 . . . . 0.0 109.927 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.3 t-20 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.743 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.761 ' CD1' HD13 ' A' ' 49' ' ' LEU . 2.5 t80 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.469 0.652 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.67 HG13 ' O ' ' A' ' 1' ' ' PHE . 12.3 m -161.53 -167.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.73 . . . . 0.0 109.467 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.436 ' C ' HG21 ' A' ' 46' ' ' ILE . 11.0 m-20 -59.9 87.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.449 -0.782 . . . . 0.0 108.976 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 46' ' ' ILE . 2.0 pt20 -130.99 178.31 6.77 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.028 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.901 ' NE2' HD11 ' A' ' 46' ' ' ILE . 36.8 m-70 -91.84 106.05 18.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.85 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -104.91 137.82 42.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.14 -0.975 . . . . 0.0 111.058 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.543 ' O ' ' C ' ' A' ' 8' ' ' GLY . 60.0 m -124.1 166.98 14.85 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.685 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -26.12 -47.91 0.04 OUTLIER Glycine 0 N--CA 1.498 2.798 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 7' ' ' CYS . 1.4 m -61.82 -69.2 0.26 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.286 . . . . 0.0 109.948 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.549 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -68.17 -10.7 56.21 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.812 -1.18 . . . . 0.0 108.763 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.814 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -73.71 -47.42 39.63 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.246 -0.909 . . . . 0.0 109.316 178.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 8' ' ' GLY . 2.9 m -71.57 -31.95 44.21 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.406 0 C-N-CA 118.789 -1.164 . . . . 0.0 108.485 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 16' ' ' TYR . 10.4 mt-10 -66.54 -54.27 25.6 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.85 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -59.69 -50.21 74.75 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.801 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.8 mt -59.92 -39.89 86.99 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.607 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 7.9 t80 -59.45 -21.54 60.19 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.71 -65.54 1.01 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.969 0.89 . . . . 0.0 108.964 179.442 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.981 HG11 ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -49.99 -27.43 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.578 0.704 . . . . 0.0 109.509 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 24' ' ' PHE . 36.2 m -90.27 -69.24 0.74 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.854 -178.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.59 -71.82 1.55 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -137.7 1.83 2.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.351 -1.088 . . . . 0.0 109.964 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.495 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 42.4 mmm-85 -63.34 -12.35 29.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.004 -1.06 . . . . 0.0 109.864 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 57' ' ' ASN . . . 85.22 90.86 0.84 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -114.3 173.93 6.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -1.16 . . . . 0.0 109.668 -179.51 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.589 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 2.2 p90 -161.21 -61.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.408 -0.807 . . . . 0.0 109.025 178.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.589 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER 162.38 -88.81 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.97 HG21 ' CB ' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -166.05 -80.06 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.09 0.948 . . . . 0.0 108.946 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.542 ' N ' ' OG1' ' A' ' 27' ' ' THR . 45.4 t0 -143.79 112.64 5.38 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -74.7 83.81 1.7 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.268 1.979 . . . . 0.0 110.84 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 p -128.2 -78.71 0.57 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.318 -0.864 . . . . 0.0 109.484 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 32' ' ' GLY . . . -106.09 -150.37 18.35 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 34' ' ' PRO . . . -60.56 -131.39 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 32' ' ' GLY . . . -40.06 98.0 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.579 ' HB2' HG23 ' A' ' 27' ' ' THR . 25.5 Cg_endo -63.12 -20.4 71.07 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.242 1.961 . . . . 0.0 109.556 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.97 ' CB ' HG21 ' A' ' 27' ' ' THR . 1.4 tpp180 -151.36 61.82 0.89 Allowed 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -38.96 -25.45 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.099 -179.36 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -45.25 -39.98 7.43 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 106.18 -2.768 . . . . 0.0 106.18 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.946 HG23 ' CE2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -93.38 -63.67 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-O 122.346 1.07 . . . . 0.0 108.261 176.691 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 3.3 t -48.82 -35.95 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.23 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 36' ' ' ARG . 3.3 tt0 -91.25 -17.07 26.58 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.076 -1.015 . . . . 0.0 109.423 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 45' ' ' SER . 33.2 tt0 -90.58 -82.91 0.27 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.359 -0.838 . . . . 0.0 109.594 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 6' ' ' LEU . 24.5 m -39.28 -41.17 0.86 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.495 -0.753 . . . . 0.0 109.731 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.483 ' N ' ' O ' ' A' ' 6' ' ' LEU . 3.7 t -73.58 -51.25 17.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 111.177 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.464 ' ND1' ' HA ' ' A' ' 40' ' ' GLU . 12.8 m80 -83.23 -41.9 17.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.871 -1.143 . . . . 0.0 109.95 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 41' ' ' GLN . 37.7 t -110.31 -121.64 0.27 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.901 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -158.94 165.6 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.794 -1.191 . . . . 0.0 109.394 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.568 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -148.09 -164.52 2.03 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.407 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.632 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 10.3 m -143.78 151.82 40.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 110.128 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.981 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -39.11 -39.85 0.63 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.734 0.778 . . . . 0.0 110.143 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.632 ' CE2' ' HB2' ' A' ' 48' ' ' SER . 1.2 p90 -63.13 -41.06 99.24 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.551 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 37.2 tp60 -63.67 -44.65 93.12 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.541 HD23 ' HG ' ' A' ' 15' ' ' LEU . 1.2 mp -72.38 -24.24 61.23 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -63.43 -24.08 67.68 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -0.821 . . . . 0.0 109.095 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -87.97 -9.16 54.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.492 -0.755 . . . . 0.0 109.457 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.946 ' CE2' HG23 ' A' ' 38' ' ' ILE . 13.7 m-85 -90.14 2.0 55.79 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -80.28 -158.21 0.17 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.483 -0.761 . . . . 0.0 110.935 -178.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 23' ' ' GLY . 22.4 t-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.656 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.642 ' CD2' ' CD1' ' A' ' 49' ' ' LEU . 6.9 p90 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 4' ' ' GLN . 12.9 m -122.21 -168.93 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.137 -0.977 . . . . 0.0 109.623 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 2' ' ' VAL . 2.5 m-20 -43.51 94.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.341 -0.849 . . . . 0.0 109.725 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.664 ' NE2' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -143.19 167.87 21.09 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.205 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 1.061 ' NE2' HD11 ' A' ' 46' ' ' ILE . 18.1 m-70 -93.14 111.79 23.54 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.947 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.2 tp -113.76 128.12 56.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.026 -1.046 . . . . 0.0 110.84 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 11' ' ' LEU . 64.6 m -111.04 167.56 10.17 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.553 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -31.36 -42.38 0.08 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 7' ' ' CYS . 42.3 m -62.68 -69.27 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.275 . . . . 0.0 109.491 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.543 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 1.1 m-20 -67.47 -10.92 56.04 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.934 -1.104 . . . . 0.0 108.484 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.711 ' CD2' HD11 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -70.78 -48.88 51.92 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.385 -0.822 . . . . 0.0 109.043 178.549 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.613 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -67.08 -28.52 43.05 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.454 0 C-N-CA 118.802 -1.159 . . . . 0.0 108.297 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 6.4 tt0 -70.32 -57.15 5.17 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.947 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.38 -49.71 69.22 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.752 ' HA ' HG23 ' A' ' 18' ' ' VAL . 3.0 mt -61.62 -44.04 97.74 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.613 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 11.5 t80 -58.5 -27.0 64.07 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -78.79 -64.04 1.27 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 122.042 0.925 . . . . 0.0 108.568 179.137 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.886 HG12 ' OE1' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -53.34 -31.79 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.509 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -86.49 -64.32 1.17 Allowed 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.601 -0.839 . . . . 0.0 109.563 -179.41 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.25 -64.63 0.39 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 19' ' ' CYS . 1.6 mt-10 -138.79 2.74 2.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.262 -1.14 . . . . 0.0 110.077 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 14.2 mmt85 -74.19 -11.21 60.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.099 -1.0 . . . . 0.0 109.882 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 69.69 93.9 0.06 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.627 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -89.7 -167.25 1.8 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -1.126 . . . . 0.0 110.061 -179.595 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.627 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 15.0 p90 -160.63 170.82 20.07 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.584 ' O ' HG22 ' A' ' 27' ' ' THR . 1.5 t80 -107.04 -108.42 0.31 Allowed 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.805 -1.184 . . . . 0.0 109.628 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.732 HG21 ' CB ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -161.23 -159.73 0.67 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.185 -1.572 . . . . 0.0 109.414 -179.673 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.507 ' N ' ' OG1' ' A' ' 27' ' ' THR . 18.4 t0 -60.14 110.55 2.93 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.682 -0.636 . . . . 0.0 109.553 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 27' ' ' THR . 36.9 Cg_endo -81.56 71.95 6.59 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.568 2.179 . . . . 0.0 110.385 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.4 p -131.66 -79.09 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 109.78 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.9 166.88 30.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.73 121.15 9.36 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.464 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 77.03 60.75 2.82 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.499 ' CB ' ' O ' ' A' ' 28' ' ' ASP . 30.4 Cg_endo -71.54 -44.95 0.89 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.439 2.093 . . . . 0.0 108.865 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.732 ' CB ' HG21 ' A' ' 27' ' ' THR . 5.5 tpt180 -108.04 36.07 2.91 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -39.48 -27.34 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.119 -177.812 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -49.65 -42.61 36.31 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.973 -2.451 . . . . 0.0 106.973 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.711 HD11 ' CD2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -93.99 -26.69 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.233 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.602 HG12 ' N ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -84.46 -60.48 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.412 -0.805 . . . . 0.0 109.462 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.602 ' N ' HG12 ' A' ' 39' ' ' VAL . 34.0 tt0 -61.63 -13.98 26.9 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.221 -0.925 . . . . 0.0 109.284 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -79.85 -85.75 0.08 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.178 -0.951 . . . . 0.0 109.845 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.57 ' HB2' HD11 ' A' ' 11' ' ' LEU . 32.3 m -38.73 -42.65 0.83 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 6' ' ' LEU . 7.4 t -67.31 -54.82 17.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.478 -0.764 . . . . 0.0 110.553 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.601 ' O ' ' CE1' ' A' ' 5' ' ' HIS . 8.2 m80 -86.29 -59.13 2.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.837 -1.164 . . . . 0.0 109.18 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.595 ' C ' HD12 ' A' ' 46' ' ' ILE . 33.0 t -83.17 -132.89 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 1.061 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.5 mp -155.94 161.29 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.846 -1.159 . . . . 0.0 108.577 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.46 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.6 OUTLIER -141.54 -157.44 0.77 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.654 -1.218 . . . . 0.0 110.655 -179.064 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.616 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 5.4 m -151.18 146.44 26.11 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.874 0.845 . . . . 0.0 110.008 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.721 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -37.7 -42.48 0.57 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.739 0.781 . . . . 0.0 111.04 -179.517 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.616 ' CE2' ' HB2' ' A' ' 48' ' ' SER . 3.6 p90 -61.94 -37.79 86.05 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.991 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.607 ' CG ' ' CZ ' ' A' ' 50' ' ' TYR . 72.0 mt-30 -67.64 -39.74 84.61 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.635 HD13 ' HE2' ' A' ' 1' ' ' PHE . 0.9 OUTLIER -71.39 -28.87 64.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 109.057 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.886 ' OE1' HG12 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -57.96 -23.04 52.01 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.214 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -89.65 -15.52 32.49 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.807 -0.558 . . . . 0.0 109.573 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.678 ' CZ ' ' HB ' ' A' ' 38' ' ' ILE . 16.4 m-85 -90.54 5.51 47.49 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.448 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.1 m -90.89 -164.25 1.15 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.623 -0.673 . . . . 0.0 109.851 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 8.3 p-10 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.936 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.664 ' O ' HG13 ' A' ' 2' ' ' VAL . 3.1 t80 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.508 0.671 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 1' ' ' PHE . 8.9 m -161.19 -167.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.49 -0.756 . . . . 0.0 109.439 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.506 ' CA ' HG21 ' A' ' 46' ' ' ILE . 3.4 m-80 -60.07 93.86 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.453 -0.779 . . . . 0.0 109.264 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.686 ' HG3' HD13 ' A' ' 6' ' ' LEU . 1.6 pt20 -134.42 173.84 11.19 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.154 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.877 ' NE2' HD11 ' A' ' 46' ' ' ILE . 43.3 m-70 -90.48 112.53 24.21 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.742 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -118.12 129.41 55.52 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.403 -0.811 . . . . 0.0 111.328 -178.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' O ' ' C ' ' A' ' 8' ' ' GLY . 98.7 m -111.61 170.42 8.14 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -29.93 -45.71 0.09 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.518 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.1 m -62.1 -68.85 0.29 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.107 -1.231 . . . . 0.0 110.171 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.572 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 1.9 m-20 -67.46 -11.63 58.32 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.859 -1.15 . . . . 0.0 108.416 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.985 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.72 -49.09 56.58 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.607 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -63.83 -30.62 50.43 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.55 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.617 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 4.7 tt0 -69.09 -56.69 6.94 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.742 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -55.15 -49.38 71.95 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.771 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.5 mt -62.86 -40.97 99.12 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.607 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 8.7 t80 -58.36 -20.44 43.7 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -90.07 -66.67 0.9 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.982 0.896 . . . . 0.0 109.006 179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -46.22 -30.08 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.47 -71.1 0.64 Allowed 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.555 -179.358 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.24 -60.41 0.25 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 19' ' ' CYS . 17.0 mt-10 -138.11 -0.05 2.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.201 -1.176 . . . . 0.0 110.381 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.572 ' CD ' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -76.74 -4.07 41.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.99 -1.069 . . . . 0.0 109.685 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.99 84.85 0.18 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.546 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -83.13 -177.44 6.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.268 -1.136 . . . . 0.0 109.421 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.546 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 8.6 p90 -161.33 -172.69 3.49 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.394 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.492 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.2 OUTLIER -144.29 102.53 3.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.473 ' O ' ' HD3' ' A' ' 35' ' ' ARG . 8.8 t -78.94 -172.78 3.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.903 -1.123 . . . . 0.0 110.18 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.616 ' HA ' ' HB2' ' A' ' 34' ' ' PRO . 1.2 p30 167.5 84.44 0.02 OUTLIER Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 34' ' ' PRO . 35.5 Cg_endo -77.01 6.19 4.43 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.637 2.224 . . . . 0.0 112.661 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.31 -85.02 0.22 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.385 -1.447 . . . . 0.0 109.808 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.468 ' O ' ' HD3' ' A' ' 34' ' ' PRO . . . 171.53 -67.56 0.13 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 33' ' ' GLY . . . -82.26 112.64 3.53 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.587 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 46.74 57.48 6.71 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.616 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 35.2 Cg_endo -75.47 -44.03 0.33 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.582 2.188 . . . . 0.0 109.205 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 27' ' ' THR . 0.7 OUTLIER -96.43 30.83 2.41 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 177.562 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.612 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -46.28 -20.03 0.1 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.479 -178.405 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.4 -44.79 16.15 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 106.267 -2.733 . . . . 0.0 106.267 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.985 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.92 -61.22 2.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 122.551 1.167 . . . . 0.0 108.229 176.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.573 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 13.9 t -49.11 -34.74 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.508 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.612 ' CB ' ' HB2' ' A' ' 36' ' ' ARG . 24.3 tt0 -93.35 -16.88 24.19 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 120.864 -1.147 . . . . 0.0 109.406 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 45' ' ' SER . 33.8 tt0 -86.65 -94.98 0.09 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.464 -0.772 . . . . 0.0 110.077 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.23 -34.9 0.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.469 -0.77 . . . . 0.0 109.895 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 16.3 t -66.34 -55.05 17.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.385 -1.447 . . . . 0.0 109.739 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.526 ' O ' ' CE1' ' A' ' 5' ' ' HIS . 13.6 m80 -84.22 -51.61 6.89 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.195 -0.941 . . . . 0.0 109.454 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' GLN . 35.1 t -98.44 -127.35 0.17 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.877 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.5 mp -148.04 164.57 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.679 -1.263 . . . . 0.0 108.818 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.769 ' SG ' HD11 ' A' ' 52' ' ' LEU . 21.4 p -149.97 -171.74 3.98 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.383 -0.823 . . . . 0.0 109.206 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.753 ' O ' HD12 ' A' ' 52' ' ' LEU . 8.1 m -147.1 156.02 42.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.855 -1.153 . . . . 0.0 110.951 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.71 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -39.29 -38.57 0.54 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.79 0.805 . . . . 0.0 110.244 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.631 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 1.4 p90 -61.83 -47.83 83.29 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 121.772 0.796 . . . . 0.0 109.095 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.631 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -67.35 -39.99 85.8 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.769 HD11 ' SG ' ' A' ' 47' ' ' CYS . 1.4 mp -75.75 -18.37 59.58 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -62.82 -26.49 68.77 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.121 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -90.16 -10.76 43.33 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.287 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.809 ' CE2' HG23 ' A' ' 38' ' ' ILE . 11.2 m-85 -87.55 -1.81 58.19 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.489 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -90.61 -165.39 1.34 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.603 -0.686 . . . . 0.0 110.134 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 56' ' ' CYS . 4.3 t-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.816 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.522 ' CE2' ' CD ' ' A' ' 4' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.464 ' O ' ' OE1' ' A' ' 4' ' ' GLN . 12.5 m -153.13 -167.56 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.858 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.544 ' CA ' HG21 ' A' ' 46' ' ' ILE . 6.6 m120 -70.26 99.82 1.6 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.479 -0.763 . . . . 0.0 109.632 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.522 ' CD ' ' CE2' ' A' ' 1' ' ' PHE . 3.0 pm0 -131.88 165.53 23.65 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.125 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 1.046 ' NE2' HD11 ' A' ' 46' ' ' ILE . 20.5 m-70 -89.72 108.53 19.74 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.907 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -112.88 128.94 56.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.139 -0.976 . . . . 0.0 110.817 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.523 ' O ' ' C ' ' A' ' 8' ' ' GLY . 67.5 m -111.26 168.06 9.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -29.6 -45.89 0.08 OUTLIER Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.9 m -60.85 -69.87 0.21 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.088 -1.242 . . . . 0.0 110.093 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.558 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 1.2 m-20 -66.43 -13.44 60.76 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.856 -1.152 . . . . 0.0 108.362 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.721 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -66.78 -50.35 62.95 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.455 -0.778 . . . . 0.0 108.982 178.372 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -65.8 -30.55 50.4 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.472 0 C-N-CA 119.019 -1.072 . . . . 0.0 108.123 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.28 -57.31 6.16 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.697 -1.224 . . . . 0.0 107.697 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.907 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.93 -49.48 71.19 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.786 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.3 mt -62.88 -42.63 99.84 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.606 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 9.9 t80 -56.74 -21.54 28.97 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.44 -66.14 0.95 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.019 0.914 . . . . 0.0 109.226 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.786 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -47.62 -28.58 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.505 0.669 . . . . 0.0 109.427 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -90.18 -70.35 0.67 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.679 -179.427 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.63 -68.74 1.83 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -130.33 -6.88 4.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.157 -1.202 . . . . 0.0 110.122 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -66.01 -11.8 50.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.036 -1.04 . . . . 0.0 109.837 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 68.07 95.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.477 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 0.5 OUTLIER -93.93 174.88 6.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -1.178 . . . . 0.0 110.238 -179.648 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 29.2 p90 -165.19 151.89 10.4 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.496 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.2 OUTLIER -70.95 -115.42 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.454 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.918 HG21 ' CG ' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -164.06 -80.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.371 -1.456 . . . . 0.0 108.611 178.542 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' A' ' 34' ' ' PRO . 6.2 t70 -106.37 99.09 22.18 Favored Pre-proline 0 C--N 1.296 -1.722 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 27' ' ' THR . 34.1 Cg_endo -75.91 85.99 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.562 2.175 . . . . 0.0 110.541 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.6 p -137.58 -77.74 0.39 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.323 -0.861 . . . . 0.0 109.77 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.89 -176.43 51.51 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.512 ' O ' ' HD3' ' A' ' 34' ' ' PRO . . . -62.13 -36.48 93.0 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.96 85.3 0.4 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 27.1 Cg_endo -64.35 -19.53 65.62 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.422 2.081 . . . . 0.0 109.519 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.918 ' CG ' HG21 ' A' ' 27' ' ' THR . 0.0 OUTLIER -148.48 58.98 1.08 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.587 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.554 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -42.55 -23.76 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.908 -179.523 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.502 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.57 -40.72 8.83 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 106.219 -2.752 . . . . 0.0 106.219 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.924 HG23 ' CE2' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -94.32 -65.52 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 122.464 1.126 . . . . 0.0 108.02 176.342 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.502 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 16.2 t -46.78 -34.85 2.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.289 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.554 ' HB3' ' O ' ' A' ' 36' ' ' ARG . 9.2 tt0 -91.63 -19.38 22.75 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.117 -0.989 . . . . 0.0 109.567 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 45' ' ' SER . 16.5 tt0 -90.36 -81.81 0.29 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.294 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.568 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 23.1 m -40.8 -41.77 1.64 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.502 -0.749 . . . . 0.0 109.113 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.518 ' N ' ' O ' ' A' ' 6' ' ' LEU . 6.8 t -69.09 -53.9 17.88 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.207 -0.933 . . . . 0.0 110.026 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.578 ' O ' ' CE1' ' A' ' 5' ' ' HIS . 9.8 m80 -83.9 -64.4 1.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 108.937 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 41' ' ' GLN . 3.7 t -82.0 -132.7 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 1.046 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -153.85 166.0 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.823 -1.173 . . . . 0.0 109.076 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.576 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -155.09 171.09 20.35 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.601 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.639 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 4.9 m -124.28 158.16 33.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.368 -0.832 . . . . 0.0 109.485 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.671 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -38.74 -39.22 0.48 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.715 0.769 . . . . 0.0 110.48 -179.408 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.639 ' CD2' ' HB2' ' A' ' 48' ' ' SER . 3.1 p90 -60.33 -36.43 77.92 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.38 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.611 ' HG2' ' CE1' ' A' ' 50' ' ' TYR . 10.5 mt-30 -71.81 -47.36 53.8 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.429 HD22 ' HB3' ' A' ' 14' ' ' ALA . 1.5 mp -69.84 -16.64 63.3 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.25 -25.82 67.07 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -87.0 -11.83 49.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.467 -0.771 . . . . 0.0 109.449 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.924 ' CE2' HG23 ' A' ' 38' ' ' ILE . 11.9 m-85 -89.83 3.18 53.72 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.146 -0.971 . . . . 0.0 108.653 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.3 m -83.3 -166.96 1.5 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.456 -0.777 . . . . 0.0 110.015 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 21.2 p-10 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.698 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.686 ' O ' HG13 ' A' ' 2' ' ' VAL . 2.0 t80 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.56 0.695 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 1' ' ' PHE . 10.2 m -161.6 -166.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.543 -0.723 . . . . 0.0 109.613 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.478 ' C ' HG21 ' A' ' 46' ' ' ILE . 10.7 m120 -62.08 88.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.005 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.575 ' OE1' ' CE2' ' A' ' 1' ' ' PHE . 1.6 pm0 -127.55 176.3 7.59 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.863 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.903 ' NE2' HD11 ' A' ' 46' ' ' ILE . 38.0 m-70 -90.48 104.55 17.12 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.992 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -102.0 139.12 38.05 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.084 -1.01 . . . . 0.0 110.684 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.553 ' O ' ' C ' ' A' ' 8' ' ' GLY . 53.6 m -127.11 167.9 15.36 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.562 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -26.49 -47.33 0.04 OUTLIER Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 7' ' ' CYS . 72.8 m -62.93 -68.95 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.095 -1.238 . . . . 0.0 110.304 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.548 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 35.1 m-20 -67.55 -10.47 52.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.826 -1.171 . . . . 0.0 108.568 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.884 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -72.34 -48.3 42.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.34 -0.85 . . . . 0.0 109.459 178.622 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.611 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -68.65 -30.52 47.52 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.497 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.292 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -68.74 -59.84 2.82 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.55 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.992 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -51.8 -49.17 63.26 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.771 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.3 mt -63.98 -43.42 95.8 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.611 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 11.0 t80 -56.52 -21.42 26.08 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -88.65 -66.73 0.89 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 122.103 0.954 . . . . 0.0 109.14 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -47.96 -30.86 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.534 0.683 . . . . 0.0 109.311 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -90.58 -73.38 0.53 Allowed 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.862 0.839 . . . . 0.0 109.288 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 43.85 23.42 0.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER 157.12 -20.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.524 -0.986 . . . . 0.0 109.807 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 3.7 mtt180 -75.31 0.41 16.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.961 . . . . 0.0 109.818 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.42 74.31 0.45 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.57 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -74.54 -175.38 2.37 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.313 -1.11 . . . . 0.0 109.881 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CE1' ' O ' ' A' ' 55' ' ' TYR . 3.7 p90 -161.99 -169.25 2.14 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.898 0.856 . . . . 0.0 109.778 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.62 ' CE2' ' HG2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -151.98 104.99 3.04 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.131 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.67 HG23 ' HD3' ' A' ' 35' ' ' ARG . 1.8 t -77.83 -166.58 0.81 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.907 -1.121 . . . . 0.0 111.0 -177.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.574 ' HA ' ' O ' ' A' ' 34' ' ' PRO . 5.9 t0 172.2 77.83 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.25 12.65 2.0 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.774 2.316 . . . . 0.0 111.479 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.92 -78.93 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.756 -1.215 . . . . 0.0 109.812 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 32' ' ' GLY . . . 178.84 -96.01 0.1 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 33' ' ' GLY . . . -44.85 140.87 4.11 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.467 ' HA2' ' HD2' ' A' ' 34' ' ' PRO . . . 52.11 94.82 0.01 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.064 -2.014 . . . . 0.0 108.064 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.62 ' HG2' ' CE2' ' A' ' 26' ' ' TYR . 21.3 Cg_endo -60.33 -15.41 35.03 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.431 2.087 . . . . 0.0 110.168 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.719 ' HB3' HD12 ' A' ' 38' ' ' ILE . 7.5 tpt85 -165.41 56.4 0.12 Allowed 'General case' 0 C--N 1.279 -2.48 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.572 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -43.59 -23.55 0.08 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.436 -179.127 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.27 -41.62 11.91 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 106.15 -2.78 . . . . 0.0 106.15 177.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.884 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -93.93 -61.08 2.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 122.339 1.066 . . . . 0.0 108.374 176.838 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 8.0 t -51.01 -34.32 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.483 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 36' ' ' ARG . 2.9 tt0 -90.8 -18.76 24.36 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.893 -1.129 . . . . 0.0 108.661 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 45' ' ' SER . 9.6 tt0 -90.59 -84.79 0.23 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.447 -0.783 . . . . 0.0 109.461 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.567 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 1.3 m -39.5 -35.89 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 0.0 109.672 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.526 ' N ' ' O ' ' A' ' 6' ' ' LEU . 4.0 t -74.63 -54.54 7.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.041 -1.037 . . . . 0.0 110.383 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 13.9 m80 -79.15 -43.02 24.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.994 . . . . 0.0 109.528 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.6 t -108.35 -126.46 0.26 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.903 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -158.44 165.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.79 -1.194 . . . . 0.0 109.231 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.567 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -155.46 177.71 11.05 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.536 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 51' ' ' GLN . 5.2 m -130.95 155.98 45.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 109.51 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -38.77 -39.06 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.458 -0.776 . . . . 0.0 110.454 -179.391 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.617 ' CE1' ' HG2' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -53.31 -40.54 64.87 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.617 ' HG2' ' CE1' ' A' ' 50' ' ' TYR . 2.8 mt-30 -72.9 -56.47 5.14 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.466 HD22 ' CB ' ' A' ' 14' ' ' ALA . 1.2 mp -54.44 -20.29 7.28 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 50' ' ' TYR . 20.2 tt0 -69.1 -18.76 64.02 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.571 ' OD1' ' CD1' ' A' ' 55' ' ' TYR . 14.6 p30 -89.02 -26.0 21.68 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.937 0.875 . . . . 0.0 108.888 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.727 ' CE2' HG23 ' A' ' 38' ' ' ILE . 15.4 m-85 -80.26 -0.65 37.36 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.0 OUTLIER -92.48 175.82 6.69 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.539 -0.726 . . . . 0.0 109.16 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.6 m-20 . . . . . 0 C--N 1.298 -1.667 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.942 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.637 ' CD1' HD13 ' A' ' 49' ' ' LEU . 27.3 t80 . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 121.462 0.649 . . . . 0.0 109.628 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.839 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER -153.82 -152.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-O 122.346 1.07 . . . . 0.0 110.455 -178.786 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.839 ' N ' HG13 ' A' ' 2' ' ' VAL . 9.7 m120 -71.1 102.1 2.4 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.775 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.604 ' O ' HG23 ' A' ' 46' ' ' ILE . 13.4 tt0 -140.0 158.63 43.75 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.674 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 1.003 ' NE2' HD11 ' A' ' 46' ' ' ILE . 22.6 m-70 -81.53 97.72 7.95 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -82.92 -170.18 2.88 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.025 -1.047 . . . . 0.0 109.589 -179.104 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.575 ' O ' ' C ' ' A' ' 8' ' ' GLY . 5.5 t 173.31 142.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.623 ' HA2' ' OH ' ' A' ' 26' ' ' TYR . . . -14.12 -57.85 0.01 OUTLIER Glycine 0 N--CA 1.5 2.948 0 N-CA-C 111.957 -0.457 . . . . 0.0 111.957 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 7' ' ' CYS . 8.0 m -56.63 -69.91 0.14 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.007 -1.29 . . . . 0.0 109.675 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.604 ' CB ' ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.4 -17.83 64.88 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.704 -1.248 . . . . 0.0 108.041 179.447 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.689 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -60.67 -51.85 67.62 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.239 -0.913 . . . . 0.0 108.679 178.108 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.63 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -64.14 -26.08 39.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.493 -1.283 . . . . 0.0 108.226 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 1.1 tt0 -72.01 -60.39 2.26 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.72 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -52.57 -46.43 66.85 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.779 ' HA ' HG23 ' A' ' 18' ' ' VAL . 3.3 mt -64.39 -44.41 91.41 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.63 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 14.0 t80 -56.44 -21.1 23.17 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.22 -65.91 0.97 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.862 0.839 . . . . 0.0 109.292 179.724 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.779 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -47.25 -30.47 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.849 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -88.08 -73.84 0.47 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 65.22 2.31 9.04 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 11.7 tt0 164.41 -23.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.87 -1.37 . . . . 0.0 109.717 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.488 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 4.6 mtt-85 -60.95 -12.21 10.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.842 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 74.98 83.08 0.41 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.598 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -81.77 -167.86 1.68 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.024 -1.28 . . . . 0.0 109.894 -179.539 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.598 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -162.47 -171.01 2.61 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.412 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.623 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 1.8 t80 -117.1 -101.06 0.43 Allowed 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 118.501 -1.28 . . . . 0.0 109.168 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.755 HG21 ' CB ' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -160.8 -155.15 0.4 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.315 -1.49 . . . . 0.0 109.879 -179.631 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.526 ' N ' ' OG1' ' A' ' 27' ' ' THR . 10.3 t0 -66.65 114.5 17.83 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.73 82.39 2.32 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.326 2.017 . . . . 0.0 110.544 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.1 p -119.62 -78.56 0.59 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.305 -0.872 . . . . 0.0 109.41 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.75 -121.83 3.07 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.4 140.37 15.99 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.553 ' HA2' HG11 ' A' ' 39' ' ' VAL . . . 61.49 56.03 25.56 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 30.9 Cg_endo -70.27 -28.11 23.21 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.412 2.075 . . . . 0.0 109.591 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.755 ' CB ' HG21 ' A' ' 27' ' ' THR . 5.1 tpt85 -125.37 49.75 1.87 Allowed 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.569 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -40.59 -21.91 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.961 -179.032 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -46.59 -40.5 11.61 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 106.152 -2.779 . . . . 0.0 106.152 177.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.752 HG23 ' CE2' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -93.34 -57.4 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-O 122.402 1.096 . . . . 0.0 108.674 177.045 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.553 HG11 ' HA2' ' A' ' 33' ' ' GLY . 8.9 t -59.15 -28.53 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.93 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 36' ' ' ARG . 2.3 mt-10 -90.96 -32.03 16.12 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 120.919 -1.113 . . . . 0.0 108.609 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 45' ' ' SER . 6.0 tt0 -78.5 -75.82 0.22 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 121.641 0.734 . . . . 0.0 109.196 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 1.7 m -41.25 -44.73 2.73 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 121.533 -0.73 . . . . 0.0 109.996 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -75.18 -45.59 39.61 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.318 -0.864 . . . . 0.0 110.726 -178.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.516 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 4.7 m80 -90.11 -60.56 1.9 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.7 -1.25 . . . . 0.0 109.422 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 41' ' ' GLN . 7.9 t -88.15 -127.73 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 108.779 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 1.003 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -153.67 160.13 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.784 -1.198 . . . . 0.0 108.975 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.459 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 1.8 m -133.29 -166.09 1.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.689 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.619 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 5.7 m -146.47 144.04 29.38 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.693 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -39.29 -39.12 0.6 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.749 0.785 . . . . 0.0 110.191 -179.431 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.619 ' CE2' ' HB2' ' A' ' 48' ' ' SER . 1.1 p90 -61.8 -38.1 86.84 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.611 ' HG3' ' CZ ' ' A' ' 50' ' ' TYR . 17.6 mt-30 -67.82 -48.26 66.74 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.444 ' HA ' ' CD2' ' A' ' 55' ' ' TYR . 1.1 mp -67.48 -24.46 65.6 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.454 ' OE1' HG12 ' A' ' 18' ' ' VAL . 6.4 tp10 -57.67 -29.17 64.42 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -90.64 -10.6 42.66 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.574 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.752 ' CE2' HG23 ' A' ' 38' ' ' ILE . 12.0 m-85 -90.01 7.74 36.04 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -91.98 -161.32 0.81 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.631 -0.668 . . . . 0.0 109.502 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 7.3 p-10 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.005 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.496 ' C ' HG21 ' A' ' 46' ' ' ILE . 10.7 m-20 -63.23 93.62 0.07 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.407 -0.808 . . . . 0.0 109.178 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.57 ' HG3' HD13 ' A' ' 6' ' ' LEU . 1.4 pt20 -130.13 175.12 9.16 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.179 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.933 ' NE2' HD11 ' A' ' 46' ' ' ILE . 34.9 m-70 -92.94 108.57 20.11 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.851 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -111.75 126.47 55.09 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.091 -1.006 . . . . 0.0 111.022 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.522 ' O ' ' C ' ' A' ' 8' ' ' GLY . 72.8 m -108.49 168.47 9.3 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.28 -45.65 0.1 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 12' ' ' VAL . 12.8 m -60.63 -69.8 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -1.189 . . . . 0.0 109.977 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.554 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -66.42 -13.9 61.4 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 120.825 -1.172 . . . . 0.0 108.203 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.072 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -67.27 -49.64 63.54 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.614 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -64.75 -28.97 46.05 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.422 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.496 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.428 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 5.1 mt-10 -69.4 -59.82 2.74 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.851 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -52.82 -48.68 66.79 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.751 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.3 mt -63.13 -40.96 99.09 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.614 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.3 t80 -61.73 -21.42 64.49 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -86.18 -61.59 1.71 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.23 1.014 . . . . 0.0 108.47 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.751 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -54.46 -33.6 26.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.088 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -86.3 -65.05 1.05 Allowed 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.365 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.44 -72.12 0.23 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -130.32 -1.34 4.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -1.189 . . . . 0.0 109.808 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -72.8 -12.03 60.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.122 -0.986 . . . . 0.0 109.441 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 75.95 97.58 0.14 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.529 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -94.17 -176.82 4.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -1.163 . . . . 0.0 109.247 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.566 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 16.8 p90 -162.6 172.85 14.75 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.496 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.84 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.633 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 111.343 0.127 . . . . 0.0 111.343 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.93 -44.51 13.56 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 106.286 -2.726 . . . . 0.0 106.286 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.072 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -93.52 -60.11 2.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 122.487 1.137 . . . . 0.0 108.399 177.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.495 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 23.6 t -51.05 -35.06 14.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.738 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.676 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 42.6 mt-10 -92.02 -20.45 21.32 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.83 -1.169 . . . . 0.0 109.593 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.557 ' O ' ' N ' ' A' ' 45' ' ' SER . 5.1 tp60 -86.21 -87.18 0.14 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.406 -0.809 . . . . 0.0 109.86 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.559 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 22.7 m -39.34 -41.09 0.87 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.618 -0.676 . . . . 0.0 109.694 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 6' ' ' LEU . 9.8 t -68.95 -53.46 20.68 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.911 -1.118 . . . . 0.0 110.948 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.676 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 13.8 m-70 -85.18 -47.53 10.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.032 -1.043 . . . . 0.0 110.015 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 41' ' ' GLN . 29.0 t -100.78 -124.82 0.17 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 108.916 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.933 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -157.93 163.05 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.754 -1.217 . . . . 0.0 109.135 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.524 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -158.76 168.97 25.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.459 -0.775 . . . . 0.0 109.571 179.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.566 ' HG ' ' HD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -119.18 163.59 16.85 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.114 0.959 . . . . 0.0 109.527 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.617 ' HB3' HG13 ' A' ' 18' ' ' VAL . 25.1 mt -42.53 -33.71 0.73 Allowed 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 121.497 0.665 . . . . 0.0 109.637 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.616 ' CE1' ' HG2' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -56.99 -37.26 71.41 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.616 ' HG2' ' CE1' ' A' ' 50' ' ' TYR . 2.0 mm-40 -69.62 -59.78 2.74 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.473 ' HB3' ' HG ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -62.02 -16.86 54.78 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.6 tm-20 -68.05 -24.2 65.05 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -91.05 -24.87 19.91 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.752 0.787 . . . . 0.0 108.911 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.641 ' CD2' HG12 ' A' ' 38' ' ' ILE . 17.0 m-85 -81.06 4.18 20.66 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.566 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -83.07 -164.66 0.91 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.395 -0.816 . . . . 0.0 109.63 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 4.1 p-10 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.793 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 3' ' ' ASN . 4.6 m . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.557 0.694 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.452 ' HA ' ' CG2' ' A' ' 46' ' ' ILE . 28.3 m120 -41.71 99.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.995 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.651 ' H ' HG23 ' A' ' 46' ' ' ILE . 4.2 tt0 -148.7 166.46 28.31 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.408 -0.808 . . . . 0.0 109.66 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 1.025 ' NE2' HD11 ' A' ' 46' ' ' ILE . 24.1 m-70 -91.79 113.86 26.24 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.885 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.2 tp -120.58 129.12 53.63 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.422 -0.799 . . . . 0.0 110.691 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.527 ' O ' ' C ' ' A' ' 8' ' ' GLY . 89.8 m -113.18 170.76 7.99 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.94 -1.1 . . . . 0.0 108.404 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.527 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.25 -45.87 0.1 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.448 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 15.7 m -63.05 -67.76 0.4 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.19 . . . . 0.0 110.216 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 2.2 m-20 -67.57 -11.59 58.43 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.75 -1.219 . . . . 0.0 108.531 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.914 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.76 -49.7 50.44 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.617 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -63.92 -30.95 51.34 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.553 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.448 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 7.8 tt0 -69.9 -55.25 10.21 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.885 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -55.64 -49.75 72.02 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.77 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.4 mt -62.63 -41.61 99.12 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.617 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 7.4 t80 -59.39 -20.23 53.21 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -90.14 -65.38 1.02 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.094 0.949 . . . . 0.0 108.881 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.77 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -48.42 -28.69 2.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.42 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.48 -70.12 0.68 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.515 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.86 -62.83 0.49 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 19' ' ' CYS . 7.9 mp0 -134.4 -2.24 2.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -1.201 . . . . 0.0 110.364 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.485 ' HD3' ' O ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -74.42 -8.96 58.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.985 -1.072 . . . . 0.0 109.606 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.42 86.55 0.11 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.574 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -83.43 179.63 7.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -1.181 . . . . 0.0 109.407 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.574 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 29.4 p90 -163.3 166.57 22.92 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.156 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.423 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.878 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.599 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 119.927 -0.082 . . . . 0.0 110.877 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.2 -41.96 8.51 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 106.147 -2.781 . . . . 0.0 106.147 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.914 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -94.12 -61.18 2.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 122.544 1.164 . . . . 0.0 108.668 176.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.581 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 37.9 t -54.79 -30.97 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.321 -177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.655 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.7 tt0 -92.73 -23.96 18.75 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 120.809 -1.182 . . . . 0.0 109.549 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 45' ' ' SER . 5.6 tt0 -82.81 -90.34 0.08 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.072 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.569 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.24 -37.09 0.88 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 109.997 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 15.3 t -68.95 -52.94 23.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.538 -1.351 . . . . 0.0 110.664 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.655 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 8.1 m-70 -91.25 -55.48 3.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.925 -1.11 . . . . 0.0 108.471 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.625 ' C ' HD12 ' A' ' 46' ' ' ILE . 64.2 m -85.47 -131.46 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 1.025 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -151.97 152.78 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.674 -1.266 . . . . 0.0 109.114 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.656 ' SG ' HD11 ' A' ' 52' ' ' LEU . 8.3 p -149.63 172.86 14.37 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.549 ' O ' HD12 ' A' ' 52' ' ' LEU . 67.4 m -136.73 169.46 17.69 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.999 -1.063 . . . . 0.0 110.272 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.702 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -41.93 -34.52 0.69 Allowed 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.795 1.283 . . . . 0.0 108.492 178.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -53.21 -52.72 58.0 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.072 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 48' ' ' SER . 2.1 mt-30 -74.11 -45.55 48.36 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.292 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.656 HD11 ' SG ' ' A' ' 47' ' ' CYS . 1.1 mp -65.83 -14.39 61.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.414 -0.804 . . . . 0.0 109.032 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.5 tt0 -70.06 -28.09 65.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.156 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -90.39 -8.32 50.93 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.528 -0.732 . . . . 0.0 109.55 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.742 ' CE2' HG23 ' A' ' 38' ' ' ILE . 12.1 m-85 -90.33 2.05 55.92 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.49 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.3 m -78.64 -166.05 0.81 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.51 -0.744 . . . . 0.0 110.092 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.6 t-20 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.895 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.456 ' O ' ' OE1' ' A' ' 4' ' ' GLN . 10.5 m . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.567 0.699 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.549 ' CA ' HG21 ' A' ' 46' ' ' ILE . 2.0 m-80 -73.06 98.88 2.63 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.539 -0.725 . . . . 0.0 109.911 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.479 ' O ' HG23 ' A' ' 46' ' ' ILE . 3.2 pm0 -132.44 170.05 15.68 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.773 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.973 ' NE2' HD11 ' A' ' 46' ' ' ILE . 27.9 m-70 -93.35 113.65 25.88 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.941 HD21 ' HB2' ' A' ' 14' ' ' ALA . 0.9 OUTLIER -114.14 144.43 43.17 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.426 -0.796 . . . . 0.0 109.899 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.578 ' O ' ' N ' ' A' ' 9' ' ' SER . 2.4 t -144.07 112.66 6.55 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.187 -0.946 . . . . 0.0 109.63 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.532 ' N ' ' HB2' ' A' ' 11' ' ' LEU . . . 40.94 -90.36 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 7' ' ' CYS . 7.5 m -37.28 -67.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.578 -0.954 . . . . 0.0 110.549 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.593 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 81.5 m-20 -68.0 -19.14 64.9 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.647 -1.283 . . . . 0.0 108.441 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.84 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -65.33 -48.5 72.8 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.409 -0.807 . . . . 0.0 109.024 178.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.62 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.6 m -67.62 -26.23 34.89 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.489 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.671 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.475 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 5.4 tt0 -71.87 -57.97 3.86 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.941 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -52.69 -49.08 66.01 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.773 ' HA ' HG23 ' A' ' 18' ' ' VAL . 3.5 mt -64.32 -41.64 96.71 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.62 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 8.2 t80 -59.76 -24.26 63.91 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -84.17 -63.52 1.33 Allowed 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 122.104 0.954 . . . . 0.0 108.899 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -53.09 -28.88 14.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.914 -179.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.37 -70.58 0.65 Allowed 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.484 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.72 -64.02 0.18 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -131.63 -0.65 3.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.172 -1.193 . . . . 0.0 109.884 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 2.2 mtt85 -77.8 -9.53 59.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.143 -0.973 . . . . 0.0 109.914 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.9 92.4 0.05 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.537 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -87.0 -176.68 5.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.338 -1.095 . . . . 0.0 110.173 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CD1' ' C ' ' A' ' 25' ' ' PHE . 13.3 p90 -162.36 173.63 13.88 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.748 0.785 . . . . 0.0 109.415 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.492 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.294 -1.826 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.532 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -53.76 -42.42 68.33 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 105.252 -3.139 . . . . 0.0 105.252 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.84 ' CG2' HD21 ' A' ' 11' ' ' LEU . 1.2 mp -93.68 -50.43 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 121.838 0.828 . . . . 0.0 108.928 177.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 9.0 t -61.06 -29.66 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.813 -0.554 . . . . 0.0 110.21 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.641 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.2 tt0 -91.28 -12.62 34.59 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -90.75 -95.59 0.12 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.763 -0.585 . . . . 0.0 109.881 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -39.95 -28.27 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.37 -0.831 . . . . 0.0 110.002 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.557 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 18.7 t -73.76 -58.05 3.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.751 -1.218 . . . . 0.0 109.409 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.641 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 16.8 m-70 -80.28 -45.49 17.8 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.341 -0.849 . . . . 0.0 109.118 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.645 ' C ' HD12 ' A' ' 46' ' ' ILE . 14.9 t -106.42 -126.69 0.25 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.973 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.7 mp -150.25 165.87 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.742 -1.224 . . . . 0.0 109.561 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.564 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 20.2 p -154.13 178.04 10.42 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.55 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -139.63 163.7 31.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.719 -1.238 . . . . 0.0 110.888 -178.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.793 ' O ' HG11 ' A' ' 18' ' ' VAL . 1.8 mp -39.2 -39.94 0.67 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.902 0.858 . . . . 0.0 109.978 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 2.3 p90 -63.36 -41.73 98.86 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.585 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 7.1 tp60 -66.18 -44.18 84.71 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.594 ' CB ' HG21 ' A' ' 18' ' ' VAL . 1.4 mp -75.75 -23.45 55.99 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.7 tt0 -60.86 -30.0 69.87 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -90.12 -8.92 50.14 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.827 ' CE2' HG23 ' A' ' 38' ' ' ILE . 13.8 m-30 -90.03 -0.45 57.59 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.54 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -90.55 -164.98 1.25 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.645 -0.659 . . . . 0.0 110.536 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.9 t-20 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.909 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.449 ' O ' ' OE1' ' A' ' 4' ' ' GLN . 17.0 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 3' ' ' ASN . 4.3 p-10 -89.17 95.41 10.29 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.412 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.541 ' N ' HG23 ' A' ' 46' ' ' ILE . 3.9 pm0 -135.51 174.22 10.86 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 118.254 -1.378 . . . . 0.0 109.933 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.979 ' NE2' HD11 ' A' ' 46' ' ' ILE . 30.1 m-70 -90.8 106.77 18.74 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.949 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -110.9 127.81 55.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.114 -0.991 . . . . 0.0 110.782 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 11' ' ' LEU . 61.1 m -111.94 169.05 9.11 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.42 -44.79 0.09 OUTLIER Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 7' ' ' CYS . 58.7 m -61.59 -69.44 0.24 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.133 -1.216 . . . . 0.0 110.078 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.541 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 31.6 m-20 -67.06 -12.52 60.16 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.906 -1.121 . . . . 0.0 108.205 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.045 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -68.21 -50.37 54.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -65.04 -31.65 54.84 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.527 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.275 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.71 -58.35 4.8 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.949 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -53.94 -51.94 62.19 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.799 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.2 mt -59.18 -44.56 92.17 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.606 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 14.5 t80 -56.07 -21.71 23.54 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.58 -67.22 0.86 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.94 0.876 . . . . 0.0 109.427 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.059 HG13 ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -46.08 -29.41 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 121.613 0.72 . . . . 0.0 109.171 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -87.74 -72.89 0.5 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.846 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 69.16 -1.11 12.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER 159.45 -19.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.053 -1.263 . . . . 0.0 110.101 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -54.87 -18.33 4.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.097 -1.002 . . . . 0.0 109.37 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.64 68.5 1.27 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.939 -1.665 . . . . 0.0 108.939 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.499 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -72.06 178.74 3.62 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.338 -1.095 . . . . 0.0 109.836 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 10.4 p90 -162.77 -175.45 4.43 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.817 0.818 . . . . 0.0 109.359 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.465 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.835 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.599 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.486 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.84 -44.08 17.41 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 106.173 -2.771 . . . . 0.0 106.173 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.045 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.81 -57.67 4.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.447 1.117 . . . . 0.0 108.7 177.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 53.7 t -56.24 -32.09 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.075 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.66 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 4.3 tt0 -91.87 -17.96 24.49 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 120.849 -1.157 . . . . 0.0 109.156 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 45' ' ' SER . 7.4 tt0 -89.97 -85.98 0.2 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.623 -0.673 . . . . 0.0 109.377 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.585 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 22.4 m -39.75 -39.01 0.71 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.845 . . . . 0.0 109.677 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 39' ' ' VAL . 6.3 t -71.0 -53.86 13.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 110.587 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.66 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 15.7 m-70 -82.58 -51.84 7.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.127 -0.983 . . . . 0.0 109.68 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' GLN . 18.4 t -97.7 -123.84 0.14 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 108.747 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.979 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -159.9 162.5 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.797 -1.19 . . . . 0.0 108.839 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.536 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -157.63 174.73 14.91 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.283 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.633 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 5.1 m -126.93 159.65 33.38 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.192 -0.942 . . . . 0.0 110.328 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.059 ' HG ' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -38.79 -37.59 0.35 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.573 0.701 . . . . 0.0 111.033 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.633 ' CD2' ' HB2' ' A' ' 48' ' ' SER . 3.4 p90 -54.53 -42.95 71.47 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.625 0.726 . . . . 0.0 109.813 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.625 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -75.01 -31.12 61.31 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.442 -0.786 . . . . 0.0 109.968 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.64 HD23 ' HG ' ' A' ' 15' ' ' LEU . 1.3 mp -79.29 -20.38 48.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.995 -1.066 . . . . 0.0 108.137 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -64.4 -23.31 67.24 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -90.44 -16.41 29.06 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.63 ' CD2' HG12 ' A' ' 38' ' ' ILE . 11.6 m-85 -86.53 1.77 50.38 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.573 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -90.81 -165.52 1.37 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.522 -0.736 . . . . 0.0 110.09 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' CYS . 3.5 t30 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.766 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 4' ' ' GLN . 6.8 m . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.561 0.696 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.505 ' HA ' ' CG2' ' A' ' 46' ' ' ILE . 2.2 m120 -41.56 96.83 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.437 -0.789 . . . . 0.0 110.075 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.577 ' HG2' ' N ' ' A' ' 5' ' ' HIS . 5.0 tt0 -140.36 164.92 28.82 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.499 -0.751 . . . . 0.0 109.592 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 1.064 ' NE2' HD11 ' A' ' 46' ' ' ILE . 23.1 m-70 -89.27 104.41 16.96 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.97 ' CD2' ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -113.18 125.49 54.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.0 -1.062 . . . . 0.0 111.236 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.558 ' O ' ' N ' ' A' ' 11' ' ' LEU . 64.5 m -106.55 168.12 9.38 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.555 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . . . -32.99 -42.1 0.14 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 7' ' ' CYS . 4.0 m -61.5 -69.95 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -1.204 . . . . 0.0 109.593 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.549 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 6.5 m-20 -66.42 -13.45 60.74 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.879 -1.138 . . . . 0.0 107.939 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.843 HD21 ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -64.74 -52.2 58.31 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.035 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.621 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -64.6 -29.3 46.98 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.512 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.443 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 4.0 tt0 -71.85 -54.08 11.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.97 ' HB2' ' CD2' ' A' ' 6' ' ' LEU . . . -54.13 -51.79 63.12 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.797 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.3 mt -61.92 -44.64 96.36 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.621 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 8.1 t80 -56.63 -21.5 27.59 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -88.11 -67.02 0.86 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.797 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -46.92 -29.68 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.22 -71.19 0.63 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.494 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.95 -66.6 0.19 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 19' ' ' CYS . 1.7 tt0 -129.23 -0.51 5.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 109.809 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.78 -6.78 55.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.995 . . . . 0.0 109.717 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 57' ' ' ASN . . . 67.77 94.5 0.04 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.513 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -91.56 -177.88 4.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.254 -1.145 . . . . 0.0 109.905 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 11.6 p90 -162.37 -178.02 6.03 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.677 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.562 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -50.35 -48.17 41.69 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.07 HG21 ' CE1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -93.43 -21.18 6.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.93 -0.747 . . . . 0.0 109.413 178.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.562 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 0.9 OUTLIER -86.56 -59.47 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 0.0 109.196 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.611 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 23.0 tt0 -62.39 -14.46 40.53 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.115 -0.991 . . . . 0.0 108.478 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -81.96 -77.75 0.21 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.308 -0.87 . . . . 0.0 108.872 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.543 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 23.6 m -42.75 -45.98 4.98 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' LEU . 11.5 t -64.54 -54.37 33.23 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.318 -0.864 . . . . 0.0 110.113 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.611 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 8.7 m-70 -86.99 -69.13 0.7 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.992 -1.067 . . . . 0.0 108.746 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.553 ' C ' HD12 ' A' ' 46' ' ' ILE . 6.7 t -75.15 -132.27 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 1.064 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.1 mp -155.3 159.68 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.805 -1.185 . . . . 0.0 109.121 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.559 ' CB ' ' NE2' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -150.45 177.6 9.84 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.744 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.469 ' OG ' ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -130.41 156.56 44.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 109.903 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.786 HD22 ' H ' ' A' ' 49' ' ' LEU . 1.8 mm? -39.91 -35.28 0.34 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.667 0.746 . . . . 0.0 110.258 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.602 ' CG ' ' N ' ' A' ' 51' ' ' GLN . 0.9 OUTLIER -52.3 -47.56 65.85 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.722 0.773 . . . . 0.0 109.178 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.609 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -75.01 -33.0 61.76 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.707 -179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.609 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 1.9 mp -78.05 -19.23 54.68 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.176 -0.953 . . . . 0.0 108.64 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 49' ' ' LEU . 19.3 tt0 -67.11 -20.43 65.78 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -90.62 -12.39 37.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.572 -0.705 . . . . 0.0 109.708 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 1.07 ' CE1' HG21 ' A' ' 38' ' ' ILE . 56.5 m-85 -90.37 4.76 49.95 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.107 -0.996 . . . . 0.0 109.084 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.57 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -81.65 -164.54 0.8 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.687 -0.633 . . . . 0.0 109.446 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 12.8 t30 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.139 -0.934 . . . . 0.0 109.575 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 4' ' ' GLN . 14.3 m . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.703 0.763 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.468 ' CA ' HG21 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -53.04 88.94 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.016 -1.052 . . . . 0.0 110.092 -179.429 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 2' ' ' VAL . 18.6 pt20 -135.76 177.6 7.7 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.366 -0.834 . . . . 0.0 109.275 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.925 ' NE2' HD11 ' A' ' 46' ' ' ILE . 30.5 m-70 -93.53 109.71 21.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.644 -0.66 . . . . 0.0 109.385 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.0 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -108.43 141.92 39.57 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.861 0.839 . . . . 0.0 110.301 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.556 ' O ' ' C ' ' A' ' 8' ' ' GLY . 60.7 m -128.93 167.82 16.87 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.579 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -25.91 -48.25 0.04 OUTLIER Glycine 0 N--CA 1.498 2.772 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 7' ' ' CYS . 24.0 m -63.17 -68.29 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -1.199 . . . . 0.0 110.227 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.547 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 16.5 m-20 -68.27 -10.24 53.27 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.792 -1.192 . . . . 0.0 108.727 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.087 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -72.81 -48.09 40.85 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.446 -0.901 . . . . 0.0 109.228 178.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.604 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -69.02 -32.05 52.83 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.428 0 C-N-CA 119.024 -1.071 . . . . 0.0 108.324 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -67.31 -57.74 6.1 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 1.0 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.3 -48.94 70.71 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.777 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.7 mt -64.4 -41.01 96.88 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.109 0.957 . . . . 0.0 108.592 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.604 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.2 t80 -57.61 -21.22 37.95 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.51 -64.92 1.07 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 122.072 0.939 . . . . 0.0 109.245 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.777 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.53 -28.32 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.412 0.625 . . . . 0.0 109.519 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -90.04 -71.41 0.62 Allowed 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.676 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.63 -59.03 0.19 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' CYS . 2.4 pm0 -129.43 -28.79 2.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.222 -1.163 . . . . 0.0 110.331 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.56 -20.69 2.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.355 -0.841 . . . . 0.0 109.645 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 72.9 94.34 0.09 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.613 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -83.45 -169.26 2.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.309 -1.112 . . . . 0.0 110.203 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.613 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 3.3 p90 -161.87 178.6 8.77 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.452 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.7 OUTLIER . . . . . 0 C--N 1.295 -1.78 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.527 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 41' ' ' GLN . . . -53.3 -43.12 64.66 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 105.377 -3.089 . . . . 0.0 105.377 177.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.087 ' CG2' HD21 ' A' ' 11' ' ' LEU . 2.4 mp -94.45 -48.0 13.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.883 0.849 . . . . 0.0 109.175 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 2.1 t -60.68 -33.07 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.508 0.67 . . . . 0.0 109.571 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.651 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.4 tt0 -90.34 -17.36 27.45 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.56 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -90.08 -88.27 0.17 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.579 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 1.2 m -39.03 -33.45 0.12 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.845 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 39' ' ' VAL . 3.3 t -77.78 -46.61 21.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.029 -1.044 . . . . 0.0 110.986 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.651 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 16.1 m-70 -91.15 -34.01 15.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.886 -1.133 . . . . 0.0 109.111 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 41' ' ' GLN . 58.7 m -114.75 -126.41 0.29 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.925 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -159.87 165.39 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.514 -1.366 . . . . 0.0 109.633 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.579 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -156.11 -160.5 1.01 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.101 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.539 ' O ' HD12 ' A' ' 52' ' ' LEU . 4.5 p -160.38 161.67 33.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.097 -1.002 . . . . 0.0 109.643 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.618 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -41.95 -35.88 0.97 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.898 1.332 . . . . 0.0 108.353 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 13.2 t80 -57.47 -53.1 61.97 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.38 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -73.41 -40.37 64.34 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.694 ' HA ' ' CD2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -68.76 -21.23 64.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.485 -0.76 . . . . 0.0 109.048 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 49' ' ' LEU . 2.1 tt0 -62.09 -25.26 67.61 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -90.59 -10.21 44.23 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.748 -0.595 . . . . 0.0 109.513 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.696 ' CD2' HG12 ' A' ' 38' ' ' ILE . 13.2 m-85 -84.32 -4.15 58.69 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 24' ' ' PHE . 1.2 m -90.79 -169.15 2.28 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.744 0.783 . . . . 0.0 111.12 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 55.5 t30 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.456 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 121.45 0.643 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.522 ' CA ' HG21 ' A' ' 46' ' ' ILE . 1.3 m-80 -77.66 87.54 3.94 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 108.936 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.622 ' HG3' HD13 ' A' ' 6' ' ' LEU . 5.9 pt20 -125.64 175.73 7.37 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.259 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.833 ' NE2' HD11 ' A' ' 46' ' ' ILE . 45.4 m-70 -92.1 112.01 23.79 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.816 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -112.92 129.11 56.59 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.332 -0.855 . . . . 0.0 111.319 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' O ' ' C ' ' A' ' 8' ' ' GLY . 91.4 m -111.15 170.52 8.06 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.522 ' HA2' ' OH ' ' A' ' 26' ' ' TYR . . . -29.93 -47.53 0.12 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.462 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 25.6 m -61.17 -68.11 0.34 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -1.189 . . . . 0.0 110.369 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.574 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 8.7 m-20 -67.46 -13.06 61.69 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.852 -1.155 . . . . 0.0 108.477 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.996 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -68.44 -49.18 61.77 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.195 -0.94 . . . . 0.0 108.551 177.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.614 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -64.48 -28.18 44.27 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.46 0 C-N-CA 119.114 -1.035 . . . . 0.0 108.509 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.4 OUTLIER -71.4 -56.55 5.75 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.816 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -55.41 -45.8 76.67 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.765 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.8 mt -66.31 -40.65 90.12 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.614 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 6.3 t80 -59.13 -20.12 50.85 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -89.95 -64.23 1.17 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 122.046 0.927 . . . . 0.0 108.791 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.765 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.75 -29.28 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.538 0.685 . . . . 0.0 109.294 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.92 -71.13 0.63 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.673 -179.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.6 -62.41 0.3 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 19' ' ' CYS . 25.6 mp0 -132.66 -10.96 3.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.132 -1.217 . . . . 0.0 110.663 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -67.96 -7.56 29.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.913 -1.117 . . . . 0.0 109.624 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.88 92.79 0.05 OUTLIER Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.626 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -86.36 -178.02 6.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.124 -1.221 . . . . 0.0 109.529 -179.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.626 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 16.6 p90 -162.19 168.38 22.54 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.522 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.29 -2.002 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.605 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.15 -44.4 14.49 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 106.358 -2.697 . . . . 0.0 106.358 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.996 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.5 -60.36 2.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 122.554 1.169 . . . . 0.0 108.43 177.015 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.574 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 34.3 t -51.56 -33.26 14.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.72 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.676 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 3.6 tt0 -93.46 -14.87 26.19 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 120.896 -1.128 . . . . 0.0 109.412 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 45' ' ' SER . 35.4 tt0 -88.53 -96.88 0.09 Allowed 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.98 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.58 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -39.75 -34.52 0.26 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.862 . . . . 0.0 109.912 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.574 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 13.4 t -67.2 -54.82 17.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.371 -1.455 . . . . 0.0 110.087 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.676 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 14.8 m-70 -84.75 -40.66 17.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 109.691 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' GLN . 9.3 t -110.39 -128.26 0.28 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.847 . . . . 0.0 108.801 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.833 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.4 mp -147.64 162.51 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.727 -1.233 . . . . 0.0 108.984 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.494 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 18.8 p -154.97 160.26 40.97 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.922 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 49' ' ' LEU . 5.3 m -114.46 159.12 20.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.48 -0.762 . . . . 0.0 109.952 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -39.64 -36.76 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.61 -0.681 . . . . 0.0 110.357 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.623 ' CZ ' ' HG2' ' A' ' 51' ' ' GLN . 0.9 OUTLIER -53.0 -39.32 63.01 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 119.673 -0.811 . . . . 0.0 108.842 -179.091 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.623 ' HG2' ' CZ ' ' A' ' 50' ' ' TYR . 1.5 mm-40 -72.98 -54.48 8.5 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.492 ' HB2' HG21 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -64.21 -12.12 37.58 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 49' ' ' LEU . 12.1 tt0 -74.47 -28.0 60.83 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -90.92 -9.8 44.84 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.65 ' CD2' HG12 ' A' ' 38' ' ' ILE . 14.0 m-85 -89.76 1.6 55.9 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.473 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -90.51 -165.81 1.44 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.596 -0.69 . . . . 0.0 110.158 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 42.7 t-20 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.922 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.842 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 122.381 1.086 . . . . 0.0 110.309 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.842 ' N ' HG13 ' A' ' 2' ' ' VAL . 10.2 m120 -74.28 92.16 2.23 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.13 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.503 ' O ' HG23 ' A' ' 46' ' ' ILE . 18.1 pt20 -132.96 175.02 9.73 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.109 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.903 ' NE2' HD11 ' A' ' 46' ' ' ILE . 39.1 m-70 -94.57 113.51 25.34 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.857 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -117.98 136.09 53.74 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.149 -0.969 . . . . 0.0 110.177 -179.224 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 9' ' ' SER . 4.4 t -135.32 116.7 14.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.102 -0.999 . . . . 0.0 109.994 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.534 ' N ' ' HB2' ' A' ' 11' ' ' LEU . . . 39.19 -90.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.567 ' N ' ' O ' ' A' ' 7' ' ' CYS . 4.2 m -36.6 -68.47 0.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.639 -0.918 . . . . 0.0 110.518 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.597 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 52.4 m-20 -67.86 -20.12 65.1 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.719 -1.238 . . . . 0.0 108.561 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.984 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -64.74 -48.82 73.19 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.462 -0.895 . . . . 0.0 108.975 177.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.624 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -66.41 -27.93 41.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.658 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.462 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 27.4 tt0 -71.7 -53.46 13.44 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.857 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -57.94 -48.42 79.98 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.751 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.5 mt -63.66 -38.61 91.75 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.624 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 10.3 t80 -62.17 -20.24 63.93 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -87.82 -63.59 1.28 Allowed 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.912 HG13 HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -48.79 -32.29 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.31 -73.23 0.53 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.846 0.832 . . . . 0.0 109.144 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 41.43 25.69 0.18 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 1.3 mt-10 162.18 -32.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.262 -1.14 . . . . 0.0 110.06 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.48 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.8 mtp85 -71.41 -4.92 29.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.394 -0.816 . . . . 0.0 109.58 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 64.75 91.27 0.03 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.491 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -88.52 178.11 6.61 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.138 -1.213 . . . . 0.0 109.812 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.453 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 33.7 p90 -163.39 158.59 21.35 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.489 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.291 -1.936 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.592 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 111.358 0.132 . . . . 0.0 111.358 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -47.03 -42.62 16.24 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.984 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -94.67 -60.82 2.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 122.629 1.204 . . . . 0.0 108.26 176.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.595 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 49.6 t -53.43 -30.75 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.112 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.644 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.8 tt0 -94.4 -16.54 23.35 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 120.795 -1.19 . . . . 0.0 109.318 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 45' ' ' SER . 2.7 tp60 -90.15 -92.64 0.13 Allowed 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.179 -178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -42.28 -32.62 0.52 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.83 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.595 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 25.3 t -68.72 -56.9 6.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.64 -1.288 . . . . 0.0 109.853 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.644 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 17.1 m-70 -83.29 -48.02 10.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.391 -0.818 . . . . 0.0 109.77 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.598 ' C ' HD12 ' A' ' 46' ' ' ILE . 19.5 t -106.38 -118.94 0.24 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.391 -0.818 . . . . 0.0 109.017 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.903 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.7 mp -151.09 165.53 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.74 -1.225 . . . . 0.0 109.013 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.885 ' SG ' HD11 ' A' ' 52' ' ' LEU . 24.2 p -146.82 -166.7 2.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.446 -0.784 . . . . 0.0 109.015 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.627 ' O ' HD12 ' A' ' 52' ' ' LEU . 5.4 m -156.25 156.51 34.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.826 -1.171 . . . . 0.0 110.555 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.912 HD12 HG13 ' A' ' 18' ' ' VAL . 1.7 mm? -39.93 -37.03 0.52 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.509 0.671 . . . . 0.0 109.901 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.604 ' CD2' ' HB2' ' A' ' 48' ' ' SER . 0.7 OUTLIER -58.34 -46.5 86.12 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.597 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -72.6 -40.77 66.28 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.885 HD11 ' SG ' ' A' ' 47' ' ' CYS . 1.6 mp -76.4 -14.74 60.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.19 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.56 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.7 tt0 -74.33 -25.71 59.71 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -90.24 -11.21 41.58 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.668 ' CD2' HG12 ' A' ' 38' ' ' ILE . 12.7 m-85 -87.59 -2.55 58.69 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -91.43 -170.66 2.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.565 -0.71 . . . . 0.0 109.976 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 28.0 t-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.237 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.527 0.68 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.51 ' CA ' HG21 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -82.06 101.38 10.32 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.629 -0.669 . . . . 0.0 109.5 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.556 ' CG ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -131.85 176.36 8.42 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.665 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.996 ' NE2' HD11 ' A' ' 46' ' ' ILE . 25.7 m-70 -93.85 108.32 20.11 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.975 ' CD2' ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -110.0 128.43 55.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.99 -1.068 . . . . 0.0 111.198 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.536 ' O ' ' N ' ' A' ' 11' ' ' LEU . 37.3 m -113.08 170.81 7.94 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -31.81 -44.51 0.15 Allowed Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.405 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 3.3 m -63.56 -67.45 0.43 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.922 -1.34 . . . . 0.0 110.028 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.563 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.12 -11.66 57.85 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.91 -1.118 . . . . 0.0 108.273 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.075 HD21 ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -67.86 -50.68 55.11 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.611 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -64.71 -29.52 47.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.443 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.498 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -71.21 -57.72 4.22 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.162 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.975 ' HB2' ' CD2' ' A' ' 6' ' ' LEU . . . -50.48 -50.55 52.27 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.771 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.6 mt -63.42 -45.77 89.44 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.611 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 2.1 t80 -55.88 -21.92 22.74 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -86.98 -66.85 0.86 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.085 0.945 . . . . 0.0 108.848 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.38 -29.6 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-O 121.618 0.723 . . . . 0.0 109.118 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.7 -74.91 0.46 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.825 0.821 . . . . 0.0 108.851 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 67.11 -0.19 8.42 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.537 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 2.7 tt0 163.1 -22.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.035 -1.274 . . . . 0.0 109.783 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.04 -17.45 6.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.114 -0.991 . . . . 0.0 109.581 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.75 77.56 1.12 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.544 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -78.88 -172.26 2.96 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.255 -1.144 . . . . 0.0 109.621 -179.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.563 ' CE2' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -162.89 -164.4 0.98 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.751 178.108 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.613 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.604 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.582 0.23 . . . . 0.0 111.518 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -56.37 -51.94 53.0 Favored Glycine 0 C--N 1.295 -1.727 0 N-CA-C 105.794 -2.923 . . . . 0.0 105.794 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.075 ' CD1' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -93.72 -29.16 4.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 1.3 t -68.58 -55.69 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.611 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.5 tm-20 -61.24 -18.57 59.01 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -82.3 -82.4 0.14 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.552 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 29.0 m -39.87 -44.11 1.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.534 -0.728 . . . . 0.0 109.114 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.51 ' N ' ' O ' ' A' ' 6' ' ' LEU . 6.0 t -67.33 -52.99 33.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 110.659 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.611 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 12.6 m-70 -84.22 -57.82 3.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.063 . . . . 0.0 109.281 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 41' ' ' GLN . 14.0 t -88.23 -126.58 0.05 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.996 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -159.49 164.87 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.567 -1.333 . . . . 0.0 109.295 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.557 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -153.31 -168.14 2.92 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.39 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.54 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.9 OUTLIER -150.44 160.45 43.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.955 . . . . 0.0 110.438 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.608 ' HG ' HG13 ' A' ' 18' ' ' VAL . 2.4 mp -42.71 -35.47 1.15 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.62 1.2 . . . . 0.0 109.061 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -54.01 -55.66 25.16 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.878 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -75.56 -37.34 60.02 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.014 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 48' ' ' SER . 0.5 OUTLIER -67.68 -19.62 65.2 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.044 179.339 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 49' ' ' LEU . 4.4 tt0 -65.6 -18.96 65.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.3 -0.875 . . . . 0.0 109.101 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -90.59 -11.39 40.14 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.394 -0.816 . . . . 0.0 109.985 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.649 ' CZ ' ' CG2' ' A' ' 38' ' ' ILE . 18.1 m-85 -90.58 6.46 43.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.995 -1.065 . . . . 0.0 109.061 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.458 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.1 m -91.91 -166.93 1.66 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.533 -0.729 . . . . 0.0 109.39 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.563 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 5.7 p-10 . . . . . 0 C--N 1.304 -1.398 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.111 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.6 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.681 0.753 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.556 ' CA ' HG21 ' A' ' 46' ' ' ILE . 1.2 m-80 -60.22 91.4 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 109.482 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.504 ' HG3' HD13 ' A' ' 6' ' ' LEU . 21.1 pt20 -132.16 175.43 9.25 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.119 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 1.01 ' NE2' HD11 ' A' ' 46' ' ' ILE . 27.2 m-70 -94.68 111.64 23.4 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.801 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -119.13 129.81 55.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.45 -0.781 . . . . 0.0 111.151 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.522 ' O ' ' C ' ' A' ' 8' ' ' GLY . 72.5 m -113.08 170.08 8.47 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.17 -44.93 0.08 OUTLIER Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.506 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.5 m -62.9 -68.39 0.34 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -1.159 . . . . 0.0 110.113 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.556 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.56 -11.09 57.24 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.863 -1.148 . . . . 0.0 108.412 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.923 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -70.36 -49.14 52.34 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.067 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.616 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 3.1 m -64.42 -31.26 52.79 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.492 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.671 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.425 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -68.61 -56.75 7.21 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.587 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.801 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.36 -50.91 66.38 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.785 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.4 mt -62.03 -41.0 97.64 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.616 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 17.9 t80 -58.78 -20.32 48.68 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -90.41 -66.94 0.88 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.898 0.856 . . . . 0.0 109.013 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.957 HG13 ' HG ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -46.21 -30.92 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.583 0.706 . . . . 0.0 109.162 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.05 -67.6 0.83 Allowed 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.799 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.06 -66.36 0.49 Allowed Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 19' ' ' CYS . 14.8 mt-10 -136.28 -1.71 2.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -1.086 . . . . 0.0 110.009 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 3.0 mtm180 -66.89 -14.4 62.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.077 -1.015 . . . . 0.0 109.767 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.49 79.51 0.93 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.544 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -81.24 -177.32 6.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.362 -1.081 . . . . 0.0 109.406 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.544 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 8.4 p90 -161.52 -172.53 3.39 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.756 0.789 . . . . 0.0 109.449 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.452 ' OH ' ' CG2' ' A' ' 39' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.298 -1.641 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.211 -0.964 0 N-CA-C 110.526 -0.175 . . . . 0.0 110.526 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -46.97 -42.75 16.1 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 106.146 -2.781 . . . . 0.0 106.146 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.935 HG23 ' CE2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -93.55 -62.38 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.553 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 2.6 t -48.54 -31.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.173 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.659 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.5 mt-10 -92.76 -22.34 19.41 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.914 -1.117 . . . . 0.0 108.873 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.488 ' HG3' ' N ' ' A' ' 42' ' ' CYS . 28.4 tp60 -82.77 -95.14 0.05 Allowed 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.434 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.57 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -40.84 -33.31 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.366 -0.834 . . . . 0.0 109.776 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 13.9 t -67.82 -58.74 4.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.483 -1.385 . . . . 0.0 109.719 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.659 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 14.6 m-70 -82.74 -58.61 2.82 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.25 -0.906 . . . . 0.0 108.922 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.618 ' C ' HD12 ' A' ' 46' ' ' ILE . 25.3 t -87.23 -129.72 0.06 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 1.01 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.5 mp -150.52 162.37 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.719 -1.238 . . . . 0.0 108.978 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.518 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 15.2 p -151.27 -168.03 2.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.43 -0.794 . . . . 0.0 109.115 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.504 ' C ' HD12 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -155.6 163.62 39.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.066 -1.021 . . . . 0.0 110.384 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.957 ' HG ' HG13 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -39.02 -39.01 0.5 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.641 0.734 . . . . 0.0 110.27 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.65 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 2.2 p90 -57.56 -44.03 84.95 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.65 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 2.8 tp60 -72.88 -41.75 64.34 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.514 ' CB ' HG21 ' A' ' 18' ' ' VAL . 1.1 mt -75.0 -15.72 60.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.125 -0.984 . . . . 0.0 109.019 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' LEU . 14.1 tt0 -70.38 -27.75 64.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.45 -0.781 . . . . 0.0 108.985 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -89.13 -10.53 46.92 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.935 ' CE2' HG23 ' A' ' 38' ' ' ILE . 10.5 m-85 -90.06 0.38 57.16 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.536 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.1 m -90.71 -165.89 1.46 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.477 -0.764 . . . . 0.0 110.293 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 56' ' ' CYS . 34.6 t30 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.911 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.59 0.709 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.539 ' CA ' HG21 ' A' ' 46' ' ' ILE . 4.6 m120 -63.96 91.29 0.07 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.414 -0.804 . . . . 0.0 109.188 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.567 ' HG3' HD13 ' A' ' 6' ' ' LEU . 2.6 pt20 -130.16 173.43 10.77 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.053 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.899 ' NE2' HD11 ' A' ' 46' ' ' ILE . 37.4 m-70 -90.92 108.46 19.86 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.939 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.2 tp -110.99 125.41 53.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 111.026 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' O ' ' C ' ' A' ' 8' ' ' GLY . 79.0 m -110.84 170.61 7.98 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -31.39 -43.99 0.11 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.406 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 9.9 m -62.5 -68.86 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.117 -1.225 . . . . 0.0 109.875 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.567 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 34.9 m-20 -66.86 -11.97 57.59 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.828 -1.17 . . . . 0.0 108.34 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.986 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.41 -48.72 60.18 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -65.87 -28.47 44.06 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.461 0 C-N-CA 119.094 -1.042 . . . . 0.0 108.489 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 1.0 OUTLIER -70.86 -60.22 2.36 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.001 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.939 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -49.42 -50.81 39.02 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.751 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.3 mt -62.25 -44.47 96.47 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.606 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.5 t80 -58.78 -24.99 62.64 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -80.25 -65.67 0.98 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 122.334 1.064 . . . . 0.0 108.315 178.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -55.53 -29.12 23.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.164 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.539 ' SG ' ' CB ' ' A' ' 24' ' ' PHE . 33.4 m -88.34 -55.42 3.74 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.113 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 45.93 61.92 3.65 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 1.9 tt0 80.49 -3.19 1.88 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.514 -0.991 . . . . 0.0 110.256 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.478 ' CB ' ' SG ' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -57.36 -17.75 14.01 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.951 -1.093 . . . . 0.0 109.008 179.484 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' CA ' ' A' ' 57' ' ' ASN . . . 95.29 65.9 0.98 Allowed Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.539 ' CB ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -87.36 178.89 6.71 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.355 -1.085 . . . . 0.0 109.44 -179.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -162.48 -163.21 0.88 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.488 178.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.502 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.294 -1.844 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.626 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -48.12 -44.08 25.94 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 106.146 -2.781 . . . . 0.0 106.146 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.986 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.19 -56.54 5.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 122.414 1.102 . . . . 0.0 108.342 177.201 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.583 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 4.2 t -55.78 -29.32 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.683 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.677 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -93.44 -28.88 15.86 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 120.818 -1.176 . . . . 0.0 109.579 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.525 ' HG3' ' N ' ' A' ' 42' ' ' CYS . 1.7 tp60 -76.25 -97.53 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.507 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.569 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -40.77 -33.76 0.32 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 110.463 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.583 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 17.0 t -67.36 -53.47 29.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.353 -1.467 . . . . 0.0 110.889 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.677 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 15.9 m-70 -84.52 -52.96 5.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.02 -1.05 . . . . 0.0 110.059 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.477 ' C ' HD12 ' A' ' 46' ' ' ILE . 32.4 t -98.48 -113.82 0.15 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 108.977 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.899 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.4 mp -159.42 161.56 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.825 -1.172 . . . . 0.0 108.668 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.513 ' SG ' ' NE2' ' A' ' 51' ' ' GLN . 14.7 p -152.76 -171.0 3.8 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.566 -0.853 . . . . 0.0 109.535 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.641 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 4.8 m -143.86 156.97 44.65 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.345 1.069 . . . . 0.0 110.589 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.607 ' O ' ' N ' ' A' ' 53' ' ' GLU . 17.5 mt -39.44 -34.4 0.21 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.622 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.65 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 5.7 p90 -51.14 -42.63 60.88 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 118.532 -1.267 . . . . 0.0 108.108 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.65 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 1.7 pt20 -74.43 -53.54 9.35 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -62.14 -14.37 36.52 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.202 -0.936 . . . . 0.0 108.653 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 49' ' ' LEU . 20.8 tt0 -72.99 -31.46 64.53 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -91.57 -13.59 31.73 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.719 -0.613 . . . . 0.0 109.573 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.653 ' CE2' HG12 ' A' ' 38' ' ' ILE . 13.1 m-85 -82.65 -0.53 47.65 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.975 -1.078 . . . . 0.0 108.44 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 22' ' ' ARG . 1.2 t -66.94 -155.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.558 -0.714 . . . . 0.0 109.779 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.526 ' CA ' ' O ' ' A' ' 23' ' ' GLY . 24.1 p30 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.823 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.487 0.661 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.525 ' CA ' HG21 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -70.15 109.36 4.57 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.474 -0.766 . . . . 0.0 109.394 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.546 ' HG2' ' N ' ' A' ' 5' ' ' HIS . 6.1 tt0 -134.54 163.13 30.4 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 110.189 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 1.071 ' NE2' HD11 ' A' ' 46' ' ' ILE . 20.0 m-70 -91.62 91.83 8.2 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.872 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -91.19 165.98 13.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.929 -1.107 . . . . 0.0 109.694 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 9' ' ' SER . 16.4 t -167.44 112.32 0.71 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.588 -1.32 . . . . 0.0 109.43 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.52 ' N ' ' HB2' ' A' ' 11' ' ' LEU . . . 39.88 -90.15 0.01 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 7' ' ' CYS . 7.1 m -40.25 -68.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.406 -1.055 . . . . 0.0 110.655 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.622 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 26.6 m-20 -65.8 -24.19 66.86 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.502 -1.374 . . . . 0.0 108.644 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.05 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -59.93 -50.76 72.51 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.387 -0.925 . . . . 0.0 108.642 177.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.628 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -64.38 -26.12 39.59 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 C-N-CA 119.127 -1.029 . . . . 0.0 108.674 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.439 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -71.75 -57.77 4.06 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.436 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.872 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.21 -48.95 70.45 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.825 ' HG ' HD12 ' A' ' 52' ' ' LEU . 2.6 mt -62.77 -41.57 99.3 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.628 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 12.3 t80 -59.26 -20.9 58.09 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -90.6 -65.8 0.98 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.971 0.891 . . . . 0.0 109.178 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.767 HG13 ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -46.72 -29.96 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-O 121.599 0.714 . . . . 0.0 109.258 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.19 -70.9 0.64 Allowed 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.543 -179.41 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.26 -67.52 0.37 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 19' ' ' CYS . 3.5 mt-10 -126.93 -7.62 6.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.223 -1.163 . . . . 0.0 109.825 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.477 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 3.8 mmt85 -70.16 -10.55 59.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.166 -0.959 . . . . 0.0 109.699 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.6 89.74 0.08 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -85.37 -177.12 6.39 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.348 -1.089 . . . . 0.0 109.731 -179.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.574 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 11.0 p90 -162.76 178.47 8.44 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.689 0.757 . . . . 0.0 109.337 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.475 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.743 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.571 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 111.339 0.125 . . . . 0.0 111.339 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -48.21 -44.04 26.47 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 106.082 -2.807 . . . . 0.0 106.082 177.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.05 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.27 -57.51 4.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 122.508 1.147 . . . . 0.0 108.513 177.145 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 54.6 t -57.03 -29.27 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.913 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.681 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.3 mt-10 -91.87 -32.96 15.11 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.862 -1.149 . . . . 0.0 109.02 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 45' ' ' SER . 1.5 tp-100 -74.86 -82.49 0.06 Allowed 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.8 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.541 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 15.5 m -42.21 -48.08 4.81 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.411 -0.805 . . . . 0.0 109.715 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 5.1 t -62.87 -47.94 81.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 110.429 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.681 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 8.8 m-70 -90.47 -65.41 1.02 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.888 -1.133 . . . . 0.0 108.963 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 41' ' ' GLN . 8.5 t -87.38 -137.31 0.09 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 1.071 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.4 mp -142.38 162.35 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.794 -1.191 . . . . 0.0 109.17 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.511 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -142.92 -161.58 1.28 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.408 179.213 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.588 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -152.45 149.81 28.96 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.329 -0.857 . . . . 0.0 109.818 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.767 ' HG ' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -38.96 -37.26 0.34 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.758 0.79 . . . . 0.0 110.805 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 1.3 p90 -60.01 -37.8 80.8 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.556 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.596 ' HG2' ' CD2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -77.56 -20.01 54.77 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.842 HD13 ' HD2' ' A' ' 55' ' ' TYR . 4.3 mm? -86.8 -28.03 23.21 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.08 -23.26 19.58 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -90.89 -23.23 20.58 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.842 ' HD2' HD13 ' A' ' 52' ' ' LEU . 17.5 m-85 -81.25 0.23 37.75 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.574 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.1 m -90.78 -165.15 1.29 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.538 -0.726 . . . . 0.0 109.958 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.442 ' C ' ' O ' ' A' ' 56' ' ' CYS . 27.3 p-10 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.876 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.853 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 122.328 1.061 . . . . 0.0 110.983 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.853 ' N ' HG13 ' A' ' 2' ' ' VAL . 5.3 m120 -63.42 93.11 0.07 Allowed 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.526 ' HG2' ' N ' ' A' ' 5' ' ' HIS . 4.6 tt0 -129.22 160.34 33.24 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.001 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 1.082 ' NE2' HD11 ' A' ' 46' ' ' ILE . 17.1 m-70 -85.05 93.89 8.71 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.662 HD13 ' CB ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -79.31 -163.79 0.55 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.174 -0.954 . . . . 0.0 109.134 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.586 ' O ' ' C ' ' A' ' 8' ' ' GLY . 0.8 OUTLIER 170.83 141.25 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.623 -179.422 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -17.15 -55.19 0.01 OUTLIER Glycine 0 N--CA 1.502 3.063 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 7' ' ' CYS . 15.3 m -60.66 -66.2 0.57 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.208 -1.172 . . . . 0.0 109.717 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.662 ' CB ' HD13 ' A' ' 6' ' ' LEU . 1.2 m-20 -67.46 -17.91 64.88 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.73 -1.231 . . . . 0.0 107.984 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.903 HD21 ' CD1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -59.58 -53.05 62.56 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.634 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -63.62 -27.94 43.97 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.44 0 C-N-CA 118.801 -1.16 . . . . 0.0 108.08 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -71.8 -60.25 2.33 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.759 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -50.79 -49.2 58.94 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.774 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.6 mt -62.81 -47.62 82.64 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 7.1 t80 -53.65 -25.55 18.44 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -82.02 -67.79 0.75 Allowed 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.101 0.953 . . . . 0.0 108.521 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.91 HG13 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -49.83 -28.74 4.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.526 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -87.21 -55.69 3.7 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.349 -0.94 . . . . 0.0 109.937 -179.07 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 21' ' ' GLU . . . 46.1 65.85 1.9 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 17.4 mm-40 80.92 -9.98 1.28 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.675 -0.897 . . . . 0.0 110.199 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 2.2 mmt180 -56.79 -17.22 8.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.915 -1.116 . . . . 0.0 109.415 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' CA ' ' A' ' 57' ' ' ASN . . . 85.19 80.02 1.12 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.608 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -92.12 179.01 5.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -1.108 . . . . 0.0 109.902 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.608 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 40.1 p90 -162.68 175.14 11.66 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.294 -1.816 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.61 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -48.82 -44.51 31.1 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.963 HG21 ' CE1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -91.87 -34.19 6.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.192 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 1.4 t -76.48 -69.79 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.615 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.1 tt0 -45.06 -25.87 0.38 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.856 -1.152 . . . . 0.0 108.57 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -80.35 -78.62 0.17 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 1.7 m -42.39 -29.03 0.24 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.592 -0.692 . . . . 0.0 109.497 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -85.08 -47.36 10.27 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.009 -1.057 . . . . 0.0 109.88 -179.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.615 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 7.0 m-70 -92.59 -53.27 4.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.11 -0.994 . . . . 0.0 109.288 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' GLN . 38.7 m -92.09 -122.85 0.08 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 1.082 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -160.6 166.07 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.652 -1.28 . . . . 0.0 109.07 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.567 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -156.35 -170.96 3.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.391 -0.818 . . . . 0.0 109.285 179.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.489 ' HG ' ' HE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -142.02 157.61 44.73 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.269 -0.894 . . . . 0.0 109.839 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.91 HD22 HG13 ' A' ' 18' ' ' VAL . 54.6 mt -42.65 -33.09 0.66 Allowed 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.661 0.743 . . . . 0.0 110.571 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.656 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 1.6 p90 -53.45 -44.01 68.53 Favored 'General case' 0 C--N 1.281 -2.406 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.046 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.656 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -74.95 -53.01 9.75 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.154 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.491 ' N ' ' CG ' ' A' ' 51' ' ' GLN . 1.2 mp -61.22 -15.47 34.83 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 49' ' ' LEU . 37.2 tt0 -70.59 -24.39 62.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -91.35 -14.18 31.19 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.635 -0.666 . . . . 0.0 109.415 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.963 ' CE1' HG21 ' A' ' 38' ' ' ILE . 59.7 m-85 -86.15 4.34 38.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.126 -0.984 . . . . 0.0 108.879 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.521 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -77.51 -164.24 0.47 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.691 -0.631 . . . . 0.0 109.98 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.448 ' CA ' ' O ' ' A' ' 23' ' ' GLY . 5.6 t-20 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.667 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.836 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 122.413 1.101 . . . . 0.0 110.387 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.836 ' N ' HG13 ' A' ' 2' ' ' VAL . 2.0 m120 -89.85 99.81 12.75 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.982 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.506 ' O ' HG23 ' A' ' 46' ' ' ILE . 4.2 pm0 -132.71 171.95 13.19 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.165 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.955 ' NE2' HD11 ' A' ' 46' ' ' ILE . 32.5 m-70 -90.77 110.16 21.35 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.833 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -112.63 134.04 54.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.132 -0.98 . . . . 0.0 111.168 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.535 ' O ' ' C ' ' A' ' 8' ' ' GLY . 34.4 m -119.08 168.09 11.17 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.555 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -28.93 -45.24 0.06 OUTLIER Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 7' ' ' CYS . 19.5 m -63.15 -68.65 0.32 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -1.201 . . . . 0.0 109.997 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.545 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 53.3 m-20 -67.79 -10.01 49.1 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.845 -1.159 . . . . 0.0 108.572 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.904 HD21 HD11 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -72.66 -48.15 41.58 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.378 -0.826 . . . . 0.0 109.05 178.487 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.616 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -67.53 -28.9 43.62 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.43 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.726 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -70.83 -55.87 7.56 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.489 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.833 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.51 -50.79 66.98 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.77 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.1 mt -60.87 -45.17 95.6 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.616 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 17.3 t80 -57.19 -21.37 32.85 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -88.77 -65.76 0.99 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.132 0.968 . . . . 0.0 109.009 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.77 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -50.29 -28.45 5.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-O 121.409 0.623 . . . . 0.0 109.602 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -86.59 -65.46 1.01 Allowed 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.39 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.47 -71.0 1.07 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -132.97 -1.2 3.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -1.137 . . . . 0.0 109.93 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.482 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 26.1 mmm-85 -69.18 -11.86 61.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.056 -1.027 . . . . 0.0 109.658 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.409 ' O ' ' CG ' ' A' ' 57' ' ' ASN . . . 69.3 89.42 0.08 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.621 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -85.01 -175.67 5.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -1.128 . . . . 0.0 109.805 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.621 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 23.9 p90 -162.8 164.65 26.08 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.491 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.293 -1.859 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 120.716 0.293 . . . . 0.0 111.488 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -49.94 -45.38 41.28 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.191 -2.364 . . . . 0.0 107.191 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.904 HD11 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -93.54 -26.19 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.413 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -82.91 -59.93 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.292 -0.88 . . . . 0.0 109.101 179.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.632 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 4.9 tt0 -58.72 -16.6 17.31 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.4 OUTLIER -80.47 -82.41 0.11 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.372 -0.83 . . . . 0.0 109.392 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.557 ' O ' ' N ' ' A' ' 6' ' ' LEU . 28.5 m -39.57 -42.5 1.17 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.36 -0.838 . . . . 0.0 108.955 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 6' ' ' LEU . 4.8 t -69.54 -53.03 20.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.829 . . . . 0.0 111.043 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.632 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 12.7 m-70 -83.51 -48.76 9.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.868 -1.145 . . . . 0.0 109.663 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 41' ' ' GLN . 45.1 t -99.95 -124.42 0.16 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.955 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -159.49 165.23 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.706 -1.246 . . . . 0.0 109.206 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.556 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -148.16 -156.64 0.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.469 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.62 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 5.6 m -160.05 154.08 23.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 110.387 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.631 ' HG ' HG13 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -39.13 -38.86 0.52 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.644 0.735 . . . . 0.0 110.412 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 1.4 p90 -57.76 -46.46 84.49 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.623 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -71.69 -37.57 70.68 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.519 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.509 ' HB3' HG21 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -76.48 -20.09 57.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.161 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 49' ' ' LEU . 26.0 tt0 -68.19 -22.66 64.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.323 -0.86 . . . . 0.0 108.868 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -89.92 -11.52 41.56 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.548 -0.72 . . . . 0.0 109.812 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.651 ' CZ ' ' HB ' ' A' ' 38' ' ' ILE . 17.5 m-85 -91.09 6.99 42.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.127 -0.983 . . . . 0.0 108.5 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.541 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.3 m -78.06 -164.55 0.54 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.715 -0.616 . . . . 0.0 109.927 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.3 t-20 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.743 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 4' ' ' GLN . 12.3 m . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.488 0.661 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.436 ' C ' HG21 ' A' ' 46' ' ' ILE . 11.0 m-20 -59.9 87.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.449 -0.782 . . . . 0.0 108.976 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 46' ' ' ILE . 20.3 pt20 -130.99 178.31 6.77 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.028 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.901 ' NE2' HD11 ' A' ' 46' ' ' ILE . 36.8 m-70 -91.84 106.05 18.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.85 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -104.91 137.82 42.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.14 -0.975 . . . . 0.0 111.058 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.543 ' O ' ' C ' ' A' ' 8' ' ' GLY . 60.0 m -124.1 166.98 14.85 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.685 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -26.12 -47.91 0.04 OUTLIER Glycine 0 N--CA 1.498 2.798 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 7' ' ' CYS . 1.4 m -61.82 -69.2 0.26 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.286 . . . . 0.0 109.948 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.549 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -68.17 -10.7 56.21 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.812 -1.18 . . . . 0.0 108.763 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.814 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -73.71 -47.42 39.63 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.246 -0.909 . . . . 0.0 109.316 178.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 8' ' ' GLY . 2.9 m -71.57 -31.95 44.21 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.406 0 C-N-CA 118.789 -1.164 . . . . 0.0 108.485 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 16' ' ' TYR . 10.4 mt-10 -66.54 -54.27 25.6 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.85 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -59.69 -50.21 74.75 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.801 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.8 mt -59.92 -39.89 86.99 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.607 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 7.9 t80 -59.45 -21.54 60.19 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.71 -65.54 1.01 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.969 0.89 . . . . 0.0 108.964 179.442 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.981 HG11 ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -49.99 -27.43 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.578 0.704 . . . . 0.0 109.509 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 24' ' ' PHE . 36.2 m -90.27 -69.24 0.74 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.854 -178.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.59 -71.82 1.55 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -137.7 1.83 2.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.351 -1.088 . . . . 0.0 109.964 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.495 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 42.4 mmm-85 -63.34 -12.35 29.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.004 -1.06 . . . . 0.0 109.864 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 57' ' ' ASN . . . 85.22 90.86 0.84 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -114.3 173.93 6.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -1.16 . . . . 0.0 109.668 -179.51 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.589 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 2.2 p90 -161.21 -61.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.408 -0.807 . . . . 0.0 109.025 178.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.589 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.298 -1.654 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.25 -39.98 7.43 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 106.18 -2.768 . . . . 0.0 106.18 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.946 HG23 ' CE2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -93.38 -63.67 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-O 122.346 1.07 . . . . 0.0 108.261 176.691 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 3.3 t -48.82 -35.95 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.23 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.672 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 3.3 tt0 -91.25 -17.07 26.58 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.076 -1.015 . . . . 0.0 109.423 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 45' ' ' SER . 33.2 tt0 -90.58 -82.91 0.27 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.359 -0.838 . . . . 0.0 109.594 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 6' ' ' LEU . 24.5 m -39.28 -41.17 0.86 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.495 -0.753 . . . . 0.0 109.731 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.483 ' N ' ' O ' ' A' ' 6' ' ' LEU . 3.7 t -73.58 -51.25 17.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 111.177 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.672 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 14.9 m-70 -83.23 -41.9 17.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.871 -1.143 . . . . 0.0 109.95 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 41' ' ' GLN . 37.7 t -110.31 -121.64 0.27 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.901 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -158.94 165.6 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.794 -1.191 . . . . 0.0 109.394 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.568 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -148.09 -164.52 2.03 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.407 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.632 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 10.3 m -143.78 151.82 40.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 110.128 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.981 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -39.11 -39.85 0.63 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.734 0.778 . . . . 0.0 110.143 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.632 ' CE2' ' HB2' ' A' ' 48' ' ' SER . 1.2 p90 -63.13 -41.06 99.24 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.551 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 37.2 tp60 -63.67 -44.65 93.12 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.541 HD23 ' HG ' ' A' ' 15' ' ' LEU . 1.2 mp -72.38 -24.24 61.23 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -63.43 -24.08 67.68 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -0.821 . . . . 0.0 109.095 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -87.97 -9.16 54.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.492 -0.755 . . . . 0.0 109.457 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.946 ' CE2' HG23 ' A' ' 38' ' ' ILE . 13.7 m-85 -90.14 2.0 55.79 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -80.28 -158.21 0.17 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.483 -0.761 . . . . 0.0 110.935 -178.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 23' ' ' GLY . 22.4 t-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.656 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 4' ' ' GLN . 12.9 m . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.674 0.75 . . . . 0.0 109.623 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -43.51 94.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.341 -0.849 . . . . 0.0 109.725 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.664 ' NE2' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -143.19 167.87 21.09 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.205 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 1.061 ' NE2' HD11 ' A' ' 46' ' ' ILE . 18.1 m-70 -93.14 111.79 23.54 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.947 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.2 tp -113.76 128.12 56.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.026 -1.046 . . . . 0.0 110.84 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 11' ' ' LEU . 64.6 m -111.04 167.56 10.17 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.553 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -31.36 -42.38 0.08 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 7' ' ' CYS . 42.3 m -62.68 -69.27 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.275 . . . . 0.0 109.491 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.543 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 1.1 m-20 -67.47 -10.92 56.04 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.934 -1.104 . . . . 0.0 108.484 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.711 ' CD2' HD11 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -70.78 -48.88 51.92 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.385 -0.822 . . . . 0.0 109.043 178.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.613 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -67.08 -28.52 43.05 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.454 0 C-N-CA 118.802 -1.159 . . . . 0.0 108.297 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 6.4 tt0 -70.32 -57.15 5.17 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.947 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.38 -49.71 69.22 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.752 ' HA ' HG23 ' A' ' 18' ' ' VAL . 3.0 mt -61.62 -44.04 97.74 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.613 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 11.5 t80 -58.5 -27.0 64.07 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -78.79 -64.04 1.27 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 122.042 0.925 . . . . 0.0 108.568 179.137 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.886 HG12 ' OE1' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -53.34 -31.79 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.509 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -86.49 -64.32 1.17 Allowed 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.601 -0.839 . . . . 0.0 109.563 -179.41 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.25 -64.63 0.39 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 19' ' ' CYS . 1.6 mt-10 -138.79 2.74 2.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.262 -1.14 . . . . 0.0 110.077 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 14.2 mmt85 -74.19 -11.21 60.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.099 -1.0 . . . . 0.0 109.882 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 69.69 93.9 0.06 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.627 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -89.7 -167.25 1.8 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -1.126 . . . . 0.0 110.061 -179.595 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.627 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 15.0 p90 -160.63 170.82 20.07 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.545 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 1.5 t80 . . . . . 0 C--N 1.297 -1.703 0 O-C-N 120.805 -1.184 . . . . 0.0 109.628 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.698 0.285 . . . . 0.0 111.119 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -49.65 -42.61 36.31 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.973 -2.451 . . . . 0.0 106.973 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.711 HD11 ' CD2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -93.99 -26.69 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.233 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.602 HG12 ' N ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -84.46 -60.48 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.412 -0.805 . . . . 0.0 109.462 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.643 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 34.0 tt0 -61.63 -13.98 26.9 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.221 -0.925 . . . . 0.0 109.284 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -79.85 -85.75 0.08 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.178 -0.951 . . . . 0.0 109.845 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.57 ' HB2' HD11 ' A' ' 11' ' ' LEU . 32.3 m -38.73 -42.65 0.83 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 6' ' ' LEU . 7.4 t -67.31 -54.82 17.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.478 -0.764 . . . . 0.0 110.553 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.643 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 10.6 m-70 -86.29 -59.13 2.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.837 -1.164 . . . . 0.0 109.18 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.595 ' C ' HD12 ' A' ' 46' ' ' ILE . 33.0 t -83.17 -132.89 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 1.061 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.5 mp -155.94 161.29 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.846 -1.159 . . . . 0.0 108.577 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.46 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.6 OUTLIER -141.54 -157.44 0.77 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.654 -1.218 . . . . 0.0 110.655 -179.064 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.616 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 5.4 m -151.18 146.44 26.11 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.874 0.845 . . . . 0.0 110.008 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.721 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -37.7 -42.48 0.57 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.739 0.781 . . . . 0.0 111.04 -179.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.616 ' CE2' ' HB2' ' A' ' 48' ' ' SER . 3.6 p90 -61.94 -37.79 86.05 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.991 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.607 ' CG ' ' CZ ' ' A' ' 50' ' ' TYR . 72.0 mt-30 -67.64 -39.74 84.61 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.581 HD23 ' HG ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -71.39 -28.87 64.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 109.057 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.886 ' OE1' HG12 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -57.96 -23.04 52.01 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.494 ' N ' ' ND2' ' A' ' 54' ' ' ASN . 1.2 m120 -89.65 -15.52 32.49 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.807 -0.558 . . . . 0.0 109.573 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.678 ' CZ ' ' HB ' ' A' ' 38' ' ' ILE . 16.4 m-85 -90.54 5.51 47.49 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.448 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.1 m -90.89 -164.25 1.15 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.623 -0.673 . . . . 0.0 109.851 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 8.3 p-10 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.936 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.9 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.398 0.618 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.506 ' CA ' HG21 ' A' ' 46' ' ' ILE . 3.4 m-80 -60.07 93.86 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.453 -0.779 . . . . 0.0 109.264 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.686 ' HG3' HD13 ' A' ' 6' ' ' LEU . 1.6 pt20 -134.42 173.84 11.19 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.154 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.877 ' NE2' HD11 ' A' ' 46' ' ' ILE . 43.3 m-70 -90.48 112.53 24.21 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.742 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -118.12 129.41 55.52 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.403 -0.811 . . . . 0.0 111.328 -178.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' O ' ' C ' ' A' ' 8' ' ' GLY . 98.7 m -111.61 170.42 8.14 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -29.93 -45.71 0.09 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.518 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.1 m -62.1 -68.85 0.29 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.107 -1.231 . . . . 0.0 110.171 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.572 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 1.9 m-20 -67.46 -11.63 58.32 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.859 -1.15 . . . . 0.0 108.416 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.985 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.72 -49.09 56.58 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.607 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -63.83 -30.62 50.43 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.55 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.617 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 4.7 tt0 -69.09 -56.69 6.94 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.742 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -55.15 -49.38 71.95 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.771 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.5 mt -62.86 -40.97 99.12 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.607 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 8.7 t80 -58.36 -20.44 43.7 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -90.07 -66.67 0.9 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.982 0.896 . . . . 0.0 109.006 179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -46.22 -30.08 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.47 -71.1 0.64 Allowed 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.555 -179.358 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.24 -60.41 0.25 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 19' ' ' CYS . 17.0 mt-10 -138.11 -0.05 2.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.201 -1.176 . . . . 0.0 110.381 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.572 ' CD ' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -76.74 -4.07 41.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.99 -1.069 . . . . 0.0 109.685 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.99 84.85 0.18 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.546 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -83.13 -177.44 6.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.268 -1.136 . . . . 0.0 109.421 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.546 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 8.6 p90 -161.33 -172.69 3.49 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.394 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.492 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.605 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.612 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.4 -44.79 16.15 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 106.267 -2.733 . . . . 0.0 106.267 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.985 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.92 -61.22 2.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 122.551 1.167 . . . . 0.0 108.229 176.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.573 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 13.9 t -49.11 -34.74 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.508 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.666 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 24.3 tt0 -93.35 -16.88 24.19 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 120.864 -1.147 . . . . 0.0 109.406 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 45' ' ' SER . 33.8 tt0 -86.65 -94.98 0.09 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.464 -0.772 . . . . 0.0 110.077 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.23 -34.9 0.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.469 -0.77 . . . . 0.0 109.895 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 16.3 t -66.34 -55.05 17.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.385 -1.447 . . . . 0.0 109.739 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.666 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 15.5 m-70 -84.22 -51.61 6.89 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.195 -0.941 . . . . 0.0 109.454 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' GLN . 35.1 t -98.44 -127.35 0.17 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.877 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.5 mp -148.04 164.57 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.679 -1.263 . . . . 0.0 108.818 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.769 ' SG ' HD11 ' A' ' 52' ' ' LEU . 21.4 p -149.97 -171.74 3.98 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.383 -0.823 . . . . 0.0 109.206 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.753 ' O ' HD12 ' A' ' 52' ' ' LEU . 8.1 m -147.1 156.02 42.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.855 -1.153 . . . . 0.0 110.951 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.71 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -39.29 -38.57 0.54 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.79 0.805 . . . . 0.0 110.244 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.631 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 1.4 p90 -61.83 -47.83 83.29 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 121.772 0.796 . . . . 0.0 109.095 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.631 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -67.35 -39.99 85.8 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.769 HD11 ' SG ' ' A' ' 47' ' ' CYS . 1.4 mp -75.75 -18.37 59.58 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -62.82 -26.49 68.77 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.121 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -90.16 -10.76 43.33 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.287 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.809 ' CE2' HG23 ' A' ' 38' ' ' ILE . 11.2 m-85 -87.55 -1.81 58.19 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.489 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -90.61 -165.39 1.34 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.603 -0.686 . . . . 0.0 110.134 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 56' ' ' CYS . 4.3 t-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.816 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.464 ' O ' ' OE1' ' A' ' 4' ' ' GLN . 12.5 m . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.513 0.673 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.544 ' CA ' HG21 ' A' ' 46' ' ' ILE . 6.6 m120 -70.26 99.82 1.6 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.479 -0.763 . . . . 0.0 109.632 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.482 ' O ' HG23 ' A' ' 46' ' ' ILE . 3.0 pm0 -131.88 165.53 23.65 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.125 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 1.046 ' NE2' HD11 ' A' ' 46' ' ' ILE . 20.5 m-70 -89.72 108.53 19.74 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.907 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -112.88 128.94 56.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.139 -0.976 . . . . 0.0 110.817 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.523 ' O ' ' C ' ' A' ' 8' ' ' GLY . 67.5 m -111.26 168.06 9.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -29.6 -45.89 0.08 OUTLIER Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.9 m -60.85 -69.87 0.21 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.088 -1.242 . . . . 0.0 110.093 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.558 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 1.2 m-20 -66.43 -13.44 60.76 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.856 -1.152 . . . . 0.0 108.362 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.721 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -66.78 -50.35 62.95 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.455 -0.778 . . . . 0.0 108.982 178.372 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -65.8 -30.55 50.4 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.472 0 C-N-CA 119.019 -1.072 . . . . 0.0 108.123 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.28 -57.31 6.16 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.697 -1.224 . . . . 0.0 107.697 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.907 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.93 -49.48 71.19 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.786 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.3 mt -62.88 -42.63 99.84 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.606 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 9.9 t80 -56.74 -21.54 28.97 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.44 -66.14 0.95 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.019 0.914 . . . . 0.0 109.226 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.786 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -47.62 -28.58 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.505 0.669 . . . . 0.0 109.427 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -90.18 -70.35 0.67 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.679 -179.427 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.63 -68.74 1.83 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -130.33 -6.88 4.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.157 -1.202 . . . . 0.0 110.122 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -66.01 -11.8 50.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.036 -1.04 . . . . 0.0 109.837 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 68.07 95.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.477 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 0.5 OUTLIER -93.93 174.88 6.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -1.178 . . . . 0.0 110.238 -179.648 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 29.2 p90 -165.19 151.89 10.4 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.496 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.294 -1.805 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.554 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.502 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.57 -40.72 8.83 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 106.219 -2.752 . . . . 0.0 106.219 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.924 HG23 ' CE2' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -94.32 -65.52 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 122.464 1.126 . . . . 0.0 108.02 176.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.502 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 16.2 t -46.78 -34.85 2.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.289 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.632 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 9.2 tt0 -91.63 -19.38 22.75 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.117 -0.989 . . . . 0.0 109.567 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 45' ' ' SER . 16.5 tt0 -90.36 -81.81 0.29 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.294 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.568 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 23.1 m -40.8 -41.77 1.64 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.502 -0.749 . . . . 0.0 109.113 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.518 ' N ' ' O ' ' A' ' 6' ' ' LEU . 6.8 t -69.09 -53.9 17.88 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.207 -0.933 . . . . 0.0 110.026 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.632 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 12.3 m-70 -83.9 -64.4 1.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 108.937 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 41' ' ' GLN . 3.7 t -82.0 -132.7 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 1.046 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -153.85 166.0 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.823 -1.173 . . . . 0.0 109.076 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.576 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -155.09 171.09 20.35 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.601 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.639 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 4.9 m -124.28 158.16 33.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.368 -0.832 . . . . 0.0 109.485 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.671 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -38.74 -39.22 0.48 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.715 0.769 . . . . 0.0 110.48 -179.408 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.639 ' CD2' ' HB2' ' A' ' 48' ' ' SER . 3.1 p90 -60.33 -36.43 77.92 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.38 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.611 ' HG2' ' CE1' ' A' ' 50' ' ' TYR . 10.5 mt-30 -71.81 -47.36 53.8 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.429 HD22 ' HB3' ' A' ' 14' ' ' ALA . 1.5 mp -69.84 -16.64 63.3 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.25 -25.82 67.07 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -87.0 -11.83 49.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.467 -0.771 . . . . 0.0 109.449 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.924 ' CE2' HG23 ' A' ' 38' ' ' ILE . 11.9 m-85 -89.83 3.18 53.72 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.146 -0.971 . . . . 0.0 108.653 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.3 m -83.3 -166.96 1.5 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.456 -0.777 . . . . 0.0 110.015 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 21.2 p-10 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.698 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.466 ' O ' ' OE1' ' A' ' 4' ' ' GLN . 10.2 m . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.505 0.669 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.478 ' C ' HG21 ' A' ' 46' ' ' ILE . 10.7 m120 -62.08 88.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.005 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.476 ' O ' HG23 ' A' ' 46' ' ' ILE . 1.6 pm0 -127.55 176.3 7.59 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.863 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.903 ' NE2' HD11 ' A' ' 46' ' ' ILE . 38.0 m-70 -90.48 104.55 17.12 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.992 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -102.0 139.12 38.05 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.084 -1.01 . . . . 0.0 110.684 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.553 ' O ' ' C ' ' A' ' 8' ' ' GLY . 53.6 m -127.11 167.9 15.36 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.562 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -26.49 -47.33 0.04 OUTLIER Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 7' ' ' CYS . 72.8 m -62.93 -68.95 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.095 -1.238 . . . . 0.0 110.304 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.548 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 35.1 m-20 -67.55 -10.47 52.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.826 -1.171 . . . . 0.0 108.568 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.884 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -72.34 -48.3 42.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.34 -0.85 . . . . 0.0 109.459 178.622 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.611 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -68.65 -30.52 47.52 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.497 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.292 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -68.74 -59.84 2.82 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.55 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.992 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -51.8 -49.17 63.26 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.771 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.3 mt -63.98 -43.42 95.8 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.611 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 11.0 t80 -56.52 -21.42 26.08 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -88.65 -66.73 0.89 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 122.103 0.954 . . . . 0.0 109.14 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -47.96 -30.86 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.534 0.683 . . . . 0.0 109.311 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -90.58 -73.38 0.53 Allowed 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.862 0.839 . . . . 0.0 109.288 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 43.85 23.42 0.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER 157.12 -20.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.524 -0.986 . . . . 0.0 109.807 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 3.7 mtt180 -75.31 0.41 16.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.961 . . . . 0.0 109.818 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.42 74.31 0.45 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.57 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -74.54 -175.38 2.37 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.313 -1.11 . . . . 0.0 109.881 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CE1' ' O ' ' A' ' 55' ' ' TYR . 3.7 p90 -161.99 -169.25 2.14 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.898 0.856 . . . . 0.0 109.778 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.513 ' OH ' ' CG2' ' A' ' 39' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.638 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.572 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.27 -41.62 11.91 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 106.15 -2.78 . . . . 0.0 106.15 177.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.884 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -93.93 -61.08 2.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 122.339 1.066 . . . . 0.0 108.374 176.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 8.0 t -51.01 -34.32 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.483 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.651 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.9 tt0 -90.8 -18.76 24.36 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.893 -1.129 . . . . 0.0 108.661 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 45' ' ' SER . 9.6 tt0 -90.59 -84.79 0.23 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.447 -0.783 . . . . 0.0 109.461 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.567 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 1.3 m -39.5 -35.89 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 0.0 109.672 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.526 ' N ' ' O ' ' A' ' 6' ' ' LEU . 4.0 t -74.63 -54.54 7.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.041 -1.037 . . . . 0.0 110.383 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.651 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 15.2 m-70 -79.15 -43.02 24.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.994 . . . . 0.0 109.528 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.6 t -108.35 -126.46 0.26 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.903 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -158.44 165.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.79 -1.194 . . . . 0.0 109.231 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.567 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -155.46 177.71 11.05 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.536 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 51' ' ' GLN . 5.2 m -130.95 155.98 45.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 109.51 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -38.77 -39.06 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.458 -0.776 . . . . 0.0 110.454 -179.391 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.617 ' CE1' ' HG2' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -53.31 -40.54 64.87 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.617 ' HG2' ' CE1' ' A' ' 50' ' ' TYR . 2.8 mt-30 -72.9 -56.47 5.14 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.466 HD22 ' CB ' ' A' ' 14' ' ' ALA . 1.2 mp -54.44 -20.29 7.28 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 50' ' ' TYR . 20.2 tt0 -69.1 -18.76 64.02 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.571 ' OD1' ' CD1' ' A' ' 55' ' ' TYR . 14.6 p30 -89.02 -26.0 21.68 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.937 0.875 . . . . 0.0 108.888 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.727 ' CE2' HG23 ' A' ' 38' ' ' ILE . 15.4 m-85 -80.26 -0.65 37.36 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.0 OUTLIER -92.48 175.82 6.69 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.539 -0.726 . . . . 0.0 109.16 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.6 m-20 . . . . . 0 C--N 1.298 -1.667 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.942 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.839 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.216 -0.706 0 CA-C-O 122.346 1.07 . . . . 0.0 110.455 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.839 ' N ' HG13 ' A' ' 2' ' ' VAL . 9.7 m120 -71.1 102.1 2.4 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.775 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.604 ' O ' HG23 ' A' ' 46' ' ' ILE . 2.8 tt0 -140.0 158.63 43.75 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.674 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 1.003 ' NE2' HD11 ' A' ' 46' ' ' ILE . 22.6 m-70 -81.53 97.72 7.95 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -82.92 -170.18 2.88 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.025 -1.047 . . . . 0.0 109.589 -179.104 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.575 ' O ' ' C ' ' A' ' 8' ' ' GLY . 5.5 t 173.31 142.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.623 ' HA2' ' OH ' ' A' ' 26' ' ' TYR . . . -14.12 -57.85 0.01 OUTLIER Glycine 0 N--CA 1.5 2.948 0 N-CA-C 111.957 -0.457 . . . . 0.0 111.957 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 7' ' ' CYS . 8.0 m -56.63 -69.91 0.14 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.007 -1.29 . . . . 0.0 109.675 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.604 ' CB ' ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.4 -17.83 64.88 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.704 -1.248 . . . . 0.0 108.041 179.447 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.689 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -60.67 -51.85 67.62 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.239 -0.913 . . . . 0.0 108.679 178.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.63 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -64.14 -26.08 39.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.493 -1.283 . . . . 0.0 108.226 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 1.1 tt0 -72.01 -60.39 2.26 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.72 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -52.57 -46.43 66.85 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.779 ' HA ' HG23 ' A' ' 18' ' ' VAL . 3.3 mt -64.39 -44.41 91.41 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.63 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 14.0 t80 -56.44 -21.1 23.17 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.22 -65.91 0.97 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.862 0.839 . . . . 0.0 109.292 179.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.779 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -47.25 -30.47 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -88.08 -73.84 0.47 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 65.22 2.31 9.04 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 11.7 tt0 164.41 -23.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.87 -1.37 . . . . 0.0 109.717 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.488 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 4.6 mtt-85 -60.95 -12.21 10.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.842 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 74.98 83.08 0.41 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.598 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -81.77 -167.86 1.68 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.024 -1.28 . . . . 0.0 109.894 -179.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.598 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -162.47 -171.01 2.61 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.412 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.623 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 1.8 t80 . . . . . 0 C--N 1.294 -1.84 0 C-N-CA 118.501 -1.28 . . . . 0.0 109.168 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.569 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.212 -0.889 0 CA-C-O 120.234 0.064 . . . . 0.0 110.961 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.505 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.59 -40.5 11.61 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 106.152 -2.779 . . . . 0.0 106.152 177.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.752 HG23 ' CE2' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -93.34 -57.4 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-O 122.402 1.096 . . . . 0.0 108.674 177.045 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 8.9 t -59.15 -28.53 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.93 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.65 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.3 mt-10 -90.96 -32.03 16.12 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 120.919 -1.113 . . . . 0.0 108.609 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 45' ' ' SER . 40.8 tt0 -78.5 -75.82 0.22 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 121.641 0.734 . . . . 0.0 109.196 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 1.7 m -41.25 -44.73 2.73 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 121.533 -0.73 . . . . 0.0 109.996 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -75.18 -45.59 39.61 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.318 -0.864 . . . . 0.0 110.726 -178.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.65 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 7.5 m-70 -90.11 -60.56 1.9 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.7 -1.25 . . . . 0.0 109.422 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 41' ' ' GLN . 7.9 t -88.15 -127.73 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 108.779 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 1.003 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -153.67 160.13 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.784 -1.198 . . . . 0.0 108.975 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.459 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 1.8 m -133.29 -166.09 1.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.689 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.619 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 5.7 m -146.47 144.04 29.38 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.693 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -39.29 -39.12 0.6 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.749 0.785 . . . . 0.0 110.191 -179.431 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.619 ' CE2' ' HB2' ' A' ' 48' ' ' SER . 1.1 p90 -61.8 -38.1 86.84 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.611 ' HG3' ' CZ ' ' A' ' 50' ' ' TYR . 63.6 mt-30 -67.82 -48.26 66.74 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.444 ' HA ' ' CD2' ' A' ' 55' ' ' TYR . 1.1 mp -67.48 -24.46 65.6 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.454 ' OE1' HG12 ' A' ' 18' ' ' VAL . 6.4 tp10 -57.67 -29.17 64.42 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -90.64 -10.6 42.66 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.574 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.752 ' CE2' HG23 ' A' ' 38' ' ' ILE . 12.0 m-85 -90.01 7.74 36.04 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -91.98 -161.32 0.81 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.631 -0.668 . . . . 0.0 109.502 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 7.3 p-10 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.005 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.657 ' O ' HG13 ' A' ' 2' ' ' VAL . 12.9 t80 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.503 0.668 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 1' ' ' PHE . 6.4 m -160.81 -167.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.496 ' C ' HG21 ' A' ' 46' ' ' ILE . 10.7 m-20 -63.23 93.62 0.07 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.407 -0.808 . . . . 0.0 109.178 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.644 ' NE2' ' CE2' ' A' ' 1' ' ' PHE . 1.4 pt20 -130.13 175.12 9.16 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.179 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.933 ' NE2' HD11 ' A' ' 46' ' ' ILE . 34.9 m-70 -92.94 108.57 20.11 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.851 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -111.75 126.47 55.09 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.091 -1.006 . . . . 0.0 111.022 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.522 ' O ' ' C ' ' A' ' 8' ' ' GLY . 72.8 m -108.49 168.47 9.3 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.28 -45.65 0.1 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 12' ' ' VAL . 12.8 m -60.63 -69.8 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -1.189 . . . . 0.0 109.977 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.554 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -66.42 -13.9 61.4 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 120.825 -1.172 . . . . 0.0 108.203 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.072 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -67.27 -49.64 63.54 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.614 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -64.75 -28.97 46.05 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.422 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.496 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.428 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 5.1 mt-10 -69.4 -59.82 2.74 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.851 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -52.82 -48.68 66.79 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.751 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.3 mt -63.13 -40.96 99.09 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.614 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.3 t80 -61.73 -21.42 64.49 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -86.18 -61.59 1.71 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.23 1.014 . . . . 0.0 108.47 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.751 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -54.46 -33.6 26.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.088 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -86.3 -65.05 1.05 Allowed 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.365 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.44 -72.12 0.23 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -130.32 -1.34 4.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -1.189 . . . . 0.0 109.808 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -72.8 -12.03 60.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.122 -0.986 . . . . 0.0 109.441 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 75.95 97.58 0.14 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.529 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -94.17 -176.82 4.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -1.163 . . . . 0.0 109.247 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.566 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 16.8 p90 -162.6 172.85 14.75 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.63 ' CE2' ' NE ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -112.14 122.4 47.64 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.224 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.914 HG23 ' CB ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -77.77 165.84 23.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.186 -0.946 . . . . 0.0 110.779 -178.062 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.551 ' O ' ' CG ' ' A' ' 34' ' ' PRO . 4.7 m-20 34.94 62.68 2.14 Favored Pre-proline 0 N--CA 1.493 1.686 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.117 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 37.1 Cg_endo -80.43 72.48 6.5 Favored 'Trans proline' 0 C--N 1.3 -1.983 0 C-N-CA 122.471 2.114 . . . . 0.0 110.209 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.1 p -146.1 -77.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.676 -1.265 . . . . 0.0 111.001 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.443 ' O ' ' HD3' ' A' ' 34' ' ' PRO . . . -84.3 179.5 51.72 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 120.329 -0.939 . . . . 0.0 110.784 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' C ' ' HD3' ' A' ' 34' ' ' PRO . . . -73.04 142.45 31.8 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.641 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 42.14 51.48 5.19 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.641 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 36.7 Cg_endo -76.62 -39.4 0.73 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.215 1.944 . . . . 0.0 108.657 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.914 ' CB ' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -97.61 34.02 1.93 Allowed 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 177.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.633 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -42.26 -21.85 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.343 -178.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.93 -44.51 13.56 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 106.286 -2.726 . . . . 0.0 106.286 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.072 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -93.52 -60.11 2.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 122.487 1.137 . . . . 0.0 108.399 177.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.641 HG21 ' HE ' ' A' ' 35' ' ' ARG . 23.6 t -51.05 -35.06 14.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.738 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.676 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 42.6 mt-10 -92.02 -20.45 21.32 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.83 -1.169 . . . . 0.0 109.593 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.557 ' O ' ' N ' ' A' ' 45' ' ' SER . 5.1 tp60 -86.21 -87.18 0.14 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.406 -0.809 . . . . 0.0 109.86 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.559 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 22.7 m -39.34 -41.09 0.87 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.618 -0.676 . . . . 0.0 109.694 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 6' ' ' LEU . 9.8 t -68.95 -53.46 20.68 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.911 -1.118 . . . . 0.0 110.948 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.676 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 13.8 m-70 -85.18 -47.53 10.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.032 -1.043 . . . . 0.0 110.015 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 41' ' ' GLN . 29.0 t -100.78 -124.82 0.17 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 108.916 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.933 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -157.93 163.05 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.754 -1.217 . . . . 0.0 109.135 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.524 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -158.76 168.97 25.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.459 -0.775 . . . . 0.0 109.571 179.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.566 ' HG ' ' HD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -119.18 163.59 16.85 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.114 0.959 . . . . 0.0 109.527 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.617 ' HB3' HG13 ' A' ' 18' ' ' VAL . 25.1 mt -42.53 -33.71 0.73 Allowed 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 121.497 0.665 . . . . 0.0 109.637 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.616 ' CE1' ' HG2' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -56.99 -37.26 71.41 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.616 ' HG2' ' CE1' ' A' ' 50' ' ' TYR . 2.0 mm-40 -69.62 -59.78 2.74 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.473 ' HB3' ' HG ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -62.02 -16.86 54.78 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.6 tm-20 -68.05 -24.2 65.05 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -91.05 -24.87 19.91 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.752 0.787 . . . . 0.0 108.911 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.641 ' CD2' HG12 ' A' ' 38' ' ' ILE . 17.0 m-85 -81.06 4.18 20.66 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.566 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -83.07 -164.66 0.91 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.395 -0.816 . . . . 0.0 109.63 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 4.1 p-10 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.793 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.587 ' CD2' ' O ' ' A' ' 2' ' ' VAL . 15.8 p90 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.587 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 4.6 m -137.71 -165.3 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.928 -1.108 . . . . 0.0 110.005 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.452 ' HA ' ' CG2' ' A' ' 46' ' ' ILE . 28.3 m120 -41.71 99.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.995 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.651 ' H ' HG23 ' A' ' 46' ' ' ILE . 4.2 tt0 -148.7 166.46 28.31 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.408 -0.808 . . . . 0.0 109.66 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 1.025 ' NE2' HD11 ' A' ' 46' ' ' ILE . 24.1 m-70 -91.79 113.86 26.24 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.885 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.2 tp -120.58 129.12 53.63 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.422 -0.799 . . . . 0.0 110.691 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.527 ' O ' ' C ' ' A' ' 8' ' ' GLY . 89.8 m -113.18 170.76 7.99 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.94 -1.1 . . . . 0.0 108.404 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.527 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.25 -45.87 0.1 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.448 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 15.7 m -63.05 -67.76 0.4 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.19 . . . . 0.0 110.216 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 2.2 m-20 -67.57 -11.59 58.43 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.75 -1.219 . . . . 0.0 108.531 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.914 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.76 -49.7 50.44 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.617 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -63.92 -30.95 51.34 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.553 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.448 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 7.8 tt0 -69.9 -55.25 10.21 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.885 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -55.64 -49.75 72.02 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.77 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.4 mt -62.63 -41.61 99.12 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.617 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 7.4 t80 -59.39 -20.23 53.21 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -90.14 -65.38 1.02 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.094 0.949 . . . . 0.0 108.881 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.77 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -48.42 -28.69 2.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.42 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.48 -70.12 0.68 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.515 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.86 -62.83 0.49 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 19' ' ' CYS . 7.9 mp0 -134.4 -2.24 2.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -1.201 . . . . 0.0 110.364 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.485 ' HD3' ' O ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -74.42 -8.96 58.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.985 -1.072 . . . . 0.0 109.606 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.42 86.55 0.11 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.574 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -83.43 179.63 7.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -1.181 . . . . 0.0 109.407 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.574 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 29.4 p90 -163.3 166.57 22.92 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.156 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.423 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.1 OUTLIER -109.01 123.09 48.58 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.596 HG23 ' HB2' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -78.86 156.64 28.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.858 -1.151 . . . . 0.0 111.201 -178.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 34' ' ' PRO . 8.1 t70 28.54 67.5 0.62 Allowed Pre-proline 0 N--CA 1.496 1.832 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.861 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 36.9 Cg_endo -79.57 63.14 8.69 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.747 2.298 . . . . 0.0 110.379 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.8 p -133.66 -79.12 0.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.822 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.14 164.98 39.56 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.25 135.24 25.55 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.524 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 48.52 57.5 8.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.53 ' CB ' ' O ' ' A' ' 28' ' ' ASP . 31.9 Cg_endo -71.93 -28.88 15.85 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.502 2.135 . . . . 0.0 109.548 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.596 ' HB2' HG23 ' A' ' 27' ' ' THR . 1.5 tpm_? -119.07 45.09 2.17 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.599 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -41.53 -22.83 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.877 -178.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.2 -41.96 8.51 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 106.147 -2.781 . . . . 0.0 106.147 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.914 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -94.12 -61.18 2.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 122.544 1.164 . . . . 0.0 108.668 176.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.581 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 37.9 t -54.79 -30.97 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.321 -177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.655 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.7 tt0 -92.73 -23.96 18.75 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 120.809 -1.182 . . . . 0.0 109.549 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 45' ' ' SER . 5.6 tt0 -82.81 -90.34 0.08 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.072 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.569 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.24 -37.09 0.88 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 109.997 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 15.3 t -68.95 -52.94 23.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.538 -1.351 . . . . 0.0 110.664 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.655 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 8.1 m-70 -91.25 -55.48 3.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.925 -1.11 . . . . 0.0 108.471 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.625 ' C ' HD12 ' A' ' 46' ' ' ILE . 64.2 m -85.47 -131.46 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 1.025 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -151.97 152.78 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.674 -1.266 . . . . 0.0 109.114 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.656 ' SG ' HD11 ' A' ' 52' ' ' LEU . 8.3 p -149.63 172.86 14.37 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 1' ' ' PHE . 67.4 m -136.73 169.46 17.69 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.999 -1.063 . . . . 0.0 110.272 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.702 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -41.93 -34.52 0.69 Allowed 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.795 1.283 . . . . 0.0 108.492 178.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -53.21 -52.72 58.0 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.072 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 48' ' ' SER . 2.1 mt-30 -74.11 -45.55 48.36 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.292 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.656 HD11 ' SG ' ' A' ' 47' ' ' CYS . 1.1 mp -65.83 -14.39 61.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.414 -0.804 . . . . 0.0 109.032 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.5 tt0 -70.06 -28.09 65.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.156 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -90.39 -8.32 50.93 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.528 -0.732 . . . . 0.0 109.55 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.742 ' CE2' HG23 ' A' ' 38' ' ' ILE . 12.1 m-85 -90.33 2.05 55.92 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.49 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.3 m -78.64 -166.05 0.81 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.51 -0.744 . . . . 0.0 110.092 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.6 t-20 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.895 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.592 ' CB ' HD13 ' A' ' 49' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 1' ' ' PHE . 10.5 m -157.58 -167.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.754 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.549 ' CA ' HG21 ' A' ' 46' ' ' ILE . 2.0 m-80 -73.06 98.88 2.63 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.539 -0.725 . . . . 0.0 109.911 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.479 ' O ' HG23 ' A' ' 46' ' ' ILE . 3.2 pm0 -132.44 170.05 15.68 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.773 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.973 ' NE2' HD11 ' A' ' 46' ' ' ILE . 27.9 m-70 -93.35 113.65 25.88 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.941 HD21 ' HB2' ' A' ' 14' ' ' ALA . 0.9 OUTLIER -114.14 144.43 43.17 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.426 -0.796 . . . . 0.0 109.899 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.578 ' O ' ' N ' ' A' ' 9' ' ' SER . 2.4 t -144.07 112.66 6.55 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.187 -0.946 . . . . 0.0 109.63 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.532 ' N ' ' HB2' ' A' ' 11' ' ' LEU . . . 40.94 -90.36 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 7' ' ' CYS . 7.5 m -37.28 -67.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.578 -0.954 . . . . 0.0 110.549 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.593 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 81.5 m-20 -68.0 -19.14 64.9 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.647 -1.283 . . . . 0.0 108.441 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.84 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -65.33 -48.5 72.8 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.409 -0.807 . . . . 0.0 109.024 178.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.62 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.6 m -67.62 -26.23 34.89 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.489 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.671 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.475 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 5.4 tt0 -71.87 -57.97 3.86 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.941 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -52.69 -49.08 66.01 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.773 ' HA ' HG23 ' A' ' 18' ' ' VAL . 3.5 mt -64.32 -41.64 96.71 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.62 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 8.2 t80 -59.76 -24.26 63.91 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -84.17 -63.52 1.33 Allowed 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 122.104 0.954 . . . . 0.0 108.899 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -53.09 -28.88 14.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.914 -179.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.37 -70.58 0.65 Allowed 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.484 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.72 -64.02 0.18 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -131.63 -0.65 3.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.172 -1.193 . . . . 0.0 109.884 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 2.2 mtt85 -77.8 -9.53 59.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.143 -0.973 . . . . 0.0 109.914 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.9 92.4 0.05 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.537 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -87.0 -176.68 5.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.338 -1.095 . . . . 0.0 110.173 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CD1' ' C ' ' A' ' 25' ' ' PHE . 13.3 p90 -162.36 173.63 13.88 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.748 0.785 . . . . 0.0 109.415 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.661 ' CZ ' ' CD ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -112.36 123.32 50.02 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.479 ' O ' ' C ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -78.1 166.16 23.13 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.956 -1.09 . . . . 0.0 110.64 -178.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 3.5 m-20 35.01 64.23 1.9 Allowed Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.485 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 36.0 Cg_endo -77.66 77.12 3.99 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.853 2.368 . . . . 0.0 110.735 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.61 -79.42 0.61 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.081 -1.012 . . . . 0.0 109.34 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.16 152.67 12.39 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.24 78.88 0.15 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.89 75.27 0.28 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 28' ' ' ASP . 31.7 Cg_endo -72.23 -29.42 14.27 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.347 2.031 . . . . 0.0 109.441 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.737 ' NE ' HD13 ' A' ' 38' ' ' ILE . 7.9 ptm180 -121.56 30.31 6.79 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.532 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -39.25 -24.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.793 -0.567 . . . . 0.0 111.931 -178.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -53.76 -42.42 68.33 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 105.252 -3.139 . . . . 0.0 105.252 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.84 ' CG2' HD21 ' A' ' 11' ' ' LEU . 1.2 mp -93.68 -50.43 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 121.838 0.828 . . . . 0.0 108.928 177.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.676 HG23 ' CG ' ' A' ' 35' ' ' ARG . 9.0 t -61.06 -29.66 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.813 -0.554 . . . . 0.0 110.21 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.641 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.2 tt0 -91.28 -12.62 34.59 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -90.75 -95.59 0.12 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.763 -0.585 . . . . 0.0 109.881 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -39.95 -28.27 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.37 -0.831 . . . . 0.0 110.002 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.557 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 18.7 t -73.76 -58.05 3.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.751 -1.218 . . . . 0.0 109.409 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.641 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 16.8 m-70 -80.28 -45.49 17.8 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.341 -0.849 . . . . 0.0 109.118 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.645 ' C ' HD12 ' A' ' 46' ' ' ILE . 14.9 t -106.42 -126.69 0.25 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.973 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.7 mp -150.25 165.87 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.742 -1.224 . . . . 0.0 109.561 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.564 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 20.2 p -154.13 178.04 10.42 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.55 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -139.63 163.7 31.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.719 -1.238 . . . . 0.0 110.888 -178.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.793 ' O ' HG11 ' A' ' 18' ' ' VAL . 1.8 mp -39.2 -39.94 0.67 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.902 0.858 . . . . 0.0 109.978 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 2.3 p90 -63.36 -41.73 98.86 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.585 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 7.1 tp60 -66.18 -44.18 84.71 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.594 ' CB ' HG21 ' A' ' 18' ' ' VAL . 1.4 mp -75.75 -23.45 55.99 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.7 tt0 -60.86 -30.0 69.87 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -90.12 -8.92 50.14 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.827 ' CE2' HG23 ' A' ' 38' ' ' ILE . 13.8 m-30 -90.03 -0.45 57.59 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.54 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -90.55 -164.98 1.25 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.645 -0.659 . . . . 0.0 110.536 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.9 t-20 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.909 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.873 ' HD2' HG22 ' A' ' 2' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.873 HG22 ' HD2' ' A' ' 1' ' ' PHE . 17.0 m -146.85 -168.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.424 -0.798 . . . . 0.0 108.925 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 3' ' ' ASN . 4.3 p-10 -89.17 95.41 10.29 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.412 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.541 ' N ' HG23 ' A' ' 46' ' ' ILE . 3.9 pm0 -135.51 174.22 10.86 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 118.254 -1.378 . . . . 0.0 109.933 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.979 ' NE2' HD11 ' A' ' 46' ' ' ILE . 30.1 m-70 -90.8 106.77 18.74 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.949 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -110.9 127.81 55.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.114 -0.991 . . . . 0.0 110.782 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 11' ' ' LEU . 61.1 m -111.94 169.05 9.11 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.42 -44.79 0.09 OUTLIER Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 7' ' ' CYS . 58.7 m -61.59 -69.44 0.24 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.133 -1.216 . . . . 0.0 110.078 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.541 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 31.6 m-20 -67.06 -12.52 60.16 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.906 -1.121 . . . . 0.0 108.205 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.045 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -68.21 -50.37 54.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -65.04 -31.65 54.84 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.527 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.275 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.71 -58.35 4.8 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.949 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -53.94 -51.94 62.19 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.799 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.2 mt -59.18 -44.56 92.17 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.606 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 14.5 t80 -56.07 -21.71 23.54 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.58 -67.22 0.86 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.94 0.876 . . . . 0.0 109.427 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.059 HG13 ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -46.08 -29.41 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 121.613 0.72 . . . . 0.0 109.171 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -87.74 -72.89 0.5 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.846 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 69.16 -1.11 12.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER 159.45 -19.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.053 -1.263 . . . . 0.0 110.101 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -54.87 -18.33 4.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.097 -1.002 . . . . 0.0 109.37 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.64 68.5 1.27 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.939 -1.665 . . . . 0.0 108.939 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.499 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -72.06 178.74 3.62 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.338 -1.095 . . . . 0.0 109.836 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 10.4 p90 -162.77 -175.45 4.43 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.817 0.818 . . . . 0.0 109.359 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.62 ' CD2' ' CZ ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -131.87 109.53 10.16 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.56 ' CG2' ' HG2' ' A' ' 35' ' ' ARG . 11.0 t -77.9 -171.32 2.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.688 -1.258 . . . . 0.0 110.68 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 34' ' ' PRO . 2.7 m-20 38.93 69.08 1.7 Allowed Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.36 72.49 5.44 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.301 2.001 . . . . 0.0 110.627 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 p -134.66 -78.72 0.45 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.452 -0.78 . . . . 0.0 109.432 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.0 175.98 23.43 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.2 59.85 7.44 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.524 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 52.52 57.66 13.23 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.552 ' HG2' ' CZ ' ' A' ' 35' ' ' ARG . 31.3 Cg_endo -72.2 -49.72 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.476 2.117 . . . . 0.0 109.753 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.69 ' HB3' HD12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -94.81 28.12 2.83 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.599 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -39.59 -24.71 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.766 -0.584 . . . . 0.0 111.782 -178.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.486 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.84 -44.08 17.41 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 106.173 -2.771 . . . . 0.0 106.173 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.045 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.81 -57.67 4.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.447 1.117 . . . . 0.0 108.7 177.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 53.7 t -56.24 -32.09 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.075 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.66 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 4.3 tt0 -91.87 -17.96 24.49 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 120.849 -1.157 . . . . 0.0 109.156 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 45' ' ' SER . 7.4 tt0 -89.97 -85.98 0.2 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.623 -0.673 . . . . 0.0 109.377 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.585 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 22.4 m -39.75 -39.01 0.71 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.845 . . . . 0.0 109.677 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 39' ' ' VAL . 6.3 t -71.0 -53.86 13.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 110.587 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.66 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 15.7 m-70 -82.58 -51.84 7.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.127 -0.983 . . . . 0.0 109.68 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' GLN . 18.4 t -97.7 -123.84 0.14 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 108.747 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.979 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -159.9 162.5 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.797 -1.19 . . . . 0.0 108.839 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.536 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -157.63 174.73 14.91 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.283 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.633 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 5.1 m -126.93 159.65 33.38 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.192 -0.942 . . . . 0.0 110.328 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.059 ' HG ' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -38.79 -37.59 0.35 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.573 0.701 . . . . 0.0 111.033 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.633 ' CD2' ' HB2' ' A' ' 48' ' ' SER . 3.4 p90 -54.53 -42.95 71.47 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.625 0.726 . . . . 0.0 109.813 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.625 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -75.01 -31.12 61.31 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.442 -0.786 . . . . 0.0 109.968 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.64 HD23 ' HG ' ' A' ' 15' ' ' LEU . 1.3 mp -79.29 -20.38 48.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.995 -1.066 . . . . 0.0 108.137 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -64.4 -23.31 67.24 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -90.44 -16.41 29.06 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.63 ' CD2' HG12 ' A' ' 38' ' ' ILE . 11.6 m-85 -86.53 1.77 50.38 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.573 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -90.81 -165.52 1.37 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.522 -0.736 . . . . 0.0 110.09 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' CYS . 3.5 t30 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.766 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.706 ' N ' HD21 ' A' ' 49' ' ' LEU . 18.2 p90 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.546 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 6.8 m -123.08 -165.65 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.014 -1.054 . . . . 0.0 110.201 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.505 ' HA ' ' CG2' ' A' ' 46' ' ' ILE . 2.2 m120 -41.56 96.83 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.437 -0.789 . . . . 0.0 110.075 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.577 ' HG2' ' N ' ' A' ' 5' ' ' HIS . 5.0 tt0 -140.36 164.92 28.82 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.499 -0.751 . . . . 0.0 109.592 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 1.064 ' NE2' HD11 ' A' ' 46' ' ' ILE . 23.1 m-70 -89.27 104.41 16.96 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.97 ' CD2' ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -113.18 125.49 54.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.0 -1.062 . . . . 0.0 111.236 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.558 ' O ' ' N ' ' A' ' 11' ' ' LEU . 64.5 m -106.55 168.12 9.38 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.555 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . . . -32.99 -42.1 0.14 Allowed Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 7' ' ' CYS . 4.0 m -61.5 -69.95 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -1.204 . . . . 0.0 109.593 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.549 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 6.5 m-20 -66.42 -13.45 60.74 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.879 -1.138 . . . . 0.0 107.939 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.843 HD21 ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -64.74 -52.2 58.31 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.035 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.621 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -64.6 -29.3 46.98 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.512 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.443 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 4.0 tt0 -71.85 -54.08 11.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.97 ' HB2' ' CD2' ' A' ' 6' ' ' LEU . . . -54.13 -51.79 63.12 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.797 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.3 mt -61.92 -44.64 96.36 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.621 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 8.1 t80 -56.63 -21.5 27.59 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -88.11 -67.02 0.86 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.797 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -46.92 -29.68 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.22 -71.19 0.63 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.494 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.95 -66.6 0.19 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 19' ' ' CYS . 1.7 tt0 -129.23 -0.51 5.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 109.809 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.78 -6.78 55.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.995 . . . . 0.0 109.717 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 57' ' ' ASN . . . 67.77 94.5 0.04 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.513 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -91.56 -177.88 4.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.254 -1.145 . . . . 0.0 109.905 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 11.6 p90 -162.37 -178.02 6.03 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.599 ' CE1' ' CZ ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -122.65 115.58 22.35 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.962 HG23 ' HG2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -78.11 167.53 21.28 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.246 -0.909 . . . . 0.0 110.327 -178.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.528 ' O ' ' CG ' ' A' ' 34' ' ' PRO . 14.4 m-20 35.0 63.67 2.01 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 35.1 Cg_endo -77.12 90.79 1.22 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.657 2.238 . . . . 0.0 110.583 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 34' ' ' PRO . 35.6 p -127.97 -78.92 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.151 -0.968 . . . . 0.0 109.459 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.0 176.47 45.77 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 46.93 -115.18 1.85 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.473 ' O ' ' HD2' ' A' ' 36' ' ' ARG . . . -132.83 89.34 0.26 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.547 ' HG2' ' CZ ' ' A' ' 35' ' ' ARG . 31.0 Cg_endo -73.05 -51.2 0.17 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.431 2.087 . . . . 0.0 108.91 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.962 ' HG2' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -99.26 33.39 2.44 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 177.146 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.562 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -46.21 -19.82 0.09 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.616 -177.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -50.35 -48.17 41.69 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.07 HG21 ' CE1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -93.43 -21.18 6.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.93 -0.747 . . . . 0.0 109.413 178.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.569 HG21 HH21 ' A' ' 35' ' ' ARG . 0.9 OUTLIER -86.56 -59.47 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 0.0 109.196 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.611 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 23.0 tt0 -62.39 -14.46 40.53 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.115 -0.991 . . . . 0.0 108.478 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -81.96 -77.75 0.21 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.308 -0.87 . . . . 0.0 108.872 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.543 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 23.6 m -42.75 -45.98 4.98 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' LEU . 11.5 t -64.54 -54.37 33.23 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.318 -0.864 . . . . 0.0 110.113 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.611 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 8.7 m-70 -86.99 -69.13 0.7 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.992 -1.067 . . . . 0.0 108.746 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.553 ' C ' HD12 ' A' ' 46' ' ' ILE . 6.7 t -75.15 -132.27 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 1.064 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.1 mp -155.3 159.68 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.805 -1.185 . . . . 0.0 109.121 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.559 ' CB ' ' NE2' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -150.45 177.6 9.84 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.744 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.469 ' OG ' ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -130.41 156.56 44.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 109.903 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.786 HD22 ' H ' ' A' ' 49' ' ' LEU . 1.8 mm? -39.91 -35.28 0.34 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.667 0.746 . . . . 0.0 110.258 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.602 ' CG ' ' N ' ' A' ' 51' ' ' GLN . 0.9 OUTLIER -52.3 -47.56 65.85 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.722 0.773 . . . . 0.0 109.178 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.609 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -75.01 -33.0 61.76 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.707 -179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.609 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 1.9 mp -78.05 -19.23 54.68 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.176 -0.953 . . . . 0.0 108.64 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 49' ' ' LEU . 19.3 tt0 -67.11 -20.43 65.78 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -90.62 -12.39 37.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.572 -0.705 . . . . 0.0 109.708 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 1.07 ' CE1' HG21 ' A' ' 38' ' ' ILE . 56.5 m-85 -90.37 4.76 49.95 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.107 -0.996 . . . . 0.0 109.084 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.57 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -81.65 -164.54 0.8 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.687 -0.633 . . . . 0.0 109.446 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 12.8 t30 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.139 -0.934 . . . . 0.0 109.575 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.65 ' CD2' ' NE2' ' A' ' 4' ' ' GLN . 22.2 p90 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.593 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 14.3 m -131.91 -165.59 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.866 -1.146 . . . . 0.0 110.583 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.468 ' CA ' HG21 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -53.04 88.94 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.016 -1.052 . . . . 0.0 110.092 -179.429 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.65 ' NE2' ' CD2' ' A' ' 1' ' ' PHE . 18.6 pt20 -135.76 177.6 7.7 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.366 -0.834 . . . . 0.0 109.275 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.925 ' NE2' HD11 ' A' ' 46' ' ' ILE . 30.5 m-70 -93.53 109.71 21.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.644 -0.66 . . . . 0.0 109.385 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.0 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -108.43 141.92 39.57 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.861 0.839 . . . . 0.0 110.301 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.556 ' O ' ' C ' ' A' ' 8' ' ' GLY . 60.7 m -128.93 167.82 16.87 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.579 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -25.91 -48.25 0.04 OUTLIER Glycine 0 N--CA 1.498 2.772 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 7' ' ' CYS . 24.0 m -63.17 -68.29 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -1.199 . . . . 0.0 110.227 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.547 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 16.5 m-20 -68.27 -10.24 53.27 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.792 -1.192 . . . . 0.0 108.727 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.087 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -72.81 -48.09 40.85 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.446 -0.901 . . . . 0.0 109.228 178.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.604 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -69.02 -32.05 52.83 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.428 0 C-N-CA 119.024 -1.071 . . . . 0.0 108.324 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -67.31 -57.74 6.1 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 1.0 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.3 -48.94 70.71 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.777 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.7 mt -64.4 -41.01 96.88 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.109 0.957 . . . . 0.0 108.592 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.604 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.2 t80 -57.61 -21.22 37.95 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.51 -64.92 1.07 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 122.072 0.939 . . . . 0.0 109.245 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.777 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.53 -28.32 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.412 0.625 . . . . 0.0 109.519 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -90.04 -71.41 0.62 Allowed 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.676 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.63 -59.03 0.19 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' CYS . 2.4 pm0 -129.43 -28.79 2.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.222 -1.163 . . . . 0.0 110.331 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.56 -20.69 2.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.355 -0.841 . . . . 0.0 109.645 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 72.9 94.34 0.09 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.613 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -83.45 -169.26 2.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.309 -1.112 . . . . 0.0 110.203 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.613 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 3.3 p90 -161.87 178.6 8.77 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.55 ' CD2' ' HB2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -130.96 114.4 15.18 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.469 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 2.4 t -78.7 -178.91 6.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.922 -1.111 . . . . 0.0 111.235 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' A' ' 34' ' ' PRO . 12.6 p-10 -176.48 94.99 0.25 Allowed Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.547 ' CD ' ' O ' ' A' ' 34' ' ' PRO . 37.1 Cg_endo -77.37 11.0 2.25 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.682 2.255 . . . . 0.0 111.553 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.727 HG22 ' N ' ' A' ' 31' ' ' GLY . 0.8 OUTLIER 179.03 -68.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.587 -1.321 . . . . 0.0 109.814 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.727 ' N ' HG22 ' A' ' 30' ' ' THR . . . 172.05 -90.32 0.09 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 31' ' ' GLY . . . -44.46 115.37 1.3 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.544 ' O ' ' CD ' ' A' ' 36' ' ' ARG . . . 60.48 72.45 0.62 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.547 ' O ' ' CD ' ' A' ' 29' ' ' PRO . 31.1 Cg_endo -72.9 -51.55 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.507 2.138 . . . . 0.0 109.171 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.832 ' CG ' HD13 ' A' ' 38' ' ' ILE . 10.1 ttt85 -95.05 28.55 2.74 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.544 ' CD ' ' O ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -55.08 -23.82 22.27 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.735 -0.603 . . . . 0.0 111.97 -177.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 41' ' ' GLN . . . -53.3 -43.12 64.66 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 105.377 -3.089 . . . . 0.0 105.377 177.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.087 ' CG2' HD21 ' A' ' 11' ' ' LEU . 2.4 mp -94.45 -48.0 13.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.883 0.849 . . . . 0.0 109.175 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 2.1 t -60.68 -33.07 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.508 0.67 . . . . 0.0 109.571 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.651 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.4 tt0 -90.34 -17.36 27.45 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.56 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -90.08 -88.27 0.17 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.579 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 1.2 m -39.03 -33.45 0.12 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.845 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 39' ' ' VAL . 3.3 t -77.78 -46.61 21.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.029 -1.044 . . . . 0.0 110.986 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.651 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 16.1 m-70 -91.15 -34.01 15.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.886 -1.133 . . . . 0.0 109.111 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 41' ' ' GLN . 58.7 m -114.75 -126.41 0.29 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.925 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -159.87 165.39 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.514 -1.366 . . . . 0.0 109.633 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.579 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -156.11 -160.5 1.01 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.101 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 1' ' ' PHE . 4.5 p -160.38 161.67 33.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.097 -1.002 . . . . 0.0 109.643 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.618 ' H ' HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -41.95 -35.88 0.97 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.898 1.332 . . . . 0.0 108.353 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 13.2 t80 -57.47 -53.1 61.97 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.38 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -73.41 -40.37 64.34 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.694 ' HA ' ' CD2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -68.76 -21.23 64.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.485 -0.76 . . . . 0.0 109.048 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 49' ' ' LEU . 2.1 tt0 -62.09 -25.26 67.61 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -90.59 -10.21 44.23 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.748 -0.595 . . . . 0.0 109.513 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.696 ' CD2' HG12 ' A' ' 38' ' ' ILE . 13.2 m-85 -84.32 -4.15 58.69 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 24' ' ' PHE . 1.2 m -90.79 -169.15 2.28 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.744 0.783 . . . . 0.0 111.12 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 55.5 t30 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.456 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 48' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.455 ' N ' ' CD1' ' A' ' 1' ' ' PHE . 12.8 m -149.45 -168.63 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.693 -1.254 . . . . 0.0 109.58 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.522 ' CA ' HG21 ' A' ' 46' ' ' ILE . 1.3 m-80 -77.66 87.54 3.94 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 108.936 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.622 ' HG3' HD13 ' A' ' 6' ' ' LEU . 5.9 pt20 -125.64 175.73 7.37 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.259 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.833 ' NE2' HD11 ' A' ' 46' ' ' ILE . 45.4 m-70 -92.1 112.01 23.79 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.816 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -112.92 129.11 56.59 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.332 -0.855 . . . . 0.0 111.319 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' O ' ' C ' ' A' ' 8' ' ' GLY . 91.4 m -111.15 170.52 8.06 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.522 ' HA2' ' OH ' ' A' ' 26' ' ' TYR . . . -29.93 -47.53 0.12 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.462 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 25.6 m -61.17 -68.11 0.34 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -1.189 . . . . 0.0 110.369 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.574 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 8.7 m-20 -67.46 -13.06 61.69 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.852 -1.155 . . . . 0.0 108.477 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.996 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -68.44 -49.18 61.77 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.195 -0.94 . . . . 0.0 108.551 177.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.614 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -64.48 -28.18 44.27 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.46 0 C-N-CA 119.114 -1.035 . . . . 0.0 108.509 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.4 OUTLIER -71.4 -56.55 5.75 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.816 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -55.41 -45.8 76.67 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.765 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.8 mt -66.31 -40.65 90.12 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.614 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 6.3 t80 -59.13 -20.12 50.85 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -89.95 -64.23 1.17 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 122.046 0.927 . . . . 0.0 108.791 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.765 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.75 -29.28 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.538 0.685 . . . . 0.0 109.294 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.92 -71.13 0.63 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.673 -179.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.6 -62.41 0.3 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 19' ' ' CYS . 25.6 mp0 -132.66 -10.96 3.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.132 -1.217 . . . . 0.0 110.663 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -67.96 -7.56 29.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.913 -1.117 . . . . 0.0 109.624 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.88 92.79 0.05 OUTLIER Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.626 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -86.36 -178.02 6.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.124 -1.221 . . . . 0.0 109.529 -179.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.626 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 16.6 p90 -162.19 168.38 22.54 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.615 ' CD1' ' HD2' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -109.18 125.87 52.66 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.889 HG23 ' HB3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -77.98 156.25 30.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.065 -1.022 . . . . 0.0 110.437 -178.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.546 ' CB ' ' HB2' ' A' ' 34' ' ' PRO . 26.7 m-20 31.61 67.17 0.92 Allowed Pre-proline 0 N--CA 1.496 1.826 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.265 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 36.3 Cg_endo -78.76 78.64 3.62 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.739 2.293 . . . . 0.0 110.745 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.65 -76.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.057 -1.027 . . . . 0.0 109.921 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.478 ' O ' ' HD3' ' A' ' 34' ' ' PRO . . . -58.9 174.95 2.99 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.468 ' C ' ' HD3' ' A' ' 34' ' ' PRO . . . -74.22 -37.72 48.02 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.551 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . -132.04 57.9 0.71 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 32.0 Cg_endo -73.49 -44.44 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.468 2.112 . . . . 0.0 109.412 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.889 ' HB3' HG23 ' A' ' 27' ' ' THR . 0.2 OUTLIER -98.22 31.52 2.74 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.605 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -40.17 -22.98 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.617 -178.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.15 -44.4 14.49 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 106.358 -2.697 . . . . 0.0 106.358 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.996 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.5 -60.36 2.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 122.554 1.169 . . . . 0.0 108.43 177.015 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.574 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 34.3 t -51.56 -33.26 14.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.72 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.676 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 3.6 tt0 -93.46 -14.87 26.19 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 120.896 -1.128 . . . . 0.0 109.412 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 45' ' ' SER . 35.4 tt0 -88.53 -96.88 0.09 Allowed 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.98 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.58 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -39.75 -34.52 0.26 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.862 . . . . 0.0 109.912 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.574 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 13.4 t -67.2 -54.82 17.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.371 -1.455 . . . . 0.0 110.087 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.676 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 14.8 m-70 -84.75 -40.66 17.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 109.691 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' GLN . 9.3 t -110.39 -128.26 0.28 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.847 . . . . 0.0 108.801 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.833 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.4 mp -147.64 162.51 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.727 -1.233 . . . . 0.0 108.984 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.494 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 18.8 p -154.97 160.26 40.97 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.922 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 1' ' ' PHE . 5.3 m -114.46 159.12 20.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.48 -0.762 . . . . 0.0 109.952 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -39.64 -36.76 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.61 -0.681 . . . . 0.0 110.357 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.623 ' CZ ' ' HG2' ' A' ' 51' ' ' GLN . 0.9 OUTLIER -53.0 -39.32 63.01 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 119.673 -0.811 . . . . 0.0 108.842 -179.091 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.623 ' HG2' ' CZ ' ' A' ' 50' ' ' TYR . 1.5 mm-40 -72.98 -54.48 8.5 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.492 ' HB2' HG21 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -64.21 -12.12 37.58 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 49' ' ' LEU . 12.1 tt0 -74.47 -28.0 60.83 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -90.92 -9.8 44.84 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.65 ' CD2' HG12 ' A' ' 38' ' ' ILE . 14.0 m-85 -89.76 1.6 55.9 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.473 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -90.51 -165.81 1.44 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.596 -0.69 . . . . 0.0 110.158 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 42.7 t-20 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.922 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.743 ' HE1' HD13 ' A' ' 52' ' ' LEU . 9.6 p90 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.721 0.772 . . . . 0.0 109.735 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.842 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER -104.34 -151.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 122.381 1.086 . . . . 0.0 110.309 -178.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.842 ' N ' HG13 ' A' ' 2' ' ' VAL . 10.2 m120 -74.28 92.16 2.23 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.13 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.615 ' NE2' ' CD2' ' A' ' 1' ' ' PHE . 18.1 pt20 -132.96 175.02 9.73 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.109 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.903 ' NE2' HD11 ' A' ' 46' ' ' ILE . 39.1 m-70 -94.57 113.51 25.34 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.857 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -117.98 136.09 53.74 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.149 -0.969 . . . . 0.0 110.177 -179.224 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 9' ' ' SER . 4.4 t -135.32 116.7 14.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.102 -0.999 . . . . 0.0 109.994 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.534 ' N ' ' HB2' ' A' ' 11' ' ' LEU . . . 39.19 -90.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.567 ' N ' ' O ' ' A' ' 7' ' ' CYS . 4.2 m -36.6 -68.47 0.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.639 -0.918 . . . . 0.0 110.518 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.597 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 52.4 m-20 -67.86 -20.12 65.1 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.719 -1.238 . . . . 0.0 108.561 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.984 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -64.74 -48.82 73.19 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.462 -0.895 . . . . 0.0 108.975 177.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.624 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -66.41 -27.93 41.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.658 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.462 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 27.4 tt0 -71.7 -53.46 13.44 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.857 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -57.94 -48.42 79.98 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.751 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.5 mt -63.66 -38.61 91.75 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.624 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 10.3 t80 -62.17 -20.24 63.93 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -87.82 -63.59 1.28 Allowed 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.912 HG13 HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -48.79 -32.29 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.31 -73.23 0.53 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.846 0.832 . . . . 0.0 109.144 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 41.43 25.69 0.18 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 1.3 mt-10 162.18 -32.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.262 -1.14 . . . . 0.0 110.06 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.48 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.8 mtp85 -71.41 -4.92 29.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.394 -0.816 . . . . 0.0 109.58 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 64.75 91.27 0.03 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.491 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -88.52 178.11 6.61 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.138 -1.213 . . . . 0.0 109.812 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.453 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 33.7 p90 -163.39 158.59 21.35 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.625 ' CD1' ' CD ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -90.86 114.37 26.79 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.511 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 7.3 t -78.23 -165.53 0.69 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.857 -1.152 . . . . 0.0 110.303 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HB2' ' HG3' ' A' ' 35' ' ' ARG . 64.3 m-20 35.45 66.09 1.71 Allowed Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 34.7 Cg_endo -76.43 72.78 5.37 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 122.42 2.08 . . . . 0.0 110.542 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 34' ' ' PRO . 7.8 p -135.77 -78.33 0.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 109.519 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 153.55 169.06 18.15 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 33' ' ' GLY . . . 65.69 69.72 1.28 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.548 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 42.4 59.35 3.11 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 33.2 Cg_endo -75.8 -45.93 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.341 2.027 . . . . 0.0 109.078 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.625 ' CD ' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -94.48 22.51 6.07 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.592 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -39.67 -25.59 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.777 -0.577 . . . . 0.0 111.358 -178.319 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -47.03 -42.62 16.24 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.984 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -94.67 -60.82 2.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 122.629 1.204 . . . . 0.0 108.26 176.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.595 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 49.6 t -53.43 -30.75 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.112 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.644 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.8 tt0 -94.4 -16.54 23.35 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 120.795 -1.19 . . . . 0.0 109.318 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 45' ' ' SER . 2.7 tp60 -90.15 -92.64 0.13 Allowed 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.179 -178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -42.28 -32.62 0.52 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.83 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.595 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 25.3 t -68.72 -56.9 6.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.64 -1.288 . . . . 0.0 109.853 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.644 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 17.1 m-70 -83.29 -48.02 10.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.391 -0.818 . . . . 0.0 109.77 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.598 ' C ' HD12 ' A' ' 46' ' ' ILE . 19.5 t -106.38 -118.94 0.24 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.391 -0.818 . . . . 0.0 109.017 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.903 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.7 mp -151.09 165.53 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.74 -1.225 . . . . 0.0 109.013 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.885 ' SG ' HD11 ' A' ' 52' ' ' LEU . 24.2 p -146.82 -166.7 2.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.446 -0.784 . . . . 0.0 109.015 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.627 ' O ' HD12 ' A' ' 52' ' ' LEU . 5.4 m -156.25 156.51 34.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.826 -1.171 . . . . 0.0 110.555 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.912 HD12 HG13 ' A' ' 18' ' ' VAL . 1.7 mm? -39.93 -37.03 0.52 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.509 0.671 . . . . 0.0 109.901 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.604 ' CD2' ' HB2' ' A' ' 48' ' ' SER . 0.7 OUTLIER -58.34 -46.5 86.12 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.597 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -72.6 -40.77 66.28 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.885 HD11 ' SG ' ' A' ' 47' ' ' CYS . 1.6 mp -76.4 -14.74 60.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.19 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.56 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.7 tt0 -74.33 -25.71 59.71 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -90.24 -11.21 41.58 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.668 ' CD2' HG12 ' A' ' 38' ' ' ILE . 12.7 m-85 -87.59 -2.55 58.69 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -91.43 -170.66 2.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.565 -0.71 . . . . 0.0 109.976 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 28.0 t-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.237 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.635 ' CE2' ' NE2' ' A' ' 4' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.83 -166.64 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.141 -0.975 . . . . 0.0 110.004 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.51 ' CA ' HG21 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -82.06 101.38 10.32 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.629 -0.669 . . . . 0.0 109.5 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.635 ' NE2' ' CE2' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -131.85 176.36 8.42 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.665 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.996 ' NE2' HD11 ' A' ' 46' ' ' ILE . 25.7 m-70 -93.85 108.32 20.11 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.975 ' CD2' ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -110.0 128.43 55.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.99 -1.068 . . . . 0.0 111.198 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.536 ' O ' ' N ' ' A' ' 11' ' ' LEU . 37.3 m -113.08 170.81 7.94 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -31.81 -44.51 0.15 Allowed Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.405 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 3.3 m -63.56 -67.45 0.43 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.922 -1.34 . . . . 0.0 110.028 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.563 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.12 -11.66 57.85 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.91 -1.118 . . . . 0.0 108.273 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.075 HD21 ' CD1' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -67.86 -50.68 55.11 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.611 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -64.71 -29.52 47.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.443 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.498 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -71.21 -57.72 4.22 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.162 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.975 ' HB2' ' CD2' ' A' ' 6' ' ' LEU . . . -50.48 -50.55 52.27 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.771 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.6 mt -63.42 -45.77 89.44 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.611 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 2.1 t80 -55.88 -21.92 22.74 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -86.98 -66.85 0.86 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.085 0.945 . . . . 0.0 108.848 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -48.38 -29.6 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-O 121.618 0.723 . . . . 0.0 109.118 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -89.7 -74.91 0.46 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.825 0.821 . . . . 0.0 108.851 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 67.11 -0.19 8.42 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.537 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 2.7 tt0 163.1 -22.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.035 -1.274 . . . . 0.0 109.783 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.04 -17.45 6.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.114 -0.991 . . . . 0.0 109.581 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.75 77.56 1.12 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.544 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -78.88 -172.26 2.96 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.255 -1.144 . . . . 0.0 109.621 -179.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.563 ' CE2' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -162.89 -164.4 0.98 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.751 178.108 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.574 ' CE2' ' HG2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -144.75 97.87 3.09 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.37 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' ASP . 9.7 t -78.48 -172.57 2.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.99 -1.069 . . . . 0.0 110.149 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.576 ' CB ' ' HA ' ' A' ' 34' ' ' PRO . 4.3 p-10 168.7 70.54 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.43 19.03 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.894 2.396 . . . . 0.0 111.37 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.2 p -134.03 -79.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.813 -1.179 . . . . 0.0 109.923 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 32' ' ' GLY . . . 168.46 177.52 39.55 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 31' ' ' GLY . . . 43.41 -122.83 3.98 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 36' ' ' ARG . . . -46.13 112.75 0.9 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.576 ' HA ' ' CB ' ' A' ' 28' ' ' ASP . 28.6 Cg_endo -67.39 -20.67 48.15 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.186 1.924 . . . . 0.0 110.247 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.519 ' HD2' ' HA ' ' A' ' 26' ' ' TYR . 14.3 mtp85 -148.19 28.87 0.9 Allowed 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.604 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -48.65 -20.1 0.42 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.518 -177.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -56.37 -51.94 53.0 Favored Glycine 0 C--N 1.295 -1.727 0 N-CA-C 105.794 -2.923 . . . . 0.0 105.794 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.075 ' CD1' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -93.72 -29.16 4.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 1.3 t -68.58 -55.69 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.611 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.5 tm-20 -61.24 -18.57 59.01 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -82.3 -82.4 0.14 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.552 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 29.0 m -39.87 -44.11 1.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.534 -0.728 . . . . 0.0 109.114 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.51 ' N ' ' O ' ' A' ' 6' ' ' LEU . 6.0 t -67.33 -52.99 33.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 110.659 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.611 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 12.6 m-70 -84.22 -57.82 3.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.063 . . . . 0.0 109.281 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 41' ' ' GLN . 14.0 t -88.23 -126.58 0.05 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.996 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -159.49 164.87 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.567 -1.333 . . . . 0.0 109.295 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.557 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -153.31 -168.14 2.92 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.39 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.54 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.9 OUTLIER -150.44 160.45 43.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.955 . . . . 0.0 110.438 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.608 ' HG ' HG13 ' A' ' 18' ' ' VAL . 2.4 mp -42.71 -35.47 1.15 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.62 1.2 . . . . 0.0 109.061 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -54.01 -55.66 25.16 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.878 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -75.56 -37.34 60.02 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.014 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 48' ' ' SER . 0.5 OUTLIER -67.68 -19.62 65.2 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.044 179.339 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 49' ' ' LEU . 4.4 tt0 -65.6 -18.96 65.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.3 -0.875 . . . . 0.0 109.101 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -90.59 -11.39 40.14 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.394 -0.816 . . . . 0.0 109.985 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.649 ' CZ ' ' CG2' ' A' ' 38' ' ' ILE . 18.1 m-85 -90.58 6.46 43.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.995 -1.065 . . . . 0.0 109.061 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.458 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.1 m -91.91 -166.93 1.66 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.533 -0.729 . . . . 0.0 109.39 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.563 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 5.7 p-10 . . . . . 0 C--N 1.304 -1.398 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.111 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.644 ' CD2' ' NE2' ' A' ' 4' ' ' GLN . 12.2 p90 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.587 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 8.6 m -129.96 -166.73 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.083 -1.01 . . . . 0.0 109.99 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.556 ' CA ' HG21 ' A' ' 46' ' ' ILE . 1.2 m-80 -60.22 91.4 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 109.482 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.644 ' NE2' ' CD2' ' A' ' 1' ' ' PHE . 21.1 pt20 -132.16 175.43 9.25 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.119 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 1.01 ' NE2' HD11 ' A' ' 46' ' ' ILE . 27.2 m-70 -94.68 111.64 23.4 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.801 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -119.13 129.81 55.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.45 -0.781 . . . . 0.0 111.151 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.522 ' O ' ' C ' ' A' ' 8' ' ' GLY . 72.5 m -113.08 170.08 8.47 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -30.17 -44.93 0.08 OUTLIER Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.506 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.5 m -62.9 -68.39 0.34 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -1.159 . . . . 0.0 110.113 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.556 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.56 -11.09 57.24 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.863 -1.148 . . . . 0.0 108.412 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.923 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -70.36 -49.14 52.34 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.067 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.616 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 3.1 m -64.42 -31.26 52.79 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.492 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.671 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.425 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -68.61 -56.75 7.21 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.587 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.801 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.36 -50.91 66.38 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.785 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.4 mt -62.03 -41.0 97.64 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.616 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 17.9 t80 -58.78 -20.32 48.68 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -90.41 -66.94 0.88 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.898 0.856 . . . . 0.0 109.013 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.957 HG13 ' HG ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -46.21 -30.92 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.583 0.706 . . . . 0.0 109.162 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.05 -67.6 0.83 Allowed 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.799 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.06 -66.36 0.49 Allowed Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 19' ' ' CYS . 14.8 mt-10 -136.28 -1.71 2.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -1.086 . . . . 0.0 110.009 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 3.0 mtm180 -66.89 -14.4 62.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.077 -1.015 . . . . 0.0 109.767 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.49 79.51 0.93 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.544 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -81.24 -177.32 6.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.362 -1.081 . . . . 0.0 109.406 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.544 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 8.4 p90 -161.52 -172.53 3.39 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.756 0.789 . . . . 0.0 109.449 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.452 ' OH ' ' CG2' ' A' ' 39' ' ' VAL . 0.6 OUTLIER -145.43 97.63 3.02 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.665 HG23 ' NE ' ' A' ' 35' ' ' ARG . 6.5 t -78.43 -176.03 4.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.927 -1.108 . . . . 0.0 110.264 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.558 ' CA ' ' HB2' ' A' ' 34' ' ' PRO . 4.2 p-10 173.5 108.28 0.06 OUTLIER Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' NH2' ' A' ' 35' ' ' ARG . 36.1 Cg_endo -74.19 6.65 2.92 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.3 2.0 . . . . 0.0 111.643 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.756 HG22 ' N ' ' A' ' 31' ' ' GLY . 0.8 OUTLIER -176.14 -69.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.619 -1.301 . . . . 0.0 110.148 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.756 ' N ' HG22 ' A' ' 30' ' ' THR . . . 153.7 179.12 28.85 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 50.55 87.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.611 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 51.02 54.31 23.37 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.063 -2.015 . . . . 0.0 108.063 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.611 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 33.3 Cg_endo -72.38 -47.42 0.4 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.561 2.174 . . . . 0.0 109.789 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.665 ' NE ' HG23 ' A' ' 27' ' ' THR . 7.3 tpp180 -99.05 36.95 1.61 Allowed 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 177.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -46.68 -17.46 0.05 OUTLIER 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.526 -179.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -46.97 -42.75 16.1 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 106.146 -2.781 . . . . 0.0 106.146 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.935 HG23 ' CE2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -93.55 -62.38 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.553 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 2.6 t -48.54 -31.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.173 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.659 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.5 mt-10 -92.76 -22.34 19.41 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.914 -1.117 . . . . 0.0 108.873 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.488 ' HG3' ' N ' ' A' ' 42' ' ' CYS . 28.4 tp60 -82.77 -95.14 0.05 Allowed 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.434 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.57 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -40.84 -33.31 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.366 -0.834 . . . . 0.0 109.776 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 13.9 t -67.82 -58.74 4.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.483 -1.385 . . . . 0.0 109.719 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.659 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 14.6 m-70 -82.74 -58.61 2.82 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.25 -0.906 . . . . 0.0 108.922 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.618 ' C ' HD12 ' A' ' 46' ' ' ILE . 25.3 t -87.23 -129.72 0.06 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 1.01 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.5 mp -150.52 162.37 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.719 -1.238 . . . . 0.0 108.978 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.518 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 15.2 p -151.27 -168.03 2.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.43 -0.794 . . . . 0.0 109.115 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.616 ' HA ' ' CZ ' ' A' ' 1' ' ' PHE . 0.3 OUTLIER -155.6 163.62 39.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.066 -1.021 . . . . 0.0 110.384 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.957 ' HG ' HG13 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -39.02 -39.01 0.5 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.641 0.734 . . . . 0.0 110.27 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.65 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 2.2 p90 -57.56 -44.03 84.95 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.65 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 2.8 tp60 -72.88 -41.75 64.34 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.514 ' CB ' HG21 ' A' ' 18' ' ' VAL . 1.1 mt -75.0 -15.72 60.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.125 -0.984 . . . . 0.0 109.019 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' LEU . 14.1 tt0 -70.38 -27.75 64.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.45 -0.781 . . . . 0.0 108.985 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -89.13 -10.53 46.92 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.935 ' CE2' HG23 ' A' ' 38' ' ' ILE . 10.5 m-85 -90.06 0.38 57.16 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.536 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.1 m -90.71 -165.89 1.46 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.477 -0.764 . . . . 0.0 110.293 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 56' ' ' CYS . 34.6 t30 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.911 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.646 ' CE2' ' NE2' ' A' ' 4' ' ' GLN . 15.0 t80 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.646 ' N ' ' CD1' ' A' ' 1' ' ' PHE . 10.9 m -160.62 -167.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.382 -0.824 . . . . 0.0 109.589 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.539 ' CA ' HG21 ' A' ' 46' ' ' ILE . 4.6 m120 -63.96 91.29 0.07 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.414 -0.804 . . . . 0.0 109.188 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.646 ' NE2' ' CE2' ' A' ' 1' ' ' PHE . 2.6 pt20 -130.16 173.43 10.77 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.053 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.899 ' NE2' HD11 ' A' ' 46' ' ' ILE . 37.4 m-70 -90.92 108.46 19.86 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.939 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.2 tp -110.99 125.41 53.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 111.026 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' O ' ' C ' ' A' ' 8' ' ' GLY . 79.0 m -110.84 170.61 7.98 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -31.39 -43.99 0.11 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.406 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 9.9 m -62.5 -68.86 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.117 -1.225 . . . . 0.0 109.875 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.567 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 34.9 m-20 -66.86 -11.97 57.59 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.828 -1.17 . . . . 0.0 108.34 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.986 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.41 -48.72 60.18 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -65.87 -28.47 44.06 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.461 0 C-N-CA 119.094 -1.042 . . . . 0.0 108.489 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 1.0 OUTLIER -70.86 -60.22 2.36 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.001 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.939 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -49.42 -50.81 39.02 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.751 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.3 mt -62.25 -44.47 96.47 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.606 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.5 t80 -58.78 -24.99 62.64 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -80.25 -65.67 0.98 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 122.334 1.064 . . . . 0.0 108.315 178.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -55.53 -29.12 23.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.164 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.539 ' SG ' ' CB ' ' A' ' 24' ' ' PHE . 33.4 m -88.34 -55.42 3.74 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.113 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 45.93 61.92 3.65 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 1.9 tt0 80.49 -3.19 1.88 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.514 -0.991 . . . . 0.0 110.256 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' CB ' ' SG ' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -57.36 -17.75 14.01 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.951 -1.093 . . . . 0.0 109.008 179.484 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' CA ' ' A' ' 57' ' ' ASN . . . 95.29 65.9 0.98 Allowed Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.539 ' CB ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -87.36 178.89 6.71 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.355 -1.085 . . . . 0.0 109.44 -179.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -162.48 -163.21 0.88 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.488 178.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.545 ' CE2' ' HD2' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -144.22 100.98 3.64 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.204 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 7.2 t -78.46 -176.2 4.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.931 -1.105 . . . . 0.0 110.935 -177.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.575 ' HA ' ' HB2' ' A' ' 34' ' ' PRO . 2.1 p30 173.43 106.42 0.06 OUTLIER Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.462 ' HD2' ' C ' ' A' ' 34' ' ' PRO . 36.0 Cg_endo -75.3 6.21 3.66 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.483 2.122 . . . . 0.0 111.924 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.747 HG22 ' N ' ' A' ' 31' ' ' GLY . 0.8 OUTLIER 179.04 -68.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.605 -1.31 . . . . 0.0 109.9 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.747 ' N ' HG22 ' A' ' 30' ' ' THR . . . 158.69 -171.03 35.33 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . 42.69 90.07 0.01 OUTLIER Glycine 0 N--CA 1.494 2.566 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.595 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 49.37 56.32 11.11 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -178.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.595 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 35.3 Cg_endo -74.31 -49.07 0.19 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.392 2.061 . . . . 0.0 109.22 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.588 ' HG3' HD12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -96.29 28.67 3.16 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.174 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.626 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -46.59 -19.33 0.09 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.499 -178.371 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -48.12 -44.08 25.94 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 106.146 -2.781 . . . . 0.0 106.146 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.986 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.19 -56.54 5.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 122.414 1.102 . . . . 0.0 108.342 177.201 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.583 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 4.2 t -55.78 -29.32 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.683 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.677 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -93.44 -28.88 15.86 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 120.818 -1.176 . . . . 0.0 109.579 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.525 ' HG3' ' N ' ' A' ' 42' ' ' CYS . 1.7 tp60 -76.25 -97.53 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.507 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.569 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -40.77 -33.76 0.32 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 110.463 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.583 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 17.0 t -67.36 -53.47 29.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.353 -1.467 . . . . 0.0 110.889 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.677 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 15.9 m-70 -84.52 -52.96 5.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.02 -1.05 . . . . 0.0 110.059 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.477 ' C ' HD12 ' A' ' 46' ' ' ILE . 32.4 t -98.48 -113.82 0.15 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 108.977 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.899 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.4 mp -159.42 161.56 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.825 -1.172 . . . . 0.0 108.668 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.513 ' SG ' ' NE2' ' A' ' 51' ' ' GLN . 14.7 p -152.76 -171.0 3.8 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.566 -0.853 . . . . 0.0 109.535 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.641 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 4.8 m -143.86 156.97 44.65 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.345 1.069 . . . . 0.0 110.589 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.607 ' O ' ' N ' ' A' ' 53' ' ' GLU . 17.5 mt -39.44 -34.4 0.21 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.622 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.65 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 5.7 p90 -51.14 -42.63 60.88 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 118.532 -1.267 . . . . 0.0 108.108 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.65 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 1.7 pt20 -74.43 -53.54 9.35 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -62.14 -14.37 36.52 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.202 -0.936 . . . . 0.0 108.653 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 49' ' ' LEU . 20.8 tt0 -72.99 -31.46 64.53 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -91.57 -13.59 31.73 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.719 -0.613 . . . . 0.0 109.573 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.653 ' CE2' HG12 ' A' ' 38' ' ' ILE . 13.1 m-85 -82.65 -0.53 47.65 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.975 -1.078 . . . . 0.0 108.44 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 22' ' ' ARG . 1.2 t -66.94 -155.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.558 -0.714 . . . . 0.0 109.779 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.526 ' CA ' ' O ' ' A' ' 23' ' ' GLY . 24.1 p30 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.823 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.546 ' HB2' HD22 ' A' ' 49' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 m -141.6 -167.1 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.89 . . . . 0.0 109.548 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.525 ' CA ' HG21 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -70.15 109.36 4.57 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.474 -0.766 . . . . 0.0 109.394 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.546 ' HG2' ' N ' ' A' ' 5' ' ' HIS . 6.1 tt0 -134.54 163.13 30.4 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 110.189 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 1.071 ' NE2' HD11 ' A' ' 46' ' ' ILE . 20.0 m-70 -91.62 91.83 8.2 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.872 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -91.19 165.98 13.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.929 -1.107 . . . . 0.0 109.694 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 9' ' ' SER . 16.4 t -167.44 112.32 0.71 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.588 -1.32 . . . . 0.0 109.43 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.52 ' N ' ' HB2' ' A' ' 11' ' ' LEU . . . 39.88 -90.15 0.01 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 7' ' ' CYS . 7.1 m -40.25 -68.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.406 -1.055 . . . . 0.0 110.655 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.622 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 26.6 m-20 -65.8 -24.19 66.86 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.502 -1.374 . . . . 0.0 108.644 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.05 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -59.93 -50.76 72.51 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.387 -0.925 . . . . 0.0 108.642 177.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.628 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -64.38 -26.12 39.59 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 C-N-CA 119.127 -1.029 . . . . 0.0 108.674 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.439 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -71.75 -57.77 4.06 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.436 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.872 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.21 -48.95 70.45 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.825 ' HG ' HD12 ' A' ' 52' ' ' LEU . 2.6 mt -62.77 -41.57 99.3 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.628 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 12.3 t80 -59.26 -20.9 58.09 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -90.6 -65.8 0.98 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.971 0.891 . . . . 0.0 109.178 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.767 HG13 ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -46.72 -29.96 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-O 121.599 0.714 . . . . 0.0 109.258 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.19 -70.9 0.64 Allowed 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.543 -179.41 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.26 -67.52 0.37 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 19' ' ' CYS . 3.5 mt-10 -126.93 -7.62 6.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.223 -1.163 . . . . 0.0 109.825 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.477 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 3.8 mmt85 -70.16 -10.55 59.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.166 -0.959 . . . . 0.0 109.699 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.6 89.74 0.08 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -85.37 -177.12 6.39 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.348 -1.089 . . . . 0.0 109.731 -179.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.574 ' CE2' ' O ' ' A' ' 56' ' ' CYS . 11.0 p90 -162.76 178.47 8.44 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.689 0.757 . . . . 0.0 109.337 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.624 ' CD1' ' HD2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -123.13 113.66 19.27 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 178.128 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.915 HG23 ' HG2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -77.24 169.75 17.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.752 -1.217 . . . . 0.0 110.835 -177.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.542 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 10.5 m-20 33.15 61.83 1.56 Allowed Pre-proline 0 N--CA 1.494 1.773 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.922 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 36.3 Cg_endo -78.11 78.41 3.61 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.727 2.285 . . . . 0.0 110.543 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.83 -78.05 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.017 -1.052 . . . . 0.0 109.715 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.473 ' O ' ' HD3' ' A' ' 34' ' ' PRO . . . -67.71 179.35 17.42 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' C ' ' HD3' ' A' ' 34' ' ' PRO . . . -77.36 -32.02 49.18 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.551 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . -130.28 56.76 0.74 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 33.8 Cg_endo -74.73 -35.95 3.11 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.492 2.128 . . . . 0.0 109.235 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.915 ' HG2' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -103.95 35.6 2.6 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 178.193 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.571 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -42.06 -21.46 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.339 -178.46 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -48.21 -44.04 26.47 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 106.082 -2.807 . . . . 0.0 106.082 177.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.05 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.27 -57.51 4.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 122.508 1.147 . . . . 0.0 108.513 177.145 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 54.6 t -57.03 -29.27 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.913 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.681 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.3 mt-10 -91.87 -32.96 15.11 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.862 -1.149 . . . . 0.0 109.02 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 45' ' ' SER . 1.5 tp-100 -74.86 -82.49 0.06 Allowed 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.8 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.541 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 15.5 m -42.21 -48.08 4.81 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.411 -0.805 . . . . 0.0 109.715 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 5.1 t -62.87 -47.94 81.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 110.429 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.681 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 8.8 m-70 -90.47 -65.41 1.02 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.888 -1.133 . . . . 0.0 108.963 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 41' ' ' GLN . 8.5 t -87.38 -137.31 0.09 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 1.071 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.4 mp -142.38 162.35 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.794 -1.191 . . . . 0.0 109.17 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.511 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -142.92 -161.58 1.28 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.408 179.213 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.588 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -152.45 149.81 28.96 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.329 -0.857 . . . . 0.0 109.818 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.767 ' HG ' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -38.96 -37.26 0.34 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.758 0.79 . . . . 0.0 110.805 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 1.3 p90 -60.01 -37.8 80.8 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.556 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.596 ' HG2' ' CD2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -77.56 -20.01 54.77 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.842 HD13 ' HD2' ' A' ' 55' ' ' TYR . 4.3 mm? -86.8 -28.03 23.21 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.08 -23.26 19.58 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -90.89 -23.23 20.58 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.842 ' HD2' HD13 ' A' ' 52' ' ' LEU . 17.5 m-85 -81.25 0.23 37.75 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.574 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.1 m -90.78 -165.15 1.29 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.538 -0.726 . . . . 0.0 109.958 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.442 ' C ' ' O ' ' A' ' 56' ' ' CYS . 27.3 p-10 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.876 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 2' ' ' VAL . 34.5 p90 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.572 0.701 . . . . 0.0 109.641 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.853 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER -94.13 -152.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 122.328 1.061 . . . . 0.0 110.983 -178.329 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.853 ' N ' HG13 ' A' ' 2' ' ' VAL . 5.3 m120 -63.42 93.11 0.07 Allowed 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.572 ' HB3' ' CD2' ' A' ' 1' ' ' PHE . 4.6 tt0 -129.22 160.34 33.24 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.001 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 1.082 ' NE2' HD11 ' A' ' 46' ' ' ILE . 17.1 m-70 -85.05 93.89 8.71 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.662 HD13 ' CB ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -79.31 -163.79 0.55 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.174 -0.954 . . . . 0.0 109.134 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.586 ' O ' ' C ' ' A' ' 8' ' ' GLY . 0.8 OUTLIER 170.83 141.25 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.623 -179.422 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -17.15 -55.19 0.01 OUTLIER Glycine 0 N--CA 1.502 3.063 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 7' ' ' CYS . 15.3 m -60.66 -66.2 0.57 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.208 -1.172 . . . . 0.0 109.717 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.662 ' CB ' HD13 ' A' ' 6' ' ' LEU . 1.2 m-20 -67.46 -17.91 64.88 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.73 -1.231 . . . . 0.0 107.984 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.903 HD21 ' CD1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -59.58 -53.05 62.56 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.634 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -63.62 -27.94 43.97 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.44 0 C-N-CA 118.801 -1.16 . . . . 0.0 108.08 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -71.8 -60.25 2.33 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.759 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -50.79 -49.2 58.94 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.774 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.6 mt -62.81 -47.62 82.64 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 7.1 t80 -53.65 -25.55 18.44 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -82.02 -67.79 0.75 Allowed 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.101 0.953 . . . . 0.0 108.521 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.91 HG13 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -49.83 -28.74 4.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.526 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -87.21 -55.69 3.7 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.349 -0.94 . . . . 0.0 109.937 -179.07 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 21' ' ' GLU . . . 46.1 65.85 1.9 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 17.4 mm-40 80.92 -9.98 1.28 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.675 -0.897 . . . . 0.0 110.199 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 2.2 mmt180 -56.79 -17.22 8.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.915 -1.116 . . . . 0.0 109.415 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' CA ' ' A' ' 57' ' ' ASN . . . 85.19 80.02 1.12 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.608 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -92.12 179.01 5.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -1.108 . . . . 0.0 109.902 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.608 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 40.1 p90 -162.68 175.14 11.66 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.88 121.17 43.87 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.698 HG23 ' HB3' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -77.61 170.99 15.62 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.004 -1.06 . . . . 0.0 110.528 -178.261 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.55 ' CB ' ' HB2' ' A' ' 34' ' ' PRO . 0.7 OUTLIER 36.0 62.1 2.79 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -179.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 36.1 Cg_endo -77.53 66.37 7.98 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.578 2.185 . . . . 0.0 110.464 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.56 -79.36 0.55 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.124 -0.985 . . . . 0.0 109.812 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.2 -160.67 34.66 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 33' ' ' GLY . . . -91.75 159.38 25.74 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.529 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 43.79 57.32 4.69 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.55 ' HB2' ' CB ' ' A' ' 28' ' ' ASP . 31.8 Cg_endo -72.24 -52.44 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.367 2.045 . . . . 0.0 108.933 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.698 ' HB3' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -97.85 31.32 2.69 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.077 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.61 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -39.93 -25.51 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.844 -177.443 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -48.82 -44.51 31.1 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.963 HG21 ' CE1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -91.87 -34.19 6.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.192 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 1.4 t -76.48 -69.79 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.615 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.1 tt0 -45.06 -25.87 0.38 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.856 -1.152 . . . . 0.0 108.57 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -80.35 -78.62 0.17 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 1.7 m -42.39 -29.03 0.24 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.592 -0.692 . . . . 0.0 109.497 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -85.08 -47.36 10.27 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.009 -1.057 . . . . 0.0 109.88 -179.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.615 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 7.0 m-70 -92.59 -53.27 4.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.11 -0.994 . . . . 0.0 109.288 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' GLN . 38.7 m -92.09 -122.85 0.08 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 1.082 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -160.6 166.07 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.652 -1.28 . . . . 0.0 109.07 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.567 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -156.35 -170.96 3.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.391 -0.818 . . . . 0.0 109.285 179.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.489 ' HG ' ' HE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -142.02 157.61 44.73 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.269 -0.894 . . . . 0.0 109.839 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.91 HD22 HG13 ' A' ' 18' ' ' VAL . 54.6 mt -42.65 -33.09 0.66 Allowed 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.661 0.743 . . . . 0.0 110.571 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.656 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 1.6 p90 -53.45 -44.01 68.53 Favored 'General case' 0 C--N 1.281 -2.406 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.046 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.656 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -74.95 -53.01 9.75 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.154 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.491 ' N ' ' CG ' ' A' ' 51' ' ' GLN . 1.2 mp -61.22 -15.47 34.83 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 49' ' ' LEU . 37.2 tt0 -70.59 -24.39 62.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -91.35 -14.18 31.19 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.635 -0.666 . . . . 0.0 109.415 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.963 ' CE1' HG21 ' A' ' 38' ' ' ILE . 59.7 m-85 -86.15 4.34 38.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.126 -0.984 . . . . 0.0 108.879 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.521 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -77.51 -164.24 0.47 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.691 -0.631 . . . . 0.0 109.98 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.448 ' CA ' ' O ' ' A' ' 23' ' ' GLY . 5.6 t-20 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.667 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.514 ' HB2' ' CD2' ' A' ' 49' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.564 0.697 . . . . 0.0 109.561 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.836 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.8 OUTLIER -126.81 -153.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-O 122.413 1.101 . . . . 0.0 110.387 -178.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.836 ' N ' HG13 ' A' ' 2' ' ' VAL . 2.0 m120 -89.85 99.81 12.75 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.982 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.506 ' O ' HG23 ' A' ' 46' ' ' ILE . 4.2 pm0 -132.71 171.95 13.19 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.165 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.955 ' NE2' HD11 ' A' ' 46' ' ' ILE . 32.5 m-70 -90.77 110.16 21.35 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.833 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -112.63 134.04 54.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.132 -0.98 . . . . 0.0 111.168 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.535 ' O ' ' C ' ' A' ' 8' ' ' GLY . 34.4 m -119.08 168.09 11.17 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.555 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -28.93 -45.24 0.06 OUTLIER Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 7' ' ' CYS . 19.5 m -63.15 -68.65 0.32 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -1.201 . . . . 0.0 109.997 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.545 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 53.3 m-20 -67.79 -10.01 49.1 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.845 -1.159 . . . . 0.0 108.572 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.904 HD21 HD11 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -72.66 -48.15 41.58 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.378 -0.826 . . . . 0.0 109.05 178.487 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.616 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.8 m -67.53 -28.9 43.62 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.43 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.726 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -70.83 -55.87 7.56 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.489 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.833 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.51 -50.79 66.98 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.77 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.1 mt -60.87 -45.17 95.6 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.616 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 17.3 t80 -57.19 -21.37 32.85 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -88.77 -65.76 0.99 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.132 0.968 . . . . 0.0 109.009 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.77 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -50.29 -28.45 5.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-O 121.409 0.623 . . . . 0.0 109.602 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -86.59 -65.46 1.01 Allowed 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.39 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.47 -71.0 1.07 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -132.97 -1.2 3.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -1.137 . . . . 0.0 109.93 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.482 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 26.1 mmm-85 -69.18 -11.86 61.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.056 -1.027 . . . . 0.0 109.658 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' O ' ' CG ' ' A' ' 57' ' ' ASN . . . 69.3 89.42 0.08 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.621 ' CD2' ' N ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -85.01 -175.67 5.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -1.128 . . . . 0.0 109.805 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.621 ' N ' ' CD2' ' A' ' 24' ' ' PHE . 23.9 p90 -162.8 164.65 26.08 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.491 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.2 OUTLIER -103.7 127.57 51.14 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.072 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.66 HG23 ' HB2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -78.45 160.64 27.61 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.063 -1.023 . . . . 0.0 110.824 -178.245 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 34' ' ' PRO . 22.5 t70 32.73 64.6 1.27 Allowed Pre-proline 0 N--CA 1.494 1.761 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.313 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 28' ' ' ASP . 36.3 Cg_endo -78.94 65.95 8.78 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.673 2.249 . . . . 0.0 110.245 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.76 -79.53 0.61 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.053 -1.029 . . . . 0.0 109.773 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.03 -156.2 32.24 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 33' ' ' GLY . . . -93.21 151.81 20.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.563 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 42.41 55.38 4.46 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 31.4 Cg_endo -72.64 -50.43 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.532 2.155 . . . . 0.0 109.078 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.66 ' HB2' HG23 ' A' ' 27' ' ' THR . 6.3 tpm_? -98.37 34.09 2.07 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -39.51 -24.36 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.488 -178.105 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -49.94 -45.38 41.28 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.191 -2.364 . . . . 0.0 107.191 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.904 HD11 HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -93.54 -26.19 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.413 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -82.91 -59.93 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.292 -0.88 . . . . 0.0 109.101 179.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.632 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 4.9 tt0 -58.72 -16.6 17.31 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.4 OUTLIER -80.47 -82.41 0.11 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.372 -0.83 . . . . 0.0 109.392 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.557 ' O ' ' N ' ' A' ' 6' ' ' LEU . 28.5 m -39.57 -42.5 1.17 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.36 -0.838 . . . . 0.0 108.955 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 6' ' ' LEU . 4.8 t -69.54 -53.03 20.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.829 . . . . 0.0 111.043 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.632 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 12.7 m-70 -83.51 -48.76 9.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.868 -1.145 . . . . 0.0 109.663 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 41' ' ' GLN . 45.1 t -99.95 -124.42 0.16 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.955 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -159.49 165.23 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.706 -1.246 . . . . 0.0 109.206 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.556 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -148.16 -156.64 0.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.469 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.62 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 5.6 m -160.05 154.08 23.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 110.387 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.631 ' HG ' HG13 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -39.13 -38.86 0.52 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.644 0.735 . . . . 0.0 110.412 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 1.4 p90 -57.76 -46.46 84.49 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.623 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -71.69 -37.57 70.68 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.519 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.509 ' HB3' HG21 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -76.48 -20.09 57.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.161 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 49' ' ' LEU . 26.0 tt0 -68.19 -22.66 64.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.323 -0.86 . . . . 0.0 108.868 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -89.92 -11.52 41.56 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.548 -0.72 . . . . 0.0 109.812 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.651 ' CZ ' ' HB ' ' A' ' 38' ' ' ILE . 17.5 m-85 -91.09 6.99 42.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.127 -0.983 . . . . 0.0 108.5 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.541 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.3 m -78.06 -164.55 0.54 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.715 -0.616 . . . . 0.0 109.927 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.3 t-20 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.743 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.761 ' CD1' HD13 ' A' ' 49' ' ' LEU . 2.5 t80 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.469 0.652 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.67 HG13 ' O ' ' A' ' 1' ' ' PHE . 12.3 m -161.53 -167.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.73 . . . . 0.0 109.467 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.436 ' C ' HG21 ' A' ' 46' ' ' ILE . 11.0 m-20 -59.9 87.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.449 -0.782 . . . . 0.0 108.976 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 46' ' ' ILE . 20.3 pt20 -130.99 178.31 6.77 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.028 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.901 ' NE2' HD11 ' A' ' 46' ' ' ILE . 36.8 m-70 -91.84 106.05 18.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.85 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -104.91 137.82 42.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.14 -0.975 . . . . 0.0 111.058 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.543 ' O ' ' C ' ' A' ' 8' ' ' GLY . 60.0 m -124.1 166.98 14.85 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.685 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -26.12 -47.91 0.04 OUTLIER Glycine 0 N--CA 1.498 2.798 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 7' ' ' CYS . 1.4 m -61.82 -69.2 0.26 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.286 . . . . 0.0 109.948 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.549 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -68.17 -10.7 56.21 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.812 -1.18 . . . . 0.0 108.763 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.814 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -73.71 -47.42 39.63 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.246 -0.909 . . . . 0.0 109.316 178.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 8' ' ' GLY . 2.9 m -71.57 -31.95 44.21 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.406 0 C-N-CA 118.789 -1.164 . . . . 0.0 108.485 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 16' ' ' TYR . 10.4 mt-10 -66.54 -54.27 25.6 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.85 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -59.69 -50.21 74.75 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.801 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.8 mt -59.92 -39.89 86.99 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.607 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 7.9 t80 -59.45 -21.54 60.19 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.71 -65.54 1.01 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.969 0.89 . . . . 0.0 108.964 179.442 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.981 HG11 ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -49.99 -27.43 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.578 0.704 . . . . 0.0 109.509 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 24' ' ' PHE . 36.2 m -90.27 -69.24 0.74 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.854 -178.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.59 -71.82 1.55 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -137.7 1.83 2.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.351 -1.088 . . . . 0.0 109.964 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.495 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 42.4 mmm-85 -63.34 -12.35 29.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.004 -1.06 . . . . 0.0 109.864 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 57' ' ' ASN . . . 85.22 90.86 0.84 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -114.3 173.93 6.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -1.16 . . . . 0.0 109.668 -179.51 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.589 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 2.2 p90 -161.21 -61.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.408 -0.807 . . . . 0.0 109.025 178.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.589 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER 162.38 -88.81 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.97 HG21 ' CB ' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -166.05 -80.06 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.09 0.948 . . . . 0.0 108.946 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.542 ' N ' ' OG1' ' A' ' 27' ' ' THR . 45.4 t0 -143.79 112.64 5.38 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -74.7 83.81 1.7 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.268 1.979 . . . . 0.0 110.84 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 p -128.2 -78.71 0.57 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.318 -0.864 . . . . 0.0 109.484 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 32' ' ' GLY . . . -106.09 -150.37 18.35 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 34' ' ' PRO . . . -60.56 -131.39 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 32' ' ' GLY . . . -40.06 98.0 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.579 ' HB2' HG23 ' A' ' 27' ' ' THR . 25.5 Cg_endo -63.12 -20.4 71.07 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.242 1.961 . . . . 0.0 109.556 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.97 ' CB ' HG21 ' A' ' 27' ' ' THR . 1.4 tpp180 -151.36 61.82 0.89 Allowed 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -38.96 -25.45 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.099 -179.36 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -45.25 -39.98 7.43 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 106.18 -2.768 . . . . 0.0 106.18 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.946 HG23 ' CE2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -93.38 -63.67 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-O 122.346 1.07 . . . . 0.0 108.261 176.691 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 3.3 t -48.82 -35.95 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.23 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.672 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 3.3 tt0 -91.25 -17.07 26.58 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.076 -1.015 . . . . 0.0 109.423 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 45' ' ' SER . 33.2 tt0 -90.58 -82.91 0.27 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.359 -0.838 . . . . 0.0 109.594 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 6' ' ' LEU . 24.5 m -39.28 -41.17 0.86 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.495 -0.753 . . . . 0.0 109.731 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.483 ' N ' ' O ' ' A' ' 6' ' ' LEU . 3.7 t -73.58 -51.25 17.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 111.177 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.672 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 14.9 m-70 -83.23 -41.9 17.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.871 -1.143 . . . . 0.0 109.95 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 41' ' ' GLN . 37.7 t -110.31 -121.64 0.27 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.901 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -158.94 165.6 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.794 -1.191 . . . . 0.0 109.394 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.568 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -148.09 -164.52 2.03 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.407 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.632 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 10.3 m -143.78 151.82 40.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 110.128 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.981 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -39.11 -39.85 0.63 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.734 0.778 . . . . 0.0 110.143 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.632 ' CE2' ' HB2' ' A' ' 48' ' ' SER . 1.2 p90 -63.13 -41.06 99.24 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.551 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 37.2 tp60 -63.67 -44.65 93.12 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.541 HD23 ' HG ' ' A' ' 15' ' ' LEU . 1.2 mp -72.38 -24.24 61.23 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -63.43 -24.08 67.68 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.386 -0.821 . . . . 0.0 109.095 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -87.97 -9.16 54.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.492 -0.755 . . . . 0.0 109.457 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.946 ' CE2' HG23 ' A' ' 38' ' ' ILE . 13.7 m-85 -90.14 2.0 55.79 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -80.28 -158.21 0.17 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.483 -0.761 . . . . 0.0 110.935 -178.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 23' ' ' GLY . 22.4 t-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.656 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.642 ' CD2' ' CD1' ' A' ' 49' ' ' LEU . 6.9 p90 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 4' ' ' GLN . 12.9 m -122.21 -168.93 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.137 -0.977 . . . . 0.0 109.623 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -43.51 94.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.341 -0.849 . . . . 0.0 109.725 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.664 ' NE2' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -143.19 167.87 21.09 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.205 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 1.061 ' NE2' HD11 ' A' ' 46' ' ' ILE . 18.1 m-70 -93.14 111.79 23.54 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.947 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.2 tp -113.76 128.12 56.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.026 -1.046 . . . . 0.0 110.84 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 11' ' ' LEU . 64.6 m -111.04 167.56 10.17 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.553 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -31.36 -42.38 0.08 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 7' ' ' CYS . 42.3 m -62.68 -69.27 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.275 . . . . 0.0 109.491 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.543 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 1.1 m-20 -67.47 -10.92 56.04 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.934 -1.104 . . . . 0.0 108.484 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.711 ' CD2' HD11 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -70.78 -48.88 51.92 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.385 -0.822 . . . . 0.0 109.043 178.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.613 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -67.08 -28.52 43.05 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.454 0 C-N-CA 118.802 -1.159 . . . . 0.0 108.297 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 6.4 tt0 -70.32 -57.15 5.17 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.947 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.38 -49.71 69.22 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.752 ' HA ' HG23 ' A' ' 18' ' ' VAL . 3.0 mt -61.62 -44.04 97.74 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.613 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 11.5 t80 -58.5 -27.0 64.07 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -78.79 -64.04 1.27 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 122.042 0.925 . . . . 0.0 108.568 179.137 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.886 HG12 ' OE1' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -53.34 -31.79 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.509 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -86.49 -64.32 1.17 Allowed 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.601 -0.839 . . . . 0.0 109.563 -179.41 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.25 -64.63 0.39 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 19' ' ' CYS . 1.6 mt-10 -138.79 2.74 2.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.262 -1.14 . . . . 0.0 110.077 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 14.2 mmt85 -74.19 -11.21 60.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.099 -1.0 . . . . 0.0 109.882 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 69.69 93.9 0.06 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.627 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -89.7 -167.25 1.8 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -1.126 . . . . 0.0 110.061 -179.595 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.627 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 15.0 p90 -160.63 170.82 20.07 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.584 ' O ' HG22 ' A' ' 27' ' ' THR . 1.5 t80 -107.04 -108.42 0.31 Allowed 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.805 -1.184 . . . . 0.0 109.628 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.732 HG21 ' CB ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -161.23 -159.73 0.67 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.185 -1.572 . . . . 0.0 109.414 -179.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.507 ' N ' ' OG1' ' A' ' 27' ' ' THR . 18.4 t0 -60.14 110.55 2.93 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.682 -0.636 . . . . 0.0 109.553 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 27' ' ' THR . 36.9 Cg_endo -81.56 71.95 6.59 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.568 2.179 . . . . 0.0 110.385 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.4 p -131.66 -79.09 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 109.78 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.9 166.88 30.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.73 121.15 9.36 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.464 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 77.03 60.75 2.82 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.499 ' CB ' ' O ' ' A' ' 28' ' ' ASP . 30.4 Cg_endo -71.54 -44.95 0.89 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.439 2.093 . . . . 0.0 108.865 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.732 ' CB ' HG21 ' A' ' 27' ' ' THR . 5.5 tpt180 -108.04 36.07 2.91 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -39.48 -27.34 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.119 -177.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -49.65 -42.61 36.31 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.973 -2.451 . . . . 0.0 106.973 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.711 HD11 ' CD2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -93.99 -26.69 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.233 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.602 HG12 ' N ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -84.46 -60.48 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.412 -0.805 . . . . 0.0 109.462 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.643 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 34.0 tt0 -61.63 -13.98 26.9 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.221 -0.925 . . . . 0.0 109.284 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -79.85 -85.75 0.08 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.178 -0.951 . . . . 0.0 109.845 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.57 ' HB2' HD11 ' A' ' 11' ' ' LEU . 32.3 m -38.73 -42.65 0.83 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 6' ' ' LEU . 7.4 t -67.31 -54.82 17.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.478 -0.764 . . . . 0.0 110.553 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.643 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 10.6 m-70 -86.29 -59.13 2.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.837 -1.164 . . . . 0.0 109.18 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.595 ' C ' HD12 ' A' ' 46' ' ' ILE . 33.0 t -83.17 -132.89 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 1.061 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.5 mp -155.94 161.29 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.846 -1.159 . . . . 0.0 108.577 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.46 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.6 OUTLIER -141.54 -157.44 0.77 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.654 -1.218 . . . . 0.0 110.655 -179.064 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.616 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 5.4 m -151.18 146.44 26.11 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.874 0.845 . . . . 0.0 110.008 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.721 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -37.7 -42.48 0.57 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.739 0.781 . . . . 0.0 111.04 -179.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.616 ' CE2' ' HB2' ' A' ' 48' ' ' SER . 3.6 p90 -61.94 -37.79 86.05 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.991 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.607 ' CG ' ' CZ ' ' A' ' 50' ' ' TYR . 72.0 mt-30 -67.64 -39.74 84.61 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.635 HD13 ' HE2' ' A' ' 1' ' ' PHE . 0.9 OUTLIER -71.39 -28.87 64.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 109.057 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.886 ' OE1' HG12 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -57.96 -23.04 52.01 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' N ' ' ND2' ' A' ' 54' ' ' ASN . 1.2 m120 -89.65 -15.52 32.49 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.807 -0.558 . . . . 0.0 109.573 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.678 ' CZ ' ' HB ' ' A' ' 38' ' ' ILE . 16.4 m-85 -90.54 5.51 47.49 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.448 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.1 m -90.89 -164.25 1.15 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.623 -0.673 . . . . 0.0 109.851 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 8.3 p-10 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.936 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.664 ' O ' HG13 ' A' ' 2' ' ' VAL . 3.1 t80 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.508 0.671 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 1' ' ' PHE . 8.9 m -161.19 -167.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.49 -0.756 . . . . 0.0 109.439 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.506 ' CA ' HG21 ' A' ' 46' ' ' ILE . 3.4 m-80 -60.07 93.86 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.453 -0.779 . . . . 0.0 109.264 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.686 ' HG3' HD13 ' A' ' 6' ' ' LEU . 1.6 pt20 -134.42 173.84 11.19 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.154 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.877 ' NE2' HD11 ' A' ' 46' ' ' ILE . 43.3 m-70 -90.48 112.53 24.21 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.742 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -118.12 129.41 55.52 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.403 -0.811 . . . . 0.0 111.328 -178.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' O ' ' C ' ' A' ' 8' ' ' GLY . 98.7 m -111.61 170.42 8.14 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -29.93 -45.71 0.09 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.518 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.1 m -62.1 -68.85 0.29 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.107 -1.231 . . . . 0.0 110.171 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.572 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 1.9 m-20 -67.46 -11.63 58.32 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.859 -1.15 . . . . 0.0 108.416 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.985 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -69.72 -49.09 56.58 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.607 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -63.83 -30.62 50.43 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.55 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.617 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 4.7 tt0 -69.09 -56.69 6.94 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.742 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -55.15 -49.38 71.95 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.771 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.5 mt -62.86 -40.97 99.12 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.607 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 8.7 t80 -58.36 -20.44 43.7 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -90.07 -66.67 0.9 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.982 0.896 . . . . 0.0 109.006 179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -46.22 -30.08 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -90.47 -71.1 0.64 Allowed 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.555 -179.358 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.24 -60.41 0.25 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 19' ' ' CYS . 17.0 mt-10 -138.11 -0.05 2.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.201 -1.176 . . . . 0.0 110.381 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.572 ' CD ' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -76.74 -4.07 41.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.99 -1.069 . . . . 0.0 109.685 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.99 84.85 0.18 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.546 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -83.13 -177.44 6.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.268 -1.136 . . . . 0.0 109.421 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.546 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 8.6 p90 -161.33 -172.69 3.49 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.394 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.492 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.2 OUTLIER -144.29 102.53 3.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.473 ' O ' ' HD3' ' A' ' 35' ' ' ARG . 8.8 t -78.94 -172.78 3.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.903 -1.123 . . . . 0.0 110.18 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.616 ' HA ' ' HB2' ' A' ' 34' ' ' PRO . 1.2 p30 167.5 84.44 0.02 OUTLIER Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 34' ' ' PRO . 35.5 Cg_endo -77.01 6.19 4.43 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.637 2.224 . . . . 0.0 112.661 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.31 -85.02 0.22 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.385 -1.447 . . . . 0.0 109.808 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.468 ' O ' ' HD3' ' A' ' 34' ' ' PRO . . . 171.53 -67.56 0.13 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 33' ' ' GLY . . . -82.26 112.64 3.53 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.587 ' N ' ' HD3' ' A' ' 34' ' ' PRO . . . 46.74 57.48 6.71 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.616 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 35.2 Cg_endo -75.47 -44.03 0.33 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.582 2.188 . . . . 0.0 109.205 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 27' ' ' THR . 0.7 OUTLIER -96.43 30.83 2.41 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 177.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.612 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -46.28 -20.03 0.1 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.479 -178.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.4 -44.79 16.15 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 106.267 -2.733 . . . . 0.0 106.267 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.985 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -93.92 -61.22 2.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 122.551 1.167 . . . . 0.0 108.229 176.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.573 ' O ' ' HB3' ' A' ' 43' ' ' CYS . 13.9 t -49.11 -34.74 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.508 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.666 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 24.3 tt0 -93.35 -16.88 24.19 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 120.864 -1.147 . . . . 0.0 109.406 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 45' ' ' SER . 33.8 tt0 -86.65 -94.98 0.09 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.464 -0.772 . . . . 0.0 110.077 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.23 -34.9 0.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.469 -0.77 . . . . 0.0 109.895 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 39' ' ' VAL . 16.3 t -66.34 -55.05 17.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.385 -1.447 . . . . 0.0 109.739 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.666 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 15.5 m-70 -84.22 -51.61 6.89 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.195 -0.941 . . . . 0.0 109.454 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' GLN . 35.1 t -98.44 -127.35 0.17 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.877 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.5 mp -148.04 164.57 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.679 -1.263 . . . . 0.0 108.818 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.769 ' SG ' HD11 ' A' ' 52' ' ' LEU . 21.4 p -149.97 -171.74 3.98 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.383 -0.823 . . . . 0.0 109.206 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.753 ' O ' HD12 ' A' ' 52' ' ' LEU . 8.1 m -147.1 156.02 42.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.855 -1.153 . . . . 0.0 110.951 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.71 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -39.29 -38.57 0.54 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.79 0.805 . . . . 0.0 110.244 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.631 ' CD1' ' N ' ' A' ' 51' ' ' GLN . 1.4 p90 -61.83 -47.83 83.29 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 121.772 0.796 . . . . 0.0 109.095 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.631 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -67.35 -39.99 85.8 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.769 HD11 ' SG ' ' A' ' 47' ' ' CYS . 1.4 mp -75.75 -18.37 59.58 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -62.82 -26.49 68.77 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.121 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -90.16 -10.76 43.33 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.287 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.809 ' CE2' HG23 ' A' ' 38' ' ' ILE . 11.2 m-85 -87.55 -1.81 58.19 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.489 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 1.2 m -90.61 -165.39 1.34 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.603 -0.686 . . . . 0.0 110.134 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 56' ' ' CYS . 4.3 t-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.816 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.522 ' CE2' ' CD ' ' A' ' 4' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.464 ' O ' ' OE1' ' A' ' 4' ' ' GLN . 12.5 m -153.13 -167.56 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.858 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.544 ' CA ' HG21 ' A' ' 46' ' ' ILE . 6.6 m120 -70.26 99.82 1.6 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.479 -0.763 . . . . 0.0 109.632 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.522 ' CD ' ' CE2' ' A' ' 1' ' ' PHE . 3.0 pm0 -131.88 165.53 23.65 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.125 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 1.046 ' NE2' HD11 ' A' ' 46' ' ' ILE . 20.5 m-70 -89.72 108.53 19.74 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.907 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -112.88 128.94 56.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.139 -0.976 . . . . 0.0 110.817 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.523 ' O ' ' C ' ' A' ' 8' ' ' GLY . 67.5 m -111.26 168.06 9.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 7' ' ' CYS . . . -29.6 -45.89 0.08 OUTLIER Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.9 m -60.85 -69.87 0.21 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.088 -1.242 . . . . 0.0 110.093 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.558 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 1.2 m-20 -66.43 -13.44 60.76 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.856 -1.152 . . . . 0.0 108.362 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.721 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -66.78 -50.35 62.95 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.455 -0.778 . . . . 0.0 108.982 178.372 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.7 m -65.8 -30.55 50.4 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.472 0 C-N-CA 119.019 -1.072 . . . . 0.0 108.123 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.28 -57.31 6.16 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.697 -1.224 . . . . 0.0 107.697 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.907 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.93 -49.48 71.19 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.786 ' HA ' HG23 ' A' ' 18' ' ' VAL . 2.3 mt -62.88 -42.63 99.84 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.606 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 9.9 t80 -56.74 -21.54 28.97 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.44 -66.14 0.95 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.019 0.914 . . . . 0.0 109.226 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.786 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -47.62 -28.58 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.505 0.669 . . . . 0.0 109.427 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -90.18 -70.35 0.67 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.679 -179.427 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.63 -68.74 1.83 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -130.33 -6.88 4.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.157 -1.202 . . . . 0.0 110.122 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -66.01 -11.8 50.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.036 -1.04 . . . . 0.0 109.837 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 68.07 95.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.477 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 0.5 OUTLIER -93.93 174.88 6.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -1.178 . . . . 0.0 110.238 -179.648 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 29.2 p90 -165.19 151.89 10.4 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.496 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 0.2 OUTLIER -70.95 -115.42 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.454 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.918 HG21 ' CG ' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -164.06 -80.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.371 -1.456 . . . . 0.0 108.611 178.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' A' ' 34' ' ' PRO . 6.2 t70 -106.37 99.09 22.18 Favored Pre-proline 0 C--N 1.296 -1.722 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 27' ' ' THR . 34.1 Cg_endo -75.91 85.99 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.562 2.175 . . . . 0.0 110.541 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.6 p -137.58 -77.74 0.39 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.323 -0.861 . . . . 0.0 109.77 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.89 -176.43 51.51 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.512 ' O ' ' HD3' ' A' ' 34' ' ' PRO . . . -62.13 -36.48 93.0 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.96 85.3 0.4 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 27.1 Cg_endo -64.35 -19.53 65.62 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.422 2.081 . . . . 0.0 109.519 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.918 ' CG ' HG21 ' A' ' 27' ' ' THR . 0.0 OUTLIER -148.48 58.98 1.08 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.587 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.554 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -42.55 -23.76 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.908 -179.523 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.502 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -45.57 -40.72 8.83 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 106.219 -2.752 . . . . 0.0 106.219 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.924 HG23 ' CE2' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -94.32 -65.52 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 122.464 1.126 . . . . 0.0 108.02 176.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.502 ' HB ' ' HA ' ' A' ' 36' ' ' ARG . 16.2 t -46.78 -34.85 2.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.289 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.632 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 9.2 tt0 -91.63 -19.38 22.75 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.117 -0.989 . . . . 0.0 109.567 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 45' ' ' SER . 16.5 tt0 -90.36 -81.81 0.29 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.294 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.568 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 23.1 m -40.8 -41.77 1.64 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.502 -0.749 . . . . 0.0 109.113 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.518 ' N ' ' O ' ' A' ' 6' ' ' LEU . 6.8 t -69.09 -53.9 17.88 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.207 -0.933 . . . . 0.0 110.026 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.632 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 12.3 m-70 -83.9 -64.4 1.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 108.937 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 41' ' ' GLN . 3.7 t -82.0 -132.7 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 1.046 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -153.85 166.0 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.823 -1.173 . . . . 0.0 109.076 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.576 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -155.09 171.09 20.35 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.601 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.639 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 4.9 m -124.28 158.16 33.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.368 -0.832 . . . . 0.0 109.485 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.671 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -38.74 -39.22 0.48 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.715 0.769 . . . . 0.0 110.48 -179.408 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.639 ' CD2' ' HB2' ' A' ' 48' ' ' SER . 3.1 p90 -60.33 -36.43 77.92 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.38 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.611 ' HG2' ' CE1' ' A' ' 50' ' ' TYR . 10.5 mt-30 -71.81 -47.36 53.8 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.429 HD22 ' HB3' ' A' ' 14' ' ' ALA . 1.5 mp -69.84 -16.64 63.3 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.25 -25.82 67.07 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -87.0 -11.83 49.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.467 -0.771 . . . . 0.0 109.449 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.924 ' CE2' HG23 ' A' ' 38' ' ' ILE . 11.9 m-85 -89.83 3.18 53.72 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.146 -0.971 . . . . 0.0 108.653 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.3 m -83.3 -166.96 1.5 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.456 -0.777 . . . . 0.0 110.015 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 21.2 p-10 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.698 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.686 ' O ' HG13 ' A' ' 2' ' ' VAL . 2.0 t80 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.56 0.695 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 1' ' ' PHE . 10.2 m -161.6 -166.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.543 -0.723 . . . . 0.0 109.613 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.478 ' C ' HG21 ' A' ' 46' ' ' ILE . 10.7 m120 -62.08 88.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.005 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.575 ' OE1' ' CE2' ' A' ' 1' ' ' PHE . 1.6 pm0 -127.55 176.3 7.59 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.863 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.903 ' NE2' HD11 ' A' ' 46' ' ' ILE . 38.0 m-70 -90.48 104.55 17.12 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.992 HD21 ' HB2' ' A' ' 14' ' ' ALA . 1.1 tp -102.0 139.12 38.05 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.084 -1.01 . . . . 0.0 110.684 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.553 ' O ' ' C ' ' A' ' 8' ' ' GLY . 53.6 m -127.11 167.9 15.36 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.562 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -26.49 -47.33 0.04 OUTLIER Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 7' ' ' CYS . 72.8 m -62.93 -68.95 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.095 -1.238 . . . . 0.0 110.304 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.548 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 35.1 m-20 -67.55 -10.47 52.16 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.826 -1.171 . . . . 0.0 108.568 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.884 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -72.34 -48.3 42.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.34 -0.85 . . . . 0.0 109.459 178.622 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.611 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -68.65 -30.52 47.52 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.497 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.292 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -68.74 -59.84 2.82 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.55 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.992 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -51.8 -49.17 63.26 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.771 ' HA ' HG23 ' A' ' 18' ' ' VAL . 1.3 mt -63.98 -43.42 95.8 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.611 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 11.0 t80 -56.52 -21.42 26.08 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -88.65 -66.73 0.89 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 122.103 0.954 . . . . 0.0 109.14 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -47.96 -30.86 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.534 0.683 . . . . 0.0 109.311 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -90.58 -73.38 0.53 Allowed 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.862 0.839 . . . . 0.0 109.288 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 43.85 23.42 0.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER 157.12 -20.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.524 -0.986 . . . . 0.0 109.807 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 3.7 mtt180 -75.31 0.41 16.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.961 . . . . 0.0 109.818 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.42 74.31 0.45 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.57 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -74.54 -175.38 2.37 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.313 -1.11 . . . . 0.0 109.881 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CE1' ' O ' ' A' ' 55' ' ' TYR . 3.7 p90 -161.99 -169.25 2.14 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.898 0.856 . . . . 0.0 109.778 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.62 ' CE2' ' HG2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -151.98 104.99 3.04 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.131 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.67 HG23 ' HD3' ' A' ' 35' ' ' ARG . 1.8 t -77.83 -166.58 0.81 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.907 -1.121 . . . . 0.0 111.0 -177.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.574 ' HA ' ' O ' ' A' ' 34' ' ' PRO . 5.9 t0 172.2 77.83 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.25 12.65 2.0 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.774 2.316 . . . . 0.0 111.479 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.92 -78.93 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.756 -1.215 . . . . 0.0 109.812 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 32' ' ' GLY . . . 178.84 -96.01 0.1 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 33' ' ' GLY . . . -44.85 140.87 4.11 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.467 ' HA2' ' HD2' ' A' ' 34' ' ' PRO . . . 52.11 94.82 0.01 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.064 -2.014 . . . . 0.0 108.064 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.62 ' HG2' ' CE2' ' A' ' 26' ' ' TYR . 21.3 Cg_endo -60.33 -15.41 35.03 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.431 2.087 . . . . 0.0 110.168 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.719 ' HB3' HD12 ' A' ' 38' ' ' ILE . 7.5 tpt85 -165.41 56.4 0.12 Allowed 'General case' 0 C--N 1.279 -2.48 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.572 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -43.59 -23.55 0.08 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.436 -179.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 36' ' ' ARG . . . -46.27 -41.62 11.91 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 106.15 -2.78 . . . . 0.0 106.15 177.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.884 ' CG2' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -93.93 -61.08 2.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 122.339 1.066 . . . . 0.0 108.374 176.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 8.0 t -51.01 -34.32 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.483 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.651 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.9 tt0 -90.8 -18.76 24.36 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.893 -1.129 . . . . 0.0 108.661 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 45' ' ' SER . 9.6 tt0 -90.59 -84.79 0.23 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.447 -0.783 . . . . 0.0 109.461 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.567 ' HB3' ' CB ' ' A' ' 6' ' ' LEU . 1.3 m -39.5 -35.89 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 0.0 109.672 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.526 ' N ' ' O ' ' A' ' 6' ' ' LEU . 4.0 t -74.63 -54.54 7.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.041 -1.037 . . . . 0.0 110.383 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.651 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 15.2 m-70 -79.15 -43.02 24.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.994 . . . . 0.0 109.528 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 41' ' ' GLN . 26.6 t -108.35 -126.46 0.26 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.903 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.2 mp -158.44 165.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.79 -1.194 . . . . 0.0 109.231 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.567 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -155.46 177.71 11.05 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.536 179.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 51' ' ' GLN . 5.2 m -130.95 155.98 45.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 109.51 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -38.77 -39.06 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.458 -0.776 . . . . 0.0 110.454 -179.391 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.617 ' CE1' ' HG2' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -53.31 -40.54 64.87 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.617 ' HG2' ' CE1' ' A' ' 50' ' ' TYR . 2.8 mt-30 -72.9 -56.47 5.14 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.466 HD22 ' CB ' ' A' ' 14' ' ' ALA . 1.2 mp -54.44 -20.29 7.28 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 50' ' ' TYR . 20.2 tt0 -69.1 -18.76 64.02 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.571 ' OD1' ' CD1' ' A' ' 55' ' ' TYR . 14.6 p30 -89.02 -26.0 21.68 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.937 0.875 . . . . 0.0 108.888 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.727 ' CE2' HG23 ' A' ' 38' ' ' ILE . 15.4 m-85 -80.26 -0.65 37.36 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 57' ' ' ASN . 1.0 OUTLIER -92.48 175.82 6.69 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.539 -0.726 . . . . 0.0 109.16 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' CYS . 1.6 m-20 . . . . . 0 C--N 1.298 -1.667 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.942 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.637 ' CD1' HD13 ' A' ' 49' ' ' LEU . 27.3 t80 . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 121.462 0.649 . . . . 0.0 109.628 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.839 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER -153.82 -152.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-O 122.346 1.07 . . . . 0.0 110.455 -178.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.839 ' N ' HG13 ' A' ' 2' ' ' VAL . 9.7 m120 -71.1 102.1 2.4 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.775 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.604 ' O ' HG23 ' A' ' 46' ' ' ILE . 2.8 tt0 -140.0 158.63 43.75 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.674 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 1.003 ' NE2' HD11 ' A' ' 46' ' ' ILE . 22.6 m-70 -81.53 97.72 7.95 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -82.92 -170.18 2.88 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.025 -1.047 . . . . 0.0 109.589 -179.104 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.575 ' O ' ' C ' ' A' ' 8' ' ' GLY . 5.5 t 173.31 142.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.623 ' HA2' ' OH ' ' A' ' 26' ' ' TYR . . . -14.12 -57.85 0.01 OUTLIER Glycine 0 N--CA 1.5 2.948 0 N-CA-C 111.957 -0.457 . . . . 0.0 111.957 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 7' ' ' CYS . 8.0 m -56.63 -69.91 0.14 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.007 -1.29 . . . . 0.0 109.675 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.604 ' CB ' ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.4 -17.83 64.88 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.704 -1.248 . . . . 0.0 108.041 179.447 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.689 HD21 ' CG2' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -60.67 -51.85 67.62 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.239 -0.913 . . . . 0.0 108.679 178.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.63 ' O ' ' CB ' ' A' ' 16' ' ' TYR . 2.9 m -64.14 -26.08 39.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.493 -1.283 . . . . 0.0 108.226 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 1.1 tt0 -72.01 -60.39 2.26 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.72 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -52.57 -46.43 66.85 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.779 ' HA ' HG23 ' A' ' 18' ' ' VAL . 3.3 mt -64.39 -44.41 91.41 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.63 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 14.0 t80 -56.44 -21.1 23.17 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -90.22 -65.91 0.97 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.862 0.839 . . . . 0.0 109.292 179.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.779 HG23 ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -47.25 -30.47 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -88.08 -73.84 0.47 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 21' ' ' GLU . . . 65.22 2.31 9.04 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 11.7 tt0 164.41 -23.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.87 -1.37 . . . . 0.0 109.717 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.488 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 4.6 mtt-85 -60.95 -12.21 10.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.842 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 74.98 83.08 0.41 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.598 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -81.77 -167.86 1.68 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.024 -1.28 . . . . 0.0 109.894 -179.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.598 ' N ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -162.47 -171.01 2.61 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.412 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.623 ' OH ' ' HA2' ' A' ' 8' ' ' GLY . 1.8 t80 -117.1 -101.06 0.43 Allowed 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 118.501 -1.28 . . . . 0.0 109.168 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.755 HG21 ' CB ' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -160.8 -155.15 0.4 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.315 -1.49 . . . . 0.0 109.879 -179.631 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.526 ' N ' ' OG1' ' A' ' 27' ' ' THR . 10.3 t0 -66.65 114.5 17.83 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.73 82.39 2.32 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.326 2.017 . . . . 0.0 110.544 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.1 p -119.62 -78.56 0.59 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.305 -0.872 . . . . 0.0 109.41 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.75 -121.83 3.07 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.4 140.37 15.99 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.553 ' HA2' HG11 ' A' ' 39' ' ' VAL . . . 61.49 56.03 25.56 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 33' ' ' GLY . 30.9 Cg_endo -70.27 -28.11 23.21 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.412 2.075 . . . . 0.0 109.591 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.755 ' CB ' HG21 ' A' ' 27' ' ' THR . 5.1 tpt85 -125.37 49.75 1.87 Allowed 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.569 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -40.59 -21.91 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.961 -179.032 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -46.59 -40.5 11.61 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 106.152 -2.779 . . . . 0.0 106.152 177.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.752 HG23 ' CE2' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -93.34 -57.4 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-O 122.402 1.096 . . . . 0.0 108.674 177.045 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.553 HG11 ' HA2' ' A' ' 33' ' ' GLY . 8.9 t -59.15 -28.53 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.93 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.65 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.3 mt-10 -90.96 -32.03 16.12 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 120.919 -1.113 . . . . 0.0 108.609 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 45' ' ' SER . 40.8 tt0 -78.5 -75.82 0.22 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 121.641 0.734 . . . . 0.0 109.196 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 1.7 m -41.25 -44.73 2.73 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 121.533 -0.73 . . . . 0.0 109.996 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -75.18 -45.59 39.61 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.318 -0.864 . . . . 0.0 110.726 -178.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.65 ' CD2' ' HA ' ' A' ' 40' ' ' GLU . 7.5 m-70 -90.11 -60.56 1.9 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.7 -1.25 . . . . 0.0 109.422 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 41' ' ' GLN . 7.9 t -88.15 -127.73 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 108.779 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 1.003 HD11 ' NE2' ' A' ' 5' ' ' HIS . 1.3 mp -153.67 160.13 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.784 -1.198 . . . . 0.0 108.975 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.459 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 1.8 m -133.29 -166.09 1.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.689 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.619 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 5.7 m -146.47 144.04 29.38 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.693 ' O ' HG11 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -39.29 -39.12 0.6 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.749 0.785 . . . . 0.0 110.191 -179.431 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.619 ' CE2' ' HB2' ' A' ' 48' ' ' SER . 1.1 p90 -61.8 -38.1 86.84 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.611 ' HG3' ' CZ ' ' A' ' 50' ' ' TYR . 63.6 mt-30 -67.82 -48.26 66.74 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.444 ' HA ' ' CD2' ' A' ' 55' ' ' TYR . 1.1 mp -67.48 -24.46 65.6 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.454 ' OE1' HG12 ' A' ' 18' ' ' VAL . 6.4 tp10 -57.67 -29.17 64.42 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -90.64 -10.6 42.66 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.574 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.752 ' CE2' HG23 ' A' ' 38' ' ' ILE . 12.0 m-85 -90.01 7.74 36.04 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -91.98 -161.32 0.81 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.631 -0.668 . . . . 0.0 109.502 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 7.3 p-10 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.005 179.89 . . . . . . . . 1 1 . 1 stop_ save_